<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns:mv="http://macVmlSchemaUri" xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=macintosh">
<style>
<!--
 /* Style Definitions */
body,p,ol,li
  {text-align: left;}
span.Section
  {font-size:24pt;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
</head>

<body lang=EN-US link=blue vlink=purple>

<div align=center>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span>Clinical</span></p>

<p style="text-align:center;"><span>Transitions </span></p>

<p style="text-align:center;"><span>2014</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section">Rheumatology,</span></p>

<p style="text-align:center;"><span
class="Section">Allergy, </span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Immunology</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>A 22-year-old man is brought
to the emergency room after being stung by several wasps. He is confused and
short of breath. His temperature is 100.4<sup>o</sup>F, pulse is 120/minute,
blood pressure is 85/55 mm Hg, and respirations are 30/minute. He has hives on
his back, wheezing over the posterior lung fields, and pitting edema of the
ankles. Intravenous access is obtained and 0.9% saline is administered. Which
of the following medicines should be administered next? </p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Furosemide</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Propranolol</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Nifedipine</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Lisinopril</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span>Atropine</p>

<p><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span>Epinephrine</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Anaphylaxis is an acute
multiorgan system reaction, potentially fatal, caused by the release of
chemical mediators from mast cells and basophils. The classic form involves
prior sensitization to an allergen with later re-exposure, producing symptoms
via an immunologic mechanism. The most common organ systems involved include
the cutaneous, respiratory, cardiovascular, and gastrointestinal systems. The
full-blown syndrome includes urticaria (hives) and/or angioedema with
hypotension and bronchospasm.<span >&nbsp; </span></p>

<p></p>

<p>Traditionally, the term
“anaphylaxis” is reserved for reactions mediated by immunoglobulin E (IgE), and
the term “anaphylactoid” is reserved for IgE-independent events (which are
clinically indistinguishable). Anaphylaxis is a type I hypersensitivity response.
IgE production requires the secretion of cytokines from T<sub>H</sub>2 cells.
These cytokines induce B cells to switch antibody production to the IgE
class.<span >&nbsp; </span>The IgE binds to Fc&#61541;
receptors on mast cells. When the antigen-binding region of IgE is cross-linked
by allergens, mast cell degranulation occurs, resulting in anaphylaxis.<span>&nbsp;&nbsp;&nbsp; </span></p>

<p></p>

<p>The physiologic responses to
the release of anaphylaxis mediators include smooth muscle spasm in the
respiratory and gastrointestinal (GI) tracts, vasodilation, increased vascular
permeability, and stimulation of sensory nerve endings. Increased mucous
secretion and increased bronchial smooth muscle tone, as well as airway edema,
contribute to the respiratory symptoms. Cardiovascular effects result from
decreased vascular tone and capillary leakage. Hypotension, cardiac
arrhythmias, syncope, and shock may result from intravascular volume loss,
vasodilation, and myocardial dysfunction. These physiologic events lead to some
or all of the classic symptoms of anaphylaxis: flushing; urticaria/angioedema;
pruritus; bronchospasm; laryngeal edema; abdominal cramping with nausea,
vomiting, and diarrhea; and feeling of impending doom. </p>

<p></p>

<p>Anaphylaxis is a medical
emergency that requires immediate recognition and intervention. Patients should
receive high-flow oxygen, cardiac monitoring, and intravenous access.
Epinephrine maintains blood pressure, antagonizes the effects of the released mediators,
and inhibits further release of mediators. Use of epinephrine for anaphylaxis
has no absolute contraindications. It is the drug of choice and it is usually
well tolerated and potentially lifesaving. Anaphylactic deaths correlate with
delayed administration of epinephrine. The initial dose can be repeated as
necessary, depending on the response. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer F is correct</b>. The presence of hypotension, tachycardia,
hives, and bronchospasm after a wasp sting suggests anaphylaxis. Epinephrine is
the drug of choice.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 35-year-old woman with a history of systemic lupus
erythematosus (SLE) is admitted to the hospital with left upper and lower
extremity weakness. Head CT reveals an ischemic stroke in the right middle
cerebral artery distribution.<span >&nbsp; </span>Labs
reveal thrombocytopenia and a prolonged aPTT.<span>&nbsp; </span>Her husband reports that she had several
miscarriages in the second trimester and a deep vein thrombosis several years
ago.<span >&nbsp; </span>What is the most likely cause
of her stroke?</span></p>

<p><span></span></p>

<ol start=1 type=A>
 <li><span>Bacterial
     endocarditis</span></li>
 <li><span>Atherosclerotic
     disease</span></li>
 <li><span>Antiphospholipid
     syndrome</span></li>
 <li><span>Vasculitis
     of the central nervous system</span></li>
 <li><span>Cocaine
     use</span></li>
 <li><span>Sepsis</span></li>
</ol>

<span><br clear=all>
</span>

<p>Antiphospholipid syndrome
(APS) is a disorder of coagulation that causes thrombosis in arteries and
veins, as well as pregnancy-related complications such as miscarriage,
stillbirth, preterm delivery, and severe preeclampsia. The most common venous
event is deep vein thrombosis of the lower extremities; the most common
arterial event is stroke. Other common findings include thrombocytopenia,
livedo reticularis, and elevated aPTT. (The elevated aPTT indicates the
presence of lupus anticoagulant or anti-cardiolipin antibodies, which interfere
with phospholipids in the aPTT assay.) Antiphospholipid syndrome is characterized
by autoimmune production of antibodies against phospholipids, such as
cardiolipin and &#946;<sub>2</sub> glycoprotein I. The antibodies interfere
with the anti-thrombotic effects of phospholipids. Primary antiphospholipid
syndrome occurs in the absence of other related disease. Secondary
antiphospholipid syndrome occurs in conjunction with other autoimmune diseases,
particularly systemic lupus erythematosus (SLE). Antiphospholipid syndrome is
typically treated with heparin, warfarin, and antiplatelet agents.<span>&nbsp; </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. The most likely cause of stroke is antiphospholipid
syndrome.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Bacterial endocarditis can cause stroke through septic
embolization. This patient does not describe fever or chills. No mention is
made of a heart murmur or findings suggestive of peripheral embolization (e.g.,
Roth spots, Osler nodes, Janeway lesions, splinter hemorrhages.) Bacterial
endocarditis is more likely to cause thrombocytosis than thrombocytopenia and
would not explain the history of miscarriages.</span></p>

<p><span></span></p>

<p><b>Answer B is incorrect</b>.
Risk factors for stroke due to atherosclerosis include advanced age, smoking,
diabetes, hypertension, hyperlipidemia, and family history of atherosclerotic
disease. </p>

<p></p>

<p><b>Answer D is incorrect</b>.
Systemic lupus erythematosus is associated with CNS vasculitis, which can cause
stroke. In this patient, the history of deep vein thrombosis and multiple
miscarriages and the presence of thrombocytopenia and an elevated aPTT is more
consistent with antiphospholipid syndrome.</p>

<p></p>

<p><b>Answer E is incorrect</b>.
Cocaine can cause stroke, but it would not explain the other findings in this
patient. </p>

<p></p>

<p><b>Answer F is incorrect</b>.
Sepsis can result in stroke and multi-organ failure. This patient has no
symptoms or signs of systemic infection. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 32-year-old man presents to the clinic with fever, cough,
and night sweats of one-month duration. He is fatigued and has lost eight
pounds unintentionally.<span >&nbsp; </span>His medical
history is significant for ankylosing spondylitis for which he takes
methotrexate and infliximab. Which of the following most likely explains his
symptoms?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Congestive heart failure</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Interstitial lung disease</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Bronchogenic carcinoma</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Tuberculosis </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Methotrexate-induced lung injury</span></p>

<span><br
clear=all>
</span>

<p><span></span></p>

<p><b><span>Infliximab</span></b><span>is a chimeric<span
 antibody<span
 tumour necrosis factor alpha
(TNF-&#945;) used to treat<span It is approved for the
treatment of<span disease,<span
 spondylitis,<span
 arthritis, rheumatoid
arthritis, and<span colitis.
Infliximab works by binding to TNF-&#945;. TNF-&#945; is a chemical messenger (cytokine)
and a key part of the autoimmune reaction. In rheumatoid arthritis, infliximab
seems to work by preventing TNF-&#945; from binding to its<span
 the cell. Infliximab is an
artificial<span It was
originally developed in mice as a mouse antibody. Because humans have immune
reactions to mouse proteins, the mouse common domains were replaced with
similar human antibody domains. Because the antibodies were produced from one
cell grown into a clone of identical cells, it is called a<span
 antibody. Furthermore, as a
combination of mouse and human antibody amino acid sequences, it is called a
chimeric monoclonal antibody.</span></p>

<p><span></span></p>

<p><span>In the United States, Infliximab can cost $19,000 to
$22,000 a year per patient wholesale.</span></p>

<p><span></span></p>

<p><span>Other monoclonal antibodies targeting TNF-&#945; are<span
 and<span
 pegol<span
 binds and inhibits the action of
TNF-&#945;, but is not a monoclonal antibody. (It is instead a fusion of<span
 an<span
 constant region.) Infliximab
is administered by<span typically at six- to eight-week intervals, at a clinic or hospital.
It cannot be administered<span the digestive system<span
 destroy the drug.</span></p>

<p><span></span></p>

<p><span>Infliximab is a significant risk factor for reactivation of
latent tuberculosis, as well as for development of other serious infections
like aspergillosis, blastomycosis, candidiasis, coccidioidomycosis,
histoplasmosis, and pneumocystosis. Anti-TNF&#945; therapy also increases the
risk of lymphoma, heart failure, drug-induced lupus, and blood disorders
(leukopenia, neutropenia, thrombocytopenia).</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. Active tuberculosis most likely explains the patient’s
fever, cough, night sweats, and weight loss.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect.</span></b><span> Ankylosing spondylitis is associated with aortic
insufficiency, and anti-TNF&#945; therapy is associated with worsening heart
failure, but this patient does not have symptoms of heart failure, such as
shortness of breath and leg swelling. Fever and night sweats are not
characteristic of heart failure. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Ankylosing spondylitis increases the risk of interstitial
lung disease, which is usually mild and associated with apical fibrosis. This
patient does not have typical symptoms of interstitial lung disease, such as
exertional dyspnea. Weight loss and night sweats are not characteristic of
interstitial lung disease. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Anti-TNF therapy increases the risk of lymphoma, but not
bronchogenic carcinoma.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Methotrexate-induced lung injury is usually dose-related
and reversible with discontinuation of the medicine. Symptoms include fatigue,
dry cough, and shortness of breath. Fever, night sweats, and weight loss are
not typical of methotrexate-induced lung injury.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 68-year-old woman has a 6-month history severe pain and
swelling of the metacarpophalangeal joints, wrists, elbows, and knees. Previous
treatment with ibuprofen and methotrexate did not relieve symptoms. The serum
creatinine level is 2.6 mg/dL and the rheumatoid factor level is increased.
Which of the following is the most appropriate treatment? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acetaminophen</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Indomethacin</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Colchicine</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Gold salts</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Etanercept</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>This patient has rheumatoid
arthritis, as indicated by the pattern of synovitis and the elevated rheumatoid
factor level. DMARDs (disease-modifying anti-rheumatic drugs) represent the
most important measure in the successful treatment of rheumatoid arthritis.
These agents can retard or prevent disease progression and reduce joint
destruction and loss of function. Consequently, early therapy with DMARDs is
the standard of care for treating rheumatoid arthritis. </p>

<p></p>

<p>DMARDs can be classified
into xenobiotic and biologic agents. The xenobiotic agents include gold salts,
D-penicillamine, chloroquine and hydroxychloroquine, sulfasalazine,
methotrexate, azathioprine, and cyclosporin A. Injectable gold salts and
D-penicillamine rarely induce sustained remission and have largely been
supplanted by more effective agents. Methotrexate and sulfasalazine are the
most active compounds and provide the best risk-benefit ratios. </p>

<p>Methotrexate (alone or in
combination with other agents) has become the standard of care for moderate to
severe RA. </p>

<p></p>

<p><span>“Biologic” agents have been developed to block tumor
necrosis factor (TNF)-alpha and interleukin-1, proinflammatory cytokines that
are important in the pathogenesis of rheumatoid arthritis. These agents improve
symptoms and significantly retard progression of joint erosions. TNF blockers
include etanercept, infliximab, and adalimumab. Most patients receiving TNF
blockers have a significant response to treatment.</span></p>

<p><span></span></p>

<p><span>Adverse effects of these agents include development of
infection, including reactivation of tuberculosis. Thoroughly searching for
latent tuberculosis using chest radiography and/or purified protein derivative
(PPD) testing is recommended before these agents are started. Rarely,
demyelinating disorders, bone marrow suppression, and formation of
auto-antibodies occur. </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E
is correct. </span></b><span>Etanercept is a biologic agent and a
DMARD. It would be an appropriate choice in a patient with active rheumatoid
arthritis who has failed methotrexate therapy. </span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect. </span></b><span>Acetaminophen is not a DMARD and would
not slow disease progression.</span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect.</span></b><span> Indomethacin is a non-steroidal
anti-inflammatory drug (NSAID). NSAIDs are not DMARDS and would not be expected
to slow disease progression. Also, NSAIDs should not be used in patients with
renal insufficiency.</span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect. </span></b><span>Colchicine is used to treat gout, not
rheumatoid arthritis. The likelihood of toxicity is increased in patients with
renal insufficiency. </span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Gold salts have been largely replaced
by more effective agents for treatment of rheumatoid arthritis. They should not
be used in patients with renal insufficiency, as they can cause renal disease. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 34-year-old man with peptic ulcer disease suddenly
develops pain, redness, and swelling of his right first metatarsophalanegal
joint. There is no history of injury. The serum uric acid level is 8 mg/dL.
Examination of the joint aspirate shows negatively birefringent crystals. Which
of the following drugs is most appropriate to treat the acute symptoms in this
patient?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Colchicine</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Allopurinol</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Probenecid</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Sulfinpyrazone</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Morphine</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Gout is a common disorder of uric acid metabolism that can
lead to deposition of monosodium urate (MSU) crystals in soft tissue, recurrent
episodes of debilitating joint inflammation, and, if untreated, joint
destruction and renal damage. Gout is definitively diagnosed by demonstration
of urate crystals in aspirated synovial fluid. </span></p>

<p><span></span></p>

<p>Acute monoarticular
arthritis is the initial presentation in 90% of patients. Podagra, inflammation
of the first metatarsophalangeal joint, is the initial joint manifestation in
50% of cases (Figure 1). The attack begins abruptly and reaches maximum
intensity within 8-12 hours. The joint is red, hot, and exquisitely tender;
even a bed sheet on the swollen joint is uncomfortable. Untreated, the first
attack resolves spontaneously in less than 2 weeks. Acute flares of gout can be
precipitated by events that raise serum uric acid levels, such as consumption
of beer or liquor, overconsumption of high-purine foods, trauma, hemorrhage,
dehydration, or the use of medications that raise uric acid levels (e.g.,
thiazide diuretics). </p>

<p></p>

<p>Patients with gout are much
more likely to develop renal stones than are healthy individuals (by a factor
of 1000). Although patients with gout often have other risk factors for renal
disease (e.g., hypertension and diabetes), chronic urate nephropathy can itself
contribute to renal insufficiency. Although gout typically causes joint
inflammation, it can also cause inflammation of bursae and tendons. Tophi are
collections of urate crystals in the soft tissues. They can develop in patients
with untreated gout and may appear as lumps or nodules. While the classic
location of tophi is along the helix of the ear, they can be found in other
locations, such as the fingers, toes, and olecranon bursae.</p>

<p></p>

<p>Gout is managed in three
stages: (1) treating the acute attack, (2) providing prophylaxis to prevent
acute flares, and (3) lowering excess stores of urate to prevent gouty flares
and tissue deposition of urate crystals. Options for treating <i>acute</i> gout include nonsteroidal
anti-inflammatory drugs (NSAIDs), colchicine, and corticosteroids. NSAIDs are
the drugs of choice in most patients<i>. </i></p>

<p><i></i></p>

<p><i>Long-term</i> management of gout focuses on lowering uric acid levels.
(The goal of therapy is to lower serum uric acid levels to approximately 6
mg/dL or less.) Agents that lower uric acid levels should not be initiated
during an acute attack, as they may intensify and prolong the attack.
Typically, they should be started a few weeks after the attack has resolved and
with the protection of prophylactic colchicine to prevent another attack. </p>

<p></p>

<p>Medicines available for <i>chronic</i> management of gout include
allopurinol and febuxostat, which reduce uric acid production by inhibiting the
enzyme, xanthine oxidase; and probenecid and sulfinpyrzone, which enhance uric
acid excretion by the kidney. </p>

<p></p>

<p style="text-align:center;"><a href="file://localhost/javascript/refimgshow(1)"><span><img border=0 width=152 height=106
src="_%20Tutorials_files/image002.png"
alt="Description: Gout. Acute podagra due to gout in an elderly man." v:shapes="Picture_x0020_12"></span></a><span></span></p>

<p style="text-align:center;"><span>Gout: Podagra</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/a/ac/Fluorescent_uric_acid.JPG"><span><img border=0 width=238 height=179
src="_%20Tutorials_files/image004.png"
alt="Description: File:Fluorescent uric acid.JPG" v:shapes="Picture_x0020_11"></span></a><span></span></p>

<p style="text-align:center;"><span>Gout: Needle-like
crystals under polarized light</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is
correct</span></b><span>. Colchicine can be used in the
treatment of an acute gouty flare. It is an acceptable option in a patient with
peptic ulcer disease in whom NSAIDs should be avoided. </span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect</span></b><span>. Allopurinol can be used in the
long-term management of gout. It lowers serum uric acid levels by inhibiting
the enzyme, xanthine oxidase. It is not useful in the treatment of an acute
gouty flare. </span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. Probenecid can be used in the
long-term management of gout. It enhances renal excretion of uric acid. It is
not useful in the treatment of an acute gouty flare. </span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Sulfinpyrazone can be used in the
long-term management of gout. It enhances renal excretion of uric acid. It is
not useful in the treatment of an acute gouty flare. </span></p>

<p><span></span></p>

<p><b><span>Answer E
is incorrect</span></b><span>. Morphine is an excellent analgesic
medicine, but it does not have anti-inflammatory properties, and its potential
for abuse makes it an unsatisfactory choice in the treatment of an acute gouty
flare. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 3-year-old girl is brought to clinic because she refuses
to walk and has stopped playing. Three weeks ago her parents noticed that her
right knee was swollen and that she was standing with her knee flexed. There is
no history of injury. Examination shows synovitis, decreased range of motion,
and a flexion contracture of the right knee. Rheumatoid factor is negative and
ANA is positive at 1:80. Which of the following statements is false?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>ANA+ juvenile idiopathic arthritis of
the oligoarthritis subtype is the most common form of childhood arthritis. </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Uveitis is likely to occur in up to
half of oligoarthritis juvenile idiopathic arthritis. </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>ANA-positivity strongly predicts
children at risk for asymptomatic uveitis. </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Nearly all juvenile oligoarthritis
patients will go on to have disabling disease. </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Rheumatoid factor is usually negative
in juvenile idiopathic oligoarthritis. </span></p>

<p><span></span></p>

<span><br
clear=all>
</span>

<p><span>This patient has juvenile idiopathic arthritis (JIA) of the
oligoarthritis subtype. Juvenile idiopathic arthritis is the most common form
of arthritis in children. It affects girls more than boys (4:1), typically in
the 1-5 year age range. Three subtypes exist: oligoarticular, polyarticular,
and systemic. The oligoarticular type is the most common. All children in this
subtype are rheumatoid factor-negative. 50% will only have only one knee
involved. 30-50% develop asymptomatic uveitis. ANA-positivity correlates with
increased risk of eye disease. ANA-positive children should have eye exams
every three months to look for asymptomatic uveitis. The arthritis usually
resolves with time, resulting in little or no disease in adulthood. Treatment
includes NSAIDS, intraarticular glucocorticoids, and aggressive physical
therapy to prevent contractures. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D
is correct. </span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A
is True</span></b><span>: Juvenile idiopathic arthritis of the
oligoarthritis subtype is the most common form of childhood arthritis.<span>&nbsp; </span><b><span>&nbsp;</span></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is True</span></b><span>: Uveitis is likely to occur in up to
half of oligoarthritis juvenile idiopathic arthritis.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer C
is True</span></b><span>: ANA-positivity predicts children at
risk for asymptomatic uveitis. </span></p>

<p><span></span></p>

<p><b><span>Answer D
is False</span></b><span>: It is <i>not</i> true that nearly all children with JIA, oligoarthritis subtype,
will go on to have disabling adult disease. In fact, most children improve with
little or no residual disease as adults.</span></p>

<p><span></span></p>

<p><b><span>Answer E
is True</span></b><span>: Rheumatoid factor is usually negative
in juvenile idiopathic oligoarthritis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 45-year-old woman presents with a 3-month history of
fatigue and painful joints. Her hands, feet, ankles, wrists, and elbows are
very stiff in the morning and improve with activity.<span>&nbsp; </span>She is taking naproxen 500 mg twice
daily with minimal improvement.<span >&nbsp;
</span>Exam shows bilateral synovitis of the metacarpophalangeal joints,
proximal interphalangeal joints, wrists, ankles, elbows, and
metatarsophalangeal joints.<span >&nbsp; </span>You
suspect rheumatoid arthritis. Which of the following serological tests would
best correlate with aggressive, erosive disease accompanied by extra-articular
manifestations?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>RF 1:80; anti-cyclic citrullinated
peptide (anti-CCP) negative</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>RF negative; anti-CCP negative</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>RF negative; anti-CCP positive at 42</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>RF 1:1280; anti-CCP positive at 220</span></p>

<span><br
clear=all>
</span>

<p><span></span></p>

<p><span>Rheumatoid arthritis (RA) is a
chronic, systemic, inflammatory disorder of unknown cause. It is characterized
by symmetrical, polyarticular pain and swelling, morning stiffness, and
fatigue. RA has a variable course, often with periods of exacerbations and,
less frequently, true remissions. Outcomes are also variable, ranging from the
rarely seen remitting disease to severe disease that brings disability and
even, in some patients, premature death. Without treatment, the majority of
patients will experience progressive joint damage. In some patients this
results in significant disability within just a few years. The past decade has
seen an unprecedented change in the treatment paradigm for this disease.
Several targeted biologic therapies are available; the most notable are the
anti-tumor necrosis factor (TNF) therapies.</span></p>

<table border=0 cellspacing=8 cellpadding=0 width="100%">
 <tr>
  <td width="96%">
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><b><span>Clinical Features</span></b></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P079010></a><span>RA is a symmetrical
    polyarthritis typically involving the small joints of the hands and feet,
    the wrists, and the ankles. Other joints frequently involved include the
    cervical spine, shoulders, elbows, hips, and knees. Any diarthrodial
    (synovial) joint may be involved, including the apophyseal,
    temporomandibular, and cricoarytenoid joints. Involved joints are swollen,
    warm, and tender, and they may have effusions. The synovium, normally a few
    cell layers thick, becomes palpable on examination&nbsp;<i>(synovitis).</i>&nbsp;Prolonged&nbsp;<i>morning
    stiffness,</i>&nbsp;usually lasting more than 1 hour and often many hours,
    is a classic feature in RA, and symptoms are generally improved with
    moderate activity.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P079011></a><span>Over time, RA
    progresses to joint destruction and deformity. Erosive lesions of bone and
    cartilage are radiographically and pathologically visible at the margins of
    bone and cartilage, the site of synovial attachment.&nbsp;<i>Tenosynovitis,</i>&nbsp;or
    inflammation of tendon sheaths, leads to tendon malalignment, stretching,
    and/or shortening. Among common deformities are ulnar deviation at the
    metacarpophalangeal joints and volar subluxation at these joints, volar
    subluxation at the wrists, and flexion and extension contractures in the
    proximal and distal interphalangeal (DIP) joints of the fingers that lead
    to characteristic<i>swan-neck deformity</i>&nbsp;(flexion contracture at
    the DIP joint and hyperextension at the proximal interphalangeal joint)
    or&nbsp;<i>boutonnière deformity</i>&nbsp;(flexion contracture at the
    proximal interphalangeal joint and hyperextension at the DIP joint).
    Erosions of the ulnar styloid can lead to sharp bony prominences and
    rupture of extensor tendons. Synovitis at the wrists can lead to median
    nerve compression and carpal tunnel syndrome. Cervical spine disease may
    lead to C1-C2 subluxation and spinal cord compression; caution should be
    taken in moving the neck when the patient is being anesthetized for a
    surgical procedure. The degree of subluxation can be monitored by looking
    at the distance between C1 and the odontoid in flexion-extension films.
    Rupture of synovial fluid from the knee into the calf (Baker cyst) may
    mimic deep-venous thrombosis or, occasionally, cellulitis.</span></p>
    <p><span></span></p>
    <p><span></span></p>
    <p><span></span></p>
    <p><span></span></p>
    <p><span></span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><span></span></p>
  <p><a name=F079001></a><span></span></p>
  <p><a name=P079012></a><a name=T079002></a><span></span></p>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width=324>
   <tr>
    <td width="100%">
    <p style="text-align:center;"><b><span>Characteristics of Rheumatoid Arthritis</span></b></p>
    </td>
   </tr>
  </table>
  <p><a name=T079002.850></a><a name=T079002.800></a><a name=T079002.750></a><a
  name=T079002.700></a><a name=T079002.650></a><a name=T079002.600></a><a
  name=T079002.550></a><a name=T079002.500></a><a name=T079002.450></a><a
  name=T079002.400></a><a name=T079002.350></a><a name=T079002.300></a><a
  name=T079002.250></a><a name=T079002.200></a><a name=T079002.150></a><a
  name=T079002.100></a><a name=T079002.50></a><span></span></p>
  <div align=center>
  <table border=1 cellspacing=0 cellpadding=0 width=344>
   <tr>
    <td valign=top>
    <p><b><span>Articular</span></b><span></span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Morning
    stiffness, &quot;gelling&quot;</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Symmetrical
    joint swelling</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Predilection
    for wrists and proximal interphalangeal, metacarpophalangeal, and
    metatarsophalangeal joints</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Erosions
    of bone and cartilage</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Joint
    subluxation and ulnar deviation</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Inflammatory
    joint fluid</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Carpal
    tunnel syndrome</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Baker
    cyst</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><b><span>Nonarticular</span></b><span></span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Rheumatoid
    nodules: subcutaneous, pulmonary, scleral</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Lung
    disease</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Vasculitis,
    especially skin, and peripheral nerves</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Pleuropericarditis</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Scleritis
    and episcleritis</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Leg
    ulcers</span></p>
    </td>
   </tr>
   <tr>
    <td valign=top>
    <p><span>Felty
    syndrome</span></p>
    </td>
   </tr>
  </table>
  </div>
  <p><span></span></p>
  <div align=center>
  <table border=0 cellspacing=0 cellpadding=0 width="90%">
   <tr>
    <td width="100%"><a
    name=""></a></td>
   </tr>
  </table>
  </div>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P079013></a><span></span></p>
    <p><span>The clinical course and severity of the arthritis are
    variable. Some patients have mild, slowly progressive disease with few
    deformities and little bony destructive change. At the opposite extreme are
    patients who have a rapidly progressive course that, if left untreated,
    leads to crippling and deforming arthritis. Most patients fall in between
    these extremes with various levels of disability; some have a waxing and
    waning course over a period of years with acute episodes of single- or
    multiple-joint exacerbations.</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  <p><span></span></p>
  <table border=0 cellspacing=0 cellpadding=0 width="100%">
   <tr>
    <td width="100%">
    <p><a name=P079014></a><span>RA is a systemic
    disease with constitutional symptoms: fatigue, low-grade fever, weight
    loss, and myalgia. Anemia is also common. Specific organs other than the musculoskeletal
    system may be involved. Grossly palpable subcutaneous&nbsp;<i>rheumatoid
    nodules</i>&nbsp;can occur almost anywhere but are common along other
    extensor tendon surfaces, especially at the elbows, and less commonly in
    the lungs, pleura, pericardium, sclerae, and other sites, including the
    heart in rare cases. The occurrence of multiple pulmonary nodules in
    patients with RA and pneumoconiosis is known as&nbsp;<i>Caplan syndrome.</i>&nbsp;Pleuritis,
    pericarditis, and interstitial lung fibrosis occur in a few patients;
    pericarditis can be severe, and acute interstitial lung disease can be
    associated with pulmonary hemorrhage. Vasculitis, associated with
    circulating complexes of immunoglobulin G (IgG) and rheumatoid factor (RF),
    leads to cutaneous lesions, including ulcers and skin necrosis, and
    mononeuritis multiplex. Secondary<i>Sjögren syndrome</i>&nbsp;(sicca complex)
    is often present.&nbsp;<i>Felty syndrome </i>(splenomegaly, leukopenia, and
    recurrent pulmonary infections) is a rare complication and is often
    accompanied by leg ulcers and vasculitis. Extra-articular manifestations of
    RA are more commonly seen among patients who test positive for RF. Even in
    patients without vasculitis or pulmonary or pleuropericardial disease, the
    mortality rate in RA is increased by a variety of causes, including side effects
    of therapy and infection. Premature and accelerated atherosclerosis is an
    increasingly recognized problem among patients with RA and is thought, at
    least, to be partially a result of the effects of chronic inflammation.</span></p>
    </td>
   </tr>
  </table>
  </td>
 </tr>
</table>

<p><span>Rheumatoid arthritis (RA) is the most common inflammatory
arthritis. It affects women 2.5 times more than men. It can occur at any age
but has a peak incidence in the fourth and fifth decades of life. It is
associated with autoantibodies including rheumatoid factor (RF) and anti-cyclic
citrullinated peptide (CCP) antibodies. High titers of RF and anti-CCP predict
aggressive erosive disease with more extra-articular manifestations (rheumatoid
nodules, pulmonary involvement, eye disease, Felty’s syndrome, pericarditis,
myositis, and vasculitis).</span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span>RF is found in 75-85% of patients with rheumatoid arthritis.
RF is an antibody directed against the Fc portion of other antibodies. Low
levels of RF are found in hepatitis C with cryoglobulinemia, subacute
endocarditis, and primary biliary cirrhosis. Anti-cyclic citrullinated peptide
antibodies (anti-CCP) are found in nearly 70% of patients with rheumatoid
arthritis.<span >&nbsp; </span>They are detectable in
about 35% of patients who are RF-negative, and may precede the diagnosis of
rheumatoid arthritis by as many at 10 years.<span>&nbsp; </span>Citrullination occurs when arginine
residues on proteins (typically vimentin or fillagrin) are deiminated by the
enzyme peptidylarginine deiminase. The modified proteins become more antigenic,
leading to autoantibody formation. Anti-CCP antibodies are highly specific for
rheumatoid arthritis (95%) but low levels can be seen in 10% of patients with
psoriatic arthritis.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct. </span></b><span>Patients with high titres of
rheumatoid factor and anti-CCP are most likely to have aggressive disease. </span><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Patients with low-titer RF and no anti-CCP are at low risk
for aggressive disease.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Patients with seronegative rheumatoid arthritis are likely
to have mild disease.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Patients with low-titer anti-CCP and negative RF are
likely to have mild disease. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 42-year-old woman has painful discoloration of her fingers
when exposed to cold and when holding a cold drink.<span>&nbsp; </span>Her fingers turn white, then blue, then
intensely red during these times.<span >&nbsp;
</span>Her hands and distal forearm feel “puffy,” and the skin in those areas
has thickened over the past 6 months. She coughs occasionally and gets short of
breath when she walks or climbs stairs. She denies fever, chest pain,
palpitations, and leg swelling. She also denies muscle aches, joint aches,
rash, heartburn, and oral ulcers. What is the most likely cause of her exertional
dyspnea?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congestive heart failure</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Valvular disorder</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pulmonary hypertension</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congenital heart disease</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Interstitial lung disease</span></p>

<span><br
clear=all>
</span>

<p><span></span></p>

<p><img width=150 height=105
src="_%20Tutorials_files/image006.png" align=left hspace=9 v:shapes="Picture_x0020_18"><img width=105 height=137
src="_%20Tutorials_files/image008.png" align=left hspace=9 v:shapes="Picture_x0020_17"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=364 height=262
src="_%20Tutorials_files/image010.png" alt="Description: 99CSC-10C07" v:shapes="Picture_x0020_10"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Scleroderma affects mainly women (&gt;75%) with a peak
incidence between 30 and 50 years of age. The etiology is unknown.<span>&nbsp; </span>It is characterized by progressive
fibrosis of the skin, but may involve internal organs. </span></p>

<p><span></span></p>

<p><span>Limited Systemic Sclerosis<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Formerly called “CREST” (an acronym for
calcinosis, Raynaud’s, esophageal dysmotility, sclerodactyly, telangiectasias)</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Skin involvement limited to hands,
face, and feet</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nail-fold capillary changes</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>10-15% risk of pulmonary hypertension,
the most serious complication of limited systemic sclerosis</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal disease is rare</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-centromere antibody (ACA) in
70-80%</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>10-year survival: 75%</span></p>

<p><span></span></p>

<p><span>Diffuse Systemic Sclerosis</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hand and face <i>plus</i> more proximal involvement (above the wrists)</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>More rapid progression</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Early incidence of heart, lung,
esophageal, and renal disease</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Heart (hypertension, enlarged heart,
heart failure) </span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lung (interstitial lung disease)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Esophagus (dysphagia, gastroesophageal
reflux)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal (scleroderma renal crisis:
malignant hypertension causing renal failure; treated with ACE-inhibitor)</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>70% lifetime risk of interstitial lung
disease, the leading cause of death in diffuse systemic sclerosis</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>5% risk of pulmonary hypertension
(late)</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-Scl-70 antibodies in 30%</span></p>

<p><span><span>&#8211;<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>10-year survival: 50%</span></p>

<p><span></span></p>

<p><span>Interstitial lung disease: </span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Leading cause of death in Diffuse
Systemic Sclerosis </span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fibrosis begins at lung bases and
progresses upward</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Symptoms: cough, exertional dyspnea,
and eventually respiratory failure</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Therapy: cyclophosphamide or bone
marrow transplant</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E
is correct</span></b><span>.<span >&nbsp;
</span>This patient most likely has systemic sclerosis, or diffuse scleroderma,
based on skin thickening, edematous hands and forearms, and severe Raynaud’s.
Skin thickening above the wrist is suggestive of diffuse scleroderma.<span>&nbsp; </span>Scleroderma has three phases: edematous,
tightening, and atrophy (with claw-like hands).</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 30-year-old woman has had high, spiking fevers daily for a
week. She reports sore throat, muscle aches, and severe pain in the knees and
wrists. She has noticed swollen glands in her neck and a pale, pink rash, which
appears during the fever and resolves overnight.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Laboratory tests show: </span></p>

<p><span></span></p>

<p><span>Hemoglobin<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>12
g/dl<span >&nbsp; </span></span></p>

<p><span>WBC count<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>17,900/mm<sup>3</sup>
(70% neutrophils)</span></p>

<p><span>Platelets<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>450,000/mm<sup>3</sup></span></p>

<p><span></span></p>

<p><span>AST <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>94
</span></p>

<p><span>ALT <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>88
</span></p>

<p><span></span></p>

<p><span>ESR <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>&gt;100
mm/h</span></p>

<p><span>ANA <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative
</span></p>

<p><span>RF<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative<span>&nbsp; </span></span></p>

<p><span>Ferritin <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12,000
ng/ml</span></p>

<p><span></span></p>

<p><span>The rash is shown here: </span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=263 height=164
src="_%20Tutorials_files/image012.png"
alt="CREATOR: gd-jpeg v1.0 (using IJG JPEG v62), quality = 85&#10;" v:shapes="Picture_x0020_9"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>What is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Subacute bacterial endocarditis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Disseminated gonococcus</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hepatitis B</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Still’s disease</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Parvovirus</span></p>

<p><span></span></p>

<span><br
clear=all>
</span>

<p><span>Adult-onset Still’s disease can occur at any age but peaks
between ages 15 and 35. Nearly all patients complain of fever and joint pain.
Most have sore throat, muscle aches, lymphadenopathy, and a salmon-pink rash
that comes and goes with the daily fevers. Other features include abdominal
pain and hepatosplenomegaly.<span >&nbsp;
</span>Laboratory tests show anemia, leukocytosis, elevated liver enzymes, and
negative ANA and RF. A very high ferritin level is classic for Still’s disease.
The disease tends to relapse and remit. Most patients respond to NSAIDs or
prednisone.</span></p>

<p><span></span></p>

<p><span>Subacute bacterial endocarditis (SBE) causes fever, myalgia,
arthralgia, and rash, but the rash is not evanescent as in Still’s disease.
Palpable purpura is the typical rash of SBE. Other cutaneous findings include
Osler nodes and Janeway lesions. Ferritin levels are elevated, but not as high
as in Still’s disease. </span></p>

<p><span></span></p>

<p><span>Disseminated gonococcus can cause fever, rash, and
arthritis.<span >&nbsp; </span>The arthritis typically
involves the wrists, hands, feet, and ankles. Knees are also commonly involved.
The rash often presents as hemorrhagic pustules on an erythematous base. The
bacterium can be cultured on Thayer-Martin media.</span></p>

<p><span></span></p>

<p><span>Acute
hepatitis B can be associated with fever, myalgia, arthralgia, elevated
AST/ALT, and rash. The rash usually takes the form of livedo reticularis or
palpable purpura. ALT and AST are very high in acute hepatitis. </span></p>

<p><span></span></p>

<p><span>Human
parvovirus 19 can cause fever, sore throat, myalgia, arthralgia, and rash. It
does not typically cause elevation of the AST or ALT.<span>&nbsp; </span>Infection can lead to transient aplastic
anemia. The rash is usually occurs in children and manifests as “slapped
cheeks” or as a maculopapular rash on the trunks and extremities. </span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Images</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=119 height=173
src="_%20Tutorials_files/image014.png" v:shapes="Picture_x0020_8"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Palpable purpura are
associated with </span></p>

<p style="text-align:center;"><span>vasculitis and
bacterial endocarditis. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=183 height=227
src="_%20Tutorials_files/image016.png" v:shapes="Picture_x0020_7"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Livedo reticularis, a
lace-like purplish discoloration, </span></p>

<p style="text-align:center;"><span>is associated with
vasculitis.</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=210 height=138
src="_%20Tutorials_files/image018.png" v:shapes="Picture_x0020_6"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Disseminated
gonococcus can appear as a </span></p>

<p style="text-align:center;"><span>hemorrhagic pustule
on an erythematous base.</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=190 height=245
src="_%20Tutorials_files/image020.png" v:shapes="Picture_x0020_5"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>“Slapped cheeks”
caused by human parvovirus 19 </span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer D
is correct.</span></b><span> The patient has Still’s disease. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 23-year-old woman has a 3-month history of photosensitive
rash, sores in her mouth, and progressive pain and stiffness in the joints of
the hands and feet, which are worse in the morning. Her laboratory tests show
leukopenia and thrombocytopenia. Her creatinine is elevated at 1.6 mg/dl, and
her urinalysis shows protein and microscopic hematuria.<span>&nbsp; </span>Autoantibody tests are ordered. Which of
the following serological tests are likely to be positive? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Rheumatoid factor 1:80 and anti-CCP</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>ANA 1:640 in a nucleolar pattern,
anti-topoisomerase I</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>ANA 1:1280 in a nuclear speckled
pattern and anti-Sm and anti-double stranded DNA</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>ANA 1:40, RF 1:40</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>ANA 1:160 in nuclear homogenous,
anti-centromere</span></p>

<span><br
clear=all>
</span>

<p><span></span></p>

<p><span>This patient has presumed systemic lupus erythematosus based
on arthralgias, photosensitivity, oral ulcers, leukopenia, and
thrombocytopenia. There are 11 criteria for lupus. Any combination of 4 or more
makes it likely that the patient has lupus. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=230 valign=top>
  <p><span>Systemic Lupus Erythematosus</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Malar rash</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Discoid rash</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Photosensitivity</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Oral ulcers</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Arthritis (non-erosive)</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Serositis (pleuritis, pericarditis)</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Renal Disorder (proteinuria or
  cellular casts)</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Neurological disorder (seizures or
  psychosis)</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Hematologic disorder (hemolytic
  anemia, lymphopenia, thrombocytopenia)</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Immunologic: anti-dsDNA, anti-Sm,
  and/or anti-phospholipid</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>ANA</span></p>
  </td>
 </tr>
</table>

</div>

<p><span><span >&nbsp;</span></span></p>

<p><span>Although the patient has joint pain with morning stiffness
consistent with rheumatoid arthritis, the photosensitive rash and oral ulcers
are not typical of RA. Behcet’s disease causes recurrent oral ulcers, as well
as vaginal or penile ulcers, and can be associated with rash but does not
typically cause joint pain or significant cytopenias. Scleroderma is unlikely
because the patient does not have skin thickening, Raynaud’s phenomenon, or
heartburn. Polymyositis and dermatomyositis are unlikely because she does not
have muscle pain or weakness. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>ANA patterns: </span></p>

<p><span></span></p>

<p style="text-align:center"><span><img border=0 width=471 height=313
src="_%20Tutorials_files/image022.png" v:shapes="Picture_x0020_4"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Antibody associations</span></p>

<p><span></span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-ds (double-stranded) DNA</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Seen in 60% of patients with SLE</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Highly specific for SLE</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Low titer may be seen in other
inflammatory conditions</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Strongest clinical association with
nephritis and CNS disease</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-Sm (Smith)</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Seen in 10% to 30% of SLE patients</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Highly specific for SLE</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>clinical association with nephritis and
CNS disease</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-DNA<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>nephritis</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-nRNP<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>myositis,
Raynaud’s, milder disease</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-P<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>depression
and psychosis</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-histone<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>drug-induced
lupus</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-Ro<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>photosensitivity,
purpura, subacute cutaneous lupus<br>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>nephritis
(w/o anti-La), pneumonitis,<br>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>C2
deficiency<br>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>lymphopenia</span></p>

<p><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp; </span><span>if mother is positive for anti-Ro, baby at risk for neonatal
heart block and neonatal lupus dermatitis<span>&nbsp; </span>
</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-La<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>absence
of nephritis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Anti-centromere and anti-nucleolar are typical patterns for
Scleroderma. SCL-70 is associated with systemic scleroderma and targets
DNA-topoiosmerase I.<span >&nbsp;
</span>Anti-centromere antibodies are typically associated with limited
scleroderma or CREST (calcinosis, Raynaud’s, esophageal dysmotility,
sclerodactyly, telangiectasias).</span></p>

<p><span></span></p>

<p><span>Rheumatoid factors are typically seen in rheumatoid arthritis
but may also be found in other diseases including chronic </span><a
href="http://en.wikipedia.org/wiki/Hepatitis" title=Hepatitis><span>hepatitis</span></a><span> C, </span><a
href="http://en.wikipedia.org/wiki/Primary_biliary_cirrhosis"
title="Primary biliary cirrhosis"><span>primary biliary cirrhosis</span></a><span>, any chronic viral infection, </span><a
href="http://en.wikipedia.org/wiki/Bacterial_endocarditis"
title="Bacterial endocarditis"><span>bacterial endocarditis</span></a><span>, </span><a
href="http://en.wikipedia.org/wiki/Leukemia" title=Leukemia><span>leukemia</span></a><span>, </span><a
href="http://en.wikipedia.org/wiki/Dermatomyositis" title=Dermatomyositis><span>dermatomyositis</span></a><span>, </span><a
href="http://en.wikipedia.org/wiki/Infectious_mononucleosis"
title="Infectious mononucleosis"><span>infectious mononucleosis</span></a><span>, </span><a
href="http://en.wikipedia.org/wiki/Systemic_sclerosis"
title="Systemic sclerosis"><span>systemic sclerosis</span></a><span> and </span><a
href="http://en.wikipedia.org/wiki/Systemic_lupus_erythematosus"
title="Systemic lupus erythematosus"><span>systemic lupus erythematosus</span></a><span> (SLE).<span >&nbsp;&nbsp;
</span>High titer RF predicts more aggressive, erosive rheumatoid arthritis.</span></p>

<p><span></span></p>

<p><span>Anti-CCP antibodies are directed again cyclic citrullinated
protein<b>. </b>During citrullination, arginine residues in proteins such as
vimentin can be enzymatically converted into citrulline residues, and if their
shapes are significantly altered, the proteins may be seen as </span><a
href="http://en.wikipedia.org/wiki/Antigens" title=Antigens><span>antigens</span></a><span> by the immune system and autoantibodies against them may
form. Anti-CCP antibodies are quite specific for rheumatoid arthritis although
low levels may be found in psoriatic arthritis. High titer anti-CCP predicts
more aggressive disease.</span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct</span></b><span>. ANA 1:1280 in a nuclear speckled pattern, anti-Sm, and
anti-double stranded DNA are most consistent with lupus.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Rheumatoid factor 1:80 and anti-CCP are most consistent
with rheumatoid arthritis.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>.<span >&nbsp; </span>ANA 1:640 in a
nucleolar pattern and anti-topoisomerase I are most consistent with systemic
scleroderma.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. ANA 1:40 and RF 1:40 are consistent with a healthy control
(10-30% of the population has low-titer ANA). </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. ANA 1:160 in a nuclear homogenous pattern and
anti-centromere are most consistent with limited scleroderma or CREST. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 73-year-old woman has a 3-week history of fever, fatigue,
and right-sided headache. Today she has blurred vision in the left eye and
fatigue with chewing. Physical examination shows tenderness over a blood vessel
in the left temporal area. Histological examination of the vessel shows
multinucleated histiocytes infiltrating the wall of a medium-sized artery.<span>&nbsp; </span>Which of the following is the most
appropriate management?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Administration of ibuprofen</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Administration of prednisone</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Doppler ultrasound of the carotid
arteries</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>MRI of the head</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Surgical removal of the blood vessel</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Temporal arteritis (TA), also known as cranial or giant cell
arteritis, is the most common systemic vasculitis in adults. It primarily
affects medium-sized arteries of the head and the neck and can cause blindness.
The condition may present insidiously with fever, malaise, and/or weight loss.
In some patients, symptoms appear abruptly and may include headache, neck pain,
scalp tenderness, visual disturbance, fatigue with chewing (jaw claudication),
and fatigue with swallowing. Patients often have fever, headache, anemia, and
an elevated erythrocyte sedimentation rate (ESR). Polymyalgia rheumatica (PMR)
with extreme muscle tenderness of the shoulder and hip girdles may be present. </span></p>

<p><span></span></p>

<p><span>The diagnosis should be strongly suspected in Caucasians of
northern European descent, especially women above the age of 50, who report
temporal headache, scalp tenderness, jaw claudication, and/or visual changes.
Visual disturbances include diplopia, blurred vision, amaurosis fugax, and
blindness in one or both eyes. Visual hallucination also can occur. The scalp
may be focally or generally tender. Temporal arteries may be tender, inflamed,
dilated, thickened, or cordlike. </span></p>

<p><span></span></p>

<p><span>Diagnosis is made aided by a temporal artery biopsy,
preferably bilateral biopsies. Temporal artery biopsies may be negative even
when disease is present secondary to skip lesions (10%). Granulomatous
vasculitis is seen histologically. </span></p>

<p><span></span></p>

<p><span>High-dose glucocorticoids (such as prednisone 60 mg daily)
are the mainstay of therapy and may prevent permanent visual loss. Steroids
should be initiated if temporal arteritis is suspected on clinical
grounds.<span >&nbsp; </span>Clinicians should NOT
delay the start of steroids while waiting for a temporal artery biopsy. </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is correct. </span></b><span>Prednisone, a glucocorticoid, is the
mainstay of therapy for temporal arteritis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 32-year-old man with a history of hepatitis B presents to
the emergency department with fever, malaise, muscle aches, joint aches, and
rash on the legs. He describes increasing postprandial periumbilical pain,
which discourages him from eating. Examination reveals a lace-like purplish
discoloration on the legs. You suspect polyarteritis nodosa (PAN). Which of the
following is least likely to be associated with this condition?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Abdominal angiogram showing
microaneurysms of the mesenteric vessels.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Full thickness skin biopsy showing
patchy transmural arteritis, fibrinoid necrosis, and disruption of the elastic
laminae.</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Positive P-ANCA</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Serum creatinine of<span>&nbsp; </span>2.5 without red blood cell casts</span></p>

<span><br
clear=all>
</span>

<p><span>Polyarteritis nodosa (PAN) is a vasculitis of medium-sized
vessels. It typically affects the gut, kidneys, nerves, muscles, and skin. Both
men and women are affected. The condition can occur at any age. 10% of cases
are associated with hepatitis B. The clinical manifestations are varied and may
include weight loss, myalgias, neuropathy, renal insufficiency (due to renal
artery involvement, not glomerulonephritis), testicular pain, abdominal angina,
bowel ischemia, and rash (livedo reticularis, ulcerations, gangrene).</span></p>

<p><span></span></p>

<p><span>Diagnosis cannot be made using blood tests. (PAN is not
associated with autoantibodies.) Unlike microscopic polyangiitis and Wegener’s
granulomatosis, PAN is not associated with ANCA antibodies.<span>&nbsp; </span>Patients may present with an elevated
BUN and creatinine and mild proteinuria but do not typically have active
urinary sediment (e.g., RBC casts). The ESR and C-reactive protein levels are
elevated. Biopsy of affected peripheral sites such as skin and muscle are
preferred for diagnosis. Biopsy typically shows transmural arteritis with
granulocytes, fibrinoid necrosis, and disruption of the elastic laminae. Renal
or mesenteric angiograms may demonstrate typical microaneurysms and strictures
(beads on a string), which support the diagnosis. </span></p>

<p><span></span></p>

<p><img width=218 height=164
src="_%20Tutorials_files/image024.png" align=left hspace=9 v:shapes="Picture_x0020_16"><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><img width=215 height=167
src="_%20Tutorials_files/image026.png" align=left hspace=9 v:shapes="Picture_x0020_15"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Fibrinoid necrosis in
PAN</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Microaneurysms in PAN<br
clear=all>
</span></p>

<p style="text-align:center;"><span>The Vasculitides</span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0 width=504>
 <tr>
  <td width=129 valign=top>
  <p style="text-align:center;"><span>Primary
  Vasculitis</span></p>
  </td>
  <td width=234 valign=top>
  <p style="text-align:center;"><span>Predominant
  Symptoms</span></p>
  </td>
  <td width=58 valign=top>
  <p style="text-align:center;"><span>Age at
  onset</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>Male:
  female</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Takayasu’s </span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Arm and leg claudication, bruits,
  decreased or absent pulses</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>15-25</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>1:9</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Giant Cell Arteritis</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Headache, jaw claudication, scalp
  tenderness, hip/shoulder stiffness, hand arthralgia</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>60-75 </span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>1:3</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Polyarteritis Nodosa</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Weight loss, fatigue, livedo
  reticularis, renal infarcts, hypertension, testicular pain, neuropathy,
  myopathy</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>40-60</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>2:1</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Churg-Strauss</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Asthma, eosinophilia, neuropathy,
  pulmonary infiltrates</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>40-60</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>2:1</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Wegener’s</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Upper and lower airways disease,
  renal disease, neuropathy</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>30-60</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>2:1</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Behcets</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Recurrent oral and genital
  ulceration, uveitis, thrombophlebitis</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>20-35</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>1:1</span></p>
  </td>
 </tr>
 <tr>
  <td width=129 valign=top>
  <p><span>Henoch-Schonlein Purpura</span></p>
  </td>
  <td width=234 valign=top>
  <p><span>Palpable purpura, arthritis,
  abdominal pain, bloody diarrhea</span></p>
  </td>
  <td width=58 valign=top>
  <p><span>5-20</span></p>
  </td>
  <td width=83 valign=top>
  <p style="text-align:center;"><span>1:1</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span><span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C
is correct. </span></b><span>Polyarteritis nodosa is not associated
with autoantibodies. <b></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 25-year-old man has been coughing up blood intermittently
for two hours. He reports low-grade fever, fatigue, chronic sinus drainage, and
frequent nosebleeds. On physical examination, he is mildly distressed.
Temperature is 100<sup>o</sup>F, pulse is 90/minute, blood pressure is 110/60
mm Hg, and respirations are 28/minute. A raised purplish-red rash is noted on
his lower legs. The oxygen saturation is 91% on room air. Chest x-ray shows
bilateral patchy infiltrates. </span></p>

<p><span></span></p>

<p><img width=183 height=159
src="_%20Tutorials_files/image028.png" align=left hspace=9 v:shapes="Picture_x0020_14"><img width=99 height=160
src="_%20Tutorials_files/image030.png" align=left hspace=9 v:shapes="Picture_x0020_13"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>You suspect vasculitis with possible diffuse alveolar
hemorrhage. Which antibody is most likely associated with this presentation?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Anti-CCP</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>ANA</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>P-ANCA</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Rheumatoid factor</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C-ANCA</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anti-glomerular basement membrane</span></p>

<span><br
clear=all>
</span>

<p><span>Wegener’s</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cardinal features: granulomatous
vasculitis of upper and lower respiratory tract, glomerulonephritis, and
variable degrees of disseminated vasculitis (which may produce<span>&nbsp; </span>palpable purpura)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Involves small arteries and veins
(hence lungs and kidneys are major targets)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Prevalence: 3 per 100,000</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Extremely rare in blacks</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Equal M:F ratio</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mean age of onset is 40</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sinus, nasal, or oral inflammation</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chest x-ray: nodules (with or without
cavitation) or fixed infiltrates</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Microhematuria or red blood cell casts
in urine</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Biopsy (sinus, lungs, kidney):
granulomatous necrotizing vasculitis</span></p>

<p><span></span></p>

<p><span>ANCA (anti-neutrophil cytoplasmic antibodies): C-ANCA and
P-ANCA</span></p>

<p><u><span><o:p><span>&nbsp;</span></o:p></span></u></p>

<p><span>C-ANCA: “classical” antineutrophil cytoplasmic antibodies </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Diffusely granular cytoplasmic staining</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Proteinase-3 (PR-3) is the major target</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Found in &gt;90% of Wegener’s<span>&nbsp; </span>(rare in microscopic polyarteritis, SBE)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Titers fluctuate with disease activity </span></p>

<p><span></span></p>

<p><span>P-ANCA: “protoplasmic” antineutrophil cytoplasmic antibodies
</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Peri-nuclear staining</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Myeloperoxidase (MPO) is the major target </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>~70% microscopic polyarteritis; ~75% Churg-Strauss; 10-30%
Goodpasture’s; </span></p>

<p><span>~10% SLE; 50-80% ulcerative colitis, sclerosing cholangitis,
autoimmune hepatitis</span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=180 height=190
src="_%20Tutorials_files/image032.png" v:shapes="Picture_x0020_3"><img border=0 width=169 height=190
src="_%20Tutorials_files/image034.png" v:shapes="Picture_x0020_2"></span><span></span></p>

<p><span></span></p>

<p><span>Differential of Palpable Purpura:</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypersensitivity vasculitis (e.g.,
drug-induced)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cryoglobulinemia (hepatitis C)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Paraneoplastic vasculitis</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Henoch-Schonlein purpura</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Wegener’s granulomatosis </span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Churg-Strauss vasculitis</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Microscopic polyarteritis </span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Polyarteritis nodosa (hepatitis B)</span></p>

<p><span><span>•<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Subacute bacterial endocarditis</span></p>

<p><span></span></p>

<p><span>Diffuse Alveolar Hemorrhage:</span></p>

<p><span>Rapidly changing patchy pulmonary
infiltrates</span></p>

<p><span>Hemoptysis (usually)</span></p>

<p><span>Diagnosis: bronchoscopy shows
progressive returns of blood</span></p>

<p><span>Therapy: intravenous high-dose
glucocorticoids</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=398 height=247
src="_%20Tutorials_files/image036.png" v:shapes="Picture_x0020_1"></span><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct</span></b><span>. This patient presents with hemoptysis, nosebleeds, chronic
sinusitis, patchy lung infiltrates, and palpable purpura, consistent with
Wegener’s granulomatosis. Wegener’s is associated with C-ANCA.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Anti-CCP is found in rheumatoid arthritis and occasionally
in psoriatic arthritis. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. ANA is typical of lupus, scleroderma, and Sjogren’s
disease. These diseases can be associated with diffuse alveolar hemorrhage, but
are not associated with chronic sinus disease.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. P-ANCA is the most common antibody found in vasculitis and
is associated with microscopic polyarteritis, a common cause of diffuse
alveolar hemorrhage. However, microscopic polyarteritis is typically not
associated with chronic sinusitis. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Rheumatoid factor is associated with a variety of diseases
including rheumatoid arthritis, chronic hepatitis C, lymphoma, and subacute
bacterial endocarditis. Rheumatoid arthritis is rarely associated with
pulmonary vasculitis.</span></p>

<p><span></span></p>

<p><b><span>Answer F is incorrect</span></b><span>. Anti-glomerular basement membrane is associated with
Goodpasture’s disease, which can lead to diffuse alveolar hemorrhage and
glomerulonephritis. However, Goodpasture’s is not associated with chronic
sinusitis or palpable purpura.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section">Fluid,</span></p>

<p style="text-align:center;"><span
class="Section">Electrolytes, </span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Acid-Base</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=188 height=204
src="_%20Tutorials_files/image038.png" v:shapes="Picture_x0020_19"></span><span></span></p>

<p><span></span></p>

<p><span>In the diagram above, point X indicates the acid-base status
of a healthy person. Which of the following is the most likely cause of the
condition indicated by point Y?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ingestion of strong acid</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Prolonged vomiting</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Diarrhea</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Adaptation to high altitude</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chronic obstructive pulmonary disease
(COPD)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Point X represents a normal acid-base status: The pH is 7.4,
the PCO<sub>2</sub> is 40 mm Hg, and the HCO<sub>3</sub><sup>-</sup> is 24
mEq/L. Point Y represents an abnormal acid-base status: the pH is almost 7.4,
the PCO<sub>2</sub> is 60 mm Hg, and the HCO<sub>3</sub><sup>-</sup> is 40
mEq/L. Note that the pH is almost identical in both cases: at or near 7.4. The
point here is that a normal pH can mean one of two things: either the patient
has a normal acid-base status or the patient has two acid-base processes that
are almost “canceling” each other out. This “canceling out” (i.e.,
“compensation”) is common in chronic acid-base disorders. In <i>acute</i> disorders, the body doesn’t have
time to compensate for the change in pH. In <i>chronic</i>
disorders, there is time to adapt. Adaptation can be (simplistically) regarded
as a partnership between lungs and kidneys.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>If the lungs retain too much CO<sub>2</sub> (respiratory
acidosis), the kidneys respond by retaining more HCO<sub>3</sub><sup>-</sup>
(metabolic alkalosis)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>If the lungs blow off too much CO<sub>2 </sub>(respiratory
alkalosis), the kidneys compensate by eliminating more HCO<sub>3</sub><sup>-</sup>
(metabolic acidosis)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>If the blood is too acidic (metabolic acidosis), the lungs
respond by blowing off more CO<sub>2</sub> (respiratory alkalosis)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>If the blood is too alkalotic (metabolic alkalosis), the
lungs respond by retaining more CO<sub>2</sub> (respiratory acidosis)</span></p>

<p><span></span></p>

<p><span>Here are some basic rules of compensation: </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Compensation rarely produces a normal
pH, although the pH may approach normal. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Overcompensation does not occur (i.e.,
the compensatory process does not overwhelm the primary process)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sufficient time must elapse for
compensation to occur (about 24 hours).</span></p>

<p><span>At Point Y, we know that the acid-base status is abnormal
because the PCO<sub>2</sub> and HCO<sub>3</sub><sup>-</sup><sub> </sub>levels
are abnormal. The PCO<sub>2</sub> level is high (respiratory acidosis) and the
HCO<sub>3</sub><sup>-</sup><sub> </sub>level is high (metabolic alkalosis).
These two processes almost cancel each other out, resulting in a near normal
pH. </span></p>

<p><span>Which is the primary process? The pH at Point Y is slightly
lower than at Point X. This suggests that the primary process is respiratory
acidosis and the compensatory process is metabolic alkalosis. This combination
is commonly seen in severe chronic obstructive pulmonary disease (COPD),
characterized by chronic retention of CO<sub>2</sub> and compensatory retention
of HCO<sub>3</sub><sup>-</sup><sub> </sub>by the kidneys.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E
is correct.</span></b><span> COPD is a chronic disorder
characterized by respiratory acidosis and metabolic compensation. The PCO<sub>2</sub>
level is high, the HCO<sub>3</sub><sup>-</sup> level is high, and the pH is
near normal (due to compensation).</span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect.</span></b><span> Ingestion of strong acid would cause
an acute metabolic acidosis (low pH, low HCO<sub>3</sub><sup>-</sup>).</span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect.</span></b><span> Prolonged vomiting causes an acute
metabolic alkalosis (high pH, high HCO<sub>3</sub><sup>-</sup>).</span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect.</span></b><span> Diarrhea causes an acute metabolic
acidosis (low pH, low HCO<sub>3</sub><sup>-</sup>).</span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect.</span></b><span> Low oxygen tension at high altitudes
results in hyperventilation (to maintain normal blood oxygen levels).
Hyperventilation causes respiratory alkalosis, which, over time, leads to
metabolic compensation: the PCO<sub>2</sub> is low, the HCO<sub>3</sub><sup>-</sup>
is low, and the pH is near normal. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><!--[if supportFields]><span><span></span><span>&nbsp;</span>SEQ CHAPTER \h \r 1</span><![endif]--><!--[if supportFields]><span><span></span></span><![endif]--><span>A 55-year-old woman undergoes routine blood tests prior to
elective sinus surgery.<span >&nbsp; </span>The serum
calcium level is elevated at 11.3 mg/dl (normal: 8.4 to10.2 mg/dl). The serum
albumin concentration is normal. A second blood test shows a serum calcium
level of 11.2 mg/dl and a parathyroid hormone (PTH) level of 58 pg/ml (normal:
20 to 72 pg/ml).<span >&nbsp; </span>What is the most
likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Milk-alkali syndrome</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypercalcemia of malignancy</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Primary hyperparathyroidism</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Secondary hyperparathyroidism</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Calcium serves two principal
physiologic functions. First, insoluble calcium salts (primarily
hydroxyapatite) provide the structural characteristics that allow bones to
protect internal organs, to bear weight, and to function as the levers on which
muscles act during locomotion. Second, soluble calcium ions in the
extracellular fluid (ECF) and cytosol are critical for a myriad of biochemical
reactions, signaling cascades, and electrical systems that are necessary for
life. </p>

<p></p>

<p><span>Most of the calcium in the body (about 99%) is found in
bone. Only 1% is contained within the ECF and soft tissues. Therefore, the
skeleton is called on as a source of calcium when the ECF concentration falls.
Of the total circulating calcium, the ionized fraction is about 50%, with the
remainder bound to serum proteins, primarily albumin. Only the ionized fraction
of total serum calcium is physiologically important, and this component is
regulated on a minute-to-minute basis. </span></p>

<p></p>

<p>Hormones and organ systems regulate
the ECF ionized calcium concentration such that it is maintained in a very
narrow physiologic range. If the calcium level falls below the physiologic
range, PTH is rapidly secreted from the parathyroid glands and activates the
release of calcium and phosphate from the skeleton. In the kidney, PTH
increases the reabsorption of calcium from the urine while simultaneously
inhibiting phosphate reabsorption to dispose <a
name=4-u1.0-B978-1-4160-2805-5..50271-8--p189></a>of the phosphate released
from the skeleton. These actions return the calcium concentration back toward
normal and thus inhibit further PTH release. When hypocalcemia persists, PTH
also stimulates the renal production of 1,25(OH)<sub>2</sub> vitamin D, which
increases intestinal calcium absorption. </p>

<p></p>

<p>In the presence of <span
 PTH secretion is suppressed, and the
various organs alter their calcium handling in an opposite fashion so
circulating calcium levels fall.</p>

<p><span></span></p>

<p style="text-align:center;"><b><span>Causes of
Hypercalcemia in Adults</span></b></p>

<p style="text-align:center;"><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td valign=top>
  <p><b><span>Hyperparathyroidism</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Malignancy-associated hypercalcemia</span></b><span></span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Humoral
  hypercalcemia of malignancy</span></p>
  <p><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>Local osteolytic
  hypercalcemia<b></b></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Granulomatous disorders</span></b><span> (e.g., sarcoidosis)<b></b></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Endocrine disorders </span></b><span>(e.g., h</span><span>yperthyroidism,<br>
  adrenal insufficiency)<b></b></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Drugs </span></b><span>(e.g., thiazide diuretics, </span><span>Vitamin D intoxication)<b></b></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Miscellaneous </span></b><span>(e.g., m</span><span>ilk-alkali syndrome*, immobilization)<b></b></span></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>*Milk-alkali syndrome is
caused by excessive consumption of milk (which is high in calcium) and certain
antacids, especially <span>calcium
carbonate</span></span> or <span>sodium
bicarbonate</span></span> (baking soda), over a long period of time. It is
associated with calcium deposits in the kidneys and in other tissues.
Consumption of excessive amounts of vitamin D, which is usually added to milk
bought at the supermarket, can worsen this condition. <b></b></p>

<p><b><span>Answer C is correct</span></b><span>. The
most likely diagnosis is primary hyperparathyroidism. In a person with a normal
feedback mechanism, high serum calcium levels should maximally suppress PTH
production by the parathyroid glands. In this vignette, however, the PTH level
is inappropriately “normal.” Thus, the normal feedback mechanism is broken. PTH
is being autonomously secreted by the parathyroid gland. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. In
PTH-independent hypercalcemic states, such as milk-alkali syndrome, regulation
of PTH secretion is normal. Elevated serum calcium levels suppress PTH
secretion, causing low PTH levels in the blood.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. In
PTH-independent hypercalcemic states, such as hypercalcemia of malignancy,
regulation of PTH secretion is normal. Elevated serum calcium levels suppress
PTH secretion, causing low PTH levels in the blood.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>.
Secondary hyperparathyroidism is not associated with hypercalcemia. In
secondary hyperparathyroidism (e.g., chronic renal failure), serum PTH levels
are high and serum calcium levels are low or inappropriately normal. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 68-year-old woman with type 2 diabetes mellitus and
hypertension presents to the clinic for a routine visit. </span></p>

<p><span></span></p>

<p><span>Blood test results: </span></p>

<p><span></span></p>

<p><span>Na<sup>+</sup> <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>142
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
136-145 mEq/L)</span></p>

<p><span>K<sup>+<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>5.8
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.0 mEq/L)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp; </span></span></p>

<p><span>Cl<sup>-<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>114
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
95-105 mEq/L)</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup> <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>16
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
22-28 mEq/L)<span >&nbsp; </span></span></p>

<p><span>BUN <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
7-18 mg/dL)</span></p>

<p><span>Creatinine <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.0
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
0.6-1.2 mg/dL)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>What is the most likely cause of hyperkalemia?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Increased dietary intake of potassium</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased mineralcorticoid activity at
the distal nephron</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal insufficiency</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Excessive release of potassium from
cells</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The principal mechanisms of hyperkalemia are excessive
intake of potassium, ineffective elimination of potassium, and excessive
release of potassium from cells. </span></p>

<p><span></span></p>

<p><i><span>Excessive
intake of potassium </span></i><span>rarely causes hyperkalemia in patients
with normal renal function.<span >&nbsp; </span>The
kidneys are proficient at excreting excess potassium. Very high doses of
potassium are required to overcome the normal renal capacity for elimination. </span></p>

<p><span></span></p>

<p><i><span>Ineffective
elimination of potassium</span></i><span> is usually due to
renal insufficiency, drugs, or low-aldosterone states. Renal insufficiency is
characterized by high BUN and creatinine levels. Many drugs, particularly
ACE-inhibitors, potassium-sparing diuretics, and NSAIDs, can cause
hyperkalemia. Low-aldosterone states should be suspected as a cause of hyperkalemia
when elevated potassium levels are accompanied by a normal-anion gap metabolic
acidosis. </span></p>

<p><span></span></p>

<p><i><span>Excessive
release of potassium from cells</span></i><span> is
caused by large-scale cellular breakdown or by conditions that shift potassium
from the intracellular to extracellular space. </span></p>

<p><span></span></p>

<p><span>These mechanisms are summarized below. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=361 valign=top>
  <p style="text-align:center;"><span>Mechanisms of Hyperkalemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=361 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=361 valign=top>
  <p><span>Excessive
  intake of potassium</span></p>
  </td>
 </tr>
 <tr>
  <td width=361 valign=top>
  <p><span>Ineffective
  elimination of potassium</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Renal insufficiency</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Drugs</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>ACE-inhibitors
  and angiotensin-receptor blockers </span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Potassium-sparing
  diuretics </span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>NSAIDs
  </span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Calcineurin
  inhibitors (e.g., cyclosporin, tacrolimus)</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Trimethoprim
  </span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Pentamidine</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Mineralcorticoid deficiency or
  resistance</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Type
  IV renal tubular acidosis</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Addison’s
  disease</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Aldosterone
  deficiency</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Congenital
  adrenal hyperplasia (some types)</span></p>
  </td>
 </tr>
 <tr>
  <td width=361 valign=top>
  <p><span>Excessive
  release of potassium from cells</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Rhabdomyolysis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Burns</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Tumor lysis syndrome</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Massive blood transfusion</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Massive hemolysis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Conditions that shift potassium from
  the intracellular to extracellular space</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Acidosis</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Low
  insulin levels</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Beta-blocker
  therapy</span></p>
  <p><span><span>o<span>&nbsp;&nbsp; </span></span></span><span>Digoxin
  overdose</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span>Answer B
is correct.<span >&nbsp; </span></span></b><span>The presence of hyperkalemia with a normal anion gap
acidosis suggests a low-aldosterone state. Several conditions are associated
with low aldosterone levels. One of the most common is type IV renal tubular
acidosis (RTA). This condition usually occurs in patients with diabetes
mellitus and hypertension. Typically, patients with type IV RTA have mild to
moderate renal insufficiency. The ability of the kidneys to produce renin is
impaired, resulting in suppression of the renin-angiotensin-aldosterone system.
</span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Increased dietary intake of potassium
rarely causes hyperkalemia in patients with normal renal function. </span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. This patient does not have renal
insufficiency, as the BUN and creatinine are normal. </span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. There is no reason to suspect major
cellular breakdown.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An 80-year-old man with dementia resides in a nursing home. He develops a
urinary tract infection, which causes an acute decline in his mental status.
Vital signs and laboratory tests before and after this decline are shown below.
</span></p>

<p><u><span>Before<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></u><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><u>After</u></span></p>

<p><span>Blood pressure<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>130/80
mm Hg<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>105/60
mm Hg</span></p>

<p><span>Pulse<span >&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>70
/ minute<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>100
/ min</span></p>

<p><span>Hemoglobin <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>15
g/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>17
g/dL</span></p>

<p><span>Sodium<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>140
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>150
mEq/L</span></p>

<p><span>Glucose<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>90
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>95
mg/dL</span></p>

<p><span>BUN<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>13
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>50
mg/dL</span></p>

<p><span>Creatinine<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.2
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.3
mg/dL</span></p>

<p><span></span></p>

<p><span>Which of the following conditions best explains the changes shown above?</span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Dehydration</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gastrointestinal
hemorrhage</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Diabetic
ketoacidosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
renal failure</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Syndrome
of inappropriate ADH (vasopressin)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hypernatremia</span> is defined as an elevated serum sodium
concentration. It is generally not caused by an excess of sodium, but rather by
a relative deficit of free water. Consequently, hypernatremia is usually
synonymous with dehydration.</p>

<p></p>

<p>Water is lost from the body
in many ways, including perspiration, insensible losses from breathing, and
fecal and urinary losses. If the amount of water ingested falls below the
amount of water lost, the serum sodium level rises, leading to hypernatremia.
Ordinarily, a rise in the sodium level triggers thirst, which leads to
increased free water intake and subsequent correction of the abnormality.
Hypernatremia usually occurs in individuals who cannot adequately replace fluid
losses, such as infants, the mentally impaired, and the elderly.</p>

<p></p>

<p>Most patients with
hypernatremia are hypovolemic. In some less common conditions, however,
hypernatremic patients may be euvolemic or hypervolemic. </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=188 valign=top>
  <p style="text-align:center;"><span>Causes of Hypernatremia</span></p>
  </td>
 </tr>
 <tr>
  <td width=188 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=188 valign=top>
  <p><span>Hypovolemia (dehydration)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Inadequate
  water intake</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Excessive water
  loss </span></p>
  <p><span>Euvolemia (diabetes insipidus)</span></p>
  <p><span>Hypervolemia </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Intake of
  hypertonic fluid (e.g. seawater)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Mineralcorticoid
  excess (Conn’s syndrome)</span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p>In most patients,
hypernatremia is synonymous with dehydration. Symptoms and signs of dehydration
appear below. </p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=268 colspan=2 valign=top>
  <p style="text-align:center;"><span>Symptoms and Signs of Dehydration</span></p>
  </td>
 </tr>
 <tr>
  <td width=268 colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=134 valign=top>
  <p><span>Headache</span></p>
  <p><span>Fatigue</span></p>
  <p><span>Confusion</span></p>
  <p><span>Thirst</span></p>
  <p><span>Dry mouth</span></p>
  <p><span>Dry skin</span></p>
  <p><span>Decreased skin turgor</span></p>
  <p><span>Decreased urination</span></p>
  <p><span>Muscle cramps</span></p>
  </td>
  <td width=134 valign=top>
  <p><span>Dizziness</span></p>
  <p><span>Hypotension (resting or orthostatic)</span></p>
  <p><span>Increased heart rate</span></p>
  <p><span>Increased respiratory rate</span></p>
  <p><span>Hyperthermia</span></p>
  <p><span>Hemoconcentration</span></p>
  <p><span>Hyperalbuminemia</span></p>
  <p><span>Increased BUN/creatinine ratio</span></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer A is correct</b>. The patient in the clincial vignette has a
normal serum sodium level on day 1 and a high serum sodium level on day 5. The
presence of hypernatremia on day 5 should alert the clinician to the
development of dehydration. (Dehydration is the most common cause of
hypernatremia.) Other findings consistent with dehydration include a drop in
blood pressure, a rise in pulse, a rise in hemoglobin level
(hemoconcentration), and an elevation in the BUN / creatinine ratio (due to
hypovolemia). </p>

<p></p>

<p><b>Answer B is incorrect</b>. Gastrointestinal hemorrhage may result in
hypotension, tachycardia, and an elevated BUN / creatinine ratio (from
hypovolemia), but hypernatremia does not usually occur, and the hemoglobin
concentration does not rise.<span >&nbsp; </span></p>

<p></p>

<p><b>Answer C is incorrect</b>. Diabetic ketoacidosis (DKA) is characterized
by hyperglycemia, ketosis, and metabolic acidosis. Hypotension, tachycardia,
and hypovolemia commonly occur. In this clinical vignette, DKA is unlikely
because of the normal serum glucose concentration.<span>&nbsp;&nbsp; </span></p>

<p></p>

<p><b>Answer D is incorrect</b>. Acute renal failure is defined as an abrupt
or rapid decline in renal filtration, usually marked by a rise in the serum
creatinine concentration. In this vignette, there is a slight rise in the
creatinine concentration and a large rise in the BUN. The increase in the BUN /
creatinine ratio is caused by hypovolemia. The presence of hypernatremia
suggests a state of dehydration. </p>

<p></p>

<p><b>Answer E is incorrect</b>.<span> The
syndrome of inappropriate ADH causes hyponatremia, not hypernatremia. </span></p>

<p></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A previously
healthy 47-year-old nurse visits the emergency department because of recurrent
episodes of nervousness, palpitations, and dizziness. The episodes resolve
after eating. She has never been hospitalized or undergone surgery. She does
not smoke or drink.<span >&nbsp; </span>Physical
examination shows no abnormalities. While in the emergency room, she has an
episode, during which her blood glucose level is found to be 43 mg/dL.
Laboratory studies during the episode show:</span></p>

<p><span></span></p>

<p><span>Blood
glucose <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>43
mg/dL</span></p>

<p><span>C
peptide <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.0
nmol/mL (N=0.5&#8211;2.5)</span></p>

<p><span>Insulin
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>15
&#956;U/mL (N=5&#8211;20)</span></p>

<p><span>Urine
sulfonylurea<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p><span>Insulin-like
growth factor II<span>&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p><span></span></p>

<p><span>Which
is the most likely cause of hypoglycemia?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Factitious insulin use</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Factitious sulfonylurea use</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Dumping syndrome</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Insulinoma</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Non-beta-cell tumor</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hypoglycemia is defined as an abnormally low plasma glucose
concentration. Clinically significant hypoglycemia is defined by Whipple’s
triad.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=316 valign=top>
  <p style="text-align:center;"><span>Whipple’s
  triad</span></p>
  </td>
 </tr>
 <tr>
  <td width=316 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=316 valign=top>
  <p><span>Signs and symptoms of hypoglycemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=316 valign=top>
  <p><span>Low plasma glucose concentration
  (&lt;45 mg /dL)</span></p>
  </td>
 </tr>
 <tr>
  <td width=316 valign=top>
  <p><span>Resolution of symptoms with
  normalization of glucose levels</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>Hormonal regulation of plasma glucose levels relies on
insulin and four counter-regulatory hormones (glucagon, epinephrine, growth
hormone, and cortisol). Insulin is the predominant hormone and glucagon is the
predominant counter-regulatory hormone. Glucagon and epinephrine are part of
the rapid response to hypoglycemia, whereas growth hormone and cortisol are
part of the delayed response (2 to 3 hours later).<span>&nbsp; </span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span>Gluconeogenesis</span></p>
  </td>
  <td width=74 valign=top>
  <p><span>Glycogenolysis</span></p>
  </td>
  <td width=74 valign=top>
  <p><span>Peripheral Glucose Utilization</span></p>
  </td>
  <td width=74 valign=top>
  <p><span>Lipolysis</span></p>
  </td>
  <td width=74 valign=top>
  <p><span>Proteolysis</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Insulin</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Glucagon</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Epinephrine</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Growth hormone</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Cortisol</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8595;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&#8593;</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>Symptoms of hypoglycemia appear below.<span>&nbsp; </span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=319 colspan=2 valign=top>
  <p style="text-align:center;"><span>Symptoms
  of Hypoglycemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=319 colspan=2 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=161 valign=top>
  <p><span>Blurred vision</span></p>
  <p><span>Confusion</span></p>
  <p><span>Convulsions</span></p>
  <p><span>Decreased alertness</span></p>
  <p><span>Dizziness</span></p>
  <p><span>Fainting</span></p>
  <p><span>Fatigue</span></p>
  <p><span>Hallucinations</span></p>
  <p><span>Headache</span></p>
  <p><span>Hunger</span></p>
  <p><span></span></p>
  </td>
  <td width=159 valign=top>
  <p><span>Insomnia</span></p>
  <p><span>Irritability</span></p>
  <p><span>Memory loss</span></p>
  <p><span>Nervousness</span></p>
  <p><span>Pallor</span></p>
  <p><span>Palpitations</span></p>
  <p><span>Sweating</span></p>
  <p><span>Tachycardia</span></p>
  <p><span>Trembling</span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span>Hypoglycemia is classified as “fasting” or “postprandial.” </span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=401 valign=top>
  <p style="text-align:center;"><span>Causes
  of Hypoglycemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=401 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=401 valign=top>
  <p><span>Fasting hypoglycemia</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Drugs (e.g., insulin, sulfonylureas, meglitinides,
  alcohol, beta-blockers)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Critical illness </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Hormone deficiencies (growth hormone, cortisol,
  epinephrine, glucagon)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Endogenous hyperinsulinemia (insulinoma)<span>&nbsp; </span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Exogenous hyperinsulinemia</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Non beta-cell tumors, which produce insulin-like growth
  factor II</span></p>
  <p><span>Postprandial hypoglycemia (e.g.,
  dumping syndrome)*</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>The cause of hypoglycemia is often apparent from the medical
history; however, sometimes laboratory tests are needed to make a diagnosis.
Key laboratory tests include serum glucose, insulin, C-peptide, sulfonylurea,
and insulin-like growth factor levels. </span></p>

<p><span>C-peptide is a marker for <i>endogenous</i> insulin production. (It is not found in <i>exogenously</i> administered insulin.)
Sulfonylureas stimulate insulin secretion by the pancreas. Insulin-like growth
factor II (IGF-II), a molecule that has insulin-like effects, is produced by
certain non-beta-cell tumors. </span></p>

<p><span></span></p>

<p><span>The following table shows the utility of laboratory tests in
distinguishing various causes of hypoglycemia.<span>&nbsp; </span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=443 colspan=6 valign=top>
  <p style="text-align:center;"><span>Selected
  Conditions Causing Fasting Hypoglycemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=443 colspan=6 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Condition</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Plasma
  glucose (mg/dL)</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Insulin
  (&#956;U/mL)</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>C-Peptide
  (nmol/L)</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Plasma
  Sulfonylurea (nmol/L)</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Insulin-like
  Growth Factor II</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
  <td width=74 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>Normal</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>5-20</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>0.5-2.5</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Insulinoma</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt; 45</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&gt; 6</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&gt;
  0.2</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Exogenous insulin</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt; 45</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&gt; 6</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt;
  0.2</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Sulfonylurea use</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt; 45</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&gt; 6</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&gt;
  0.2</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>+</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
 </tr>
 <tr>
  <td width=74 valign=top>
  <p><span>Tumor secreting IGF II</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt; 45</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt; 6</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>&lt;
  0.2</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>-</span></p>
  </td>
  <td width=74 valign=top>
  <p style="text-align:center;"><span>+</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>*Dumping syndrome occurs in people who have undergone
gastric surgery (e.g., gastrectomy, gastrojejunostomy, pyloroplasty, gastric
bypass, or vagotomy), and can be purely a mechanical complication of the
surgery. Rapid emptying into the upper small bowel of a meal rich in simple
carbohydrates results in abrupt hyperglycemia, early marked hyperinsulinemia,
and subsequent hypoglycemia.<span >&nbsp; </span>Other
GI surgery patients may have a more complicated mechanism underlying
post-prandial hypoglycemia that involves beta cell hyperplasia and GLP-1
secretion.</span></p>

<p><b><span>Answer D
is correct</span></b><span>. Hypoglycemia normally suppresses
insulin production. The C-peptide level should be &lt; 0.2 nmol/L and the
insulin level should be &lt;6 &#956;U/mL in hypoglycemic states not induced by
insulin. In this vignette, the insulin level (15 &#956;U/mL) is inappropriately
elevated. Either the patient is producing too much insulin or taking exogenous
insulin. If she were taking exogenous insulin, the C-peptide would be
suppressed (&lt; 0.2 nmol/L). Because the C-peptide is inappropriately high
(1.0 nmol/mL) we know that the insulin is endogenously derived. The best
explanation for this is insulinoma (an insulin-producing tumor).<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>.
Factitious insulin use would lead to suppression of the C-peptide (&lt; 0.2
nmol/L).</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>.
Factitious sulfonylurea use would produce detectable levels of sulfonylurea in
the blood and urine. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Dumping
syndrome causes post-prandial hypoglycemia. It occurs in patients who have
undergone gastric surgery. This patient has no history of gastric surgery.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Most
non-beta-cell tumors cause hypoglycemia by elaborating insulin-like growth
factor II. In such situations, C-peptide and insulin levels would be
suppressed. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
30-year-old woman has been “weak and tired” for a month. Physical examination
shows no abnormalities. Laboratory studies show:</span></p>

<p><span></span></p>

<p><span>Serum</span></p>

<p><span>Sodium <span>&nbsp;&nbsp;&nbsp;&nbsp; </span>140
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
136-145 mEq/L)</span></p>

<p><span>Potassium <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.2
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.0 mEq/L)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Chloride <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>84 mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
95-105 mEq/L)</span></p>

<p><span>Bicarbonate<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>34 mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
22-28 mEq/L)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Urine</span></p>

<p><span>Sodium<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>70
mEq/24 h</span></p>

<p><span>Potassium<span> </span>150 mEq/24 h</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which
of the following is most likely?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Diarrhea</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Aldosterone deficiency</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Surreptitious use of diuretics</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Laxative abuse</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal tubular acidosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Potassium is the most abundant intracellular cation.
Potassium deficiency causes many problems, the most dangerous of which is
cardiac dysrhythmia. Hypokalemia, defined as an abnormally low serum potassium
concentration, may be the result of poor oral intake, potassium redistribution,
renal potassium loss, or extrarenal potassium loss. Redistribution refers to
the movement of potassium from the extracellular to the intracellular
space.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The following conditions are associated with hypokalemia.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=239 valign=top>
  <p style="text-align:center;"><span>Causes
  of Hypokalemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Inadequate intake</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Extra-renal loss<span>&nbsp; </span>(urine K<sup>+</sup> &lt; 20 mEq/L)</span></p>
  <p><span>(e.g., diarrhea)</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Renal loss<span>&nbsp; </span>(urine K<sup>+ </sup>&gt; 20 mEq/L)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Drugs (e.g., diuretics, amphotericin B, cisplatin)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Diabetic ketoacidosis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Hypomagnesemia</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>High aldosterone states</span></p>
  <p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Renal artery stenosis</span></p>
  <p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Cushing syndrome</span></p>
  <p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Primary
  hyperaldosteronism</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Shift from extracellular to
  intracellular space</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Alkalosis</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Drugs (e.g., insulin, epinephrine, &#946;-agonists)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Hereditary defects (e.g., hypokalemic periodic paralysis)</span></p>
  </td>
 </tr>
</table>

</div>

<p style="text-align:center;"><span></span></p>

<p><span>The cause of hypokalemia is usually apparent from the
medical history. When it is not apparent, the following parameters may be
useful diagnostically.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=143 valign=top>
  <p style="text-align:center;"><span>Important
  Parameters in</span></p>
  <p style="text-align:center;"><span>Evaluating
  Hypokalemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=143 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=143 valign=top>
  <p><span>Acid-base status</span></p>
  </td>
 </tr>
 <tr>
  <td width=143 valign=top>
  <p><span>Urinary potassium level</span></p>
  </td>
 </tr>
 <tr>
  <td width=143 valign=top>
  <p><span>Presence of hypertension</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The following table lists common causes of hypokalemia,
along with their acid-base and electrolyte patterns. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=359 colspan=4 valign=top>
  <p style="text-align:center;"><span>Common
  Causes of Hypokalemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=359 colspan=4 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Condition</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Acid-base status</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>Urinary
  potassium</span></p>
  <p style="text-align:center;"><span>(mEq/L)</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span>Presence
  of hypertension</span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span></span></p>
  </td>
  <td width=82 valign=top>
  <p><span></span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Decreased intake</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Normal</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&lt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Vomiting</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic alkalosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>variable</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Diarrhea</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic acidosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&lt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Diuretic use</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic alkalosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Laxative abuse</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Variable</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&lt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Hypomagnesemia</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Variable</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Diabetic Ketoacidosis</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic acidosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Renovascular hypertension</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic alkalosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span>Yes</span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Primary hyperaldosteronism</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic alkalosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span>Yes</span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Cushing’s syndrome</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic alkalosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span>Yes</span></p>
  </td>
 </tr>
 <tr>
  <td width=105 valign=top>
  <p><span>Renal tubular acidosis</span></p>
  <p><span>(types I and II)</span></p>
  </td>
  <td width=82 valign=top>
  <p><span>Metabolic acidosis</span></p>
  </td>
  <td width=85 valign=top>
  <p style="text-align:center;"><span>&gt;20</span></p>
  </td>
  <td width=87 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C
is correct</span></b><span>. The patient in the vignette has an
elevated bicarbonate level, indicating metabolic alkalosis. She also has a high
urinary potassium concentration, indicating renal potassium wasting. Diuretic
use is a common cause of metabolic alkalosis and renal potassium wasting.</span></p>

<p><span><span >&nbsp; </span></span></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Diarrhea causes metabolic acidosis.
Urinary potassium levels would be low.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect</span></b><span>. Aldosterone excess, not deficiency,
leads to metabolic alkalosis and renal potassium wasting.</span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Laxative abuse results in low urinary
potassium levels.</span></p>

<p><span></span></p>

<p><b><span>Answer E
is incorrect</span></b><span>. Renal tubular acidosis (types I and
II) causes metabolic acidosis, not alkalosis.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
65-year-old man presents to the emergency department with vomiting and
confusion. Review of the medical record reveals several previous visits for
“gastritis.” The patient carries a diagnosis of dementia and neuropathy. The ER
doctor tells you that the patient lives “under a bridge” and is a “frequent
flyer.”<span >&nbsp; </span>Physical examination shows
altered sensorium, jaundice, extensive bruising, telangiectasias on the upper
chest, gynecomastia, ascites, splenomegaly, palmar erythema, and testicular
atrophy. </span></p>

<p><span></span></p>

<p><span>Blood test
results: </span></p>

<p><span></span></p>

<p><span>Hemoglobin<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>12 gm/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
13.5-17.5 g/dL)</span></p>

<p><span>WBC count<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>9,000/mm<sup>3</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
4,500-11,000/mm<sup>3</sup>)</span></p>

<p><span>Platelets<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>80,000/mm<sup>3<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>(Normal:
150,000-400,000/mm<sup>3</sup>)</span></p>

<p><span></span></p>

<p><span>Na<sup>+<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>132
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
136-145 mEq/L)</span></p>

<p><span>K<sup>+</sup>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.8
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.0 mEq/L)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Cl<sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>92
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
95-105 mEq/L)</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup> <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>24
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
22-28 mEq/L)<span >&nbsp; </span></span></p>

<p><span>BUN <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>16
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
7-18 mg/dL)</span></p>

<p><span>Creatinine
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.1
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
0.6-1.2 mg/dL)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Mg<sup>++</sup>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.2
mEq/L<span >&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal: 1.5-2.0 mEq/L)</span></p>

<p><span></span></p>

<p><span>Albumin <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.8
gm/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.5 g/dL)</span></p>

<p><span>Bilirubin
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>3.0
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
0.1-1.0 mg/dL)</span></p>

<p><span>AST<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>160
U/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
8-20 U/L)</span></p>

<p><span>ALT<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp; </span>70 U/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
8-20 U/L)</span></p>

<p><span></span></p>

<p><span>PT<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>18
seconds<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
11-15 seconds)</span></p>

<p><span>aPTT<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>35
seconds<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
25-40 seconds)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>What is
the most likely cause of hypomagnesemia?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Renal insufficiency</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Autosomal recessive defect</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chronic alcohol ingestion</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Hypokalemia </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Long-term alcohol abuse has many complications, including
cirrhosis, pancreatitis, gastritis, dementia, polyneuropathy, cardiomyopathy,
nutritional deficiencies, and sexual dysfunction. The patient in this vignette
has signs of cirrhosis: telangiectasias, ascites, palmar erythema,
gynecomastia, and testicular atrophy. Blood test results are compatible with a
diagnosis of cirrhosis: The patient has thrombocytopenia, hyponatremia,
hyperbilirubinemia, elevated transaminases, hypoalbuminemia, and elevated prothrombin
time. Chronic alcohol abuse is the most common cause of cirrhosis. Although no
history of alcohol use is elicited in this confused patient, alcohol abuse
should be suspected.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Hypomagnesemia is present. The most common causes of
hypomagnesemia are alcoholism, malnutrition, malabsorption, chronic diarrhea,
and medication (e.g., diuretics). Hypomagnesemia occurs in 30% of patients with
alcoholism and 85% of patients with delirium tremens. Malnutrition and chronic
diarrhea contribute to the hypomagnesemia. Also, alcohol stimulates renal
excretion of magnesium. </span></p>

<p><span></span></p>

<p><span>Patients with hypomagnesemia are often hypokalemic. The key
to restoring potassium levels in such patients is to replenish magnesium. As
long as magnesium levels remain low, the kidneys will “leak” potassium. Merely
giving potassium is not enough. Both magnesium and potassium must be
supplemented. Hypomagnesemia should be suspected when hypokalemia does not
correct with potassium supplementation. (Note: Hypomagnesemia causes
hypokalemia; hypokalemia does <i>not</i>
cause hypomagnesemia.)</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C
is correct</span></b><span>. Chronic alcohol ingestion would
explain the myriad abnormal findings in this patient. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
36-year-old woman presents with mild confusion of three days duration. Her
medical history is unremarkable and she takes no medication.<span>&nbsp; </span>On physical examination, her supine
blood pressure and pulse are 110/70 mm Hg and 84/minute; the sitting blood
pressure and pulse are 104/62 mm Hg and 90/minute. (The patient cannot stand
because of confusion and weakness.) The heart is regular, the lungs are clear,
and the abdomen is scaphoid. There is no peripheral edema and no focal
neurological findings.<span >&nbsp; </span></span></p>

<p><span><span>&nbsp; </span></span></p>

<p><span>Blood test results: </span></p>

<p><span></span></p>

<p><span>Na<sup>+ <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>130
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
136-145 mEq/L)</span></p>

<p><span>K<sup>+<span >&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>5.5
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.0 mEq/L)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Cl<sup>-</sup> <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>88
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
95-105 mEq/L)</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>20
mEq/L <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
22-28 mEq/L)<span >&nbsp; </span></span></p>

<p><span>BUN <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>26
mg/dL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
7-18 mg/dL)</span></p>

<p><span>Cr <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.0
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
0.6-1.2 mg/dL)<span >&nbsp; </span></span></p>

<p><span>Glucose <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>88
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
40-70 mg/dL)</span></p>

<p><span>Uric acid <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>8.5
mg/dL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.0-8.2 mg/dL)</span></p>

<p><span></span></p>

<p><span>Which of the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Surreptitious use of furosemide</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cirrhosis of the liver</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Addison’s disease</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>SIADH (syndrome of inappropriate ADH)</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nephrotic syndrome</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hyponatremia is a common disorder with numerous potential
causes. Patients with hyponatremia should be classified as 1) edematous, 2)
euvolemic, or 3) volume-contracted.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><i><span>Edematous</span></i><span> patients have bilateral, gravity-dependent edema. Common
causes of edema include congestive heart failure, hepatic cirrhosis, and
chronic renal failure (especially nephrotic syndrome). In these conditions, the
extracellular space is expanded, but the “effective circulating fluid volume”
is reduced. The body has excess total body sodium, but due to decreased
effective circulating volume, ADH is secreted, which causes water retention and
hyponatremia. </span></p>

<p><span></span></p>

<p><i><span>Euvolemic</span></i><span> patients are neither orthostatic nor edematous.
Hyponatremia in euvolemic patients may be caused by SIADH (syndrome of
inappropriate ADH), drugs (many medications cause hyponatremia), polydipsia, or
hypothyroidism. (Note: Technically, these patients are hypervolemic <i>physiologically</i>, but they are euvolemic <i>clinically</i>. Hyponatremic patients are
classified using clinical criteria; consequently, patients who are not
orthostatic or edematous are considered euvolemic, even if the extracellular
volume is mildly increased.)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><i><span>Hypovolemic</span></i><span> patients
have a positive “tilt” sign; i.e., they have orthostatic hypotension.
(Orthostatic hypotension is characterized by a drop in systolic blood pressure
of at least 20 mm Hg and a drop in diastolic blood pressure of at least 10 mm
Hg when moving from a supine to a standing position. Typically the pulse rises
by at least 10 beats per minute.) In hypovolemic patients, total body sodium is
low, resulting in a real decrease in extracellular and circulating fluid. The
hyponatremia is caused by “appropriate” release of ADH as a compensatory
response to volume contraction. </span></p>

<p><span></span></p>

<p><span>Distinguishing
euvolemia from hypovolemia can be difficult. In this vignette, for example, the
blood pressure falls as the patient moves from supine to sitting (the patient
cannot stand), but not by 20 mm Hg. Also, the pulse rises by less than
10/minute. Thus, the patient could be mildly volume-contracted. </span></p>

<p><span></span></p>

<p><span>Mild
volume-contraction can be identified by measuring the fractional excretion of
sodium, the serum uric acid level, and the BUN-creatinine ratio. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=248 valign=top>
  <p style="text-align:center;"><span>Manifestations
  of Volume Contraction</span></p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p><span>Low fractional excretion of sodium
  (FE<sub>Na </sub><u>&lt;</u>1%)</span></p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p><span>High serum uric acid level</span></p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p><span>High BUN-creatinine ratio (&gt;10)</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>The <b>fractional
excretion of sodium</b> (FE<sub>Na</sub>) is the percentage of the sodium
filtered by the kidney that is excreted in the urine. The kidneys are very
sensitive to volume contraction and respond by conserving sodium, leaving very
little sodium in the urine. In a patient who is volume-contracted, the FE<sub>Na
</sub>is usually <u>&lt;</u> 1%. Volume contraction also raises the serum uric
acid level. (Uric acid excretion is volume-dependent; consequently, serum uric
acid levels are inversely proportional to extracellular volume.) Finally,
volume contraction raises the BUN-creatinine ratio. </span></p>

<p><b><span>Answer C
is correct</span></b><span>. The patient in the vignette has signs
of volume contraction: drop in blood pressure and rise in pulse when moving
from supine to sitting, high BUN-creatinine ratio, and high serum uric acid
level. Volume contraction occurs in Addison’s disease, which is characterized
by mineralcorticoid (aldosterone) deficiency. Sodium is lost in the urine,
resulting in volume depletion and appropriate release of ADH, which causes
hyponatremia. Potassium excretion in the distal tubule is impaired, resulting
in hyperkalemia.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>.
Furosemide (Lasix) causes hypokalemia, not hyperkalemia.<span>&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. This
patient has no stigmata of chronic liver disease and is not edematous. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. SIADH
is associated with low serum uric acid levels (due to volume expansion) and
normal serum potassium levels.<span >&nbsp;&nbsp;
</span></span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>.
Nephrotic syndrome causes generalized edema (anasarca). </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 30-year-old man experiences vomiting and diarrhea for five
days while traveling in Mexico. He is dizzy when he stands. His serum sodium
concentration is 129 mEq/L. Which of the following is most likely? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Increased intravascular volume </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Increased serum atrial natriuretic
peptide</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased serum aldosterone level</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Decreased serum ADH (vasopressin) level</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Urine osmolality greater than serum
osmolality</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Fluid loss can result in hypovolemia, or decreased blood
volume. Common causes include vomiting, diarrhea, sweating, hemorrhage, severe
burns, and diuretic use. Symptoms include fatigue, muscle cramps, postural
dizziness, and, in severe cases, syncope and coma. Findings include dry mucous
membranes, decreased skin turgor, postural hypotension, postural tachycardia,
and decreased jugular venous pressure. Hypovolemia results in four major
physiological responses: </span></p>

<p><span></span></p>

<p><b><span>Baroreflex
response.</span></b><span> In hypovolemic states, baroreceptors
have reduced responses due to reduced blood pressure. The reduced activation
results in enhanced sympathetic outflow which increases heart rate, increases
cardiac contractility, and produces arterial vasoconstriction. The results are
increased cardiac output and increased total peripheral resistance.</span></p>

<p><span></span></p>

<p><b><span>Renal
response.</span></b><span> Hypovolemia activates the
renin-angiotensin-aldosterone axis. Specialized cells in the kidney release
renin, which initiates the conversion of angiotensinogen to angiotensin I. Angiotensin
I is converted to angiotensin II by angiotensin-converting enzyme. Angiotensin
II causes arterial vasoconstriction and stimulates the release of aldosterone
from the adrenal cortex as well as release of ADH (vasopressin) from the
posterior pituitary. Aldosterone causes the kidneys to reabsorb sodium, which
leads to water reabsorption. ADH (vasopressin) causes the kidneys to absorb
water. The effect is to increase urine osmolality. </span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Cardiac
response.</span></b><span> In hypovolemic states, atrial
baroreceptors are <i>not</i> activated and,
therefore, atrial natriuretic peptide is <i>not</i>
released. Atrial natriuretic peptide is a potent vasodilator and facilitates
salt and water excretion, responses that are opposite to what would be desired
in hypovolemia. </span></p>

<p><span></span></p>

<p><b><span>Central
nervous system response</span></b><span>: Thirst is elicited
by activation of the renin-angiotensin system and by reduction in atrial
natriuretic peptide levels.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E
is correct</span></b><span>. Hypovolemia activates the renin-angiotensin
system, which leads to increased levels of aldosterone and ADH (vasopressin).
Water is absorbed from the kidney and the urine concentration (osmolality) is
increased. </span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Loss of fluid leads to contraction,
not expansion, of intravascular volume. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is incorrect</span></b><span>. In hypovolemic states, atrial
baroreceptors are not stimulated to release atrial natriuretic peptide. </span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. Hypovolemia activates the
renin-angiotensin system, which raises aldosterone levels. </span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Hypovolemia activates the
renin-angiotensin system, which raises ADH (vasopressin) levels. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 35-year old man with a 5-day history of severe diarrhea
feels dizzy when he stands. His blood pressure while supine is 115/75 mm Hg and
his pulse is 88/minute. While standing, his blood pressure is 80/60 mm Hg and
his pulse is 120/minute. In addition to controlling his diarrhea, which of the
following is the most appropriate initial therapy for intravenous
administration?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>5% Dextrose in water</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fresh frozen plasma</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Desmopressin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>0.9%<span>&nbsp; </span>Saline</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The patient in this vignette has orthostatic hypotension, a
sign of hypovolemia. In severe hypovolemia, the primary goal is to replenish
intravascular volume. This can be done by administering intravenous fluids. </span></p>

<p><span></span></p>

<p><span>Two types of fluids are commonly used for intravenous
therapy: crystalloid and colloid. Crystalloids are aqueous solutions of mineral
salts. An example of a crystalloid solution would be saline solution, which
contains sodium chloride. Colloids contain larger insoluble molecules. An
example of a colloid solution would be whole blood. </span></p>

<p><span></span></p>

<p>Crystalloids are categorized
by their tonicity (i.e., osmolality). A fluid that is <i>isotonic</i> has the same number of particles (i.e., the same
osmolality) as plasma. Isotonic fluids remain confined to the extracellular
space. They do not promote fluid shift into or out of cells. </p>

<p></p>

<p>0.9% Saline, also known as
“normal” or “physiologic” saline, is the most commonly used isotonic fluid. It
is the mainstay of resuscitation therapy. Most patients who are hypovolemic
because of vomiting, diarrhea, excessive perspiration, or decreased oral intake
can be safely treated with intravenous normal saline. Patients who are
hypovolemic because of severe blood loss may require blood transfusion.<span>&nbsp; </span></p>

<p></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D
is correct.<span >&nbsp; </span></span></b><span>0.9% Saline is “normal,” or isotonic, saline. It is the most
commonly used intravenous fluid for treatment of hypovolemia. Its distribution
is limited to the extracellular fluid (ECF) space.<span>&nbsp;&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A
is incorrect.<span >&nbsp; </span></span></b><span>Administering 5% Dextrose is the equivalent of administering
pure water. The dextrose (glucose) is rapidly consumed, and the water is
distributed throughout the total body water compartment, of which 2/3 is
intracellular and 1/3 is extracellular. Because most of the fluid goes into the
intracellular space, it is not a good therapy for hypovolemia. (The goal of
treating hypovolemia is to restore extracellular volume.)<span>&nbsp; </span>5% Dextrose is known as a “maintenance”
fluid; 0.9% Saline is known as a “replacement” fluid.<span>&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is incorrect. </span></b><span>F<span>resh frozen plasma</span> (FFP) refers to the liquid portion of human
blood that has been frozen and preserved, and will be used for blood
transfusion. FFP is used to treat deficiencies of coagulation proteins for
which specific factor concentrates are unavailable or undesirable. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C
is incorrect. </span></b><span>Desmopressin is a synthetic replacement
for the hormone, vasopressin. It is used to treat diabetes insipidus. </span></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 45-year-old man is brought to the emergency room because
of blurred vision, headache, abdominal pain, and vomiting. His blood pressure
is 125/80, pulse is 55, and respirations are 26/min. Lab studies show:</span></p>

<p><span></span></p>

<p><span>Arterial blood gas analysis (on room air):</span></p>

<p><span></span></p>

<p><span>pH<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>7.30<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
7.35-7.45)</span></p>

<p><span>pO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>104
mmHg<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
75-105 mm Hg)</span></p>

<p><span>pCO<sub>2</sub><span>&nbsp;&nbsp; </span>24
mmHg<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
33-45 mm Hg)</span></p>

<p><span></span></p>

<p><span>Serum chemistries:</span></p>

<p><span></span></p>

<p><span>Na<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>140
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
136-145 mEq/L)</span></p>

<p><span>K<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>4.5
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.0 mEq/L)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Cl<sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>85
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
95-105 mEq/L)</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>15
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
22-28 mEq/L)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Which of the following would best explain these findings?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acetaminophen intoxication</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Narcotic intoxication</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Methanol intoxication</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Excessive diuretic use </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pneumonia</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The normal pH of arterial blood is 7.40 <u>+</u> 0.03. This
patient has a low pH (7.30), indicating acidosis. Acidosis may be classified as
respiratory or metabolic. Respiratory acidosis is characterized by a primary
increase in pCO<sub>2</sub> with a compensatory increase in HCO<sub>3</sub><sup>-
</sup>. Metabolic acidosis is characterized by a primary decrease in HCO<sub>3</sub><sup>-</sup>
and a compensatory decrease in pCO<sub>2</sub>. This patient has a low serum
HCO<sub>3</sub><sup>-</sup> of 15 mEq/L (normal is 22-28 mEq/L) and a low
arterial pCO<sub>2</sub> of 24 mmHg (normal is 35-45), indicating metabolic
acidosis.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>There are two types of metabolic acidosis: “normal anion
gap” and “increased anion gap.” The anion gap is calculated as follows: Na<sup>
</sup>&#8211; (Cl<sup> </sup>+<sup> </sup>HCO<sub>3</sub>). A normal anion gap
is 12 <u>+</u> 2 mmol/L. In this patient, the anion gap is 40. Thus, the
patient has an increased anion gap metabolic acidosis. The principal causes of
increased anion gap metabolic acidosis are:</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=392 valign=top>
  <p style="text-align:center;"><span>Increased
  Anion Gap Metabolic Acidosis </span></p>
  </td>
 </tr>
 <tr>
  <td width=392 valign=top>
  <p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Ketoacidosis
  (caused by diabetes, alcohol, or starvation)</span></p>
  <p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Lactic acidosis
  (due to tissue hypoxia)</span></p>
  <p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Chronic renal
  failure (accumulation of sulfates, phosphates, and uric acid)</span></p>
  <p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Intoxication
  (salicylates, ethanol, methanol, formaldehyde, ethylene glycol, paraldehyde,
  isoniazid, metformin)</span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><span><span >&nbsp;</span></span></p>

<p><span>General symptoms of acidosis include headache, fatigue,
sleepiness, abdominal pain, nausea, and vomiting. Treatment depends on the
underlying cause.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C
is correct</span></b><span>. Methanol intoxication causes an
increased anion gap acidosis.* </span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Acetaminophen intoxication causes
liver damage by depleting hepatic glutathione, which leads to accumulation of a
hepatotoxic metabolite. Treatment with acetylcysteine, a substrate for
glutathione, can prevent liver damage. </span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect</span></b><span>. Narcotic intoxication causes
respiratory depression, which results in respiratory acidosis. </span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Excessive diuretic use is associated
with metabolic alkalosis. </span></p>

<p><span></span></p>

<p><b><span>Answer E
is incorrect</span></b><span>. Pneumonia may be associated with
respiratory alkalosis. </span></p>

<p><span></span></p>

<p><span>*Note: Methanol and ethylene glycol intoxication produce
similar symptoms. Methanol is found in gas-line antifreeze, carburetor fluid,
duplicator fluid, and windshield washer fluid. Ethylene glycol is found in
anti-freeze and windshield de-icer. Both methanol and ethylene glycol are
metabolized by alcohol dehydrogenase. Methanol is metabolized to formic acid;
ethylene glycol is metabolized to glycolate. Both methanol and ethylene glycol
intoxication are treated with intravenous ethanol (which inhibits alcohol
dehydrogenase), intravenous sodium bicarbonate (to reverse life-threatening
acidosis), and hemodialysis (to remove the alcohols and their metabolites). A
major difference between methanol and ethylene glycol intoxication is that
methanol causes visual disturbance (blurred vision, decreased visual acuity,
whiteness of the visual field), whereas ethylene glycol causes renal failure
(due to calcium oxalate crystal deposition) and cardiopulmonary failure. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 24-year-old woman is worried about recent weight gain. She
has gained 3 lbs in the last 3 months. Her height is 5’6”. Her weight is 125
lbs. Her lab tests show:</span></p>

<p><span></span></p>

<p><span>Arterial blood gas analysis (on room air):</span></p>

<p><span></span></p>

<p><span>pH<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>7.34<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
7.35-7.45)</span></p>

<p><span>pO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>102
mmHg<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
75-105 mm Hg)</span></p>

<p><span>pCO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>31
mmHg<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
33-45 mm Hg)</span></p>

<p><span></span></p>

<p><span>Serum chemistries:</span></p>

<p><span></span></p>

<p><span>Na<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>140
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
136-145 mEq/L)</span></p>

<p><span>K<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.8
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
3.5-5.0 mEq/L)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Cl<sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>113
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
95-105 mEq/L)</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>15
mEq/L<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
22-28 mEq/L)<span >&nbsp; </span></span></p>

<p><span>BUN<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
7-18 mg/dL)</span></p>

<p><span>Cr<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.1
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>(Normal:
0.6-1.2 mg/dL)<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>UA: pH 6.5; no blood, protein, or casts</span></p>

<p><span></span></p>

<p><span>Urine Na<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>65
mEq/L</span></p>

<p><span>Urine K<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>8
mEq/L</span></p>

<p><span>Urine Cl<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>94
mEq/L</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>What is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Diuretic abuse</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Laxative abuse</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Surreptitious vomiting</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Renal tubular acidosis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Alcoholic ketoacidosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<span><br
clear=all>
</span>

<p><span>This patient has a low pH of 7.34, indicating acidosis. The
HCO<sub>3</sub><sup>- </sup>is low (15 mEq/L), indicating a metabolic acidosis.
The anion gap is normal at 12. Therefore, this patient has a normal anion gap
metabolic acidosis. </span></p>

<p><span></span></p>

<p><span>The two most common causes of normal anion gap acidosis are:</span></p>

<p><span><span>1)<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Diarrhea</span></p>

<p><span><span>2)<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal tubular acidosis. </span></p>

<p><span></span></p>

<p><span>To distinguish these two, the urine anion gap is calculated.</span></p>

<p><span></span></p>

<p><span>Urine anion gap = Urine (Na + K &#8211; Cl).</span></p>

<p><span></span></p>

<p><span>In normal subjects, the urine anion gap is approximately
zero<strong>. </strong></span></p>

<p><strong><span></span></strong></p>

<p><span>In metabolic acidosis, the kidneys get rid of acid by
excreting NH<sub>4</sub><sup>+</sup> in the urine (if the kidneys are working
properly.) When NH<sub>4</sub><sup>+</sup> is excreted in the urine, Cl<sup>-</sup>
is excreted along with it. The rise in urinary Cl<sup>-</sup> causes the urine
anion gap to become negative, usually ranging from -20 to more than -50 meq/L. </span></p>

<p><span></span></p>

<p><span>An example of this situation would be diarrhea, which causes
metabolic acidosis. To get rid of the acid, the kidneys excrete NH<sub>4</sub><sup>+</sup>.
In the process of excreting NH<sub>4</sub><sup>+</sup>, Cl<sup>- </sup>is also
excreted. This increases the amount of Cl<sup>-</sup> in the urine, causing the
urine anion gap to become negative.<span >&nbsp;
</span></span></p>

<p><span>By contrast, if the kidneys cannot excrete NH<sub>4</sub><sup>+</sup>
adequately (e.g., renal tubular acidosis) the urine Cl<sup>-</sup> level does
not rise. The result is a positive urine anion gap. </span></p>

<p><span>In summary,</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A positive urine anion gap suggests
renal tubular acidosis. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A negative urine anion gap suggests
diarrhea. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is
correct</span></b><span>. This patient has a normal
anion gap metabolic acidosis. The two most common causes of this are diarrhea
and renal tubular acidosis, which can be distinguished by calculating the urine
anion gap. Here, the urine anion gap is 65+8 - 94 = -21 mEq/L. A negative urine
anion gap is consistent with diarrhea, which could be due to laxative abuse.
(Laxative abuse occurs in some patients who obsess over weight gain.)</span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Diuretic abuse causes a metabolic
alkalosis.</span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. Vomiting causes a metabolic
alkalosis.</span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Renal tubular acidosis causes a
normal anion gap metabolic acidosis with a positive urine anion gap. In this
patient, the urine anion gap is negative.</span></p>

<p><span></span></p>

<p><b><span>Answer E
is incorrect</span></b><span>. Ketoacidosis causes an increased
anion gap metabolic acidosis.</span></p>

<p><span></span></p>

<p><i><span>Note</span></i><span>: All of the choices above &#8211; diuretic abuse, laxative
abuse, surreptitious vomiting, renal tubular acidosis, and alcoholic
ketoacidosis &#8211; can cause hypokalemia. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 34-year-old man presents with a 3-day history of vomiting.<span>&nbsp; </span>He feels lightheaded when he stands or
walks. Which of the following arterial blood gas values would be expected?</span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>pH<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>pCO<sub>2</sub><span>&nbsp; </span>(mmHg)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>HCO<sub>3</sub><sup>-</sup>
(mEq/dL)</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>7.30<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>28<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>15</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>7.30<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>55<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>27</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>7.40<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>40<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>24</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>7.50<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>30<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>22</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>7.50<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>47<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>35</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<span><br
clear=all>
</span>

<p><span>Prolonged vomiting causes volume depletion, which reduces
GFR, thereby stimulating the renin-angiotensin-aldosterone axis. This leads to
bicarbonate reabsorption in the kidney, which causes metabolic alkalosis.
Metabolic alkalosis is characterized by an elevated pH and an elevated serum
bicarbonate (HCO<sub>3</sub><sup>-</sup>)<b>
</b>level. Respiratory compensation (through hypoventilation) increases the
arterial pCO<sub>2</sub>, which blunts the rise in the arterial pH.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E
is correct</span></b><span>.<span >&nbsp;
</span>Prolonged vomiting is associated with metabolic alkalosis. <b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A
is incorrect</span></b><span>. These values (low pH, low HCO<sub>3</sub><sup>-</sup>)
indicate metabolic acidosis with a compensatory decrease in pCO<sub>2</sub>.</span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect</span></b><span>. These values (low pH, high pCO<sub>2</sub>)
indicate respiratory acidosis with a compensatory increase in HCO<sub>3</sub><sup>-</sup>.</span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. These values are within the normal
range.</span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. These values (high pH, low pCO<sub>2</sub>)
indicate respiratory alkalosis with a compensatory decrease in HCO<sub>3</sub><sup>-</sup>.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 20-year-old man has been weak and dizzy for the past two
days. He just returned from Mexico where he developed abdominal cramping and
diarrhea that have not yet subsided. The diarrhea is watery, voluminous, and
non-bloody. He has mild nausea but no vomiting. On examination, his supine
blood pressure is 115/65 mm Hg and his pulse is 110/minute. While standing, his
blood pressure is 80/50 mm Hg and his pulse is 160/minute. He is afebrile and
his abdomen is non-tender. The stool is heme-negative. What is the most
important initial treatment?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ciprofloxacin</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Erythromycin</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Metronidazole</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Rehydration</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Potassium chloride</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Gastrointestinal fluid loss from vomiting or diarrhea can
lead to severe volume depletion. In such individuals, rehydration is a top
priority. The presence of orthostatic hypotension in a patient with voluminous
diarrhea suggests significant volume depletion. (Orthostatic hypotension is
defined as a drop in systolic blood pressure of at least 20 mm Hg or a drop in
diastolic blood pressure of at least 10 mm Hg after rising from the supine to
the standing position.) The presence of resting tachycardia, as well as
tachycardia that increases with standing, also suggests volume depletion.
Worsening hypovolemia can lead to shock and cardiovascular collapse. These
complications can be prevented with prompt rehydration. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D
is correct</span></b><span>. Rehydration is the most important
initial treatment in a patient who is severely volume depleted.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 59-year-old man with diabetes, hypertension, and chronic
renal insufficiency is seen for a routine clinic visit.<span>&nbsp; </span>He is feeling well.<span>&nbsp; </span>His only medicines are metformin and
amlodipine.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Lab test results show: </span></p>

<p><span></span></p>

<p><span>Na<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>138
mEq/L</span></p>

<p><span>K<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>5.5
mEq/L</span></p>

<p><span>Cl<sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>110
mEq/L</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>19
mEq/L</span></p>

<p><span>Glucose<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>188
mg/dL</span></p>

<p><span>BUN<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>25
mg/dL</span></p>

<p><span>Cr<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2.0
mg/dL</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of the following best explains these values?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Diabetic ketoacidosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hyporeninemic hypoaldosteronism</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lactic acidosis </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Metabolic acidosis secondary to
end-stage renal disease</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Metabolic acidosis secondary to
persistent diarrhea</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<span><br
clear=all>
</span>

<p><span>The low bicarbonate concentration indicates metabolic
acidosis. The anion gap is normal: 138 - (110+19) = 9. Common causes of a
normal-anion gap metabolic acidosis include diarrhea and renal tubular acidosis
(RTA). Patients with diarrhea usually have low or normal serum potassium
levels. Patients with RTA have variable serum potassium levels, depending on
the type of RTA. The most common type of RTA is type IV RTA, which usually
occurs in people with diabetes. Diabetes affects the kidneys in such a way that
renin production is impaired. This leads to “blunting” of the
renin-angiotensin-aldosterone axis (renin, angiotensin, and aldosterone levels
are reduced). Reduction in aldosterone results in hyperkalemia and a
normal-anion gap metabolic acidosis. The combination of hyperkalemia and a
normal anion gap acidosis suggests type IV RTA, or hyporeninemic
hypoaldosteronism.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B
is correct</span></b><span>. The combination of hyperkalemia and a
normal anion gap acidosis suggests type IV RTA, or hyporeninemic
hypoaldosteronism.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Diabetic ketoacidosis (DKA) causes a
high-anion gap metabolic acidosis. Hyperglycemia is usually severe. Patients
feel ill and must be admitted to the hospital. </span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. Lactic acidosis causes a high-anion
gap metabolic acidosis.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. End-stage renal disease causes a
high-anion gap metabolic acidosis (usually with a higher serum creatinine level
than is seen in this patient). </span></p>

<p><span></span></p>

<p><b><span>Answer E
is incorrect</span></b><span>. Diarrhea can cause a normal-anion gap
metabolic acidosis, usually associated with hypokalemia, not hyperkalemia. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 54-year-old man presents with a 3-month history of
exertional shortness of breath. He sleeps on three pillows to breathe
comfortably, and often wakes up at night coughing, wheezing, and gasping for
air. Physical examination shows jugular venous distension, an S3 at the cardiac
apex, late inspiratory crackles in the lung bases, and pitting edema of the
legs. The level of which of the following substances found in the pulmonary
capillaries would be increased in this patient? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Renin</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Angiotensin-converting enzyme</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Angiotensin II</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Aldosterone</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Vasopressin</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The patient has symptoms and signs of congestive heart
failure. Left-sided heart failure causes orthopnea (sleeping on three pillows
to breathe comfortably), paroxysmal nocturnal dyspnea (waking up at night
coughing, wheezing, and gasping for air), and pulmonary edema (crackles in the
lung bases).<span >&nbsp; </span>Right-sided heart
failure causes jugular venous distension and pitting edema of the legs.<span>&nbsp; </span>Decreased cardiac output results in
decreased “effective circulating volume,” which activates the
renin-angiotensin-aldosterone system and the sympathetic nervous system. </span></p>

<p><span></span></p>

<p><span>These are the steps in the renin-angiotensin-aldosterone
system:</span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Decreased perfusion of the
juxtaglomerular apparatus in the kidney's macula densa stimulates the
juxtaglomerular cells to release the enzyme renin.</span></p>

<p><span></span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renin cleaves an inactive peptide, <span>angiotensinogen</span>, converting it into <span>angiotensin I</span>.</span></p>

<p><span></span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Angiotensin I is converted to <span>angiotensin II</span> by
angiotensin-converting enzyme (ACE), which is found mainly in lung capillaries.</span></p>

<p><span></span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Angiotensin II is the major bioactive
product of the renin-angiotensin system. It is a potent vasoconstrictor of
arterioles throughout the body. In the kidney, it constricts afferent and
efferent arterioles within the glomerulus, and stimulates sodium reabsorption
in the tubules. In the adrenal cortex, it stimulates release of aldosterone
from the zona glomerulosa. </span></p>

<p><span></span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Aldosterone</span><span> stimulates reabsorption of sodium and water and secretion
of potassium in the distal convoluted tubules of the kidneys. This increases
blood volume and blood pressure.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B
is correct. </span></b><span>Angiotensin-converting enzyme is
produced mainly by the pulmonary vascular endothelium. </span></p>

<p><span></span></p>

<p><b><span>Answer A
is incorrect. </span></b><span>Renin is produced by juxtaglomerular
cells in the kidney. </span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect.</span></b><span> Angiotensin I is converted to
angiotensin II through removal of two C-terminal residues by the enzyme <span>angiotensin-converting enzyme.</span> </span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect.</span></b><span> Aldosterone is produced by the zona
glomerulosa cells of the adrenal gland.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><b><span>Answer E
is incorrect.</span></b><span> Vasopressin is produced by the
hypothalamus and stored in the posterior pituitary. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An 82-year-old woman with a history of diabetes mellitus and
osteoarthritis is brought to the emergency department because of confusion. Her
blood pressure is 108/52 mm Hg, pulse is 92/minute, and respirations are
24/minute. </span></p>

<p><span></span></p>

<p><span>Lab studies show:</span></p>

<p><span></span></p>

<p><span>Arterial blood gas analysis (on room air):</span></p>

<p><span></span></p>

<p><span>pH<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>7.25</span></p>

<p><span>pO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>97
mmHg</span></p>

<p><span>pCO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>22
mmHg</span></p>

<p><span>HCO<sub>3</sub><sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12
mEq/L</span></p>

<p><span></span></p>

<p><span>Serum chemistries:</span></p>

<p><span></span></p>

<p><span>Na<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>136
mEq/L</span></p>

<p><span>K<sup>+</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>3.9
mEq/L</span></p>

<p><span>Cl<sup>-</sup><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>102
mEq/L</span></p>

<p><span>CO<sub>2</sub><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12
mEq/L</span></p>

<p><span>Glucose<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>200
mg/dL</span></p>

<p><span>BUN<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>18
mg/dL</span></p>

<p><span>Cr<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1.4
mg/dL</span></p>

<p><span></span></p>

<p><span>Ketones<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of the following would best explain these findings?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Diabetic ketoacidosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Prolonged vomiting</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal tubular acidosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Diarrhea</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Salicylate intoxication</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<span><br
clear=all>
</span>

<p><span>The patient has a low pH, indicating acidosis. The serum HCO<sub>3</sub>
is also low, indicating metabolic acidosis. The anion gap is elevated at 22.
Thus, the patient has a high-anion gap metabolic acidosis. Salicylate
intoxication is associated with a high-anion gap metabolic acidosis. (The
history of osteoarthritis in this patient is a clue that she may be taking
aspirin.)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E
is correct</span></b><span>. Salicylate intoxication is associated
with a high-anion gap metabolic acidosis.<b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A
is incorrect</span></b><span>. Diabetic ketoacidosis causes a
high-anion gap metabolic acidosis, but the presence of serum ketones is
required to make the diagnosis. </span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect</span></b><span>. Prolonged vomiting causes metabolic
alkalosis. </span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>. Renal tubular acidosis causes a
normal-anion gap metabolic acidosis.</span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>. Diarrhea causes a normal-anion gap
metabolic acidosis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 65-year-old man with a history of congestive heart failure
due to coronary artery disease presents with a 4-day history of fever, myalgia,
productive cough, and worsening shortness of breath. On exam he is noted to be
agitated and confused. Temperature is 39.2</span><span><span>°</span></span><span>C,
pulse is 130/minute, blood pressure is 80/40 mmHg, and respirations are
32/minute. He is flushed and diaphoretic with warm skin. His neck veins are
flat. Cardiac exam reveals a rapid rate and a short systolic ejection murmur.
Chest exam reveals increased fremitus, dullness to percussion, and crackles in
the right mid-lung field. The left chest is unremarkable. Laboratory tests show
a white blood cell count of 16,000/mm<sup>3</sup>. The electrocardiogram is
unchanged from a previous reading, except for the presence of sinus
tachycardia. Transthoracic echocardiogram reveals normal chamber size, good biventricular
contractility, and a left ventricular ejection fraction of 60%. What is the
most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Cardiogenic
shock</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hemorrhagic
shock</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Septic
shock</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Shock
due to massive pulmonary embolism</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cardiac
tamponade</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>Shock is
the final common pathway for several potentially lethal clinical events,
including severe hemorrhage, extensive trauma or burns, large myocardial
infarction, massive pulmonary embolism, and microbial sepsis. <span>Shock is characterized by systemic hypotension
due either to reduced cardiac output or to reduced effective circulating blood
volume</span>. The consequences are <span>impaired
tissue perfusion and cellular hypoxia</span>. At the outset the cellular injury
is reversible; however, prolonged shock eventually leads to irreversible tissue
injury that often proves fatal.</span></p>

<p><span>The causes
of shock fall into three general categories:<a
name=4-u1.0-B978-1-4377-0792-2..50009-2--celi> </a></span></p>

<p><span><span></span></span></p>

<table border=0 cellpadding=0>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Cardiogenic
  shock</span></i><span>
  results from low cardiac output due to myocardial pump failure. This can be
  due to intrinsic myocardial damage (infarction), ventricular arrhythmias,
  extrinsic compression (e.g., cardiac tamponade<a
  name=4-u1.0-B978-1-4377-0792-2..50009-2--intr></a>), or outflow obstruction
  (e.g., pulmonary embolism).</span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Hypovolemic
  shock</span></i><span>
  results from low cardiac output due to the loss of blood or plasma volume,
  such as can occur with massive hemorrhage or fluid loss from severe burns.</span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Septic
  shock</span></i><span>
  results from vasodilation and peripheral pooling of blood as part of a
  systemic immune reaction to bacterial or fungal infection. Its complex
  pathogenesis is discussed in further detail below.</span></p>
  </td>
 </tr>
</table>

<span></span>

<p><a name=4-u1.0-B978-1-4377-0792-2..50009-2--ceta></a><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=bottom>
   <p style="text-align:center;"><b><span>Type of Shock</span></b></p>
   <p style="text-align:center;"><b><span></span></b></p>
   </td>
   <td valign=bottom>
   <p style="text-align:center;"><b><span>Clinical Example</span></b></p>
   <p style="text-align:center;"><b><span></span></b></p>
   </td>
   <td width=148 valign=bottom>
   <p style="text-align:center;"><b><span>Principal Mechanisms</span></b></p>
   <p style="text-align:center;"><b><span></span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td width=444 colspan=3 valign=top>
  <p><b><span></span></b></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>&nbsp;<b>CARDIOGENIC</b></span></p>
  <p><span></span></p>
  </td>
  <td width=206 valign=top>
  <p><span>Myocardial
  infarction</span></span></p>
  <p><span>Ventricular
  rupture</span></span></p>
  <p><span>Arrhythmia</span></span></p>
  <p><span>Cardiac
  tamponade</span></span></p>
  <p><span>Pulmonary
  embolism</span></span><span></span></p>
  </td>
  <td width=148 valign=top>
  <p><span>Failure
  of myocardial pump resulting from intrinsic myocardial damage, extrinsic
  pressure, or obstruction to outflow</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>HYPOVOLEMIC</span></b></p>
  <p><span></span></p>
  </td>
  <td width=206 valign=top>
  <p><span>Fluid
  loss (e.g., hemorrhage, vomiting, diarrhea, burns, or trauma)</span></p>
  </td>
  <td width=148 valign=top>
  <p><span>Inadequate
  blood or plasma volume</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>&nbsp;<b>SEPTIC</b></span></p>
  </td>
  <td width=206 valign=top>
  <p><span>Overwhelming
  microbial infections (bacterial and fungal)</span></p>
  <p><span>Superantigens
  (e.g., toxic shock syndrome)</span></p>
  </td>
  <td width=148 valign=top>
  <p><span>Peripheral
  vasodilation and pooling of blood; endothelial activation/injury;
  leukocyte-induced damage, disseminated intravascular coagulation; activation
  of cytokine cascades</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
principal signs of shock are low blood pressure, decreased urine output, and
confusion, but these are not always present. Common findings in shock are
listed below.<span >&nbsp; </span></span></p>

<p><b><span></span></b></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=243 valign=top>
  <p style="text-align:center;"><span>Signs and Symptoms</span></p>
  <p><b><span></span></b></p>
  </td>
  <td width=236 valign=top>
  <p style="text-align:center;"><span>Physiology</span></p>
  </td>
 </tr>
 <tr>
  <td width=243 valign=top>
  <p><b><span></span></b></p>
  </td>
  <td width=236 valign=top>
  <p><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=243 valign=top>
  <p><span>Cardiogenic
  shock</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Distended jugular veins<span>&nbsp; </span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Weak or absent pulse </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Arrhythmia (sometimes) </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Pulsus paradoxus (in the case of tamponade) </span></p>
  <p><b><span></span></b></p>
  </td>
  <td width=236 valign=top>
  <p><span>Cardiogenic
  shock</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Central
  venous pressure: &#8593; </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Cardiac
  output: &#8595; </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Systemic
  vascular resistance: &#8593; </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Venous
  oxygen saturation: &#8595; </span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=243 valign=top>
  <p><span>Hypovolemic
  shock</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Tachycardia</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Rapid, weak, thready pulse </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Cool, clammy skin </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Rapid and shallow respirations </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Hypothermia </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Thirst and dry mouth </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Cold and mottled skin</span></p>
  </td>
  <td width=236 valign=top>
  <p><span>Hypovolemic
  shock </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Central
  venous pressure: &#8595;<span >&nbsp; </span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Cardiac
  output: &#8595;<span >&nbsp; </span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Systemic
  vascular resistance: &#8593;</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Venous
  oxygen saturation: &#8595; </span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=243 valign=top>
  <p><span>Septic
  shock</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Fever</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Warm and sweaty skin</span></p>
  </td>
  <td width=236 valign=top>
  <p><span>Septic
  shock</span></p>
  <p><span></span></p>
  <p><span>Early</span></p>
  <p><span></span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Central
  venous pressure: variable </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Cardiac
  output: &#8593; </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Systemic
  vascular resistance: &#8595; </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Venous O<sub>2</sub>
  saturation: &#8593;</span></p>
  <p><span>Late</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Central
  venous pressure: variable </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Cardiac
  output: &#8595; </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Systemic
  vascular resistance: &#8593;</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Venous O<sub>2</sub>
  saturation: variable </span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct. </span></b><span>The
presence of fever, productive cough, consolidative findings on lung exam, and
elevated white blood cell count suggest that the patient has pneumonia and
hypotension is due to septic shock. Septic shock develops as a consequence of
vasodilation, particularly of the capacitance vessels, by nitric oxide and
other mediators produced as part of the generalized systemic inflammatory
response syndrome. The vasodilation causes a relative intravascular volume
deficit and large volumes of fluid must be administered to restore the
intravascular volume. Cardiac output is maintained during the initial stages of
the disease, although vasopressors such as norepinephrine are sometimes needed
to restore the systemic blood pressure and prevent subsequent organ failure. </span></p>

<p><span></span></p>

<p><b><span>Answer
A is incorrect</span></b><span>.
Cardiogenic shock is unlikely because the patient has no acute EKG changes,
left ventricular contractility is well preserved, and lung exam does not show
evidence of pulmonary edema. </span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect</span></b><span>.
This patient has no history of hematemesis, melena, or trauma. </span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect</span></b><span>.
Hypotension due to massive pulmonary embolism is caused by obstruction of the
pulmonary vasculature and inadequate filling of the left ventricle.
Characteristic findings on echocardiogram include an enlarged right ventricle
with decreased contractility. </span></p>

<p><span></span></p>

<p><b><span>Answer
E is incorrect</span></b><span>.
Cardiac tamponade is associated with jugular venous distension, hypotension,
tachycardia, and pulsus paradoxus. This patient does not have jugular venous
distension, and pericardial fluid was not seen on the echocardiogram. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 66-year-old
man with a 30 pack-year smoking history presents with a cough and weight loss
of three months duration. The cough is productive of bloody sputum. The patient
has lost 15 pounds.<span >&nbsp; </span>Temperature is
37.4<sup>o</sup>C, blood pressure is 140/70 mm Hg without orthostatic change,
pulse is 80/minute, and respiratory rate is 24/minute.<span>&nbsp; </span>Lung examination reveals dullness to
percussion in the right lower posterior lung field. The legs are not edematous.</span></p>

<p><span></span></p>

<p><span>Blood test
results: </span></p>

<p><span></span></p>

<p><span>Na<sup>+<span>&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>120
mEq/L </span></p>

<p><span>K<sup>+<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>
</sup>4.0 mEq/L </span></p>

<p><span>Cl<sup>-<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>
</sup>88 mEq/L </span></p>

<p><span>HCO<sub>3</sub><sup>-</sup><span>&nbsp; </span>24 mEq/L </span></p>

<p><span>BUN <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>10
mg/dL</span></p>

<p><span>Creatinine
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1
mg/dL</span></p>

<p><span></span></p>

<p><span>What is
the most likely cause of hyponatremia?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Congestive
heart failure</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Diuretic
use</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>SIADH</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Starvation</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The patient in this vignette is hyponatremic and
clinically euvolemic. (He is considered “euvolemic” because he is neither
orthostatic nor edematous.) Causes of euvolemic hyponatremia include: </span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>SIADH
(syndrome of inappropriate ADH)</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Drugs
(many medications cause hyponatremia)</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Polydipsia</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypothyroidism</span></p>

<p><span></span></p>

<p><span>SIADH is characterized by “inappropriate”
release of ADH, i.e., release independent of serum osmolality. Common causes of
SIADH include small-cell carcinoma of the lung, pneumonia, brain tumor, head
trauma, stroke, meningitis, and encephalitis. (SIADH is usually due to
pulmonary or intracranial pathology.) The presence of significant hyponatremia
in a clinically euvolemic patient should raise concern for SIADH.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. SIADH is an important
cause of hyponatremia. Typically, patients with SIADH are clinically
euvolemic.<span >&nbsp; </span>A major cause of SIADH
is small-cell carcinoma of the lung. The findings of weight loss, hemoptysis,
pleural effusion, and tachypnea in this patient are worrisome for lung cancer.
The final diagnosis was small cell carcinoma of the lung, which caused SIADH
and all the presenting symptoms and signs. </span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section">Molecular
</span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Cellular</span></p>

<p style="text-align:center;"><span
class="Section">Systems</span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of
the following is <i>not</i> true of
apoptosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>It
can occur under normal physiological conditions</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is characterized by chromatin aggregation, nuclear condensation, and
cytoplasmic shrinking</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is characterized by partition of the nucleus and cytoplasm into membrane-bound
vesicles, which are phagocytized</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>It
elicits a major inflammatory response</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is an energy-dependent process</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><i><span>A<span>poptosis</span></span></i><span> is a pathway of cell
death that is induced by a tightly regulated “suicide” program in which cells
destined to die activate enzymes that degrade the cells’ own nuclear DNA and
nuclear and cytoplasmic proteins. Apoptotic cells break up into fragments, called
apoptotic bodies, which contain portions of the cytoplasm and nucleus. The
plasma membrane of the apoptotic bodies remains intact, but its structure is
altered in such a way that it becomes a “tasty” target for phagocytes. The dead
cell and its fragments are rapidly devoured, before the contents have leaked
out, and therefore cell death by this pathway does not elicit an inflammatory
reaction in the host. </span></p>

<p><span></span></p>

<p><span>Apoptosis
is a unique mechanism of cell death, distinct from necrosis. Necrosis is
characterized by loss of membrane integrity, enzymatic digestion of cells,
leakage of cellular contents, and frequently a host reaction. </span></p>

<p><span></span></p>

<p><span>CAUSES OF
APOPTOSIS </span></p>

<p><span>Apoptosis
occurs normally both during development and throughout adulthood, and serves to
eliminate unwanted, aged, or potentially harmful cells. It is also a pathologic
event when diseased cells become damaged beyond repair and are eliminated.</span></p>

<p><span></span></p>

<p><span>Apoptosis
in Physiologic Situations </span></p>

<p><span></span></p>

<p><i><span>Death
by apoptosis is a normal phenomenon that serves to eliminate cells that are no
longer needed, and to maintain a steady number of various cell populations in
tissues</span></i><span>.
It is important in the following physiologic situations: </span></p>

<p><span></span></p>

<table border=0 cellpadding=0>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>The
  programmed destruction of cells during embryogenesis</span></i><span>, including
  implantation, organogenesis, developmental involution, and metamorphosis. </span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Involution
  of hormone-dependent tissues upon hormone withdrawal</span></i><span>, such as endometrial
  cell breakdown during the menstrual cycle, ovarian follicular atresia in menopause,
  the regression of the lactating breast after weaning, and prostatic atrophy
  after castration.</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Cell
  loss in proliferating cell populations</span></i><span>, such as immature lymphocytes in the bone
  marrow and thymus that fail to express useful antigen receptors<a
  name=4-u1.0-B978-1-4377-0792-2..50006-7--intr>, B lymphocytes in germinal
  centers, and epithelial cells in intestinal crypts.</a></span></p>
  <span></span>
  <p><span><span></span></span></p>
  </td>
  <span></span>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><span><i><span>Elimination of
  potentially harmful self-reactive lymphocytes</span></i></span><span><span>, either before or
  after they have completed their maturation, so as to prevent reactions against
  one’s own tissues.</span></span></p>
  <span></span>
  <p><span><span></span></span></p>
  </td>
  <span></span>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><span>Death of
  host cells that have served their useful purpose, such as neutrophils in an <i>acute
  inflammatory response</i>, and lymphocytes at the end of an <i>immune
  response</i>. In these situations cells undergo apoptosis because they are
  deprived of necessary survival signals, such as growth factors.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span>Apoptosis
in Pathologic Conditions </span></p>

<p><i><span>Apoptosis
eliminates cells that are injured beyond repair without eliciting a host
reaction, thus limiting collateral tissue damage</span></i><span>. Death by apoptosis is
responsible for loss of cells in a variety of pathologic states:<a
name=4-u1.0-B978-1-4377-0792-2..50006-7--celi> </a></span></p>

<p><span><span></span></span></p>

<table border=0 cellpadding=0>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>DNA
  damage</span></i><span>.
  Radiation, cytotoxic anticancer drugs, and hypoxia can damage DNA, either
  directly or via production of free radicals. If repair mechanisms cannot cope
  with the injury, the cell triggers intrinsic mechanisms that induce
  apoptosis. In these situations elimination of the cell may be a better
  alternative than risking mutations in the damaged DNA, which may result in
  malignant transformation. These injurious stimuli can cause apoptosis if the
  insult is mild, but larger doses of the same stimuli may result in necrotic
  cell death.</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Accumulation
  of misfolded proteins</span></i><span>. Improperly folded proteins may arise because of
  mutations in the genes encoding these proteins or because of extrinsic
  factors, such as damage caused by free radicals. Excessive accumulation of
  these proteins in the endoplasmic reticulum results in apoptotic cell death.
  Apoptosis caused by the accumulation of misfolded proteins may be responsible
  for certain degenerative diseases of the central nervous system and other
  organ systems.</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Cell
  death in certain infections</span></i><span>, particularly viral infections, in which loss
  of infected cells is largely due to apoptosis that may be induced by the
  virus (as in adenovirus and HIV infections) or by the host immune response
  (as in viral hepatitis). An important host response to viruses consists of
  cytotoxic T lymphocytes <a name=4-u1.0-B978-1-4377-0792-2..50006-7--p26></a>specific
  for viral proteins, which induce apoptosis of infected cells in an attempt to
  eliminate reservoirs of infection. During this process there can be
  significant tissue damage. The same T-cell-mediated mechanism is responsible
  for cell death in <i>tumors</i> and cellular rejection of <i>transplants</i>.</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=7>
  <p><span>&nbsp;&nbsp;</span></p>
  </td>
  <td width="4%" valign=top>
  <p><b><span>•</span></b><span>&nbsp;&nbsp;&nbsp; </span></p>
  </td>
  <td>
  <p><i><span>Pathologic
  atrophy in parenchymal organs after duct obstruction</span></i><span>, such as occurs in
  the pancreas, parotid gland, and kidney.</span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

<span></span>

<p><a name=4-u1.0-B978-1-4377-0792-2..50006-7--cese></a><span></span></p>

<p><span>CELLULAR
CHANGES IN APOPTOSIS </span></p>

<p><b><span></span></b></p>

<p><b><span>Overview. </span></b><span>The
morphological features of apoptosis consist of chromatin condensation, cell
shrinkage, and membrane blebbing, which can be clearly observed by light</span></span><span> microscopy. The
biochemical features include DNA fragmentation, protein cleavage at specific locations,
increased mitochondrial membrane permeability, and the appearance of
phosphatidylserine on the cell membrane surface.</span></p>

<p><span></span></p>

<p><b><span>Cell
shrinkage</span></b><span>.
The cell is smaller in size; the cytoplasm is dense; and the organelles, though
relatively normal, are more tightly packed. (Recall that in other forms of cell
injury, an early feature is cell swelling, not shrinkage.)</span></p>

<p><span></span></p>

<p><b><span>Chromatin
condensation</span></b><span>.
This is the most characteristic feature of apoptosis. The chromatin aggregates
peripherally, under the nuclear membrane, into dense masses of various shapes
and sizes. The nucleus itself may break up, producing two or more fragments.</span></p>

<p><span></span></p>

<p><b><span>Formation
of cytoplasmic blebs and apoptotic bodies</span></b><span>. The apoptotic cell first shows
extensive surface blebbing, then undergoes fragmentation into membrane-bound
apoptotic bodies composed of cytoplasm and tightly packed organelles, with or
without nuclear fragments.</span></p>

<p><span></span></p>

<p><b><span>Phagocytosis
of apoptotic cells or cell bodies, usually by macrophages</span></b><span>. The apoptotic bodies
are rapidly ingested by phagocytes and degraded by the phagocyte's lysosomal
enzymes.</span></p>

<p><span>Plasma
membranes are thought to remain intact during apoptosis, until the last stages,
when they become permeable to normally retained solutes. This classical
description is accurate with respect to apoptosis <a
name=4-u1.0-B978-1-4377-0792-2..50006-7--p27></a>during physiologic conditions
such as embryogenesis and deletion of immune cells. However, forms of cell
death with features of necrosis as well as of apoptosis are not uncommon after
many injurious stimuli. Under such conditions the severity rather than the
nature of the stimulus determines the pathway of cell death, necrosis being the
major pathway when there is advanced ATP depletion and membrane damage.</span></p>

<p><span></span></p>

<p><span>On
histologic examination, in tissues stained with hematoxylin and eosin, the
apoptotic cell appears as a round or oval mass of intensely eosinophilic
cytoplasm with fragments of dense nuclear chromatin. Because the cell shrinkage
and formation of apoptotic bodies are rapid and the pieces are quickly
phagocytosed, considerable apoptosis may occur in tissues before it becomes
apparent in histologic sections. In addition, apoptosis&#8212;in contrast to
necrosis&#8212;does not elicit inflammation, making it more difficult to detect
histologically.</span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=348 height=249
src="_%20Tutorials_files/image040.png" alt="Description: Apoptosis" v:shapes="Picture_x0020_347188"></span><span></span></p>

<p style="text-align:center;"><span><img border=0 width=399 height=264
src="_%20Tutorials_files/image042.png" alt="Description: Necrosis" v:shapes="Picture_x0020_347187"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. Apoptosis does <i>not</i> elicit a major inflammatory
response.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 38-year-old woman has a cast removed from her leg after 8 weeks of
immobilization. Which of the following best characterizes her gastrocnemius
muscle at this time?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Decrease
in number of fibers</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Conversion
to fast fibers</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Increase
in cytoplasmic content</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Increase
in mitochondrial content</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Increase
in number of satellite cells</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Atrophy is a reduction in the size of a tissue or organ. It is
associated with a reduction in the size and number of cells comprising that
tissue or organ</span><span>.
Atrophy may be physiologic or pathologic. P<span>hysiologic atrophy</span> is normal; examples include dissolution of
the thyroglossal duct during fetal development and decrease in uterine size
after childbirth. <span>Pathologic atrophy,
by contrast, </span>is abnormal and is usually caused by one of the following: </span></p>

<p><span></span></p>

<p><i><span>Disuse</span></i><span>. When a fractured bone
is immobilized in a plaster cast or when a patient is restricted to bed rest,
atrophy of skeletal muscle ensues. At first, there is a decrease in cell size,
which is reversible. With prolonged disuse, there is a decrease in the number
of muscle fibers due to apoptosis. Muscle atrophy may be accompanied by
increased bone resorption, resulting in osteoporosis.</span></p>

<p><span></span></p>

<p><i><span>Denervation</span></i><span>. Nerve damage can cause
muscle atrophy.</span></p>

<p><span></span></p>

<p><i><span>Ischemia</span></i><span>.</span><span> Decrease in blood
supply to a tissue can cause atrophy. Senile atrophy, for example, is a
progressive atrophy of the brain due to atherosclerosis. </span></p>

<p><span></span></p>

<p><i><span>Malnutrition</span></i><span>. Protein-calorie
malnutrition (marasmus) can cause muscle atrophy. Muscle protein is broken down
to produce energy after adipose stores are depleted. “Cachexia” is a term used
for profound muscle wasting. It can occur in marasmus, cancer, and chronic
inflammatory diseases. </span></p>

<p><span></span></p>

<p><i><span>Loss of
endocrine stimulation</span></i><span>.
Many tissues are dependent on endocrine stimulation for normal function. Loss
of estrogen stimulation after menopause results in atrophy of the breast,
endometrium, and vaginal epithelium.</span></p>

<p><span></span></p>

<p><i><span>Pressure</span></i><span>. Prolonged tissue
compression causes atrophy. An example would be a decubitus ulcer in a
bedridden patient.<span >&nbsp; </span><a
name=4-u1.0-B978-1-4377-0792-2..50006-7--p10></a></span></p>

<p><span></span></p>

<p><span>Atrophy is associated with decreased protein synthesis and increased
protein degradation. At first, the </span><span></span></p>

<p><span>cell size
and the number of organelles is reduced. In muscle cells, there is loss of
mitochondria and myofilaments. This “downsizing” reduces the metabolic needs of
the cell, allowing it to survive in an adverse environment. If the
precipitating cause of atrophy continues, the cell may become irreversibly
damaged and die, often by apoptosis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct. </span></b><span>Muscle atrophy, characterized
by a decrease in the number of muscle fibers, would be expected after eight
weeks of immobilization.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
69-year-old man with a history of prostatic hypertrophy has the recent onset of
increased difficulty urinating. Symptoms began shortly after he started taking
a nasal decongestant orally for cold symptoms. Which of the following types of
receptors is most likely to be involved in these adverse events?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>&#945;1-adrenergic</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>&#946;1-adrenergic</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>&#946;2-adrenergic</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>nicotinic
at the neuromuscular junction</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>muscarinic
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>There are
two types of adrenergic receptors: alpha and beta. The beta receptors are
further divided into beta 1 and beta 2. Norepinephrine excites alpha receptors
mainly. Epinephrine excites alpha and beta receptors equally. Certain alpha
functions are excitatory while others are inhibitory. Likewise, certain beta
functions are excitatory while others are inhibitory. The major adrenergic
receptor functions are listed below. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=174 valign=top>
  <p><span>Alpha-adrenergic
  receptor</span></p>
  </td>
  <td width=198 valign=top>
  <p><span>Beta-adrenergic
  receptor</span></p>
  </td>
 </tr>
 <tr>
  <td width=174 valign=top>
  <p><span></span></p>
  </td>
  <td width=198 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=174 valign=top>
  <p><span>Vasoconstriction
  (&#945;<sub>1</sub>)</span></p>
  <p><span>Pupillary
  dilatation (&#945;<sub>1</sub>)</span></p>
  <p><span>Intestinal
  relaxation (&#945;<sub>1</sub>)</span></p>
  <p><span>Pilomotor
  contraction (&#945;<sub>1</sub>)</span></p>
  <p><span>Bladder
  sphincter contraction(&#945;<sub>1</sub>)</span></p>
  </td>
  <td width=198 valign=top>
  <p><span>Cardiac
  acceleration (&#946;<sub>1</sub>)</span></p>
  <p><span>Increased
  myocardial contractility (&#946;<sub>1</sub>)</span></p>
  <p><span>Vasodilatation
  (&#946;<sub>2</sub>)</span></p>
  <p><span>Intestinal
  relaxation (&#946;<sub>2</sub>)</span></p>
  <p><span>Uterus
  relaxation (&#946;<sub>2</sub>)</span></p>
  <p><span>Bronchodilatation
  (&#946;<sub>2</sub>)</span></p>
  <p><span>Bladder
  wall relaxation (&#946;<sub>2</sub>)</span></p>
  <p><span>Glycogenolysis
  (&#946;<sub>2</sub>)</span></p>
  <p><span>Lipolysis
  (&#946;<sub>1</sub>)</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>There are
two types of cholinergic receptors: nicotinic and muscarinic. These receptors
are activated by acetylcholine. Nicotinic receptors are found in the synapses
between the pre- and postganglionic neurons of both the sympathetic and
parasympathetic systems and also in the membranes of skeletal muscle fibers at
the neuromuscular junction. Muscarinic receptors are found in all effector
cells stimulated by the postganglionic cholinergic neurons of the
parasympathetic nervous system. The major muscarinic receptor functions are
listed below.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=230 valign=top>
  <p style="text-align:center;"><span>Muscarinic receptor</span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><span>Pupillary
  constriction</span></p>
  <p><span>Ciliary
  muscle contraction</span></p>
  <p><span>Gland
  stimulation (nasal, lacrimal, salivary, gastric, pancreatic, sweat)</span></p>
  <p><span>Cardiac
  deceleration</span></p>
  <p><span>Decreased
  myocardial contractility</span></p>
  <p><span>Bronchoconstriction</span></p>
  <p><span>Increased
  peristalsis</span></p>
  <p><span>Bladder
  wall contraction</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct</span></b><span>. Oral decongestants
stimulate alpha-adrenergic receptors, resulting in bladder sphincter
contraction. In patients already predisposed to bladder outlet obstruction
because of prostatic hypertrophy, the administration of a nasal decongestant
can cause difficulty with urination and urinary retention. Any male patient who
is having trouble with urination should be asked about his use of nasal
decongestants. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 15-year-old boy is severely burned. Nitrogen loss occurs during the
first few days after the burn. During this period, which of the following
substances plays a major role in nitrogen loss? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Insulin</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Cortisol </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Growth hormone</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Parathyroid hormone</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Erythropoietin</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Catabolism</span> is the process by which large molecules (polymers) are
broken into smaller molecules (monomers) to produce energy. Specifically,
polysaccharides, lipids, proteins, and nucleic acids are broken down into
monosaccharides, fatty acids, amino acids, and nucleotides. The monomers may
then be used to construct new polymers or they may be broken down further to
produce energy. During the breakdown process, waste products are released.
These include lactic acid, acetic acid, carbon dioxide, ammonia, and urea. Some
of the energy released by catabolism is lost as heat; the rest is used to
synthesize adenosine triphosphate (ATP). This molecule provides the chemical
energy needed for anabolism. Hormones are important regulators of catabolism;
traditionally, they have been classified as anabolic or catabolic. The
“classic” catabolic hormones are cortisol, glucagon, and epinephrine. These are
released during periods of high stress, such as in burns, sepsis, trauma, or
surgery.<span >&nbsp; </span></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/1/11/Catabolism_schematic.svg"><span><img border=0 width=235 height=217
src="_%20Tutorials_files/image044.png"
alt="Description: File:Catabolism schematic.svg" v:shapes="Picture_x0020_347186"></span></a></p>

<p style="text-align:center;">Catabolism</p>

<p><span>Anabolism, by contrast,</span> is the process by which molecules are
constructed from smaller units. This utilizes energy, usually in the form
adenosine triphosphate, which is derived from catabolism. Anabolic processes
tend to “build up” organs and tissues. They allow growth and differentiation of
cells and an increase in body size. Examples of anabolic processes include
growth and mineralization of bone and increase in muscle mass &#8211; processes
that involve synthesis of complex molecules. The “classic” anabolic hormones
are insulin, testosterone, estrogen, and growth hormone. </p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer B is correct</b>. Major burns result in a severe catabolic
state. The rate of catabolism is proportional to the surface area burned. The
release of catabolic hormones &#8211; cortisol, glucagon, epinephrine &#8211;
triggers breakdown of carbohydrates, fats, and proteins. Cortisol triggers
protein breakdown, which causes muscle wasting and nitrogen loss. </p>

<p></p>

<p><b>Answer A is incorrect</b>. Insulin is an anabolic hormone. It promotes
glucose uptake by muscle and adipose tissue, stimulates glycogen and fatty acid
synthesis, and inhibits lipolysis and proteolysis.</p>

<p></p>

<p><b>Answer C is incorrect</b>. Growth hormone stimulates protein synthesis
and increases muscle mass and mineralization of bone.</p>

<p></p>

<p><b>Answer D is incorrect</b>. Parathyroid hormone promotes release of
calcium from bone, absorption of calcium in the kidney, and absorption of
calcium in the intestine.</p>

<p></p>

<p><b>Answer E is incorrect</b>. Erythropoietin stimulates red blood cell
production.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Each of
the following photomicrographs represents changes in the respiratory epithelium
caused by smoking. Which image illustrates squamous metaplasia? </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=462 height=291
src="_%20Tutorials_files/image046.png" alt="Description: respiratory pathology"
v:shapes="Picture_x0020_347185"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Cellular adaptation</b>
refers to changes made by a cell in response to adverse environmental changes.
The adaptation may be physiologic or pathologic. The five major types of
adaptation are atrophy, hypertrophy, hyperplasia, dysplasia, and metaplasia.</p>

<p></p>

<p><b>Atrophy</b> is a decrease
in cell size. If enough cells in an organ atrophy, the entire organ will
decrease in size. Thymus atrophy in childhood is an example of physiologic
atrophy. Skeletal muscle atrophy is a pathologic adaptation to skeletal muscle
disuse. Tissue and organs especially susceptible to atrophy include skeletal
muscle, cardiac muscle, secondary sex organs, and the brain.</p>

<p></p>

<p><b>Hypertrophy</b> is an
increase in cell size. If enough cells of an organ hypertrophy, the organ
itself will enlarge. The heart and kidneys are especially susceptible to
hypertrophy. Hypertrophy may be caused by mechanial signals (e.g., stretch) or
trophic signals (e.g., growth factors). Physiologic hypertrophy occurs in
skeletal muscle with sustained weight-bearing exercise. Pathologic hypertrophy
occurs in cardiac muscle as a result of hypertension.</p>

<p></p>

<p><b>Hyperplasia</b> is an
increase in the number of cells due to increased cell mitosis. Physiologic
hyperplasia may be compensatory or hormonal. Compensatory hyperplasia permits
tissue and organ regeneration. It is common in epithelial cells of the
epidermis and intestine, hepatocytes, bone marrow cells, and fibroblasts.
Hormonal hyperplasia occurs mainly in organs that depend on estrogen (e.g.,
endometrial cells during pregnancy). Pathologic hyperplasia is an abnormal
increase in cell division (e.g., endometriosis).</p>

<p></p>

<p><b>Metaplasia</b> occurs
when a differentiated cell type is replaced by another cell type, which may be
less differentiated. It is a reversible process. Metaplasia occurs in the
respiratory tract as a response to smoking. Bronchial cells convert from
mucus-secreting, ciliated, columnar epithelium to non-mucous-secreting,
non-ciliated, squamous epithelium. The cells may become dysplasic or cancerous
if the stimulus (e.g., cigarette smoking) is not removed.</p>

<p><b></b></p>

<p><b>Dysplasia</b> refers to
abnormal changes in cellular shape, size, and organization. Sometimes called
&quot;atypical hyperplasia,” dysplasia is not a true adaptation but, rather,
the earliest pre-cancerous lesion recognizable in a biopsy. Tissues prone to
dysplasia include cervical and respiratory epithelia. Dysplasia can be mild (low-grade),
moderate, or severe (high-grade). Mild dysplasia is at low risk of transforming
into cancer. Severe dysplasia is at high risk. In most organs, carcinoma <i>in situ</i> (CIS) is synonmyous with severe
(high-grade) dysplasia. CIS immediately precedes the development of frank
carcinoma and resembles invasive carcinoma except for the lack of basement
membrane disruption.<span >&nbsp; </span></p>

<p></p>

<p><span encountered principally in epithelia, and it is characterized by a
constellation of changes that <span>include
a loss in the uniformity of the individual cells as well as a loss in their
architectural orientation</span>. Dysplastic cells exhibit considerable
pleomorphism and often contain large hyperchromatic nuclei with a high
nuclear-to-cytoplasmic ratio. The architecture of the tissue may be disorderly.
For example, in squamous epithelium the usual progressive maturation of tall
cells in the basal layer to flattened squamous cells on the surface may be lost
and replaced by a scrambling of dark basal-appearing cells throughout the epithelium.
Mitotic figures are more abundant than usual. Frequently, they appear in
abnormal locations within the epithelium. For example, in dysplastic stratified
squamous epithelium, mitoses are not confined to the basal layers but instead
may appear at all levels, including surface cells. When dysplastic changes are
marked and involve the entire thickness of the epithelium but the lesion
remains confined by the basement membrane, it is considered a preinvasive
neoplasm and is referred to as <i>carcinoma in situ</i>. Once the tumor cells
breach the basement membrane, the tumor is said to be <i>invasive</i>. </p>

<p></p>

<p style="text-align:center;">Photomicrographs
of normal respiratory epithelium appear below.</p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span><img border=0 width=247 height=307
src="_%20Tutorials_files/image048.png" alt="Description: respiratory epithelium"
v:shapes="Picture_x0020_347184"></span></p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=353 height=264
src="_%20Tutorials_files/image050.png"
alt="Description: respiratory epithelium 2" v:shapes="Picture_x0020_347183"></span></p>

<p></p>

<p>Respiratory epithelium
lining the upper airways is classified as <i>ciliated pseudostratified columnar
epithelium.</i> Although all cells in the epithelium touch the basement
membrane and, therefore, comprise a single layer, the nuclei are not aligned in
the same plane. Thus, the epithelium appears to have several layers. The term
“pseudostratified” describes this arrangement.</p>

<p></p>

<p>The majority of cells
composing the <i>ciliated pseudostratified columnar epithelium</i> are of three
types: a) ciliated cells, b) goblet cells, and c) basal cells. The ciliated
cells are columnar epithelial cells with specialized ciliary modifications.
Goblet cells, so named because they are shaped like a wine goblet, are columnar
epithelial cells that secrete mucus. The basal cells are small, nearly cuboidal
cells that differentiate into other cells types. They respond to epithelial
injury by migrating to the denuded site and differentiating to restore the
epithelial cell layer.</p>

<p>Some of the earliest changes
in smoking-damaged respiratory epithelium include goblet cell hyperplasia <b>(A)</b>,
basal cell hyperplasia <b>(B)</b>, and squamous metaplasia <b>(C)</b>. More
ominous changes include the appearance of squamous dysplasia <b>(D)</b>,
characterized by the presence of disordered squamous epithelium, with loss of
nuclear polarity, nuclear hyperchromasia, pleomorphism, and mitotic figures.
Squamous dysplasia may, in turn, progress through the stages of mild, moderate,
and severe dysplasia. Carcinoma-in-situ (CIS) <b>(E)</b> is the stage that
immediately precedes invasive squamous carcinoma <b>(F)</b>, and apart from the
lack of basement membrane disruption in CIS, the cytologic features are similar
to those in frank carcinoma. Unless treated, CIS will eventually progress to
invasive cancer.</p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer C is correct.<span >&nbsp; </span></b>This
image illustrates<b> </b>squamous cell
metaplasia, which can occur in the respiratory tract as a response to smoking.
In squamous cell metaplasia, bronchial cells are converted from
mucus-secreting, ciliated, columnar epithelium to non-mucus-secreting,
non-ciliated, squamous epithelium.</p>

<p></p>

<p>Here’s a key to the images: <b></b></p>

<p><b><span><span>A.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><span>Goblet cell hyperplasia</span></p>

<p><b><span><span>B.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><span>Basal cell hyperplasia</span></p>

<p><b><span><span>C.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><span>Squamous metaplasia</span></p>

<p><b><span><span>D.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><span>Squamous dysplasia</span></p>

<p><b><span><span>E.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><span>Carcinoma in situ (CIS)</span></p>

<p><b><span><span>F.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><span>Squamous carcinoma</span></p>

<p><span></span></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Several
contiguous cells are labeled with a fluorescent dye that cannot cross cell
membranes. One cell is experimentally bleached with light that destroys the
dye, but the cell soon recovers dye fluorescence. This recovery is best
explained by the presence of which of the following structures between the
bleached cell and the fluorescent neighbor? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Cell
membrane</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Basal
lamina</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tight
junctions</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Desmosomes</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gap
junctions</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>In many
tissues (e.g., connective tissue), each cell is separated from the next by an
extracellular coating or matrix. In some tissues (e.g., </span><a
href="http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/A/AnimalTissues.html#epithelial"><span>epithelia</span></a><span>), however, the plasma
membranes of adjacent cells are pressed together by junctions. </span></p>

<p><span></span></p>

<p><span>There are
three major types of cellular junction: </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tight junctions</span><span> </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Anchoring junctions</span><span> (e.g., desmosomes)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Gap junctions</span><span> </span></p>

<p><a name=tight><b><span></span></b></a></p>

<p><span><b><span>Tight</span></b></span><b><span> Junctions</span></b></p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span><img border=0 width=281 height=226
src="_%20Tutorials_files/image052.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1"
v:shapes="Picture_x0020_347182"></span><span></span></p>

<p style="text-align:center;"><b><span></span></b></p>

<p style="text-align:center;"><span>Tight junction</span></p>

<p><b><span></span></b></p>

<p><span>Epithelial
cells provide the interface between masses of cells and a cavity or space (a
lumen). The part of the cell exposed to the lumen is called its <span>apical</span> surface. The rest of the cell
(i.e., its sides and base) make up the <span>basolateral</span>
surface. </span></p>

<p><span></span></p>

<p><span>Tight
junctions seal adjacent epithelial cells in a narrow band just beneath their
apical surface. They have two major functions: </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>They
prevent the passage of molecules and ions through the space between cells. (In
order to pass through the tissue, therefore, molecules must enter the cell
itself by diffusion or active transport.)<span >&nbsp;
</span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>They
block the movement of membrane proteins between the apical and basolateral
surfaces of the cell, allowing the unique function of each surface to be
preserved (e.g., receptor-mediated endocytosis can be restricted to the apical
surface, and exocytosis can be restricted to the basolateral surface.</span></p>

<p><a name=adherens><b><span></span></b></a></p>

<p><span><b><span>Anchoring</span></b></span><b><span> Junctions</span></b></p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span><img border=0 width=282 height=226
src="_%20Tutorials_files/image054.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1"
v:shapes="Picture_x0020_347181"></span><span></span></p>

<p style="text-align:center;"><span>Belt desmosome</span></p>

<p><span>Anchoring
junctions provide strong mechanical attachments between adjacent cells. They
hold epithelial cells together and bind <span>cardiac
muscle</span> cells tightly. The most common anchoring junction is the
desmosome. “Ordinary” desmosomes form spot welds between cells. “Belt”
desmosomes form a belt that encircles the cell. Anchoring junctions are built
from <span>cadherins, </span>transmembrane
proteins with extracellular segments that bind to each other and intracellular
segments that bind to stress fibers (e.g., actin, keratin). </span></p>

<p><span></span></p>

<p><span>Note: <span>Pemphigus</span> is an autoimmune disease
characterized by formation of antibodies against </span><a
href="http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/J/Junctions.html#adherens#adherens"><span>cadherins</span></a><span>. The loosening of the
adhesion between adjacent epithelial cells causes blistering. </span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Gap Ju<span>nctions</span></span></b></p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span><img border=0 width=180 height=308
src="_%20Tutorials_files/image056.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-0-323-07155-0&amp;eid=4-u1"
v:shapes="Picture_x0020_347180"></span><b><span></span></b></p>

<p style="text-align:center;"><span>Gap junction</span></p>

<p><span>Gap
junctions are intercellular channels that permit the free passage of ions and
small molecules between cells. They are cylinders constructed from six copies
of transmembrane proteins (<span>connexins)</span>.<span>&nbsp; </span>Because ions can flow through them, gap
junctions allow changes in the membrane potential to pass from cell to cell. </span></p>

<p><span></span></p>

<p><b><span>Examples:</span></b><span> </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>The
action potential in cardiac muscle flows from cell to cell through gap
junctions, allowing rhythmic contraction to occur. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>At
some “electrical synapses” in the brain, gap junctions transmit action
potentials to the postsynaptic cell without release of neurotransmitters. This
allows for faster signal transmission. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>As
birth approaches, gap junctions between smooth muscle cells in the uterus allow
for powerful, coordinated contractions.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E is correct</span></b><span>. Gap junctions are
intercellular channels that permit the free passage of small molecules between
cells.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A newborn baby undergoes chromosomal
analysis. Some cells have a 46, XY karyotype and others have a 45, X karyotype.
Which of the following mechanisms best explains this abnormality?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Nondisjunction
in mitosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Reciprocal
translocation</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Robertsonian
translocation</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Genetic imprinting</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Uniparental
disomy</span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Chromosome
abnormalities fall into two categories: numerical and structural. </span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0 width=158>
 <tr>
  <td width=158>
  <p style="text-align:center;"><b><span>Numerical</span></b><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image058.png" alt="Description:  " v:shapes="Picture_x0020_347179"></span><a
  href="http://www.ncbi.nlm.nih.gov/bookshelf/?book=hmg&amp;part=A3037&amp;rendertype=def-item&amp;id=A3393"><span>Trisomy</span></a><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image060.png" alt="Description:  " v:shapes="Picture_x0020_347178"></span><span>Monosomy</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image062.png" alt="Description:  " v:shapes="Picture_x0020_347177"></span><span>Mosaicism</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p style="text-align:center;"><b><span>Structural</span></b><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image064.png" alt="Description:  " v:shapes="Picture_x0020_347176"></span><span>Deletion</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image066.png" alt="Description:  " v:shapes="Picture_x0020_347175"></span><span>Inversion</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image068.png" alt="Description:  " v:shapes="Picture_x0020_347174"></span><span>Duplication</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image070.png" alt="Description:  " v:shapes="Picture_x0020_347173"></span><span>Insertion</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image072.png" alt="Description:  " v:shapes="Picture_x0020_347172"></span><span>Ring</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image074.png" alt="Description:  " v:shapes="Picture_x0020_347171"></span><a
  href="http://www.ncbi.nlm.nih.gov/bookshelf/?book=hmg&amp;part=A3037&amp;rendertype=def-item&amp;id=A3246"><span>Marker</span></a><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image076.png" alt="Description:  " v:shapes="Picture_x0020_347170"></span><a
  href="http://www.ncbi.nlm.nih.gov/bookshelf/?book=hmg&amp;part=A3037&amp;rendertype=def-item&amp;id=A3388"><span>Translocation</span></a><span>, reciprocal</span></p>
  </td>
 </tr>
 <tr>
  <td width=158>
  <p><span><img border=0 width=11 height=3
  src="_%20Tutorials_files/image078.png" alt="Description:  " v:shapes="Picture_x0020_347169"></span><a
  href="http://www.ncbi.nlm.nih.gov/bookshelf/?book=hmg&amp;part=A3037&amp;rendertype=def-item&amp;id=A3388"><span>Translocation</span></a><span>, Robertsonian</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><a name=Background></a><b><span>Abnormalities of
Chromosome Number</span></b></p>

<p><b><span></span></b></p>

<p><i><span>Trisomy</span></i><span>
is a type of aneuploidy (abnormal chromosome number) in which there are three
copies of a particular chromosome (instead of the usual two). Trisomy is not
usually compatible with life. An exception is trisomy 21, the cause of Down
syndrome. </span></p>

<p><span></span></p>

<p><i><span>Monosomy</span></i><span>
is a type of aneuploidy in which there is one copy of a chromosome (instead of
the usual two). This is almost always fatal. The only complete monosomy
compatible with life is Turner syndrome, in which there is one X chromosome
(instead of the usual pair). </span></p>

<p><span></span></p>

<p><span>Aneuploidy
is usually caused by <i>meiotic <span>nondisjunction</span></i><span>, which</span> is an error in the production
of germ cells (eggs and sperm). To produce germ cells with 23 chromosomes,
cells in the ovary and testes (each with 46 chromosomes) undergo two separate
cell divisions: meiosis I and meiosis II. With nondisjunction, the chromosomes
do not segregate properly during one of these divisions, and one of the
daughter cells ends up with too many chromosomes while the other ends up with
too few. </span></p>

<p><span></span></p>

<p><span>The
origin of the extra chromosome depends on the timing of nondisjunction. If
nondisjunction occurs in meiosis I, the germ cell will have two different
copies of a certain chromosome, one from the individual’s mother and one from
the father (i.e., the future embryo’s grandmother and grandfather). If
nondisjunction occurs in meiosis II, the germ cell will have two identical
copies of a chromosome, either from the individual’s mother or father (i.e.,
the future embryo’s grandmother or grandfather). </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=345 height=289
src="_%20Tutorials_files/image080.jpg" alt="Description: meiotic nondisjunction"
v:shapes="Picture_x0020_347168"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Meiotic Nondisjunction</span></p>

<p><span></span></p>

<p><span></span></p>

<p><a name="Abnormalities_of_Chromosome_Structure"></a><b><span>Abnormalities of Chromosome Structure</span></b></p>

<p><b><span></span></b></p>

<p><span>Abnormalities
of chromosomal structure can be either <i>unbalanced</i>
or <i>balanced</i>. Unbalanced
rearrangements have missing or extra genetic material, which usually leads to
major abnormalities. Balanced rearrangements, by contrast, involve no extra or
missing genetic material and may occur in healthy individuals.</span></p>

<p><span></span></p>

<p><span>Unbalanced
rearrangements include <i>deletions</i>, <i>duplications</i>, <i>marker</i> or <i>ring</i>
chromosomes, and <i>isochromosomes</i>. A
deletion results in loss of a chromosomal segment. A duplication results in
repetition of a chromosome segment. Generally, duplications are less harmful
than deletions. A marker chromosome is a very small, unidentified chromosome
that can be seen on a karyotype. Individuals with a marker chromosome usually
have this chromosome in addition to the normal 46 chromosomes. A ring
chromosome occurs when a chromosome is broken in two places and the ends unite
(with or without loss of genetic information). An <span>isochromosome</span> is a chromosome that has lost one of its arms and
replaced it with an exact copy of the other arm. (A person with 46 chromosomes
containing an isochromosome has a single copy of one arm, and three copies of
the other arm.) </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=250 height=182
src="_%20Tutorials_files/image082.png" alt="Description: three" v:shapes="Picture_x0020_347167"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp; </span>Deletion<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>Duplication<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>Inversion</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=316 height=243
src="_%20Tutorials_files/image084.png" alt="Description: marker" v:shapes="Picture_x0020_347166"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Marker chromosome (mar)</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=388 height=250
src="_%20Tutorials_files/image086.png" alt="Description: ring" v:shapes="Picture_x0020_347165"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Ring Chromosome</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=204 height=234
src="_%20Tutorials_files/image088.png" alt="Description: isochromosome" v:shapes="Picture_x0020_347164"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Isochromosome</span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Balanced
rearrangements include <i>inversions</i> (<i>pericentric</i> or <i>paracentric</i>) and <i>translocations</i>
(<i>Robertsonian or reciprocal</i>). An
inversion occurs when there are two breaks in a chromosome and the area in
between is inverted (turned around) and reinserted. The inversion is called
pericentric if the centromere is included and paracentric if the centromere is
not included. Many inversions in the general population are considered normal
variants. </span></p>

<p><span></span></p>

<p><span>Translocations</span><span> are of two major types. A Robertsonian
translocation occurs when two acrocentric chromosomes fuse near the centromere
region with loss of the short arms. (An acrocentric chromosome is a chromosome
with the centromere near one end.) The resulting balanced karyotype has only 45
chromosomes, including the translocation chromosome, which, in effect, is made
up of the long arms of two chromosomes.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=249 height=139
src="_%20Tutorials_files/image090.png" alt="Description: robertsonian.gif"
v:shapes="Picture_x0020_347163"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Robertsonian translocation</span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span>A
reciprocal translocation involves the breakage of nonhomologous chromosomes
with an even exchange of broken-off segments. Usually two chromosomes are
involved and the total number of chromosomes is unchanged. Reciprocal
translocations are relatively common and are usually harmless. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=210 height=164
src="_%20Tutorials_files/image092.png" alt="Description: reciprocal.png"
v:shapes="Picture_x0020_347162"></span><span></span></p>

<p style="text-align:center;"><a name=Mosaicism></a><span>Reciprocal Translocation</span></p>

<p><span></span></p>

<p><b><span>Mosaicism</span></b></p>

<p><b><span></span></b></p>

<p><span>Most
chromosomal anomalies appear in every cell of the body. However, sometimes
different cells have different chromosomal constitutions. For example, a person
may have 46 chromosomes in half of their cells and 45 in the other half. This
is known as mosaicism. </span></p>

<p><span></span></p>

<p><span>Mosaicism
is usually caused by <i>mitotic
nondisjunction</i>. The effects of mosaicism depend on the timing of
nondisjunction, the chromosomal anomaly, the fraction of the body's cells
carrying the anomaly, and the tissues affected. Generally a person with
mosaicism is less severely affected than someone carrying the genetic anomaly
in every cell.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Genetic imprinting and
Uniparental disomy</span></b></p>

<p><b><span></span></b></p>

<p><i><span>Genomic imprinting</span></i><span> is a phenomenon in
which expression of alleles is influenced by chemical changes to the DNA, such
as covalent modification or methylation, rather than changes to the sequence
itself. Genomic imprinting is a reversible type of gene inactivation because
the sequence is not changed.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><i><span>Uniparental disomy</span></i><span> is a phenomenon in
which both paired chromosomes originate from a single parent. (Normally, the
chromosomes originate from different parents.) The presence of two identical
chromosomes from the same parent is called <i>isodisomy</i>.
The presence of different chromosomes from the same parent is called <i>heterodisomy</i>. Prader-Willi syndrome
(“rag doll” syndrome) and Angelman syndrome (“happy puppet” syndrome) are the
principal examples of uniparental disomy. </span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=305 height=209
src="_%20Tutorials_files/image094.png" alt="Description: isodisomy" v:shapes="Picture_x0020_347161"></span><span></span></p>

<p><span></span></p>

<div>

<p><b><span>Testing</span></b></p>

<p><span></span></p>

<p><span>A fetus can be tested
for chromosomal abnormalities using amniocentesis and chorionic villus
sampling. With both techniques, pictures of the chromosomes are taken,
producing a karyotype.</span></p>

<p><span>The chromosomes are
evaluated for size and structure.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct</span></b><span>. M<span>osaicism</span>
denotes the presence of two populations of cells with different genotypes in a
single individual. It is caused by mitotic nondisjunction.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. A reciprocal translocation involves breakage
of nonhomologous chromosomes with an even exchange of broken-off segments.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. A Robertsonian translocation occurs when two
acrocentric chromosomes fuse near the centromere region with loss of the short
arms.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>.<i> </i>Genomic
imprinting is a phenomenon in which the expression of alleles is influenced by
chemical changes to the DNA (e.g., methylation) rather than changes in the
sequence itself.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Uniparental disomy occurs when both paired
chromosomes originate from a single parent. </span></p>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
1-week-old newborn has microcephaly, intrauterine growth retardation, widely
spaced eyes, and a cat-like cry. Which of the following karyotypes is most
likely? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>47,XX,+21</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>45,X</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>47,XXY</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>46,XX,del(5)(p15)</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>69,XXY</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Down syndrome</b></p>

<p><b></b></p>

<p>Down syndrome is
characterized by the presence of an extra copy of genetic material from
chromosome 21, either in whole (trisomy 21) or in part (such as due to
translocations). The syndrome is usually associated with impaired cognitive
ability and physical growth. Features include small chin, round face, big
tongue, almond-shapes eyes, upslanting palpebral fissures, short limbs, a
single transverse palmar crease, poor muscle tone, and a larger than normal
space between the big and second toes. Affected individuals are at higher risk
of congenital heart defects, gastroesophageal reflux disease, recurrent ear
infections, obstructive sleep apnea, and thyroid dysfunction. Three cytogenetic
variants cause Down syndrome: trisomy 21, chromosomal translocation, and
mosaicism. </p>

<p><span></span></p>

<p><i><span>Trisomy 21</span></i><span> accounts for nearly 95% of all patients
with Down syndrome and is due to meiotic nondisjunction. With nondisjunction, a
gamete (<span>i.e.</span>, a sperm or egg
cell) is produced with an extra copy of chromosome 21; the gamete thus has 24
chromosomes. When combined with a normal gamete from the other parent, the
embryo now has 47 chromosomes, with three copies of chromosome 21. The
likelihood of nondisjunction in the mother increases with maternal age.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><i>Robertsonian translocation</i> in one of the parents is responsible for
2-3% of Down cases. The long arm of chromosome 21 becomes attached to another
chromosome, often chromosome 14. A person with such a translocation is phenotypically
normal. During reproduction, normal disjunctions have a significant chance of
creating a gamete with an extra chromosome 21, producing a child with Down
syndrome. “Translocation Down syndrome” is often referred to as “<span>familial Down syndrome</span>.” </p>

<p></p>

<p><i><span>Mosaicism</span></i><span> explains 1-2% of Down cases. In mosaic Down,
some cells in the body are normal and others have trisomy 21. This is due to
mitotic nondisjunction during an early cell division in a normal embryo.
Individuals with mosaic Down have a normal cell line and usually milder
physical stigmata.</span></p>

<p><span></span></p>

<p><b>Turner syndrome</b></p>

<p><b></b></p>

<p><span>Turner syndrome </span>encompasses several conditions, of which monosomy
X (absence of an entire sex chromosome, the Barr body) is most common. Monosomy
X is caused by meiotic nondisjunction in either parent. In some individuals
with Turner syndrome, the X chromosome is missing in some cells but not others,
a condition referred to as mosaicism. Mosaicism is caused by mitotic
nondisjunction. </p>

<p></p>

<p>Affected individuals are
phenotypic females with features that include short stature, broad chest, low
hairline, low-set ears, and webbed neck. Gonadal dysfunction (non-working
ovaries) results in amenorrhea and sterility. Other potential findings include
cognitive deficits, congenital heart disease, diabetes, hypothyroidism, and
difficulty with vision and hearing. </p>

<p></p>

<p></p>

<p></p>

<p><b>Klinefelter syndrome</b></p>

<p><b></b></p>

<p>Klinefelter syndrome is the
most common chromosomal disorder to be associated with male hypogonadism and
infertility. The “classic” karyotype is 47, XXY, although some individuals have
additional X and Y chromosomes. The syndrome is characterized by hypogonadism
(small testes, aspermia), gynecomastia in late puberty, psychosocial problems,
and elevated urinary gonadotropin levels.</p>

<p></p>

<p>The XXY karyotype can be
caused by nondisjunction in the first meiotic division in the mother,
nondisjunction in the second meiotic division in the mother, or nondisjunction
in the first meiotic division of the father. The XXY karyotype cannot be caused
by nondisjunction in the second meiotic division of the father. The likelihood
of nondisjunction in the mother increases with maternal age.</p>

<p></p>

<p><b>Patau syndrome</b></p>

<p><b></b></p>

<p>Patau syndrome (trisomy 13)
is the least common and most severe of the viable autosomal trisomies. Median
survival is fewer than 3 days. </p>

<p></p>

<p><b>Edwards syndrome</b></p>

<p><b></b></p>

<p><span>Edwards syndrome</span> (trisomy 18) is the second most common autosomal
trisomy (after Down syndrome). The survival rate is very low due to heart and
kidney abnormalities.</p>

<p></p>

<p><b>Cri du chat syndrome</b></p>

<p><b></b></p>

<p><span>Cri du chat syndrome</span>, also known as <span>Lejeune syndrome</span>, is a rare genetic disorder caused by partial
deletion of the short arm of chromosome 5. Its name refers to the cat-like
“meow” of affected children (cry of the cat, in French). Features include
microcephaly, mental retardation, intrauterine growth retardation, and widely
spaced eyes. </p>

<p><b></b></p>

<p><b>Prader-Willi syndrome</b></p>

<p><b></b></p>

<p>Prader-Willi syndrome is a
disorder caused by loss of expression of genes on <i>paternally</i> derived chromosome 15. It is an example of genomic
“imprinting,” in which certain genes are expressed in a parent-of-origin-specific
manner. Features include diminished fetal activity, obesity, mental
retardation, hypotonia, short stature, and small hands and feet.</p>

<p></p>

<p><b>Angelman syndrome</b></p>

<p><b></b></p>

<p>Angelman syndrome is a
disorder caused by loss of expression of genes on <i>maternally</i> derived chromosome 15. It is an example of genomic
“imprinting,” in which certain genes are expressed in a
parent-of-origin-specific manner. Features include intellectual and
developmental delay, seizures, jerky movements (especially hand-flapping),
frequent laughter or smiling, and usually a happy demeanor.</p>

<p><b>Triploidy</b></p>

<p><b></b></p>

<p>Triploidy is a chromosomal
abnormality where three complete sets of the haploid genome instead of the
normal two sets are present within the conceptus. A triploid conceptus will
possess 69 chromosomes. Generally, triploidy is incompatible with life, and is
associated with miscarriage and hydatidiform moles.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect.</span></b><span><span>&nbsp; </span>47,XX,+21 (trisomy 21) corresponds to
Down syndrome.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect.</span></b><span><span>&nbsp; </span>45,X, (monosomy X) corresponds to Turner
syndrome.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect.</span></b><span><span>&nbsp; </span>47,XXY corresponds to Klinefelter
syndrome.</span></p>

<p><span></span></p>

<p><b><span>Answer D is correct.</span></b><span><span>&nbsp;&nbsp;&nbsp;&nbsp; </span>46,XX,del(5)(p15)
corresponds to cri du chat syndrome. The designation indicates deletion of band
15 on the short arm (p) of chromosome 5. </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect.</span></b><span><span>&nbsp; </span>69,XXY is an example of triploidy.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
21-year-old man is admitted to the emergency room with fever, headache,
somnolence, irritability, muscle aches, and vomiting of 24 hours duration. He
has been hospitalized three times prior to this for meningococcal meningitis.
One of his brothers was hospitalized six months ago with meningococcal
meningitis. On physical examination, the patient is disoriented and lethargic.
His temperature is 102.6<sup>o </sup>F; blood pressure is 90/60 mm Hg. Nuchal
rigidity is noted. Petechiae are present on the upper and lower extremities.
Cerebrospinal fluid (CSF) tests show the following:</span></p>

<p><span></span></p>

<p><span>Color<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>turbid
</span></p>

<p><span>Cell count<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span> <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>5300/mm<sup>3</sup>
(normal: 0-5/mm<sup>3</sup>)</span></p>

<p><span>97% neutrophils</span></p>

<p><span>3% monocytes</span></p>

<p><span>rare red blood cells</span></p>

<p><span>Glucose<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>70
mg/dL (normal: 40-70 mg/dL) </span></p>

<p><span>Protein<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>45
mg/dL (normal: &lt;40 mg/dL) </span></p>

<p><span></span></p>

<p><span>CSF Gram
stain shows gram-negative diplococci. The patient is treated with ceftriaxone,
which leads to clinical improvement. Blood cultures grow <i>Neisseria
meningitidis</i>. After immunization against pneumococcus, meningococcus, and <i>Haemophilus
influenzae</i>, the patient has no more episodes of meningitis.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>Which of
the following conditions has most likely predisposed the patient to recurrent
infection?</span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Bruton’s
agammaglobulinemia</span></p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Complement
C2 deficiency</span></p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Terminal
complement deficiency</span></p>

<p><span>D.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Asplenia</span></p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Chronic
granulomatous disease</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>The complement system helps,
or “complements,” the ability of antibodies and phagocytic cells to clear
pathogens. It is part of the innate immune system, which is not adaptable and
does not change over the course of an individual's life. However, it can be
recruited and brought into action by the adaptive immune system.</p>

<p></p>

<p>The complement system
consists of a number of small proteins found in the blood, generally
synthesized by the liver, and normally circulating as inactive precursors
(pro-proteins). When stimulated by one of several triggers, proteases in the
system cleave specific proteins to release cytokines and initiate an amplifying
cascade of further cleavages. The end-result is massive amplification of the
response and activation of the cell-killing membrane attack complex (MAC). </p>

<p></p>

<p>Over 25 proteins and protein
fragments make up the complement system, including serum proteins, serosal
proteins, and cell membrane receptors. Most of these proteins are synthesized
by hepatocytes, but significant numbers are produced by tissue macrophages,
blood monocytes, and epithelial cells. Complement accounts for about 5% of the
globulin fraction of blood serum. The basic functions of complement are listed
below.</p>

<p></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Opsonization
- enhancing phagocytosis of antigens </span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chemotaxis
- attracting macrophages and neutrophils </span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lysis
- rupturing membranes of foreign cells </span></p>

<p><span></span></p>

<p>Three biochemical pathways
activate the complement system: the classical pathway, the alternative pathway,
and the mannose-binding lectin (MBL) pathway (Figure 1).</p>

<p><span>All three
pathways generate variants of the protease, C3-convertase. The classical
pathway typically requires antigen/antibody complexes for activation (specific
immune response), whereas the alternative and mannose-binding lectin (MBL)
pathways are activated by C3 hydrolysis or by antigens without the presence of
antibodies (non-specific immune response). </span></p>

<p><span></span></p>

<p><span>In all
three pathways, a C3-convertase cleaves and activates C3, creating C3a and C3b.
This causes a cascade of further cleavage and activation. C3b binds to the
surface of pathogens, leading to greater internalization by phagocytic cells
(opsonization). <span C5a, and, to a lesser extent, C4a are
called “anaphylatoxins” because they stimulate histamine release from mast
cells, which increases vascular permeability and causes vasodilation. C5a is a
powerful chemotactic agent for neutrophils, monocytes, eosinophils, and
basophils. </span>C5b initiates the membrane attack pathway, which results in
the membrane attack complex (MAC), consisting of C5b, C6, C7, C8, and polymeric
C9. The MAC is the cytolytic end-product of the complement cascade; it forms a
transmembrane channel, which causes osmotic lysis of the target cell (Figure
2).</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Figure 1</span></p>

<p style="text-align:center;"><span><img border=0 width=272 height=235
src="_%20Tutorials_files/image096.png"
alt="Description: http://www.surgicalnotes.co.uk/files/images/complement.gif"
v:shapes="Picture_x0020_347160"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Figure 2</span></p>

<p style="text-align:center;"><span><img border=0 width=471 height=469
src="_%20Tutorials_files/image098.png" alt="Description: 008006" v:shapes="Picture_x0020_347159"></span><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct</span></b><span>.<span> </span>Complement deficiencies in the late phase can
compromise formation of the membrane attack complex (MAC) and inhibit lysis of
target cells. The problem may not be apparent until the late teenage years.
Patients with terminal complement deficiency often have recurrent infections
with <i>Neisseria meningitidis</i>, which can be fatal. It is not unusual for
patients to have recurrent infections with the same serotype, usually Y or
W135. In this vignette, the patient had a deficiency of C8.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
A is incorrect</span></b><span>.
Patients with Bruton’s agammaglobulinemia usually suffer from recurrent
pyogenic bacterial infections in the first year of life due to lack of
opsonizing antibodies. The defect is in the gene coding for Bruton’s tyrosine
kinase, an enzyme essential to B cell, but not T cell, development.<span>&nbsp; </span>T cell numbers and function are normal,
so patients typically do not have problems with viral or other intracellular
infections.<span >&nbsp; </span>Most cases are
X-linked, affecting predominantly males, although females with two defective
genes will have the disease. </span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect</span></b><span>.
Complement deficiencies in the early phase (e.g., C2) can result in poor
opsonization and increased susceptibility to infection. This is usually
observed early in life (not in a 21-year-old, as in this case). Any deficiency
of early components of the classical, alternative, or MBL (mannose-binding
lectin) pathways &#8211; or in C3b itself &#8211; can compromise opsonization.</span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect</span></b><span>.
Asplenic patients are at a high risk for infection with encapsulated
bacteria.<span >&nbsp; </span>The spleen plays an
important role in the removal of opsonized bacteria, senescent cells, and other
particles, such as immune complexes. Asplenic infants under six months of age
are susceptible to Gram-negative pathogens such as <i>Escherichia coli</i> and <i>Klebsiella</i>,
whereas older infants and adults are susceptible to <i>Streptococcus
pneumoniae, Haemophilus influenza type b, </i>and <i>Neisseria meningitidis</i>.</span></p>

<p><span></span></p>

<p><b><span>Answer
E is incorrect</span></b><span>.
Patients with Chronic Granulomatous Disease (CGD) are not unduly susceptible to
infection with <i>Neisseria meningitidis</i>. CGD results from a defect in the
phagocyte oxidase enzyme complex, which results in deficient production of
reactive oxygen species in phagocytes. These ions are important in the
bactericidal activity of phagocytes. Patients with CGD disease are susceptible
to bacterial and fungal infections, particularly with catalase-positive
organisms. These include <i>Staphylococcus aureus, Aspergillus fumigatus, </i>and<i>
Candida albicans</i>.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 52-year-old man with
hepatic cancer is treated with a new chemotherapeutic agent that, as a side
effect, blocks kinesin. One week later, he develops skeletal muscle weakness.
Which of the following most likely explains his weakness?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp; </span></span>Decrease
in the number of pre-synaptic neurotransmitter vesicles</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span>Decrease
in the number of post-synaptic neurotransmitter receptors</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span>Decrease
in pre-synaptic neuron calcium permeability</p>

<p><span>D.<span>&nbsp;&nbsp; </span></span>Impaired
motorneuron action potential conduction</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span>Impaired
skeletal muscle action potential conduction</p>

<p></p>

<p><span>&nbsp; </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>The <span>cytoskeleton</span> is a cellular &quot;scaffolding&quot; or
&quot;skeleton&quot; within the cytoplasm. It is composed of protein and plays
an important role in both intracellular transport (e.g., the movement of
vesicles and organelles) and cellular division. Eukaryotic cells contain three
main kinds of cytoskeletal filaments: microfilaments, intermediate filaments,
and microtubules. (Microfilaments and intermediate filaments are the “cables”;
microtubules are the “support beams.”)<span >&nbsp;
</span></p>

<p></p>

<p><span (actin filaments)<b> </b>a</span>re the thinnest filaments of
the cytoskeleton. They are composed of linear polymers of actin subunits, which
generate force by elongation at one end and shrinkage at the other, causing net
movement of the intervening strand. Actin filaments serve as tracks for the
movement of myosin molecules, which attach to the microfilaments and
&quot;walk&quot; along them.</p>

<p></p>

<p><i><span>Intermediate filaments</span></i><span> are more heterogeneous
and stable than actin filaments. Like actin, they maintain cell shape by
bearing tension. They anchor organelles, provide structural support for the
nuclear lamina and sarcomere, and participate in some cell-cell and cell-matrix
junctions.</span></p>

<p><span></span></p>

<p><span>The
following proteins are found in various intermediate filaments:</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>vimentins,
which provide structural support to many cells </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>keratin,
found in skin, hair, and nails </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>neurofilaments,
found in neural cells </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>lamin,
which gives structural support to the nuclear envelope</span></p>

<p><i><span></span></i></p>

<p><i><span>Microtubules</span></i><span> are hollow cylinders that play a key
role in the mitotic spindle and in intracellular transport. They are comprised
of polymers of alpha and beta tubulin and are typically organized by the
centrosome. Microtubules employ proteins called kinesins and dyneins to
transport vesicles and organelles (e.g., mitochondria) within the cell. </span></p>

<p><span></span></p>

<p><span>Kinesins
transport cargo in an anterograde direction (usually from the cell center to
the periphery). Dyneins transport cargo in a retrograde direction (usually from
the periphery to the center). Kinesins and dyneins “walk”unidirectionally along
microtubule tracks, using one molecule of ATP at each step. Thse movements
allow mitosis, meiosis, and intracellular transport (e.g., axonal transport) to
occur. </span></p>

<p><span></span></p>

<p><span>To
transmit nerve impulses, neurons release neurotransmitters from the terminal of
the axon. The neuron must constantly supply new materials&#8197;to the terminal
to replenish substances lost by exocytosis. Molecules must be synthesized in
the cell body and transported down the axon (in some cases, several meters in
length) to the synapse. This process of axonal transport occurs on
microtubules. <span>Anterograde transport
using </span>kinesins proceeds from the cell body to the synapse and is
responsible for axonal growth and renewal of synaptic vesicles. R<span>etrograde transport, by contrast, is used to
move</span> “old” materials from the synapse to cell body where they can be degraded
by lysosomes. </span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct</span></b><span>. Kinesins interact with
microtubules to move “cargo” (e.g., vesicles, organelles) in an anterograde
direction (usually from the cell body to the periphery). In neurons, they
transport vesicles (e.g., neurotransmitter vesicles) from the cell body, where
they are manufactured, to the synapse, where they are released. Interference
with this process by a chemotherapeutic agent would decrease the number of
pre-synaptic neurotransmitter vesicles.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An
11-month-old girl is developmentally delayed and has had three seizures in the
past month. Her skin is fair and her hair is lighter in color than that of
other family members. Her diapers have a musty odor. She was born at home and
did not undergo neonatal screening. Which of the following substances will most
likely be found in high concentrations in the urine?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Phenylacetic
acid</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Isoleucine</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Homocysteine</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Homogentisic
acid</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Phenylketonuria
(PKU) is an autosomal recessive disorder and one of the most common disorders
of amino acid metabolism. The most important disorders of amino acid metabolism
are listed below.</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=194 valign=top>
  <p><span>Disorders
  of Amino Acid Metabolism</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p style="text-align:center;"><span>Phenylketonuria</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p style="text-align:center;"><span>Maple Syrup Urine Disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p style="text-align:center;"><span>Homocystinuria</span></p>
  </td>
 </tr>
 <tr>
  <td width=194 valign=top>
  <p style="text-align:center;"><span>Tyrosinemia</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>Hereditary
disorders of amino acid processing can result from defects either in the
breakdown of amino acids or in the body's ability to get amino acids into
cells. Because these disorders cause symptoms early in life, newborns are
routinely screened for several common ones. In the U.S., newborns are commonly
screened for phenylketonuria, maple syrup urine disease, homocystinuria, and
tyrosinemia.</span></p>

<p><span></span></p>

<p><b><span>PHENYLKETONURIA (PKU)<a
name=sec23-ch282-ch282c-1447></a><span></span></span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1447a></a><a name=sec23-ch282-ch282c-1448></a><span>Phenylketonuria (PKU) is
a disorder that causes a buildup of the essential amino acid phenylalanine.
(Essential amino acids cannot be synthesized in the body and must be consumed
in food.) Excess phenylalanine is normally converted to tyrosine, another amino
acid, and eliminated from the body. Without the enzyme that converts it to
tyrosine (phenylalanine hydroxylase), phenylalanine builds up in the blood and
is toxic to the brain, causing intellectual disability. PKU is usually caused
by deficiency of phenylalanine hydroxylase; however, rare cases have been
associated with impaired metabolism of biopterin, an essential cofactor in the
phenylalanine hydroxylase reaction. </span></p>

<p><span></span></p>

<p style="text-align:center;"><b><span><img border=0 width=186 height=194
src="_%20Tutorials_files/image100.png" v:shapes="Picture_x0020_347158"></span></b><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><a name=sec23-ch282-ch282c-1448a></a><a name=Symptoms></a><b><span>Symptoms</span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1450></a><span>Newborns with PKU rarely have symptoms right
away, although sometimes they are sleepy or eat poorly. If not treated, affected
infants progressively develop intellectual disability over the first few years
of life. Other symptoms include seizures, nausea and vomiting, eczema-like
rash, lighter skin and hair than their family members, aggressive or
self-injurious behavior, hyperactivity, and psychiatric symptoms. Untreated
children often give off a musty body and urine odor as a result of a by-product
of phenylalanine (phenylacetic acid) in the urine and sweat.</span></p>

<p><span></span></p>

<p><a name=sec23-ch282-ch282c-1450a></a><a name=Diagnosis></a><b><span>Diagnosis</span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1450b></a><span>PKU is usually diagnosed with a blood test.<a
name=sec23-ch282-ch282c-1450c></a> Amniocentesis or chorionic villus sampling
with DNA analysis can be done to determine whether a fetus has the disorder.<a
name=sec23-ch282-ch282c-1450d></a> </span></p>

<p><span></span></p>

<p><a name=sec23-ch282-ch282c-1450e></a><a name=Prognosis></a><b><span>Prognosis</span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1450f></a><span>A phenylalanine-restricted diet, if started
early and maintained well, allows for normal development. However, if very
strict control of the diet is not maintained, affected children may begin to
have difficulties in school.<a name=sec23-ch282-ch282c-1450g></a> A
phenylalanine-restricted diet should continue for life, otherwise intelligence
may decrease and neurologic and psychiatric problems may ensue.</span></p>

<p><span></span></p>

<p><a name="Prevention%0Aand_Treatment"></a><a
name=sec23-ch282-ch282c-1450h></a><b><span>Prevention and Treatment</span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1451></a><span>To prevent intellectual disability, people must
restrict phenylalanine intake (but not eliminate it altogether because people
need some phenylalanine to live) beginning in the first few weeks of life.
Because all natural sources of protein contain too much phenylalanine for
children with PKU, affected children cannot have meat, milk, or other common
foods that contain protein. Instead, they must eat a variety of
phenylalanine-free processed foods, which are specially manufactured.
Low-protein natural foods, such as fruits, vegetables, and restricted amounts
of certain grain cereals can be eaten. Special nutritional products, including
infant formula without phenylalanine, are also available. </span></p>

<p><span></span></p>

<p><a name=sec23-ch282-ch282c-1454></a><b><span>Maple Syrup Urine
Disease</span></b></p>

<p><b><span></span></b></p>

<p><a
name=sec23-ch282-ch282c-1454a></a><a name=sec23-ch282-ch282c-1455></a>Maple
syrup urine disease (MSUD), also called branched-chain ketoaciduria, is an
autosomal recessive metabolic disorder affecting branched-chain amino acids.
The condition gets its name from the distinctive sweet odor of affected
infants’ urine. </p>

<p></p>

<p>MSUD is caused by a
deficiency of the branched-chain alpha-keto dehydrogenase complex (BCKDH),
leading to a buildup of the branched-chain amino acids (leucine, isoleucine,
and valine) and their toxic by-products in the blood and urine.</p>

<p></p>

<p>The disease is characterized
by the presence of sweet-smelling urine, with an odor similar to that of maple
syrup. Infants with this disease seem healthy at birth but if left untreated
suffer severe brain damage and eventually die. From early infancy, symptoms
include poor feeding, vomiting, dehydration, lethargy, hypotonia, seizures,
hypoglycemia, ketoacidosis, and neurological decline.</p>

<p></p>

<p><a name=sec23-ch282-ch282c-1457></a><span>In the U.S., newborns are routinely screened for
maple syrup urine disease with a blood test.<a name=sec23-ch282-ch282c-1458></a>
Children with the disease must consume a special artificial diet that is low in
three amino acids (leucine, isoleucine, and valine). </span></p>

<p><span></span></p>

<p><a name=sec23-ch282-ch282c-1459></a><b><span>Homocystinuria</span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1459a></a><a name=sec23-ch282-ch282c-1460></a><span>Homocystinuria, also
called cystathionine beta synthase deficiency, is an autosomal recessive
disorder. Children with the condition are unable to metabolize the amino acid
homocysteine, which, along with certain toxic by-products, builds up to cause a
variety of symptoms. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=385 height=204
src="_%20Tutorials_files/image102.png" v:shapes="Picture_x0020_347157"></span><span></span></p>

<p><span></span></p>

<p><a name=sec23-ch282-ch282c-1461></a><span></span></p>

<p><span>Infants
with this disorder are normal at birth. Early symptoms begin after three years
of age and include dislocation of the lens of the eye. Most children have
skeletal abnormalities, including osteoporosis. Children are usually tall and
thin with a curved spine, chest deformities, elongated limbs, and long,
spiderlike fingers. Homocystinuria has several features in common with Marfan syndrome,
but unlike Marfan syndrome in which the joints tend to be “loose,” the joints
in homocystinuria tend to be “tight.” Without early diagnosis and treatment,
psychiatric disorders and intellectual disability occur. Homocystinuria causes
a hypercoagulable state, resulting in strokes and other thromboembolic events. <a
name=sec23-ch282-ch282c-1462></a>In the U.S., newborns are routinely screened
for homocystinuria with a blood test. </span></p>

<p><a name=sec23-ch282-ch282c-1463></a><span></span></p>

<p><a name=sec23-ch282-ch282c-1464></a><b><span>Tyrosinemia</span></b></p>

<p><b><span></span></b></p>

<p><a name=sec23-ch282-ch282c-1464a></a><span>There are three types of tyrosinemia. Each is <a
name=sec23-ch282-ch282c-1465></a>characterized by deficiency of a specific
enzyme involved in the metabolism of tyrosine. Accumulation of toxic
by-products may result in liver failure, renal failure, and mental retardation.
</span></p>

<p><b><span>Answer A is correct</span></b><span>. Seizures, fair skin,
light-colored hair, a musty body odor, and developmental delays suggest a
diagnosis of phenylketonuria (PKU). PKU is caused by deficiency of
phenylalanine hydroxylase, the enzyme that converts phenylalanine to tyrosine.
Phenylacetic acid appears in high concentrations in the urine.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Isoleucine is a branched-chain amino acid. Patients with
maple syrup urine disease have an accumulation of branched-chain amino acids
(leucine, isoleucine, and valine) due to a deficiency in </span>branched-chain
alpha-keto dehydrogenase complex<span>. Symptoms include po</span>or
feeding, vomiting, dehydration, lethargy, hypotonia, seizures, hypoglycemia,
ketoacidosis, and neurological decline. <span>The urine
smells sweet, not musty as in phenylketonuria.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Homocysteine
accumulates in patients with cystathionine beta synthase deficiency
(homocystinuria). This results in a Marfan-like syndrome. Symptoms include
dislocation of the lens of the eye; tall, thin body habitus; curved spine;
chest deformity; elongated limbs; and long, spiderlike fingers. Patients with
homocystinuria are predisposed to thromboembolic events. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Homogentisic acid
appears in the urine of patients with alkaptonuria (<span>black urine disease),</span> which is a rare, autosomal recessive
disorder of phenylalanine and tyrosine metabolism. A defect in the enzyme
homogentisate</span><a
href="http://en.wikipedia.org/wiki/Homogentisate_1,2-dioxygenase"
title="Homogentisate 1,2-dioxygenase"></a><span> 1, 2-dioxygenase results in accumulation of
homogentisic acid. This leads to ochronosis (blue or brownish-blue
discoloration of cartilage and connective tissue, especially in the ears,
sclerae, and joints). Patients with alkaptonuria have black urine, skin
pigmentation, and arthritis. Heart valve deformities and kidney stones are
common.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An inherited metabolic disorder is characterized by increased
concentrations of hepatic glycogen and no detectable increase in glucose levels
after oral administration of fructose. Deficiency of which of the following
enzymes is most likely?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Glucokinase</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Fructokinase</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Glucose-6-phosphatase</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Phosphoglucomutase </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Glycogen synthase</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Glycogen storage disease type I</span><span> (<span>GSD I</span>),
or <span>von Gierke's disease</span>, is the
most common glycogen storage disease. It is an autosomal recessive disease
caused by deficiency of glucose-6-phosphatase. This deficiency inhibits two
pathways needed to produce glucose in the liver: glycogenolysis and
gluconeogenesis. The result is hypoglycemia, which occurs during periods of
fasting. Glycogen accumulates in the liver and kidneys, causing enlargement of
these organs. </span></p>

<p><span></span></p>

<p>Hepatic glycogen serves as a
form of rapidly accessible glucose, allowing blood glucose levels to be maintained
between meals. For about three hours after a carbohydrate-containing meal,
insulin directs liver cells to take glucose from the blood, convert it to
glucose-6-phosphate, and add this molecule to glycogen strands (glycogen
synthesis).<span >&nbsp; </span></p>

<p></p>

<p>When digestion of a meal is
complete, insulin levels fall and glucose molecules are removed from glycogen
in the form of glucose-6-phosphate. This process is called glycogenolysis. The
glucose-6-phosphate remains in the liver cell until phosphate is cleaved by
glucose-6-phosphatase. This dephosphorylation produces free glucose, which can
be transported out of the liver and into the blood, where it can travel to the
brain and other organs. Glycogenolysis can supply glucose needs for 12&#8211;18
hours.</p>

<p></p>

<p>When fasting continues for
more than a few hours, falling insulin levels permit catabolism of
triglycerides in adipose tissue and protein in muscle tissue. The products of
these processes are free fatty acids and amino acids, respectively. Free fatty
acids are converted to acetyl-CoA, some of which is diverted to produce
ketones. Amino acids are used to synthesize new glucose-6-phosphate in liver
cells by the process of gluconeogenesis. The last step of gluconeogenesis, like
the last step of glycogenolysis, is the dephosphorylation of
glucose-6-phosphate to free glucose by glucose-6-phosphatase.</p>

<p></p>

<p>Thus, glucose-6-phosphatase
mediates the final steps in both pathways of glucose production: glycogenolysis
and gluconeogenesis.<span >&nbsp; </span></p>

<p><span></span></p>

<p><span>The
principal metabolic effects of glucose-6-phosphatase deficiency (glycogen
storage disease type I, or von Gierke’s disease) are:</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypoglycemia
(fasting)</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lactic
acidosis </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hyperuricemia</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypertriglyceridemia<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Hypoglycemia</span></b><span> is “fasting” or
“post-absorptive” because it occurs after digestion of the meal (usually about
four hours later). The inability to maintain adequate blood glucose levels
during a fast occurs because of impaired glycogenolysis and gluconeogenesis.
Fasting hypoglycemia is the most significant complication of GSD I. Chronic
hypoglycemia results in chronically low insulin levels and high levels of
glucagon and cortisol.</span></p>

<p><span></span></p>

<p><b><span>Lactic
acidosis</span></b><span>
occurs because of impaired gluconeogenesis. In the liver and muscle, lactic
acid is oxidized to form pyruvic acid, which is then converted to
glucose-6-phosphate through gluconeogenesis. Accumulation of
glucose-6-phosphate inhibits conversion of lactate to pyruvate.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Hyperuricemia</span></b><span> is due to several
factors. First of all, patients with GSD I are in a catabolic state, and purine
catabolism produces uric acid. Also, uric acid is produced when excess
glucose-6-phosphate is metabolized via the pentose phosphate pathway. Finally,
uiric acid competes with lactic acid and other organic acids for renal
excretion in the urine. </span></p>

<p><span></span></p>

<p><span>Clinical
manifestations of GSD I are discussed below.</span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Post-absorptive
hypoglycemia can be mild, cause developmental delays, or lead to seizures and
coma. </span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tissue
accumulation of glycogen causes liver and kidney enlargement. </span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lactic
acidosis causes vomiting and hyperventilation.</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hyperuricemia
can cause gout and renal disease.</span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Impaired
growth occurs because of chronically low insulin levels, high levels of
counterregulatory hormones, acidosis, decreased caloric intake, and
malabsorption. </span></p>

<p></p>

<p>The diagnosis of GSD I is
made by genetic testing and/or liver biopsy with an assay for
glucose-6-phosphatase activity. The mainstay of treatment is frequent ingestion
of food that is high in glucose or starch. (Starch is readily digested to
glucose).</p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=339 height=288
src="_%20Tutorials_files/image104.png" v:shapes="Picture_x0020_347156"></span><span></span></p>

<p style="text-align:center;"><span>Fructose metabolism</span></p>

<p><span></span></p>

<p><span>Fructose
did not result in increased blood glucose, so the block must be in an enzyme
that is common to all pathways leading to free glucose secretion in the liver.</span></p>

<p style="text-align:center;"><span><img border=0 width=332 height=303
src="_%20Tutorials_files/image106.png" alt="Description: TXT-200812288725161"
v:shapes="Picture_x0020_347155"></span><span></span></p>

<p><i><span>Glucokinase</span></i><span>: phosphorylates glucose to produce
glucose-6-phosphate<i></i></span></p>

<p><i><span>Fructokinase</span></i><span>: <span> </span>phosphorylates
fructose to produce fructose-1-phosphate</span></p>

<p><i><span>Glucose-6-phosphatase</span></i><span>: hydrolyzes
glucose-6-phosphate to produce glucose</span></p>

<p><i><span>Phosphoglucomutase</span></i><span>: interconverts glucose
1-phosphate and glucose 6-phosphate</span></p>

<p><i><span>Glycogen synthase</span></i><span>: converts short
polymers of glucose into long polymers</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct. </span></b><span>Glucose-6-phosphatase catalyzes the final step in gluconeogeneis and
glycogenolysis. Deficiency of the enzyme results in fasting hypoglycemia and
high concentrations of hepatic glycogen. Hypoglycemia occurs because of
impaired gluconeogenesis. Fructose administration does not solve the problem
because gluconeogenesis is needed to convert fructose to glucose. Glycogen
accumulates in the liver because it cannot be broke down into glucose (due to
impaired glycogenolysis). </span></p>

<p><b><span><span >&nbsp;</span></span></b></p>

<p><b><span>Answer A is incorrect.</span></b><span> Glucokinase is an
enzyme that phosphorylates glucose to produce glucose-6-phosphate. This is the
first step in glycolysis and glycogen synthesis. Deficiency of this enzyme
causes hyperglycemia. In fact, mutations of the glucokinase gene are
responsible for certain types of diabetes. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect.</span></b><span> Fructokinase is an
enzyme that phosphorylates fructose to produce fructose-1-phosphate. Enzyme
deficiency results in high fructose levels in the serum and urine (after
fructose ingestion). This is a benign condition.<span>&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect. </span></b><span>Phosphoglucomutase
interconverts glucose 1-phosphate and glucose 6-phosphate. This is important in
glycogen synthesis and glycogenolysis.<span >&nbsp;
</span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect.</span></b><span> Glycogen synthase
converts short glucose polymers into long polymers. Enzyme deficiency results
in glycogen deficiency. Glyogen is needed to produce glucose in the fasting
state. If glycogen stores are inadequate, fasting results in hypoglycemia.
After a meal, glucose is used to make glycogen. If glycogen synthesis is
impaired, glucose levels rise, causing postprandial hyperglycemia. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
3-year-old girl with a history of fractures of the right humerus and left tibia
presents with pain in her left forearm after a fall. Physical examination shows
blue sclerae. Which of the following is true?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Her
condition is transmitted as an autosomal dominant trait</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Her
condition results from a defect in type 1 collagen</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Her
condition is associated with early deafness</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Her
condition is associated with osteoporosis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>All
of the above</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Common
inherited disorders of connective tissue appear below. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=221 valign=top>
  <p><span>Inherited
  Disorders of Connective Tissue</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p style="text-align:center;"><span>Marfan</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p style="text-align:center;"><span>Ehlers-Danlos</span></p>
  </td>
 </tr>
 <tr>
  <td width=221 valign=top>
  <p style="text-align:center;"><span>Osteogenesis Imperfecta</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span>Marfan syndrome</span></b><span> is an autosomal
dominant disorder with an incidence of about 1 in 10,000 births. Nearly 30% of
cases are due to spontaneous (sporadic) mutations. The condition is caused by
abnormal biosynthesis of fibrillin-1, a protein that is the major component of
elastic tissue and nonelastic tissues such as aortic adventitia and the
suspensory ligament of the eye. In Marfan syndrome, elastic fibers in the
extracellular matrix are not correctly formed.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><a
name=4-u1.0-B978-1-4160-2450-7..50702-7--cese></a>Individuals with Marfan are
typically tall, with long limbs and long thin fingers. The most serious
complications are defects of the heart valves and aorta. There are no unique
signs or symptoms, but the constellation of long limbs, dislocated lenses, and
aortic root dilation is sufficient to make the diagnosis. More than thirty
clinical features are associated with the syndrome, most involving the
skeleton, skin, and joints. Considerable variability exists within families
carrying the same mutation.</p>

<p></p>

<p>Skeletal abnormalities
include scoliosis, pectus excavatum or pectus carinatum, and abnormal joint
flexibility. Ocular abnormalities include dislocation of the lens (80%),
near-sightedness, astigmatism, detachment of the retina, and glaucoma. Affected
individuals are predisposed to spontaneous pneumothorax. The most serious
complications involve the cardiovascular system and include prolapse of the
mitral and aortic valves resulting in regurgitation, aortic aneurysm, and
angina. Heart problems may be unapparent until weakening of the connective
tissue (cystic medial degeneration) in the ascending aorta causes aortic
dissection. </p>

<p></p>

<p><span><span>Ehlers</span></b></span><b><span>-<span syndrome</span></b><span> is a group of
genetically heterogeneous connective tissue disorders in which the essential
defect is a deficiency of fibrillar collagen. The syndrome is characterized by <a
name=4-u1.0-B978-1-4160-2450-7..50486-2--intr></a>soft, velvety skin that is
hyperelastic; lax, hypermobile joints that are easily subluxed; easy bruising
due to fragile skin and blood vessels; delayed wound healing; and unusual
scarring. More than ten variants have been described. The most serious variants
are associated with rupture of visceral organs. </span></p>

<p><span></span></p>

<p><b><span>Osteogenesis imperfecta (OI)</span></b><span>, or brittle bone
disease, is an autosomal dominant disorder characterized by structural and/or
quantitative defects in type I collagen, the primary component of the extracellular
matrix of bone and skin. It is a generalized disorder of connective tissue and
the most common genetic cause of osteoporosis. The clinical spectrum is broad,
ranging from a lethal form in infancy to a mild form in adults. The prevalence
in infants is about <a name=4-u1.0-B978-1-4160-2450-7..50701-5--p288></a>1 in
20,000. The disorder is characterized by a triad of symptoms: fragile bones,
blue sclerae, and early deafness. Bone fractures occur with only mild trauma.
Other findings include dental abnormalities, easy bruising, joint laxity, and
short stature.</span></p>

<p>[Collagen is the main
component of connective tissue and is the most abundant protein in mammals,
making up about 25% to 35% of the whole-body protein content. It is found in
fibrous tissues, such as tendon, ligament and skin, and is also abundant in cornea,
cartilage, bone, blood vessels, the gut, and intervertebral disc. Fibroblasts
create collagen. Collagen molecules are comprised of three polypeptide strands.
Each strand forms a helix, and the three helices are twisted together into a
triple helix or “super helix,” stabilized by numerous hydrogen bonds. Collagen
is broken down by a special group of collagenases called matrix
metalloproteinases.]</p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer E is correct</b>. Osteogenesis imperfecta is an autosomal
dominant disorder characterized by defects in type I collagen. It is the most
common genetic cause of osteoporosis. The disorder is characterized by a triad
of symptoms: fragile bones, blue sclerae, and early deafness.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 3-month-old boy is
unresponsive when he arrives in the emergency room. His mother says that he
stopped eating the previous day and has been vomiting. Examination shows
hepatomegaly. Serum studies show hypoglycemia. Ketones are absent in the serum
and urine. The boy regains consciousness after glucose infusion. Which of the
following is most likely? </p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Fructose-1,6-bisphosphatase deficiency</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Glucose-6-phosphatase deficiency </p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Medium-chain acyl CoA dehydrogenase deficiency</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Methylmalonyl-CoA mutase deficiency</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span>Ornithine carbamoyltransferase deficiency</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>In this vignette, the infant
presents with hypoglycemia. Answering the question requires an understanding of
carbohydrate and lipid metabolism. </p>

<p></p>

<p>The brain depends on glucose
for fuel. The importance of glucose to the brain is apparent from the number of
nervous, hormonal, and metabolic responses to falling glucose levels. The three
most important responses are <i>glycogenolysis</i>, <i>gluconeogenesis</i>, and
<i>fatty acid oxidation.</i></p>

<p></p>

<p><span>When the body is denied glucose for more
than 4 hours, hepatic glycogen is used for fuel. Through glycogenolysis,
glycogen is broken down to glucose monomers. The liver contains about 12 hours
worth of glycogen. When hepatic glycogen is depleted, three events occur. 1)
Muscle glycogen is broken down, which may continue for days. 2) Gluconeogenesis
occurs, in which glucose is generated from non-carbohydrate substrates. 3)
Lipolysis occurs, in which fats (triglycerides) are broken down into glycerol
and fatty acids. </span></p>

<p><span></span></p>

<p><span>Each triglyceride molecule is composed of
one glycerol and three fatty acid molecules. Fatty acids are transported from
the cytosol to the mitochondria by carnitine (a quaternary ammonium compound).
In the mitochondria, fatty acids are broken down through beta-oxidation to
produce acetyl CoA, which enters the Krebs cycle to produce energy. If fatty
acid breakdown is excessive, the Krebs cycle is overwhelmed and “extra” acetyl
CoA is used to produce ketones, which the brain uses for energy. (The brain
cannot use fatty acids directly because they do not cross the blood-brain
barrier.) </span></p>

<p><span></span></p>

<p><span>The three metabolic responses to
hypoglycemia are regulated by hormones. As glucose levels drop, insulin
secretion is suppressed and counter-regulatory hormone secretion is enhanced.
Counter-regulatory hormones (glucagon, epinephrine, norepinephrine, cortisol,
and growth hormone) oppose insulin action. </span></p>

<p><span></span></p>

<p><span>Hypoglycemia may be ketotic or
non-ketotic. Ketones are formed by fatty acid oxidation. The principal ketones
are acetoacetate and beta-hydroxybutyrate. Prolonged fasting causes ketosis
because a fall in blood glucose triggers lipolysis, fatty acid oxidation, and
ketone production. In patients with disorders that impede fatty acid oxidation,
ketone production will be impaired. These patients will develop a non-ketotic
hypoglycemia.</span></p>

<p><span></span></p>

<p><span>The infant in this vignette has <i>non-ketotic</i>
hypoglycemia, suggesting a disorder of fatty acid oxidation. Of the five
inherited metabolic disorders listed, only one represents a disorder of fatty
acid metabolism: medium-chain acyl-CoA dehydrogenase deficiency. </span></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p style="text-align:center;"><span><img border=0 width=430 height=365
src="_%20Tutorials_files/image108.png" v:shapes="Picture_x0020_347154"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Glycolysis
and Gluconeogenesis</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span><img border=0 width=424 height=427
src="_%20Tutorials_files/image110.png" v:shapes="Picture_x0020_347153"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=415 height=275
src="_%20Tutorials_files/image112.png" alt="Description: FA-Ox" v:shapes="Picture_x0020_347152"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Ketogenesis</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=313 height=417
src="_%20Tutorials_files/image114.png" alt="Description: Ketogenesis" v:shapes="Picture_x0020_347151"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b>Answer C is correct</b>.
Medium-chain acyl CoA dehydrogenase (MCAD) is an enzyme involved in fatty acid
oxidation (&#946;-oxidation). If the enzyme is deficient, fatty acids cannot be
catabolized in response to falling glucose levels. The result is lipid
accumulation and liver enlargement. Ketones are not produced. The patient
develops <i>non-ketotic</i> hypoglycemia.<span >&nbsp;
</span></p>

<p></p>

<p><b>Answer A is incorrect</b>.
Fructose-1,6-bisphosphatase is necessary for gluconeogenesis. It converts
fructose-1,6-bisphosphate to fructose-6-phosphate. Deficiency of this enzyme
inhibits gluconeogenesis, and impaired gluconeogenesis results in hypoglycemia.
Ketone production is not inhibited because fatty acid metabolism still takes
place.<span >&nbsp;&nbsp; </span></p>

<p></p>

<p><b>Answer B is incorrect</b>.
Glucose-6-phosphatase is an enzyme that catalyzes the final step in
gluconeogenesis and glycogenolysis. Enzyme deficiency leads to fasting
hypoglycemia. This condition is called glycogen storage disease type 1, or von
Gierke’s disease. It is the most common glycogen storage disorder. Glycogen
accumulates in the liver causing hepatomegaly. Lactic acidosis occurs because
of impaired gluconeogenesis. Ketosis occurs because breakdown of fatty acids
remains intact.<span >&nbsp;&nbsp; </span></p>

<p></p>

<p><b><span>Answer D is incorrect</span></b><span>. Methylmalonyl-CoA
mutase converts methylmalonyl CoA to succinyl CoA, a metabolite in the Krebs
cycle. Deficiency of this enzyme leads to methylmalonic acidemia, a type of
organic acidemia.<span >&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b>Answer E is incorrect</b>.
Ornithine carbamoyltransferase is a urea cycle enzyme. It converts ornithine to
citrulline. Enzyme deficiency results in hyperammonemia and neurological
problems. Ornithine carbamoyltransferase deficiency is the most common urea
cycle disorder. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 2-week-old baby girl
delivered at term is brought to the physician by her mother because of an
increasingly severe diaper rash since birth. No congenital anomalies were noted
after delivery. Physical examination shows a red and swollen umbilical remnant
that has not separated. There are ulcerations of the skin but no purulent
exudate in the area of the diaper. A culture of one of the ulcers grows <i>Staphylococcus
aureus</i>. Despite antibiotic therapy, 1 month later she develops a perirectal
fissure, culture of which grows <i>Escherichia
coli</i> but a smear of which shows scarce segmented neutrophils. Laboratory
studies show:<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><u>Patient’s
value</u><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><u>Normal
value</u></span></p>

<p><span>Hemoglobin <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12.6
g/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>11-17
g/dL</span></p>

<p><span>Hematocrit<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>38%<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>30-40%</span></p>

<p><span>Mean corpuscular volume<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>98 &#956;m<sup>3<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>86-110
&#956;m<sup>3</sup></span></p>

<p><span>Leukocyte count<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>89,000/mm<sup>3<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>6-17.5/
mm<sup>3</sup></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Neutrophils<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>89%<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>31%<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>Bands<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>6%<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>6-14%</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Lymphocytes<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>3%<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>61%</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Monocytes<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>2%<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>5%</span></p>

<p><span>Platelet count<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>250,000/mm<sup>3<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></sup>250-475,000/mm<sup>3</sup></span></p>

<p><span>Serum</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>IgA<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>92
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0-5
mg/dL</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>IgG<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>766
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>831-1231
mg/dL</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>IgM<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>101
mg/dL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>6-16
mg/dL</span></p>

<p><span></span></p>

<p><span>Peripheral blood smear: <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>normochromic,
normocytic erythrocytes</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>leukocytes
with normal morphology</span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span>This patient most likely
has which of the following conditions?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
myelogenous leukemia </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Acquired
immunodeficiency syndrome</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Chédiak-Higashi
syndrome</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Common
variable immunodeficiency</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Leukocyte
adhesion deficiency</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Because leukocytes play
a central role in host defense, defects in leukocyte function, both inherited
and acquired, lead to increased vulnerability to infection. Impairments of
virtually every phase of leukocyte function have been identified &#8211; from
adherence to vascular endothelium to microbicidal activity. These include the
following:<a name=4-u1.0-B978-1-4377-0792-2..50007-9--celi></a> </span></p>

<p><span></span></p>

<table border=0 cellpadding=0 width="95%">
 <tr>
  <td width="3%" valign=top>
  <p><span>• </span></p>
  </td>
  <td>
  <p><b><span>Inherited
  defects in leukocyte adhesion</span></b><span>. Peripheral blood leukocytes undergo a
  sequence of activation that leads to migration of cells into the site of
  inflammation. First, the cells roll along endothelial surfaces, a process
  that requires expression of selectins on the endothelial cells and their
  ligands on leukocytes. Next, cells adhere to the endothelial surface and
  enter the tissues by diapedesis; this process requires the family of
  integrins. Genetic defects of integrins and selectin-ligands cause <i>leukocyte
  adhesion deficiencies </i>(LAD) types 1 and 2. LAD is characterized by marked
  leukocytosis and localized bacterial infections that are difficult to detect
  until they have progressed extensively (due to lack of leukocyte recruitment
  at the site of infection). Affected individuals suffer from bacterial
  infections beginning in the neonatal period. Infections such as omphalitis
  (infection of the umbilical cord stump), pneumonia, gingivitis, abscesses,
  and peritonitis are common and often life-threatening. </span></p>
  </td>
 </tr>
 <tr>
  <td width="3%" valign=top>
  <p><span>• </span></p>
  </td>
  <td>
  <p><b><span>Inherited
  defects in phagolysosome function</span></b><span>. One such disorder is <i>Chédiak-Higashi
  syndrome</i>, an autosomal recessive condition characterized by defective
  fusion of phagosomes and lysosomes in phagocytes (causing susceptibility to
  infection), as well as abnormalities in 1) melanocytes (leading to albinism),
  2) nerve cells (associated with nerve defects), and 3) platelets (causing
  bleeding disorders). The main leukocyte abnormalities are neutropenia
  (decreased numbers of neutrophils), defective degranulation, and delayed
  microbial killing. Leukocytes contain giant granules, which can be readily
  seen in peripheral blood smears and are thought to result from aberrant
  phagolysosome fusion. </span></p>
  </td>
 </tr>
 <tr>
  <td width="3%" valign=top>
  <p><span>• </span></p>
  </td>
  <td>
  <p><b><span>Inherited
  defects in microbicidal activity</span></b><span>. The importance of oxygen-dependent
  bactericidal mechanisms is shown by the existence of a group of congenital
  disorders called <i>chronic granulomatous disease</i>, which are
  characterized by defects in bacterial killing and render patients susceptible
  to recurrent bacterial infection. Chronic granulomatous disease results from
  inherited defects in the genes encoding components of phagocyte oxidase,
  which generates <span>superoxide</span>. The name of
  the disease comes from the macrophage-rich chronic inflammatory reaction that
  tries to control the infection when the initial neutrophil defense is
  inadequate. This often leads to collections of activated macrophages that
  wall off microbes, forming aggregates called granuloma<i>s</i>.</span></p>
  </td>
 </tr>
 <tr>
  <td width="3%" valign=top>
  <p><span>• </span></p>
  </td>
  <td>
  <p><b><span>Acquired
  deficiencies</span></b><span>.
  Clinically, the most frequent cause of leukocyte defects is <i>bone marrow
  suppression</i>, leading to <a name=4-u1.0-B978-1-4377-0792-2..50007-9--p56></a>decreased
  production of leukocytes. This is seen following therapies for cancer
  (radiation and chemotherapy) and when the marrow space is compromised by
  tumors, which may arise in the marrow (e.g., leukemias) or be metastatic from
  other sites.</span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

<p style="text-align:center;"><a
name=4-u1.0-B978-1-4377-0792-2..50007-9--ceta></a><span><br>
Defects in Leukocyte Function</span></p>

<p style="text-align:center;"><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=bottom>
   <p><span>Disease</span></p>
   </td>
   <td valign=bottom>
   <p><span>Defect</span></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td colspan=2 valign=top>
  <p><span>GENETIC</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Leukocyte
  adhesion deficiency 1</span></p>
  </td>
  <td valign=top>
  <p><span>Defective
  leukocyte adhesion because of mutations affecting &#946; chain of CD11/CD18 <i>integrins</i></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Leukocyte
  adhesion deficiency 2</span></p>
  </td>
  <td valign=top>
  <p><span>Defective
  leukocyte adhesion because of mutations affecting enzyme required for
  synthesis of ligand for <i>selectins</i></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Chronic
  granulomatous disease </span></p>
  <p><span></span></p>
  </td>
  <td valign=top>
  <p><span>Decreased
  oxidative burst</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Myeloperoxidase
  deficiency (MPO)</span></p>
  </td>
  <td valign=top>
  <p><span>Decreased
  microbial killing because of defective MPO&#8212;H<sub>2</sub>O<sub>2</sub>
  system</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Chédiak-Higashi
  syndrome</span></p>
  </td>
  <td valign=top>
  <p><span>Decreased
  leukocyte functions because of mutations affecting protein involved in
  lysosomal membrane traffic</span></p>
  </td>
 </tr>
 <tr>
  <td colspan=2 valign=top>
  <p><span>ACQUIRED</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Bone
  marrow suppression: tumors, radiation, and chemotherapy</span></p>
  </td>
  <td valign=top>
  <p><span>Production
  of leukocytes</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Diabetes,
  malignancy, sepsis, chronic dialysis</span></p>
  </td>
  <td valign=top>
  <p><span>Adhesion
  and chemotaxis</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Leukemia,
  anemia, sepsis, diabetes, malnutrition</span></p>
  </td>
  <td valign=top>
  <p><span>Phagocytosis
  and microbicidal activity</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
E is correct. </span></b><span>The
presence of recurrent, hard-to-eradicate bacterial infections in a newborn is
worrisome for some hereditary defect of immunity or leukocyte function. Several
clues in the vignette reveal the diagnosis. The skin ulcers are infected, but
there is no purulence. Also, the perirectal fissure is infected, but neutrophils
are scarce. Clearly, something is inhibiting the normal neutrophil response to
bacterial infection. One might suspect that the patient is neutropenic and
cannot generate an inflammatory response, but the opposite is true. The patient
has a profound leukocytosis. (The leukocyte count is 89,000/mm<sup>3</sup>.)
Thus, the patient is mounting a dramatic response to infection, but the
leukocytes cannot make their way to the site of infection. This can be
explained by leukocyte adhesion deficiency (LAD), a genetic disorder associated
with a defect in integrins or in the ligand for selectins, which are necessary
for leukocyte adhesion, an important step in the leukocytic response to
infection. (Also, of note, the patient has omphalitis, which occurs in LAD.) </span></p>

<p><span></span></p>

<p><b>Answer A is incorrect. </b>Acute
myeloid leukemia (AML), also known as acute myelogenous leukemia, is a cancer
of the myeloid line of blood cells, characterized by the rapid growth of
abnormal white blood cells that accumulate in the bone marrow and interfere
with the production of normal blood cells. (The word “myeloid” is used to
describe any leukocyte that is not a lymphocyte). AML is the most common acute
leukemia affecting adults, and its incidence increases with age. Symptoms are
caused by replacement of normal bone marrow with leukemic cells, which causes a
drop in red blood cells, platelets, and normal white blood cells. This can
result in fatigue, shortness of breath, easy bruising and bleeding, and
increased risk of infection. Several risk factors and chromosomal abnormalities
have been identified, but the specific cause is not clear. As an acute
leukemia, AML progresses rapidly and is typically fatal within weeks or months
if left untreated.</p>

<p></p>

<p><b>Answer B is incorrect. </b>Acquired
immunodeficiency syndrome (AIDS) is caused by the human immunodeficiency virus
(HIV), a retrovirus that primarily infects cells of the immune system, such as
CD4<sup>+</sup> T cells, macrophages, and dendritic cells. The virus
progressively weakens the immune system, leaving individuals susceptible to
opportunistic infections and tumors. </p>

<p></p>

<p><b><span>Answer
C is incorrect. </span></b><span>Chédiak-Higashi
syndrome is a rare autosomal recessive disorder caused by a mutation in the
lysosomal trafficking regulator gene, LYST. The mutation disrupts microtubule
polymerization, resulting in impaired phagolysosome formation. (A phagolysosome
is a membrane-enclosed organelle that forms when a phagosome fuses with a
lysosome. Under normal conditions, after fusion, the pathogen contained within
the phagosome is digested by enzymes in the lysosome.) Chédiak-Higashi syndrome
is characterized by recurrent pyogenic infections, partial albinism, and
peripheral neuropathy. </span></p>

<p><span></span></p>

<p><b>Answer D is incorrect. </b>Common
variable immunodeficiency (CVID) is a group of approximately 150 disorders
characterized by low serum immunoglobulin levels. Affected individuals are
predisposed to recurrent infection of the ears, sinuses, and respiratory
system, as well as digestive problems, blood disorders, and cancer. Symptoms
typically occur in children ages 2 to 8 or in adults above age 30. </p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 2-year-old boy with mental retardation
presents with weakness and a protuberant abdomen. Physical examination shows
hepatosplenomegaly. His blood hemoglobin level is 9 mg/dl and his platelet
count is 20,000/mm<sup>3</sup>. Bone marrow examination shows lipid-laden
macrophages. Additional studies show accumulation of glucocerebroside in the
reticuloendothelial cells (macrophage system). Which of the following enzymes
is most likely deficient?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ceramidase
</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>&#945;-Galactosidase
</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>&#946;-Glucosidase</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Hexosaminidase
</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>&#945;-L-Iduronidase</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Sphingomyelinase
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><a
href="http://en.wikipedia.org/wiki/Lysosome" title=Lysosome></a>Lysosomes are
organelles that serve as the cell’s “recycling center.” They process unwanted
materials into substances that the cell can use. Specific enzyme deficiencies
can result in lysosomal storage diseases (LSDs), a group of about forty
disorders in which intracellular accumulation of lipid, glycoprotein, or <a
href="http://en.wikipedia.org/wiki/Mucopolysaccharides"
title=Mucopolysaccharides>mucopolysaccharide</a> results in organ failure.<span>&nbsp; </span>The most common lysosomal storage
disease is Gaucher disease. Other lysosomal storage diseases include Tay-Sachs,
Niemann-Pick, Fabry, Farber, and Hurler disease.</p>

<p></p>

<p><b>Gaucher disease</b> is the most common of the lysosomal storage
diseases. It is an aut<span>osomal recessive </span>disorder
characterized by the accumulation of lipid in certain cells (e.g., macrophages)
and organs. The disease is caused by a hereditary deficiency of the enzyme
glucocerebrosidase (also known as acid &#946;-glucosidase). When the enzyme is
deficient, glucocerebroside accumulates, particularly in the liver, spleen,
kidneys, lungs, brain, and bone marrow. Symptoms include distended abdomen;
enlarged liver, spleen, and lymph nodes; anemia and thrombocytopenia; skeletal
disorders; severe neurologic complications, including mental retardation; and
yellow fatty deposits on the sclerae. Affected individuals are predisposed to
infection. Some forms of Gaucher's disease may be treated with enzyme
replacement therapy. </p>

<p></p>

<p>Ceramidase deficiency causes
<b>Farber disease</b>, an autosomal
recessive disorder that results in arthritis, hepatosplenomegaly, dysphagia,
and mental retardation. Swollen joints and joint contractures occur. </p>

<p></p>

<p>&#945;-Galactosidase
deficiency causes <b>Fabry disease</b>, an
X-linked disorder that results in renal failure, cardiomyopathy,
angiokeratomas, anhidrosis, Raynaud’s phenomenon, neuropathy, and keratopathy.</p>

<p></p>

<p>Hexosaminidase deficiency
causes <b>Tay-Sach disease</b>, an
autosomal recessive disorder that results in blindness, deafness, neurological
impairment, and paralysis. A “cherry-red” macula is seen in all patients.
Hepatosplenomegaly does not occur.</p>

<p></p>

<p>&#945;-L-Iduronidase
deficiency causes <b>Hurler syndrome</b>,
an autosomal recessive disorder that results in mental retardation, an abnormal
face, dwarfism, and hepatosplenomegaly.<span >&nbsp;
</span></p>

<p></p>

<p>Sphingomyelinase deficiency
causes <b>Niemann-Pick disease</b>, an
autosomal recessive disorder that results in ataxia, dysarthria, dysphagia,
dystonia, hepatosplenomegaly, and thrombocytopenia. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b><span>Answer C is correct</span></b><span>. The patient has Gaucher disease, caused by
&#946;-Glucosidase deficiency.</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
3-year-old boy has a tendency toward self-mutilation. He bites his fingers and
lips. He has choreoathetosis, delayed motor development, and arthritis. Serum
uric acid levels are very high. Which of the following is most likely?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Phosphoribosylpyrophosphate
(PRPP) synthetase deficiency</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Adenine
phosphoribosyltransferase (APRT) deficiency</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Hypoxanthine-guanine
phosphoribosyltransferase (HPRT) deficiency </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Xanthine
oxidase inhibition</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Uric acid
is a product of purine metabolism. Purines are essential for life. In addition
to being part of DNA and RNA, they are components of ATP, GTP, cAMP, NADH, and
coenzyme A. The most common purines appear below. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=349 height=209
src="_%20Tutorials_files/image116.png" alt="Description: Purines.gif" v:shapes="Picture_x0020_347150"></span><span></span></p>

<p><span></span></p>

<p><span>Adenine
and guanine are purines that are used to make DNA. Their breakdown results in
uric acid. The following conditions are associated with elevated serum uric
acid levels (hyperuricemia). </span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=479 colspan=2 valign=top>
  <p style="text-align:center;"><span>Causes of Hyperuricemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span></span></p>
  </td>
  <td width=239 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p style="text-align:center;"><span>Increased Urate Production (10%)</span></p>
  </td>
  <td width=239 valign=top>
  <p style="text-align:center;"><span>Decreased Urate Excretion (90%)</span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=239 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=239 valign=top>
  <p><span>Ethanol</span></p>
  <p><span>Disorders
  of purine metabolism</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>PRPP synthetase
  overactivity</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>HPRT deficiency </span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Glucose-6-phosphatase
  deficiency</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>G6PD deficiency</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Fructose-1-phosphate
  aldolase deficiency<span >&nbsp; </span></span></p>
  <p><span>Conditions
  with increased cell turnover</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Cytotoxic drugs (tumor
  lysis syndrome)</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Myeloproliferative
  diseases</span></p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Sickle cell disease,
  thalassemia</span></p>
  </td>
  <td width=239 valign=top>
  <p><span>Dehydration</span></p>
  <p><span>Renal
  insufficiency </span></p>
  <p><span>Acidosis</span></p>
  <p><span>Hypothyroidism</span></p>
  <p><span>Drugs
  (e.g., diuretics, low-dose salicylates)</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>To
understand how specific enzyme disorders can increase uric acid levels, one
must understand purine metabolism. A schematic of purine metabolism appears
below. </span></p>

<p style="text-align:center;"><span><img border=0 width=390 height=245
src="_%20Tutorials_files/image118.png" alt="Description: Purine metabolism.jpg"
v:shapes="Picture_x0020_347149"></span><span></span></p>

<p><span></span></p>

<p><span>PRPP:
Phosphoribosylpyrophosphate</span></p>

<p><span>HPRT:
Hypoxanthine-guanine phosphoribosyltransferase</span></p>

<p><span>APRT:
Adenine phosphoribosyltransferase</span></p>

<p><span></span></p>

<p><span>Purine
metabolism has three major components: </span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>De novo</span></i><span> synthesis of purines via PRPP</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Purine
interconversion (GMP &#8596; IMP &#8596; AMP)</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>“Salvage”
pathways that recapture intermediate breakdown products, preventing further
breakdown to uric acid</span></p>

<p><span></span></p>

<p><span>Many
enzymes are involved in purine metabolism. These enzymes include PRPP
synthetase, PRPP amidotransferase, APRT, and xanthine oxidase. Deficiency (or
inhibition) of any of these enzymes will decrease uric acid production. <i>Deficiency
of hypoxanthine-guanine phosphoribosyltransferase (HPRT), however, has the
opposite effect</i>. This enzyme participates in the <i>salvage pathway</i> of
purine metabolism. It converts hypoxanthine to IMP and guanine to GMP.<span>&nbsp; </span>Deficiency of this enzyme <i>increases</i>
uric acid production because intermediate breakdown products have no other
“path” to follow.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>HPRT
deficiency results in Lesch-Nyhan syndrome, which is a rare X-linked disorder
characterized by self-mutilating behavior, neurological impairment, and
arthritis. Uric acid levels are extremely high. </span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct</span></b><span>.
HPRT is part of the “salvage” pathway. It recaptures intermediate breakdown
products, preventing further degradation to uric acid. Deficiency of this
enzyme blocks the salvage pathway, forcing intermediate products to be further
degraded to uric acid.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
A is incorrect</span></b><span>.
Phosphoribosylpyrophosphate (PRPP) synthetase converts ribose-5-phosphate to
PRPP. This is the first step of <i>de novo</i> purine synthesis. Deficiency of
this enzyme inhibits purine metabolism and reduces uric acid formation. PRPP
synthetase <i>overactivity</i>, not deficiency, is associated with high uric
acid levels. </span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect</span></b><span>.
Adenine phosphoribosyltransferase (APRT) converts adenine to AMP. Deficiency of
this enzyme reduces uric acid production. </span></p>

<p><span></span></p>

<p><b><span>Answer
C is incorrect</span></b><span>.
Allopurinol is a drug used in the treatment of gout. It works by inhibiting
xanthine oxidase. Xanthine oxidase converts 1) hypoxanthine to xanthine and 2)
xanthine to uric acid. By blocking xanthine oxidase, allopurinol lowers uric
acid levels, thus preventing gouty attacks, which are caused by the deposition
of uric acid crystals in joints. </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>The control curve in the
graph below illustrates the relationship between initial velocity of reaction
and substrate concentration for an enzyme obeying Michaelis-Menten kinetics.
Which of the following curves best represents the results that would be obtained
by halving the amount of enzyme? </p>

<p style="text-align:center;"><span><img border=0 width=215 height=170
src="_%20Tutorials_files/image120.png" v:shapes="Picture_x0020_347148"></span></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Curve 1</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Curve 2</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Curve 3</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Control curve</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Enzymes speed up the rate of
a chemical reaction without being consumed in the process. They achieve this by
temporarily binding to a <span>substrate,
thereby l</span>owering the activation energy needed to convert it to a
product. </p>

<p><span></span></p>

<p><span>The rate
at which an enzyme works is influenced by several factors: </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Substrate
concentration. Adding more substrate keeps the enzyme active site occupied more
often, thus allowing the reaction to occur more frequently. This makes the
apparent rate of reaction higher. At higher substrate concentrations, however,
the enzyme will eventually be saturated and the observed rate is maximized.
This is evidenced by the plateau in the curve at high substrate
concentrations.<span >&nbsp; </span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Temperature.
Higher temperatures accelerate the reaction.<span>&nbsp; </span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Inhibitors.
Adding inhibitors keeps the active site from working on the productive
reaction, thus the apparent rate of reaction is lower.<span>&nbsp;&nbsp; </span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Acidity.
The pH affects protein conformation and charge state, which influence enzymatic
activity.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The study
of the rate at which an enzyme works is called <span>enzyme kinetics</span>. The following figure shows the relationship
between substrate concentration and velocity of reaction.</span></p>

<p style="text-align:center;"><span><img border=0 width=202 height=250
src="_%20Tutorials_files/image122.png" alt="Description: Michaelis_Menten"
v:shapes="Picture_x0020_347147"></span><span></span></p>

<p><span></span></p>

<p><span>From the
figure, we see that <a name="Michaelis_Menten"></a>at low levels of substrate,
the velocity of reaction rises almost linearly with increased substrate
concentration. As substrate levels rise further, the gains in velocity level
off. The asymptote represents the maximum velocity of the reaction. The
substrate concentration that produces a velocity that is one-half of the
maximum velocity is called the Michaelis-Menten constant (<span>K<sub>m</sub></span>). This constant is
inversely related to the affinity between substrate and enzyme. The lower the <span>K<sub>m</sub></span>, the greater is the
affinity. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>There are
two types of enzyme inhibitors. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Competitive
inhibitors “compete” with a substrate for a specific site on an enzyme. By
binding to that site, the inhibitor prevents the substrate from binding </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Noncompetitive
inhibitors bind to the enzyme at a different site, taking it “out of
commission.”<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The
difference between competitive and noncompetitive inhibition is illustrated
below.<span >&nbsp; </span></span></p>

<p style="text-align:center;"><span><img border=0 width=191 height=164
src="_%20Tutorials_files/image124.png" alt="Description: Michaelis_Menten2"
v:shapes="Picture_x0020_347146"></span><span></span></p>

<p><a name="Competitive_Inhibition"><span></span></a></p>

<p><span><span>Competitive Inhibition</span></span><span></span></p>

<p><span></span></p>

<p><span>When a
competitive inhibitor is present, higher substrate concentrations are needed to
displace the inhibitor and achieve the same velocity. <span>V<sub>max</sub></span> can still be reached if enough substrate is
available. The <span>K<sub>m</sub></span> is
larger because the enzyme’s affinity for substrate is diminished by the
inhibitor.</span></p>

<p><span></span></p>

<p><a name="Noncompetitive_Inhibition"><span>Noncompetitive Inhibition</span></a><span></span></p>

<p><span></span></p>

<p><span>When a
noncompetitive inhibitor is present, it binds to the enzyme, taking it “out of
commission.” The velocity of reaction is reduced for all substrate
concentrations. The <span>K<sub>m</sub></span>
is unchanged, however, because enzymes still “in commission” have the same
affinity for substrate. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct. </span></b><span>Halving the amount of
enzyme is the functional equivalent of using a noncompetitive inhibitor to
inactivate half of the enzymes present. The curve produced by halving the
amount of enzyme would, therefore, resemble the curve for non-competitive
inhibition. In both cases, t<span>he velocity
of reaction would be reduced for all concentrations of substrate, and V<sub>max</sub>
would be reduced as well.<span >&nbsp;&nbsp;&nbsp;
</span><sub></sub></span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A normal
peptide has 100 amino acids. Following mutation, it has only 20. Amino acids
1-10 are the same as the normal peptide; 11-20 differ from the normal peptide.
Which of the following mutations occurred?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Nucleotide
substitution in codon 11 (the codon that codes for amino acid 11)</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nucleotide
deletion in codon 11</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nucleotide
substitution in codon 20</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Nucleotide
deletion in codon 20</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nucleotide
insertion in codon 20</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The effect
of a genetic mutation depends on its location and its ability to alter protein
function. <span>The major types of mutation
appear below. </span></span></p>

<p><span></span></p>

<p><b><span>Substitution.
</span></b><span>A</span><span> single nucleotide is exchanged for another. There are three
basic types:</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Silent
mutation, which codes for the same amino acid </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Missense
mutation, which codes for a different amino acid<span>&nbsp; </span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nonsense
mutation, which codes for a stop codon </span></p>

<p><b><span></span></b></p>

<p><b><span>Insertion.</span></b><span> One or more nucleotides
is inserted into DNA. The mutation is often reversible. The reading frame may
be altered.</span></p>

<p><span></span></p>

<p><b><span>Deletion.
</span></b><span>O</span><span>ne or more nucleotides is deleted from DNA. The mutation is
usually irreversible. The reading frame may be altered. </span></p>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td>
  <p><b><span>Frameshift.<span>&nbsp; </span></span></b><span>If the number
  of nucleotides inserted or deleted is not divisible by three, a frameshift
  mutation occurs. This is because each codon contains three nucleotides. The
  addition or deletion of only one or two nucleotides alters the reading frame,
  </span><span>resulting
  in a completely different protein.</span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><b><span>Answer B is correct.<span>&nbsp; </span></span></b><span>In the clinical vignette, amino acids
  1-10 are unchanged and amino acids 11-20 are different. Thus, the first amino
  acid to be altered is amino acid 11, indicating that the mutation must be in
  codon 11 (which codes for amino acid 11). Could this mutation be a
  substitution? Consider the following: If a silent mutation had occurred, the
  amino acid sequence would not have changed. If a missense mutation had
  occurred, amino acid 11 would have changed, but amino acids 12-20 would have
  been the same. If a nonsense mutation had occurred, the sequence would have
  ended at amino acid 10, not amino acid 20. Therefore, a substitution mutation
  cannot explain the new sequence. The only way to explain a change in sequence
  that encompasses the entire remaining length of the protein is with a
  frameshift mutation. This mutation could be an insertion or a deletion.
  Either way, the number of nucleotodes inserted or deleted would not be
  divisible by three. (If the number were divisible by three, the reading frame
  would not have “shifted.”) The answer is, therefore, B (i.e., a deletion in
  codon 11) because this is the only option that produces a frameshift mutation
  at codon 11. Also, we can assume that the frameshift mutation resulted in a
  nonsense codon at position 21, since the protein was terminated at amino acid
  20. </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>In patients with AIDS, the failure to form granulomas in tissues infected
by <i>Mycobacterium tuberculosis</i> is most
likely due to which of the following?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Inability of T lymphocytes to provide helper
functions for B lymphocytes</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Inability of T lymphocytes to recruit and
immobilize monocytes</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Clonal deletion of T lymphocytes reactive to
mycobacterial antigens</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Decreased production of tumor necrosis
factor-&#945; by macrophages</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Poor phagocytic activity of macrophages</span></p>

<p><span><span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A granuloma</span> is an<b> </b><span>organized
collection of macrophages</span> that have gathered around a microorganism or
foreign substance to “wall it off” from the body (see Figure 1). Macrophages
(also known as histiocytes) define the granuloma.<span> They originate as monocytes, which are recruited by T-cells into tissues
where they differentiate into macrophages. Cytokines produced by T-cells
“activate” macrophages, rendering them more “aggressive.” </span></p>

<p><span></span></p>

<p>Granulomatous macrophages
are sometimes called “epithelioid” because they resemble epithelial cells.
These macrophages form a tight “ball” around the microorganism or foreign
substance. They are so tightly clustered that the borders of individual cells
are difficult to appreciate. The “ball” of macrophages is surrounded by a
collar of lymphocytes, which produce cytokines that keep the macrophages
activated. Some macrophages fuse to form multinucleated giant cells (Langhans
giant cells). (See Figure 2.) </p>

<p></p>

<p>Granulomas form in response
to antigens that are resistant to &quot;first-responder&quot; inflammatory
cells, such as neutrophils and eosinophils. Thus, granulomas represent a type
of chronic inflammation. Some granulomas contain areas of necrosis. The
identification of necrosis usually indicates that the granuloma has an
infectious cause. The term “caseation” (turning into cheese) is used to describe
necrosis that looks “cheese-like” to the unaided eye. Caseating necrosis is
typical of tuberculosis. </p>

<p></p>

<p>T<span>uberculosis is the prototypic granulomatous disease and should always
be considered in the differential diagnosis in patients with granulomatous inflammation.
</span>Granulomas occur in the following conditions.</p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=top>
   <p><b><span>Disease</span></b></p>
   </td>
   <td valign=top>
   <p><b><span>Cause</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td valign=top>
  <p><span>Tuberculosis</span></p>
  </td>
  <td valign=top>
  <p><i><span>Mycobacterium
  tuberculosis</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Leprosy</span></p>
  </td>
  <td valign=top>
  <p><i><span>Mycobacterium
  leprae</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Syphilis</span></p>
  </td>
  <td valign=top>
  <p><i><span>Treponema
  pallidum</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Fungal
  disease</span></p>
  </td>
  <td valign=top>
  <p><i><span>Histoplasma,
  Coccidioides, Cryptococcus</span></i></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Cat-scratch
  disease</span></p>
  </td>
  <td valign=top>
  <p><i><span>Bartonella</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Sarcoidosis</span></p>
  </td>
  <td valign=top>
  <p><span>Unknown</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Crohn’s
  disease </span></p>
  </td>
  <td valign=top>
  <p><span>Unknown</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Wegener’s
  granulomatosis</span></p>
  </td>
  <td valign=top>
  <p><span>Unknown</span></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b></b></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/f/f2/Necrogran10x.jpg"><span><img border=0 width=281 height=212
src="_%20Tutorials_files/image126.png" alt="Description: File:Necrogran10x.jpg"
v:shapes="Picture_x0020_347145"></span></a></p>

<p style="text-align:center;"><span>Figure 1. Granuloma in a patient with tuberculosis </span></p>

<p style="text-align:center;"><b></b></p>

<p style="text-align:center;"><span><img border=0 width=269 height=181
src="_%20Tutorials_files/image128.png"
alt="Description: giant_cell_S98-40211-03" v:shapes="Picture_x0020_347144"></span></p>

<p style="text-align:center;"><span>Figure 2. Langhans giant cells</span></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer B is correct. </b>A granuloma is an organized collection of
macrophages. T cells recruit monocytes into tissues where they differentiate to
form macrophages. T cells also elaborate cytokines that activate macrophages.
In patients with AIDS, T cells are depleted and granuloma formation is
impaired. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A specific congenital form of deafness results from mutation of a
sequence of connexin 26 that encodes the channel within the connexin of the gap
junction. The mutation is most likely to affect which of the following domains
of the protein? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Amino terminus</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Carboxyl terminus</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Cytoplasmic loop</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Extracellular loop</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Transmembrane region</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Gap junction beta-2</span> (GJB2) also known as <b>connexin-26</b><b> (Cx26)</b> is a protein that in humans is
encoded by the <i>GJB2</i> gene. Defects in this gene lead to the most common
form of congenital deafness in developed countries, called DFNB1, also known as
Connexin 26 deafness or GJB2-related deafness. <span>The
prevalence and availability of interventions makes identifying those individuals
with hearing loss a public health issue. Universal newborn screening for
hearing loss has been widely adopted since it is known that early
identification and management of deafness is important for the development of
language and social skills. Research has shown that children with hearing loss
identified before six months of age and who have begun appropriate
interventions immediately after diagnosis demonstrate superior language skills
over those identified after six months of age.</span></p>

<p><span></span></p>

<p one in 1000 infants has profound hearing loss, with
at least half of these cases thought to be of genetic origin. Despite this
number, genetic causes of hearing loss are frequently undiagnosed. Also,
children who are the only deaf individuals in their families may have a genetic
or inherited cause for their deafness. There are many genes that contribute to
hearing loss. These genes may be inherited in a variety of fashions: autosomal
dominant, autosomal recessive, X-linked, or mitochondrial. <span>Infection in the mother during pregnancy or illness of the
infant requiring care in a neonatal intensive care unit may result in isolated
or sporadic cases of newborn hearing loss within families. </span></p>

<p><span></span></p>

<p><span>The most
common cause of congenital deafness in children is caused by a mutation
(autosomal recessive) of a gene called GBJ2. The gap junction gene called GJB2
encodes the protein connexin 26(Cx26). Many people simply refer to the gene as
the “<span>connexin 26 gene</span>.” In
two-thirds of persons with Cx26-related deafness, a single mutation is found
called 35delG. This mutation causes a defect in the transmembrane region of the
connexin protein. Connexins are expressed in many different tissues. Connexin
26 functions in the inner ear and is involved in junctions that allow the transport
of materials between cells.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span>**</span></p>

<p><b>Presbycusis</b>, or
age-related hearing loss, is the cumulative effect of aging on hearing. It is
defined as a progressive bilateral symmetrical age-related sensorineural
hearing loss. The hearing loss is most marked at higher frequencies. Hearing
loss that accumulates with age but is caused by factors other than normal aging
is not presbycusis. Deterioration in hearing has been found to start from about
the age of 18 years. Age affects high frequencies more than low frequencies and
men more frequently than women. One early consequence is that even young adults
may lose the ability to hear very high frequency tones. Despite this,
age-related hearing loss may only become noticeable later in life. The effects
of age can be exacerbated by exposure to environmental noise, whether at work
or in leisure time (shooting, music, etc.). With presbycusis, detection of
high-pitched sounds becomes more difficult, and speech perception is affected. </p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer E is correct.</b> Mutation of the connexin 26 gene causes a
defect in the transmembrane region of the connexin protein. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 31-year-old woman with type 1 diabetes mellitus stops taking her
insulin. Two days later she develops nausea, vomiting, abdominal pain, and
frequent urination. Blood tests reveal a metabolic acidosis with increased
anion gap. While performing the physical examination, her physician notices
that her breath has “fruity” odor. Which of the following substances most
likely explains that odor?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Oxaloacetate</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Malate</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Fumarate</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Succinate</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Acetone</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span>Ketones<b> </b></span>are by-products of fatty acid oxidation, produced
mainly in the mitochondria of liver cells. They are a fuel source for the brain
and are synthesized when glucose levels are low and when carbohydrate stores
(e.g., glycogen) have been exhausted.<span >&nbsp;
</span></p>

<p></p>

<p>Fatty acids are
enzymatically broken down during &#946;-oxidation to form acetyl-CoA. Under
normal conditions, acetyl-CoA is further oxidized and its energy transferred as
electrons to NADH, FADH<sub>2</sub>, and GTP in the citric acid cycle (TCA
cycle). However, if the amount of acetyl-CoA generated in &#946;-oxidation
(fatty acid oxidation) overwhelms the processing capacity of the TCA cycle,
acetyl-CoA is then used instead in the biosynthesis of ketones.</p>

<p></p>

<p><span>After they
are produced in the liver, ketones are transported to other tissues, such as
the brain and heart. Ketones can cross the blood-brian barrier and enter the
central nervous system. In the brain, they can be reconverted to acetyl-CoA to
produce energy, via the citric acid cycle. The heart has little need for
ketones, as it can burn fatty acids. The brain cannot burn fatty acids and must
rely on ketones when glucose is not available. </span></p>

<p><span></span></p>

<p>The three principal ketones
are acetoacetic acid, beta-hydroxybutyric acid, and acetone. Acetone is
produced by spontaneous decarboxylation of acetoacetate. It is not used as an
energy source, but is instead exhaled or excreted as waste. It is responsible
for the characteristic “fruity” odor of the breath of persons in ketoacidosis. </p>

<p></p>

<p>Ketogenesis may or may not
occur, depending on levels of available carbohydrates in the cell or body. </p>

<p></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>When
the body has ample carbohydrates available as energy source, glucose is
completely oxidized to CO<sub>2</sub>; acetyl-CoA is formed as an intermediate
in this process, first entering the citric acid cycle followed by complete
conversion of its chemical energy to ATP in oxidative phosporylation. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>When
the body has excess carbohydrates available, some glucose is fully metabolized,
and some of it is stored by using acetyl-CoA to create fatty acids.<span>&nbsp; </span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>When
the body has no free carbohydrates available, fat must be broken down into
acetyl-CoA in order to get energy. Acetyl-CoA is not being recycled through the
citric acid cycle because the citric acid cycle intermediates (mainly
oxaloacetate) have been depleted to feed the gluconeogenesis pathway, and the
resulting accumulation of acetyl-CoA activates ketogenesis. </span></p>

<p><span></span></p>

<p><span>Ketone
bodies are created at moderate levels in everyone’s bodies, such as during
sleep and other times when no carbohydrates are available. However, when
ketogenesis happens at higher-than-normal levels, the body is said to be in a
state of ketosis. Both acetoacetate and beta-hydroxybutyrate are acidic, and, if
levels of these ketones are too high, the pH of the blood drops, resulting in
ketoacidosis. Ketoacidosis occurs in individuals with untreated type I diabetes
mellitus (diabetic ketoacidosis) and in alcoholics after prolonged
binge-drinking without sufficient intake of carbohydrates (alcoholic
ketoacidosis). Ketoacidosis produces an increased-anion-gap metabolic acidosis.
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Ketogenesis</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=303 height=328
src="_%20Tutorials_files/image130.png" alt="Description: ketogenesis_pathway"
v:shapes="Picture_x0020_347143"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer E is correct. </span></b><span>In this patient with
type 1 diabetes mellitus, failure to take insulin has led to a state of
diabetic ketoacidosis (DKA). (In the absence of insulin, glucose cannot enter
the cell. The cell is “starved” of glucose, and ketogenesis occurs.) DKA is
commonly associated with nausea, vomiting, abdominal pain, and frequent
urination (due to hyperglycemia). Ketones are produced in abundance, resulting
in a metabolic acidosis with an increased anion gap. The main ketones are
acetoacetate, &#946;-hydroxybutyrate, and acetone. Acetone is responsible for
the “fruity” breath of people with DKA. <b></b></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
14-year-old boy falls and scrapes his knee. Which of the following complement
components will enhance vascular permeability and attract inflammatory cells to
the area of injury?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>C1q</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C4b</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C5a</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>C7</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C9</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The
principal mediators of inflammation (and their actions) are listed below. </span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=bottom>
   <p><b><span>Mediator</span></b></p>
   </td>
   <td valign=bottom>
   <p><b><span>Principal
   Sources</span></b></p>
   </td>
   <td valign=bottom>
   <p><b><span>Actions</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td colspan=3 valign=top>
  <p><b><span>CELL-DERIVED</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Histamine</span></p>
  </td>
  <td valign=top>
  <p><span>Mast
  cells, basophils, platelets</span></p>
  </td>
  <td valign=top>
  <p><span>Vasodilation,
  increased vascular permeability, endothelial activation</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Serotonin</span></p>
  </td>
  <td valign=top>
  <p><span>Platelets</span></p>
  </td>
  <td valign=top>
  <p><span>Vasodilation,
  increased vascular permeability</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Prostaglandins</span></p>
  </td>
  <td valign=top>
  <p><span>Mast
  cells, leukocytes</span></p>
  </td>
  <td valign=top>
  <p><span>Vasodilation,
  pain, fever</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Leukotrienes</span></p>
  </td>
  <td valign=top>
  <p><span>Mast
  cells, leukocytes</span></p>
  </td>
  <td valign=top>
  <p><span>Increased
  vascular permeability, chemotaxis, leukocyte adhesion and activation</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Platelet-activating
  factor</span></p>
  </td>
  <td valign=top>
  <p><span>Leukocytes,
  mast cells</span></p>
  </td>
  <td valign=top>
  <p><span>Vasodilation,
  increased vascular permeability, leukocyte adhesion, chemotaxis,
  degranulation, oxidative burst</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Reactive
  oxygen species</span></p>
  </td>
  <td valign=top>
  <p><span>Leukocytes</span></p>
  </td>
  <td valign=top>
  <p><span>Killing
  of microbes, tissue damage</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Nitric
  oxide</span></p>
  </td>
  <td valign=top>
  <p><span>Endothelium,
  macrophages</span></p>
  </td>
  <td valign=top>
  <p><span>Vascular
  smooth muscle relaxation, killing of microbes</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Cytokines
  (TNF, IL-1)</span></p>
  </td>
  <td valign=top>
  <p><span>Macrophages,
  endothelial cells, mast cells</span></p>
  </td>
  <td valign=top>
  <p><span>Local
  endothelial activation (expression of adhesion molecules),
  fever/pain/anorexia/hypotension, decreased vascular resistance (shock)</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Chemokines</span></p>
  </td>
  <td valign=top>
  <p><span>Leukocytes,
  activated macrophages</span></p>
  </td>
  <td valign=top>
  <p><span>Chemotaxis,
  leukocyte activation</span></p>
  </td>
 </tr>
 <tr>
  <td colspan=3 valign=top>
  <p><b><span>PLASMA
  PROTEIN&#8211;DERIVED</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Complement</span></b><span> products (C5a, C3a, C4a)</span></p>
  </td>
  <td valign=top>
  <p><span>Plasma (produced
  in liver)</span></p>
  </td>
  <td rowspan=3 valign=top>
  <table border=0 cellpadding=0>
   <tr>
    <td width=1>
    <p><span>&nbsp;&nbsp;</span></p>
    </td>
    <td width="4%" valign=top>
    <p><span></span></p>
    </td>
    <td>
    <p><span>Leukocyte
    chemotaxis and activation, vasodilation (mast cell stimulation)</span></p>
    </td>
   </tr>
   <tr>
    <td width=1>
    <p><span>&nbsp;&nbsp;</span></p>
    </td>
    <td width="4%" valign=top>
    <p><span></span></p>
    </td>
    <td>
    <p><span>Increased
    vascular permeability, smooth muscle contraction, vasodilation, pain</span></p>
    </td>
   </tr>
   <tr>
    <td width=1>
    <p><span>&nbsp;&nbsp;</span></p>
    </td>
    <td width="4%" valign=top>
    <p><span></span></p>
    </td>
    <td>
    <p><span>Endothelial
    activation, leukocyte recruitment</span></p>
    </td>
   </tr>
  </table>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Kinins</span></p>
  </td>
  <td valign=top>
  <p><span>Plasma (produced
  in liver)</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><span>Proteases
  activated during coagulation</span></p>
  </td>
  <td valign=top>
  <p><span>Plasma
  (produced in liver)</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td>
  <p><a
  name=4-u1.0-B978-1-4377-0792-2..50007-9--spar></a><span>IL-1 = interleukin-1; MAC = membrane
  attack complex; TNF = tumor necrosis factor</span></p>
  </td>
 </tr>
</table>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct.</span></b><span><span>&nbsp; </span>Complement components C5a, C3a, and C4a
are mediators of inflammation. Their actions include vasodilation, increased
vascular permeability, and leukocyte chemotaxis.<span>&nbsp; </span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Each of
the following conditions is associated with necrosis of a specific
morphological type. Match each condition with the corresponding type of
necrosis. </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Abscess
due to <i>Staphylococcus aureus</i></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Active
tuberculosis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Acute
pancreatitis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Polyarteritis
nodosa</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Renal
infarction</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Coagulation
necrosis</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Liquefactive
necrosis</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Caseous
necrosis</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fat
necrosis</span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fibrinoid
necrosis </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Tissue
necrosis can be classified into several distinct morphological categories. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=131 valign=top>
  <p style="text-align:center;"><span>Morphological Patterns of Tissue Necrosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span>Coagulative necrosis</span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span>Liquefactive necrosis</span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span>Gangrenous necrosis</span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span>Caseous necrosis</span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span>Fat necrosis</span><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p><span>Fibrinoid necrosis</span><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span>Coagulative
necrosis</span></b><span>
is the type of necrosis seen in <span>infarcts
(ischemic necrosis) of any organ</span> except the brain. The basic tissue
architecture is preserved for at least a few days. Cell outlines can still be
seen by light microscopy. Proteolysis of dead cells does not occur and the
tissue retains a firm texture. Eosinophilic, anucleate cells may be present for
days or weeks. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=452 height=173
src="_%20Tutorials_files/image132.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1"
v:shapes="Picture_x0020_347142"></span><span></span></p>

<p><span></span></p>

<p><span>Coagulative
necrosis. <b>A.</b> Wedge-shaped kidney infarct (yellow). <b>B.</b> Microscopic
view of the edge of the infarct, with normal kidney (N) and necrotic cells in
the infarct (I) showing preserved cellular outlines with loss of nuclei and an
inflammatory infiltrate (which is difficult to discern at this magnification).</span></p>

<p style="text-align:center;"><span>***</span></p>

<p><b><span>Liquefactive
necrosis</span></b><span>
occurs in bacterial<b> </b>and sometimes
fungal infection. Micro-organisms attract leukocytes, and the enzymes of the
leukocytes digest (“liquefy”) tissue. Dead cells are completely digested, and
the tissue is transformed into a viscous material. Following acute
inflammation, the material may be creamy yellow (pus). Note: Although ischemia
causes coagulative necrosis in most tissues, it causes liquefactive necrosis in
the brain.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=284 height=226
src="_%20Tutorials_files/image134.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1"
v:shapes="Picture_x0020_347141"></span><span></span></p>

<p style="text-align:center;"><span>Liquefactive necrosis. An infarct in the brain, showing
dissolution of the tissue.</span></p>

<p style="text-align:center;"><span>***</span></p>

<p><b><span>Gangrenous
necrosis</span></b><span>
is not a distinctive pattern, but the term is commonly used in clinical
practice. It usually applies to a limb that has lost its blood supply. If an
ischemic limb becomes secondarily infected with bacteria, “dry gangrene” may
turn into “<span>wet gangrene,” which is a
mixture of </span>coagulative necrosis (from ischemia) and liquefactive
necrosis (from bacterial infection). </span></p>

<p style="text-align:center;"><span>***</span></p>

<p><b><span>Caseous
necrosis</span></b><span>
is characteristic of tuberculous infection. The term “caseous” (cheese-like) is
derived from the friable, yellow-white appearance of the necrotic area seen
with the unaided eye. On microscopic examination, the necrotic focus appears as
a collection of lysed cells with an amorphous granular <a
name=4-u1.0-B978-1-4160-2973-1..50004-1--p11></a>appearance. The tissue
architecture is obliterated and cellular outlines cannot be seen. Foci of
necrosis may be enclosed within a distinctive inflammatory border, producing a
“granuloma.”</span></p>

<p style="text-align:center;"><span><img border=0 width=284 height=226
src="_%20Tutorials_files/image136.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1"
v:shapes="Picture_x0020_347140"></span><span></span></p>

<p><span>Caseous
necrosis. Tuberculosis of the lung, with a large area of caseous necrosis
containing yellow-white, cheesy debris.&nbsp; </span></p>

<p style="text-align:center;"><span>***</span></p>

<p><b><span>Fat
necrosis</span></b><span>
occurs with acute pancreatitis. Pancreatic enzymes leak out of acinar cells and
ducts, liquefying the membranes of fat cells in the peritoneum. Lipase breaks
down the triglyceride esters. Fatty acids are released, which combine with
calcium to produce a chalky white substance (fat saponification). </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=284 height=189
src="_%20Tutorials_files/image138.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1"
v:shapes="Picture_x0020_347139"></span><span></span></p>

<p><span></span></p>

<p><span>Fat
necrosis. The areas of white chalky deposits represent foci of fat necrosis
with calcium soap formation (saponification) at sites of lipid breakdown in the
mesentery.</span></p>

<p style="text-align:center;"><span>***</span></p>

<p><b><span>Fibrinoid
necrosis</span></b><span>
occurs in certain types of vasculitis (e.g., polyarteritis nodosa). Immune
complexes are deposited in the walls of arteries. When stained with H&amp;E,
these immune complexes, together with fibrin that has leaked out of the
vessels, have a bright, pink appearance, called “fibrinoid.”<span>&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=284 height=189
src="_%20Tutorials_files/image140.png"
alt="Description: bbmapAsset?appID=MDC&amp;isbn=978-1-4377-0792-2&amp;eid=4-u1"
v:shapes="Picture_x0020_347137"></span><span></span></p>

<p><span>Fibrinoid
necrosis in an artery. The wall of the artery shows a circumferential bright
pink area of necrosis.&nbsp;</span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answers </span></b></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>2</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>3</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>4</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>5</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>1</span></p>

<p><span></span></p>

<p><a name=4-u1.0-B978-1-4160-2973-1..50004-1--cete></a><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
4-month-old white female was admitted to the hospital with a two-week history
of fever, nasal congestion, and cough. She was well until two months ago when
she developed an oral ulcer, intermittent fever, recurrent otitis, decreased
appetite, and weight loss. On physical examination, tonsils are absent and
lymph nodes are not palpable. Bilateral wheezing is heard over the anterior and
posterior lung fields. Chest radiograph shows patchy infiltrates and no thymic
shadow. A nasal-wash viral culture is positive for parainfluenza 3 virus, and a
blood PCR is positive for adenovirus. She is treated with trimethoprim /
sulfamethoxazole for suspected infection with <i>Pneumocystis jiroveci</i>;
however, she dies on the fifth hospital day due to overwhelming adenoviral infection.
Her parents had premature twin girls who died shortly after birth. Currently,
they have a healthy two-year-old son.<span >&nbsp;
</span></span></p>

<p><span></span></p>

<p><u><span>Immunologic
Data<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Patient’s
Value <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Normal
Value</span></u></p>

<p><span></span></p>

<p><span>Serum
immunoglobulins</span></p>

<p><span>IgG,
mg/dL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>65
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>192&#8211;515</span></p>

<p><span>IgA,
mg/dL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>12&#8211;31</span></p>

<p><span>IgM,
mg/dL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>39&#8211;92</span></p>

<p><span>IgE,
IU/mL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>5
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0&#8211;150</span></p>

<p><span>Anti-A,
titer, counts per minute<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>&gt;1:32</span></p>

<p><span>Anti-B,
titer, counts per minute<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>&gt;1:16</span></p>

<p><span>Diphtheria
toxoid antibody, IU/mL <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0.19
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>&gt;0.10</span></p>

<p><span>Tetanus
toxoid antibody, IU/mL<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0.05
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>&gt;0.16</span></p>

<p><span>Lymphocyte
subpopulations, cells per mm<sup>3</sup></span></p>

<p><span>CD3+
T cells <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>1111&#8211;5183</span></p>

<p><span>CD20+
B cells <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>0
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>144&#8211;671</span></p>

<p><span>CD16+
NK cells <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>142
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>152&#8211;709</span></p>

<p><span>CD56+
NK cells <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>134
<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>223&#8211;1040</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of
the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Severe
congenital neutropenia</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Bruton’s
agammaglobulinemia</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Severe
combined immunodeficiency </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>DiGeorge
syndrome</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Wiskott-Aldrich
syndrome</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Ataxia-telangiectasia</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Common
variable immunodeficiency</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>Hyper-IgM
Syndrome</span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Job’s
syndrome (Hyperimmunoglobulin E syndrome)</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Selective
IgA deficiency</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=443 valign=top>
  <p style="text-align:center;"><span>Immunodeficiency Syndromes</span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Severe
  combined immunodeficiency (SCID)</span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: Stem cell disorder
  causing near complete failure of the immune system (B and T cells), usually
  due to a defect in common gamma chain protein or adenosine deaminase</span></p>
  <p><span></span></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent infection
  with viral, bacterial, and fungal pathogens; chronic diarrhea, ear
  infections, profuse oral candidiasis, recurrent pneumonia; death by age 1 if
  untreated</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Ataxia-telangiectasia
  </span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: Defect in DNA repair
  caused by a mutation in the ATM gene</span></p>
  <p><span></span></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent
  infections, imbalance, slurred speech, poor coordination, telangiectasias,
  IgA deficiency</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Job’s
  syndrome (Hyperimmunoglubulin E syndrome)</span></p>
  <p><b><span><span>&nbsp;</span></span></b><span><span >&nbsp;</span></span></p>
  <p><i><span>Description</span></i><span>: Failure of T helper
  cells to produce interferon-&#947; (a macrophage-activating factor)</span></p>
  <p><span></span></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent “cold”
  staphylococcal infections, eczema-like skin rash, severe lung infections with
  pneumatoceles, and very high IgE levels</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Bruton’s
  agammaglobulinemia</span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: X-linked disorder; mutation
  of tyrosine kinase gene impairs B-cell maturation</span></p>
  <p><span></span></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent infection
  with extracellular, pyogenic bacteria (<i>Staphylococcus aureus,
  Streptococcus pneumoniae, Streptococcus pyogenes, Hemophilus influenzae</i>);
  no circulating B cells; low serum levels of all antibody classes; normal T
  lymphocyte levels</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Common
  variable immunodeficiency<span >&nbsp; </span></span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: Group of disorders
  resulting in inadequate antibody production</span></p>
  <p><i><span></span></i></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent
  infections; low serum levels of IgG, IgA, and IgM; normal B and T lymphocyte
  levels</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Hyper-IgM
  syndrome</span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: Defect in CD40
  ligand on T helper cells inhibits “class switch” between immunoglobulin
  subtypes</span></p>
  <p><i><span></span></i></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent upper and
  lower respiratory tract infections, high IgM levels, undetectable IgG and IgA
  levels</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Selective
  IgA deficiency </span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: Defect of B-cell
  maturation that impairs IgA production</span></p>
  <p><i><span></span></i></p>
  <p><i><span>Manifestation</span></i><span>: Usually healthy; may
  have recurrent ear, sinus, and lung infections; low serum IgA levels</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>Wiskott-Aldrich
  Syndrome</span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: X-linked disorder;
  mutation of WASp gene impairs IgM response to bacteria</span></p>
  <p><i><span></span></i></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent pyogenic
  infections, eczema, thrombocytopenia (classic triad); low serum levels of
  IgM; high serum levels of IgA and IgE; normal IgG levels</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=443 valign=top>
  <p><span>DiGeorge
  Syndrome</span></p>
  <p><span></span></p>
  <p><i><span>Description</span></i><span>: Deletion of small
  piece of chromosome 22 causing maldevelopment of thymus and parathyroid
  glands, results in T cell deficiency and hypocalcemia </span></p>
  <p><i><span></span></i></p>
  <p><i><span>Manifestation</span></i><span>: Recurrent infections
  with viral and fungal pathogens; T cell deficiency; CATCH mnemonic (Cardiac
  abnormality, Abnormal faces, Thymic aplasia, Cleft palate, Hypocalcemia)</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Selected
gene mutations resulting in devastating immunodeficiency diseases are shown
below</span></p>

<p><b><span></span></b></p>

<p><span><img border=0 width=450 height=338
src="_%20Tutorials_files/image142.png"
alt="Description: S9781416046882-012-f002" v:shapes="Picture_x0020_347136"></span><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
C is correct.</span></b><span><span>&nbsp; </span>Most children with Severe Combined
Immunodeficiency Disease (SCID) appear normal at birth but begin to have
repeated infections at two to four months of age, which corresponds with waning
levels of maternal IgG acquired <i>in utero</i>.<span>&nbsp; </span>Most cases of SCID are due to mutations
in the gene encoding the common gamma chain (&#947;<sub>c</sub>), a protein
that is shared by the receptors for interleukins IL-2, IL-4, IL-7, IL-9, IL-15
and IL-21. These interleukins and their receptors are involved in the
development and differentiation of T and B cells. Because the common gamma
chain is shared by many interleukin receptors, mutations that result in a
non-functional common gamma chain cause widespread defects in interleukin
signaling. The result is a near complete failure of the immune system to
develop and function, with low or absent T cells and NK cells and
non-functional B cells. The second most common form of SCID is caused by a
defective enzyme, adenosine deaminase (ADA), necessary for the breakdown of
purines. Numerous other mutations are associated with SCID (including mutations
of Janus kinase 3, <i>RAG-1</i>,<i> RAG-2</i>,<i> </i>and <i>Artemis</i>).
Serious viral infections, lack of peripheral B and T lymphocytes, radiographic
absence of a thymic shadow, absence of tonsils, and absence of palpable lymph
nodes are all consistent with a diagnosis of SCID.</span></p>

<p><span></span></p>

<p><b><span>Answer
A is incorrect.</span></b><span><span>&nbsp; </span>Patients with severe congenital
neutropenia present with very low circulating neutrophil counts and severe
infections, which usually occur when the absolute neutrophil count is &lt;500
cells/mm<sup>3</sup>.<span >&nbsp; </span>Infections
occur in the oral and mucosal surfaces (gingivitis, periodontitis), skin,
perirectal and genital areas, lungs, GI tract, and bloodstream. The condition
has its onset in infancy. Affected children can be treated with exogenous
G-CSF.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
B is incorrect.</span></b><span><span>&nbsp; </span>Patients with Bruton’s agammaglobulinemia
usually suffer from recurrent pyogenic bacterial infections due to a lack of
opsonizing antibodies.<span >&nbsp; </span>The defect
is in Bruton’s tyrosine kinase, an enzyme essential to B-cell, but not T-cell,
development.<span >&nbsp; </span>T-cell number and
function are normal, so patients typically do not have problems with viral or
other intracellular infections.<span >&nbsp;
</span>Most cases are X-linked, but females with two defective genes will also
have the disease.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect.</span></b><span><span>&nbsp; </span>Children with DiGeorge syndrome suffer
from recurrent viral and fungal infections within the first year of life.<span>&nbsp; </span>They also exhibit <i>c</i>ardiac
defects, <i>a</i>bnormal facial features, <i>t</i>hymic hypoplasia, <i>c</i>left
palate, <i>h</i>ypocalcemia, and chromosome 22 deletion (CATCH-22).<span>&nbsp; </span>DiGeorge syndrome occurs when there is
defective embryogenesis that affects the thymus and other organs that derive
from the third and fourth pharyngeal pouches.<span>&nbsp; </span>Because these patients have little to no
thymic tissue, T cells are low to absent.<span >&nbsp;
</span>The number of B cells is not affected, although patients will exhibit
reduced immunoglobulin levels due to a paucity of T helper cells.</span></p>

<p><span></span></p>

<p><b><span>Answer
E is incorrect.</span></b><span>
Children with Wiskott-Aldrich syndrome (WAS) present with thrombocytopenia
associated with petechiae, purpura, mucosal bleeding, and intermittent bloody diarrhea.<span>&nbsp;&nbsp; </span>They have eczema, as well as
recurrent bacterial and viral infections, especially in the ear.<span>&nbsp; </span>The disease is due to a mutation of the
WAS protein, which is important for reorganization of the actin
cytoskeleton.<span >&nbsp; </span>Cell adhesion and
migration is affected, which impairs the function of hematopoietic-derived
cells.<span >&nbsp; </span>The disease is X-linked, so
males with the gene will be affected, while females will be asymptomatic
carriers. Patients typically have decreased IgM and increased IgA and IgE
levels.<span >&nbsp; </span>T cell subsets are usually
decreased.</span></p>

<p><span></span></p>

<p><b><span>Answer
F is incorrect. </span></b><span>Ataxia-telangiectasia
is a rare, inherited, neurodegenerative disease that causes severe disability.
Patients present with poor coordination (because of cerebellar dysfunction) and
small, dilated blood vessels in the skin and mucous membranes
(telangiectasias).<span >&nbsp; </span>The immune
system is affected in the majority of patients. Symptoms usually begin in early
childhood (toddler stage) with imbalance, slurred speech, and increased
infections. The condition is caused by a defect in the ATM gene, which is
responsible for recognizing and correcting errors in duplicating DNA.</span></p>

<p><span></span></p>

<p><b>Answer G is incorrect. </b>Common
variable immunodeficiency (CVID) is a group of 20-30 immunological disorders
manifested by hypogammaglobulinemia. Patients are predisposed to infection with
common bacterial and viral pathogens. CVID is the most commonly encountered
primary immunodeficiency.</p>

<p></p>

<p><b>Answer H is incorrect. </b>Hyper-IgM
syndrome is a heterogeneous group of disorders in which a defect in the CD40
ligand on T helper cells inhibits “class switch” between immunoglobulin
subtypes. Patients have high IgM levels and undetectable IgG and IgA levels.
This predisposes them to recurrent upper and lower respiratory tract
infections.</p>

<p></p>

<p><b>Answer I is incorrect. </b>Job’s
syndrome (Hyperimmunoglobulin E syndrome) is a group of disorders characterized
by abnormal neutrophil chemotaxis. T-cell production of interferon gamma is
impaired. Patients present with recurrent &quot;cold&quot; staphylococcal
infections, unusual eczema-like skin rashes, severe lung infections resulting
in pneumatoceles (balloon-like lesions in the lung), and very high
concentrations of the serum IgE.</p>

<p></p>

<p><b><span>Answer
J is incorrect. </span></b><span>Selective
IgA deficiency is a disorder of B-cell maturation resulting in decreased or
absent serum IgA levels. Serum IgG and IgM levels are normal. Patients may be
asymptomatic or may have recurrent ear, sinus, or lung infections.</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A
4-year-old boy presents with recurrent pyogenic infections. He had normal
antibody responses to childhood immunizations and recovered normally from
chicken pox and measles. Deficiency or dysfunction of which of the following
cells is most likely to explain his condition?<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>B
lymphocyte</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>T
lymphocyte</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Neutrophil</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Macrophage</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Eosinophil</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Pus</span> is a viscous exudate, typically whitish-yellow that forms at
the site of an infection. An accumulation of pus in an enclosed tissue space is
known as an abscess, whereas a visible collection of pus within or beneath the
epidermis is known as a pustule. Pus is comprised of dead leukocytes (mostly
neutrophils) in a protein-rich fluid. The fluid is usually whitish-yellow, but
other colors can occur. (Blue-green pus may result from infection with <i>Pseudomonas
aeruginosa</i><span> and brown pus is
typical of a</span>moebic abscesses in the liver.)</p>

<p></p>

<p>During infection,
macrophages and other cells of the innate immune system release chemokines that
trigger neutrophils to seek the site of infection (chemotaxis). The neutrophils
engulf and destroy bacteria.<span >&nbsp; </span>Some
bacteria fight back by releasing toxins called leukocidins.<a
href="http://en.wikipedia.org/wiki/Pus#cite_note-Biology-1#cite_note-Biology-1"></a>
As neutrophils die, they are engulfed and destroyed by macrophages, forming
viscous pus.</p>

<p></p>

<p>Bacteria causing pus
formation are called <span>suppurative</span>,
<span>pyogenic</span>, or <span>purulent</span>. “Pyogenic” means
pus-forming. Examples of pyogenic bacteria include <i>Staphylococcus aureus </i><span>and</span> <i>Streptococcus pneumoniae.</i><span> </span></p>

<p><span></span></p>

<p>Defense against pyogenic
bacteria depends on intact neutrophil function and adequate humoral immunity.
Humoral immunity depends on antibodies, which are produced by B-lymphocytes.
B-lymphocytes are assisted by T helper cells. Therefore, neutrophils,
B-lymphocytes, and T-lymphocytes are all involved in defense against pyogenic
infections. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct</span></b><span>.<span>&nbsp; </span>The patient in this vignette had a
normal antibody response to childhood immunizations, suggesting adequate
B-lymphocyte function. He also recovered normally from two viral infections,
chicken pox and measles, suggesting adequate T-lymphocyte function. Neutrophil
deficiency or dysfunction is, therefore, the likely source of the problem.<span>&nbsp; </span>Possible causes include congenital
neutropenias and chronic granulomatous disease.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>[Note: The
importance of neutrophils in protecting against pyogenic infection is apparent
from studies done on patients with Job’s syndrome (hyperimmunoglobulin-E
syndrome). These patients have impaired neutrophil chemotaxis, which
predisposes them to recurrent staphylococcal infections.]</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>The
illustration below shows the dose-response curve for drug X. Which curve
represents the dose-response curve for drug X plus a non-competitive receptor
antagonist? </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=204 height=164
src="_%20Tutorials_files/image144.png" v:shapes="Picture_x0020_31"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>A</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>B</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>D</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>E</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>A
non-competitive receptor antagonist binds <i>irreversibly</i>
to the receptor. This reduces the efficacy, or maximum response, of the drug.
Because the binding is irreversible, the drug cannot overcome the antagonism
even if it is administered in high doses. Consequently, the height of the curve
is shortened (Curve C), meaning that the <i>efficacy</i>
of the drug is reduced. </span></p>

<p><span></span></p>

<p><span>By
contrast, a competitive antagonist binds <i>reversibly</i>
to the receptor. Antagonism <i>can</i> be
overcome by increasing the dose of the drug. Thus, the efficacy of the drug is <i>not</i> reduced. The drug can still produce
a maximum response if administered at high enough doses. The <i>potency </i>of the drug, however, is
reduced, because more drug is needed to produce the same effect. (Potency is
inversely related to the amount of drug needed to produce a given effect.) This
reduction in potency produced by a competitive antagonist is represented by
Curve D. </span></p>

<p><span></span></p>

<p><span>Non-competitive
antagonists reduce efficacy. Competitive antagonists reduce potency. </span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Dose-response curve</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=249 height=304
src="_%20Tutorials_files/image146.png"
alt="Description: competitive%20and%20noncompetitive%20antagonist" v:shapes="Picture_x0020_30"></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. Curve C represents the
dose-response curve for drug X plus a non-competitive receptor antagonist.</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
30-year-old woman presents with fatigue, weakness, body aches, and
light-headedness upon standing. She is found to have primary adrenal
insufficiency (Addison disease). Treatment is initiated with prednisone, a
glucocorticoid. Through which of the following receptor types do
glucocorticoids produce their effects?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Ligand-gated
ion channel </span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>G-protein
coupled receptor </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Enzyme-linked
receptor </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Nuclear
receptor </span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Immunoglobulin-like
receptor</span></p>

<p><span></span></p>

<span><br clear=all>
</span>

<p><span>Receptors are proteins that “translate” extracellular signals into
intracellular effects. T</span>hey may be located in the cell membrane or
within the cytoplasm or nucleus. Molecules (e.g., drugs, hormones,
neurotransmitters) that bind to receptors are called ligands. Ligands may
activate or inactivate a receptor. Activated receptors regulate cellular
biochemical processes (e.g., ion conductance, enzymatic activity, DNA
transcription). </p>

<p>Receptors are <span>classified into four major types: </span><span>&nbsp;</span></p>

<p></p>

<p><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Ligand-gated ion channels. These transmembrane
receptors contain a central pore, or ion channel, which opens in response to
the binding of a ligand. The channel is usually selective to one or more ions
(e.g., Na<sup>+</sup>, K<sup>+</sup>, Ca<sup>2+</sup>, or Cl<sup>-</sup>). Ion
channels are especially important at certain neuronal synapses, where they
convert chemical signals from neurotransmitters to electrical signals in the
postsynaptic neuron. The prototype of a ligand-gated ion channel is the
nicotinic acetylcholine receptor. When acetylcholine binds to the receptor, the
receptor’s configuration changes, allowing the pore to open. Na<sup>+</sup>
ions flow down an electrochemical gradient into the cell. When many channels
open at once, the intracellular Na<sup>+</sup> concentration rises to a level
at which the positive charge within the cell is enough to depolarize the
membrane, initiating an action potential.</p>

<p></p>

<p><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>G-protein-coupled receptors.<span>&nbsp; </span>These transmembrane receptors do <i>not</i> contain a central pore, or ion
channel. Instead, they are <i>indirectly</i>
linked with ion channels through G- proteins, which serve as signal
transducers. G-proteins may activate other enzymes, such as adenyl cyclase or
phospholipase. Because several steps exist between receptor activation and ion
channel opening, these ion channels take longer to open than ligand-gated ion
channels &#8211; and they stay open longer than ligand-gated channels.
G-protein-coupled receptors include receptors for norepinephrine, epinephrine,
dopamine, serotonin, histamine, muscarinic acetylcholine, and GABA<sub>B</sub>.
</p>

<p></p>

<p><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span>Enzyme-linked
receptors. These</span> transmembrane receptors have enzymatic activity on the
intracellular side, triggered by ligand binding on the extracellular side. Most
enzyme-linked receptors are tyrosine kinases, which phosphorylate tyrosine
residues. Tyrosine kinases include the receptors for insulin, peptide hormones,
and growth factors (e.g., epidermal growth factor, fibroblast growth factor,
vascular endothelial growth factor). </p>

<p><span></span></p>

<p><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span>Nuclear
receptors. These receptors are located in the cytosol or in the nucleus (rather
than in the cell membrane). They </span>have the ability to directly bind DNA
and regulate the expression of adjacent genes. These receptors are considered
transcriptional activators. Steroid hormones and thyroid hormones bind to
nuclear receptors. There are two major types of nuclear receptors. Class I
receptors are located in the cytosol. When activated by ligand, they
translocate to the nucleus, bind to a specific DNA sequence, and enhance DNA
transcription. Class II receptors are located in the nucleus (regardless of
ligand-binding status). When bound by ligand, they promote DNA transcription. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<div align=center>

<table border=0 cellspacing=0 cellpadding=0 width=375>
 <tr>
  <td width=375 colspan=4>
  <p style="text-align:center;"><b><span>Types of Receptors</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=92 valign=top>
  <p style="text-align:center;"><b><span>Type</span></b></p>
  </td>
  <td width=123 valign=top>
  <p style="text-align:center;"><b><span>Structure</span></b></p>
  </td>
  <td width=71 valign=top>
  <p style="text-align:center;"><b><span>Cellular Location</span></b></p>
  </td>
  <td width=89 valign=top>
  <p style="text-align:center;"><b><span>Examples</span></b></p>
  </td>
 </tr>
 <tr>
  <td width=92 valign=top>
  <p><span>Ligand-gated
  ion channels</span></p>
  </td>
  <td width=123 valign=top>
  <p style="text-align:center;"><span><img border=0 width=87 height=44
  src="_%20Tutorials_files/image148.png"
  alt="Description: MMPE_20RX_TAB304_01a_eps" v:shapes="Picture_x0020_29"></span><span></span></p>
  </td>
  <td width=71 valign=top>
  <p><span>Cell
  surface transmembrane</span></p>
  </td>
  <td width=89 valign=top>
  <p><span>Acetylcholine
  (nicotinic)</span></p>
  <p><span>GABA<sub>A</sub>
  </span></p>
  </td>
 </tr>
 <tr>
  <td width=92 valign=top>
  <p><span>G-protein&#8211;coupled
  receptors</span></p>
  </td>
  <td width=123 valign=top>
  <p style="text-align:center;"><span><img border=0 width=114 height=44
  src="_%20Tutorials_files/image150.png"
  alt="Description: MMPE_20RX_TAB304_01b_eps" v:shapes="Picture_x0020_28"></span><span></span></p>
  </td>
  <td width=71 valign=top>
  <p><span>Cell
  surface transmembrane</span></p>
  </td>
  <td width=89 valign=top>
  <p><span>Acetylcholine
  (muscarinic)</span></p>
  <p><span>GABA<sub>B</sub></span></p>
  <p><span>Norepinephrine</span></p>
  <p><span>Epinephrine</span></p>
  <p><span>Dopamine</span></p>
  <p><span>Serotonin</span></p>
  <p><span>Histamine</span></p>
  <p><span>Eicosanoids</span></p>
  </td>
 </tr>
 <tr>
  <td width=92 valign=top>
  <p><span>Enzyme-linked
  receptors</span></p>
  </td>
  <td width=123 valign=top>
  <p style="text-align:center;"><span><img border=0 width=84 height=59
  src="_%20Tutorials_files/image152.png"
  alt="Description: MMPE_20RX_TAB304_01c_eps" v:shapes="Picture_x0020_27"></span><span></span></p>
  </td>
  <td width=71 valign=top>
  <p><span>Cell
  surface transmembrane</span></p>
  </td>
  <td width=89 valign=top>
  <p><span>Insulin </span></p>
  <p><span>Peptide
  hormones</span></p>
  <p><span>Growth
  factors</span></p>
  </td>
 </tr>
 <tr>
  <td width=92 valign=top>
  <p><span>Nuclear
  receptors</span></p>
  </td>
  <td width=123 valign=top>
  <p style="text-align:center;"><span><img border=0 width=101 height=61
  src="_%20Tutorials_files/image154.png"
  alt="Description: MMPE_20RX_TAB304_01d_eps" v:shapes="Picture_x0020_26"></span><span></span></p>
  </td>
  <td width=71 valign=top>
  <p><span>Cytoplasm</span></p>
  </td>
  <td width=89 valign=top>
  <p><span>Steroid hormones</span></p>
  <p><span>Thyroid
  hormone</span></p>
  <p><span>Vitamin
  D</span></p>
  <p><span>Vitamin
  A</span></p>
  </td>
 </tr>
 <tr>
  <td width=375 colspan=4 valign=top>
  <p style="text-align:center;"><span>GABA = &#947;-aminobutyric acid; GTP =
  guanosine triphosphate; GDP = guanosine diphosphate.</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct.</span></b><span> The glucocorticoid
receptor is a nuclear receptor. It functions, therefore, as a transcriptional
activator. Nuclear receptors are multi-domain proteins consisting of a ligand
binding domain (LBD), transactivation domain (AD), and DNA-binding domain (DBD).
The effect of ligand binding has differing effects depending on the specific
hormone receptor.</span></p>

<p><span></span></p>

<p><span>The
glucocorticoid receptor is a soluble protein found in the cytosol and nucleus.
In the absence of ligand, it is tethered to other proteins in large aggregates
in the cytosol. Upon binding to glucocorticoid, the conformation of the
receptor is altered, which allows its release from the protein aggregate. The
freed receptor then travels into the nucleus and binds to specific elements in
the promoters of certain genes. This binding causes the transactivation domain
to recruit and facilitate assembly of the RNA polymerase II initiation complex,
which transcribes DNA. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=434 height=249
src="_%20Tutorials_files/image156.png"
alt="Description: iMac HD:Users:Karla:Downloads:ch10f67.jpg" v:shapes="Picture_x0020_25"></span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Southern
blot analysis is performed on a patient with sickle cell trait. The single
base-pair mutation destroys the MstII restriction enzyme site marked by the
asterisk. The arrows show restriction enzyme-binding sites. DNA from this
patient is treated with MstII and run on an electrophoresis gel. The fragments
are then hybridized with a labeled probe that binds to the normal gene at the
position shown on the map. Which lane in this Southern blot analysis represents
the patient?</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span><img border=0 width=239 height=104
src="_%20Tutorials_files/image158.png" v:shapes="Picture_x0020_24"></span><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>A</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>B</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>C</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>D</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>E</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>F</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is correct</span></b><span>. Patients with sickle
cell trait are heterozygous for the sickle cell gene. The &#946;<sub>A</sub>
globin gene results in a 1.15-Kb fragment after treatment with MstII. The
&#946;<sub>S</sub> globin gene results in a 1.35-Kb fragment due to loss of the
Mst restriction site. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Lane A represents a
patient with sickle cell anemia (homozygous for the &#946;<sub>S</sub> globin
gene).</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Lane C represents a
normal patient (homozygous for the &#946;<sub>A</sub> globin gene).<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answers D, E, and F are incorrect</span></b><span>. These lanes represent
no patient. The probe does not bind the 0.2-Kb fragment that results from MstII
cleavage. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 7-month-old boy is brought
to the clinic because his eyes have been crossed for 3 days. Physical
examination shows strabismus and a white pupillary reflex in the left eye.
Ophthalmologic examination shows a solitary retinal tumor in the left eye.
Molecular analysis of the tumor shows two faulty copies of a gene for a protein
that serves as an important inhibitor of cell-cycle progression. Where in the
cell cycle does this regulatory protein exert its effect? </p>

<p style="text-align:center;"><span><img border=0 width=241 height=156
src="_%20Tutorials_files/image160.png" v:shapes="Picture_x0020_23"></span></p>

<p style="text-align:center;"></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>A</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>B</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>C</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>D</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=390 height=287
src="_%20Tutorials_files/image162.png" alt="Description: CellCycle" v:shapes="Picture_x0020_22"></span></p>

<p>The cell cycle consists of
four phases: G<sub>1</sub> phase, S phase (synthesis), G<sub>2</sub> phase, and
M phase (mitosis). The M phase (mitosis) is composed of two processes: mitosis,
in which the cell's chromosomes are divided between the two daughter cells, and
cytokinesis, in which the nucleus, cytoplasm, organelles, and cell membrane are
separated in two. In the G<sub>1</sub> (Gap 1) phase, cell growth occurs. This
phase is marked by protein synthesis, cytoplasmic enlargement, and organelle
production. In the S phase (synthesis), DNA replication occurs. In the G<sub>2</sub>
(Gap 2) phase, the cell resumes its growth and prepares for mitosis. The G<sub>0</sub>
phase is a state of quiescence in which cells have temporarily or reversibly
stopped dividing. </p>

<p></p>

<p><span>Retinoblastoma</span> is the most common primary malignant intraocular tumor
of childhood. Hereditary and nonhereditary forms exist. The hereditary form is
usually bilateral and multifocal, whereas the nonhereditary form is usually
unilateral and unifocal. <a name=4-u1.0-B978-1-4160-2450-7..50631-9--p260></a>In
most patients, the initial sign is a white pupillary reflex (leukocoria),
caused by the reflection of light off the white tumor (see image below). The
second most common sign is strabismus. The cure rate for retinoblastoma is
approximately 95%.</p>

<p></p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=152 height=116
src="_%20Tutorials_files/image164.png" alt="Description: cancer4" v:shapes="Picture_x0020_21"></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;">Leukocoria
in child with retinoblastoma</p>

<p style="text-align:center;"></p>

<p>The hereditary form of
retinoblastoma is associated with inactivation of the <span gene (RB1), a tumor suppressor gene </span>located
on chromosome 13.<span >&nbsp; </span>Tumor suppressor
genes are sometimes called “anti-oncogenes.” They protect cells from
progressing to cancer. Mutations of these genes facilitate progression to
cancer.<span> Unlike oncogenes</span>, tumor
suppressor genes generally follow the “two-hit hypothesis”; i.e., two
mutational events are required for tumor development<a
name=4-u1.0-B978-1-4160-2450-7..50504-1--intr></a>. </p>

<p></p>

<p>In the inherited form of <span
 both RB1 alleles are usually mutated.
One mutation is inherited through the germinal cells; the other occurs later in
somatic retinal cells. (Usually both alleles must be mutated because a single
normal allele can produce enough protein to prevent progression to cancer.)
Mutations of tumor suppressor genes are usually recessive; mutations of
oncogenes, by contrast, are usually dominant.</p>

<p></p>

<p>Tumor-suppressor genes work
by inhibiting the cell cycle or by promoting apoptosis. The first
tumor-suppressor gene discovered was the retinoblastoma gene, which codes for
retinoblastoma protein (pRb). This protein blocks the cell cycle so that the
cell cannot leave the G<sub>1 </sub>phase and enter the S phase. Thus, the cell
remains stalled in the G<sub>1</sub> phase. This is a protective mechanism. It
prevents damaged DNA from replicating. If the retinoblastoma gene is mutated,
replication of damaged DNA goes unregulated, and cancer can occur.</p>

<p></p>

<p></p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=347 height=397
src="_%20Tutorials_files/image166.png"
alt="Description: Figure 24-9. The seven types of proteins that participate in controlling cell growth."
v:shapes="Picture_x0020_20"></span></p>

<h3><span><span seven types of proteins that
participate in controlling cell growth</span></span></h3>

<h3><span></span></h3>

<p><span>Cancer
can result from expression of mutant forms of these proteins: growth factors
(I), growth factor receptors (II), signal-transduction proteins (III),
transcription factors (IV), pro- or anti-apoptotic proteins (V), cell cycle
control proteins (VI), and DNA repair proteins (VII). Mutations changing the
structure or expression of proteins in classes I&#8197;&#8211;&#8197;IV
generally give rise to dominantly active <i>oncogenes</i>.
The class VI proteins mainly act as <i>tumor
suppressors</i>; mutations in the genes encoding these proteins act recessively
to release cells from control and surveillance, greatly increasing the
probability that the mutant cells will become tumor cells. Class VII mutations
greatly increase the probability of mutations in the other classes.
Virus-encoded proteins that activate growth-factor receptors (Ia) also can
induce cancer.</span></p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer D is correct. </b>The retinoblastoma gene codes for
retinoblastoma protein (pRb), which blocks the cell cycle so that the cell
cannot leave the G<sub>1 </sub>phase and enter the S phase. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Smoking
increases the risk of each of the following <i>except</i>:
</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Pancreatic
cancer</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Aortic
aneurysm</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Susceptibility
to pneumonia</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Ulcerative
colitis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Spontaneous
abortion</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Leukoplakia</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Osteoporosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><b><span>Health Hazards of Tobacco Use</span></b></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="50%" valign=top>
  <p><b><span>CANCER</span></b></p>
  <p><span>Lung</span></p>
  <p><span>Larynx</span></p>
  <p><span>Oral
  cavity</span></p>
  <p><span>Esophagus</span></p>
  <p><span>Pancreas</span></p>
  <p><span>Bladder</span></p>
  <p><span>Kidney</span></p>
  <p><span>Stomach</span></p>
  <p><span>Leukemia</span></p>
  <p><span>Cervix</span></p>
  <p><b><span></span></b></p>
  <p><b><span>CARDIOVASCULAR
  DISEASE</span></b></p>
  <p><span>Sudden
  death</span></p>
  <p><span>Acute
  myocardial infarction</span></p>
  <p><span>Unstable
  angina</span></p>
  <p><span>Stroke</span></p>
  <p><span>Peripheral
  arterial occlusive disease </span></p>
  <p><span>Aortic
  aneurysm</span></p>
  <p><b><span></span></b></p>
  <p><b><span>PULMONARY
  DISEASE</span></b></p>
  <p><span>Lung
  cancer</span></p>
  <p><span>Chronic
  bronchitis</span></p>
  <p><span>Emphysema</span></p>
  <p><span>Asthma</span></p>
  <p><span>Susceptibility
  to pneumonia</span></p>
  <p><span>Susceptibility
  to pulmonary tuberculosis</span></p>
  <p><span>Increased
  morbidity from viral respiratory infection</span></p>
  <p><b><span></span></b></p>
  <p><b><span></span></b></p>
  <p><span></span></p>
  </td>
  <td width="50%" valign=top>
  <p><b><span>GASTROINTESTINAL
  DISEASE</span></b><span>
  </span></p>
  <p><span>Peptic
  ulcer</span></p>
  <p><span>Gastroesophageal
  reflux</span></p>
  <p><span>Crohn's
  disease</span></p>
  <p><b><span></span></b></p>
  <p><b><span>REPRODUCTIVE
  DISTURBANCES</span></b><span></span></p>
  <p><span>Reduced
  fertility</span></p>
  <p><span>Premature
  birth</span></p>
  <p><span>Lower
  birth weight</span></p>
  <p><span>Spontaneous
  abortion</span></p>
  <p><span>Abruptio
  placentae</span></p>
  <p><span>Premature
  rupture of membranes</span></p>
  <p><span>Increased
  perinatal mortality</span></p>
  <p><b><span></span></b></p>
  <p><b><span>ORAL
  DISEASE</span></b><span></span></p>
  <p><span>Oral
  cancer</span></p>
  <p><span>Leukoplakia</span></p>
  <p><span>Gingivitis</span></p>
  <p><span>Gingival
  recession</span></p>
  <p><span>Tooth
  staining</span></p>
  <p><b><span></span></b></p>
  <p><b><span>OTHER</span></b><span></span></p>
  <p><span>Non&#8211;insulin-dependent
  diabetes mellitus</span></p>
  <p><span>Earlier
  menopause</span></p>
  <p><span>Osteoporosis</span></p>
  <p><span>Cataract</span></p>
  <p><span>Tobacco
  amblyopia</span></p>
  <p><span>Age-related
  macular degeneration</span></p>
  <p><span>Premature
  skin wrinkling</span></p>
  <p><span>Graves'
  disease, including ophthalmopathy</span></p>
  <p><span>Aggravation
  of hypothyroidism</span></p>
  <p><span>Altered
  drug metabolism or effects<b></b></span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. Smokers have an
increased risk of developing Crohn’s disease and a decreased risk of developing
ulcerative colitis.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>In each of
four tubes is placed a DNA fragment with DNA polymerase, a radiolabeled primer,
and the adenine, thymine, cytosine, and guanine deoxynucleotides. Each tube
contains one of the four bases as dideoxynucleotides. The tubes are run on
electrophoresis gel and viewed by autoradiography. What is this technique
called?<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Northern
blot</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Southern
blot</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Western
blot</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Sequencing</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Polymerase
chain reaction (PCR)</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Enzyme-linked
immunosorbent assay (ELISA)</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>Allele-specific
oligonucleotide probe</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is correct</span></b><span>. Sequencing uses
dideoxynucleotides to terminate growing DNA strands. DNA fragments are
separated by gel electrophoresis and the sequence is determined by the position
of the bands on the gel. </span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. In the Northern blot
technique, RNA is separated by electrophoresis, denatured, and transferred to
filter paper. Radiolabeled DNA is used as a probe. The hybridized DNA/RNA
strand is visualized by autoradiography.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. In the Southern blot
technique, DNA is separated by electrophoresis, denatured, and transferred to
filter paper. Radiolabeled DNA is used as a probe. The hybridized DNA/DNA
strand is visualized by autoradiography.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. In the Western blot
technique, protein is separated by electrophoresis and labeled antibodies are
used as a probe. </span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Polymerase chain
reaction (PCR) is used to produce many copies of a DNA segment. The DNA segment
is mixed with primer, polymerase, and deoxynucleotides. The solution is heated
to denature the DNA and cooled to allow synthesis. Through repeated cycles of
heating a cooling, DNA can be amplified more than a million times. </span></p>

<p><span></span></p>

<p><b><span>Answer F is incorrect</span></b><span>. In the enzyme-linked
immunosorbent assay (ELISA), labeled antibodies are used to determine if the
serum contains antibodies against a specific antigen on the ELISA plate. </span></p>

<p><span></span></p>

<p><b><span>Answer G is incorrect</span></b><span>. Allele-specific
oligonucleotide probes are short, radiolabeled DNA sequences complementary to
an allele of interest. The probes can be used to detect disease-causing
mutations. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 42-year-old woman receives an allogeneic bone marrow transplant from a
matched, unrelated donor. She is treated with cyclosporine. One month later she
develops fever, enteritis, hepatitis, and dermatitis. Which of the following
best explains these findings?</span></p>

<p><span><span >&nbsp;</span></span></p>

<p><span>A. Hyperacute transplant rejection</span></p>

<p><span>B. Acute transplant rejection</span></p>

<p><span>C. Chronic transplant rejection</span></p>

<p><span>D. Graft-versus-host disease</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Transplant rejection</span><span> occurs when the host’s immune system attacks a transplanted
organ or tissue. </span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=320 colspan=2 valign=top>
  <p style="text-align:center;"><span>Types of Transplant</span></p>
  </td>
 </tr>
 <tr>
  <td width=68 valign=top>
  <p><span></span></p>
  </td>
  <td width=252 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=68 valign=top>
  <p><span>Autograft</span></p>
  </td>
  <td width=252 valign=top>
  <p><span>Tissue
  transplanted from one part of the body to another in the same individual</span></p>
  </td>
 </tr>
 <tr>
  <td width=68 valign=top>
  <p><span>Isograft</span></p>
  </td>
  <td width=252 valign=top>
  <p><span>Donor
  and recipient are genetically identical individuals</span></p>
  </td>
 </tr>
 <tr>
  <td width=68 valign=top>
  <p><span>Allograft</span></p>
  </td>
  <td width=252 valign=top>
  <p><span>Donor
  and recipient are genetically non-identical members of the same species</span></p>
  </td>
 </tr>
 <tr>
  <td width=68 valign=top>
  <p><span>Xenograft</span></p>
  </td>
  <td width=252 valign=top>
  <p><span>Donor
  and recipient belong to different species</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span>Transplant
rejection is a normal occurrence because the immune system is designed to
distinguish “self” from “foreign” antigens as a means of protecting the
individual from foreign invasion. The main types of transplant rejection are
hyperacute, acute, and chronic. </span></p>

<p><span></span></p>

<p><i>Hyperacute rejection</i> usually occurs within 24 hours of
transplantation. The response is so quick that the graft never becomes
vascularized. Hyperacute rejection is characterized by thrombotic occlusions
and hemorrhages of the graft vasculature that begin minutes to hours after the
graft is placed. These occur because of preexisting host antibodies that bind
to antigens present in the graft endothelium. The complement system is
activated and there is an influx of neutrophils. Endothelial cells and
platelets shed lipid particles, which promote coagulation. The resulting
inflammation prevents vascularization of the graft. The graft suffers
irreversible damage from ischemia. </p>

<p></p>

<p>There are several
explanations for the preexisting antibodies that initiate hyperacute rejection.
Recipients of blood transfusions sometimes develop antibodies to major
histocompatibility class (MHC) antigens from the transfused blood. If some of
these antigens match those in a graft, then hyperacute rejection may occur.
Multiple pregnancies may also expose woman to the paternal antigens of the
fetus, resulting in the creation of antibodies. Finally, prior recipients of
transplants may have already formed antibodies to other MHC antigens &#8211;
antibodies that may be present at the time of a second transplant. Usually
hyperacute rejection can be avoided by screening for anti-graft antibodies
(crossmatching).<span >&nbsp;&nbsp; </span></p>

<p></p>

<p><i><span>Acute rejection</span></i><span> usually begins a week
after transplantation and most likely occurs to some degree in all transplants
(except between identical twins). It is caused by mismatched HLA antigens that
are present on all cells. HLA antigens are polymorphic; therefore, the chance
of a perfect match is extremely rare. The reason that acute rejection occurs a
week after transplantation is because the T cells involved in rejection must
differentiate and the antibodies must be produced before rejection is
initiated. Some T cells cause graft cells to lyse; others produce cytokines
that recruit other inflammatory cells, eventually causing necrosis of allograft
tissue. Endothelial cells in vascularized grafts such as kidneys are some of
the earliest victims of acute rejection. Damage to the endothelial lining is an
early predictor of irreversible acute graft failure. The risk of acute
rejection is highest in the first three months after transplantation and is
lowered by immunosuppressive agents. The diagnosis of acute rejection is based
on clinical data, laboratory testing, and tissue biopsy. </span></p>

<p><span></span></p>

<p><i><span>Chronic rejection</span></i><span> occurs months to years
following transplantation. It is characterized by graft arterial occlusions,
which result from the proliferation of smooth muscle cells and the production
of collagen by fibroblasts. This process, termed accelerated or graft
arteriosclerosis, results in fibrosis, which can cause ischemia and cell death.
The fibrous lesions occur without evidence of an overt cause (such as vascular
injury or infection), although it is hypothesized that chronic rejection is the
result of multiple acute rejections. This hypothesis is based on the knowledge
that the resulting fibrosis is similar to the fibrosis that accompanies the
natural healing of a wound. Now that there are treatments for acute rejection,
chronic rejection is the major cause of graft loss. Most recipients must take
immunosuppressive drugs for the rest of their lives, and even that may not be
enough to combat chronic rejection. This poses a dilemma in the trend of
immunotherapy, since immunosuppression is highly focused to prevent acute
rejection and does not substantially address chronic rejection mechanisms. </span></p>

<p><span></span></p>

<p><i>Graft-versus-host disease</i> (GVHD) is a common complication of
allogeneic bone marrow<a
href="http://en.wikipedia.org/wiki/Hematopoietic_stem_cell_transplantation"
title="Hematopoietic stem cell transplantation"></a> transplantation in which
functional T cells in the transplanted marrow recognize the recipient as
&quot;foreign&quot; and mount an immunologic attack. <i>Acute</i> graft-versus-host-disease occurs within the first 100 days
and is characterized by selective damage to the gastrointestinal tract, liver,
and skin. Gastrointestinal involvement may result in severe intestinal
inflammation, sloughing of the mucosal membrane, severe diarrhea, abdominal pain,
nausea, and vomiting. Liver involvement results in hepatitis and serum
bilirubin elevation. Skin disease may manifest as a diffuse, often lacy,
maculopapular rash. <i>Chronic</i>
graft-versus-host disease occurs more than 100 days after transplantation. As
in acute disease, the gastrointestinal tract, liver, and skin are affected.
Additionally, connective tissue and exocrine glands may be damaged. </p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=330 height=278
src="_%20Tutorials_files/image168.png" alt="Description: GvHdisease" v:shapes="Picture_x0020_347138"></span></p>

<p style="text-align:center;">Rash
in graft-versus-host disease</p>

<p></p>

<p>The most commonly used drugs
in transplant patients include steroids, which block cytokine secretion;
cyclosporine and tacrolimus, which inhibit calcineurin; and azathioprine and
mycophenolate mofetil, which block T-cell proliferation. </p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer D is correct</b>. Acute graft-versus-host disease (GVHD) occurs
when T cells in the transplanted marrow attack host cells. It typically
presents as enteritis, hepatitis, and dermatitis within 100 days of allogeneic
bone marrow transplant.<span >&nbsp; </span></p>

<p></p>

<p><b>Answer A is incorrect</b>. Hyperacute transplant rejection is an
immediate antibody and complement-mediated response to transplanted tissue
caused by pre-existing antibodies to tissue antigens.<span>&nbsp;&nbsp; </span></p>

<p></p>

<p><b>Answer B is incorrect</b>. Acute transplant rejection occurs when host
T cells attack transplanted tissue cells because of HLA mismatch. </p>

<p></p>

<p><b>Answer C is incorrect</b>. Chronic transplant rejection occurs months
to years after transplantation and results in fibrosis of the graft.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span lang=EN-GB>Bilateral ovarian masses are identified on pelvic
examination of a 40-year-old woman. Ultrasound examination reveals
multiloculated cystic masses involving both ovaries. The patient is treated
with total abdominal hysterectomy with removal of both adnexa. Pathologic
examination demonstrates papillary carcinoma producing serous fluid. Which of
the following tumor markers would be most useful in monitoring for recurrence?</span></p>

<p><span lang=EN-GB>&nbsp;</span></p>

<p><span
lang=EN-GB><span>A.<span>&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Alpha-fetoprotein</span></p>

<p><span
lang=EN-GB><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Beta-2-microglobulin</span></p>

<p><span
lang=EN-GB><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>BCR-ABL</span></p>

<p><span
lang=EN-GB><span>D.<span>&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>CA 19-9</span></p>

<p><span
lang=EN-GB><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>CA-125</span></p>

<p><span
lang=EN-GB><span>F.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>CEA</span></p>

<p><span
lang=EN-GB><span>G.<span>&nbsp;&nbsp; </span></span></span><span
lang=EN-GB>Her2/neu</span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p>Tumor markers are substances
that are produced by cancer cells or by other cells of the body in response to
cancer. Most tumor markers are made by normal cells as well as by cancer cells;
however, they are produced at much higher levels in cancerous conditions. These
substances can be found in the blood, urine, stool, tumor tissue, or other
tissues or bodily fluids of some patients with cancer. Most tumor markers are
proteins. However, more recently, patterns of gene expression and changes to
DNA have also begun to be used as tumor markers. Markers of the latter type are
assessed in tumor tissue specifically.</p>

<p></p>

<p>Thus far, more than 20
different tumor markers have been characterized and are in clinical use. Some
are associated with only one type of cancer, whereas others are associated with
two or more cancer types. There is no “universal” tumor marker that can detect
any type of cancer.</p>

<p>There are some limitations
to the use of tumor markers. Sometimes, noncancerous conditions can cause the
levels of certain tumor markers to increase. In addition, not everyone with a
particular type of cancer will have a higher level of a tumor marker associated
with that cancer. Moreover, tumor markers have not been identified for every
type of cancer.</p>

<p></p>

<p></p>

<p>Some of the most commonly
used tumor markers appear below. </p>

<p></p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><b><span>Tumor Marker</span></b><span></span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><b><span>Cancer Type</span></b><span></span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><b><span>Tissue Analyzed</span></b><span></span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><b><span>How Used</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Alpha-fetoprotein (AFP)</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Liver cancer;<br>
  germ cell tumors</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To help diagnose liver cancer and follow
  response to treatment; to assess stage, prognosis, and response to treatment
  of germ cell tumors</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Beta-2-microglobulin (B2M)</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Multiple myeloma; chronic lymphocytic
  leukemia; some lymphomas</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood, urine, or cerebrospinal fluid</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To determine prognosis and to follow response
  to treatment</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Beta-human chorionic gonadotropin (Beta-hCG)</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Choriocarcinoma;<br>
  testicular cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Urine or blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To assess stage, prognosis, and response to
  treatment of testicular cancer</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>BCR-ABL</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Chronic myeloid leukemia</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood and/or bone marrow</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To confirm diagnosis and monitor disease
  status</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>CA19-9</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Pancreatic cancer;<br>
  gallbladder cancer;<br>
  bile duct cancer;<br>
  gastric cancer</span></p>
  <p style="text-align:center;"><span>&nbsp;</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To assess whether treatment is working</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>CA-125</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Ovarian cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To help in diagnosis, assessment of response
  to treatment, and evaluation of recurrence</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Calcitonin</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Medullary thyroid cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To aid in diagnosis, to check whether
  treatment is working, and to assess recurrence</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Carcinoembryonic antigen (CEA)</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Colorectal cancer; breast cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To check whether colorectal cancer has spread;
  to look for breast cancer recurrence and assess response to treatment</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Estrogen receptor (ER)/progesterone receptor
  (PR)</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Breast cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Tumor tissue</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To determine whether treatment with hormonal
  therapy (such as tamoxifen) is appropriate</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>HER2/neu</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Breast cancer; gastric cancer; esophageal
  cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Tumor tissue</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To determine whether treatment with
  trastuzumab is appropriate</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Immunoglobulins</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Multiple myeloma; Waldenstrom
  macroglobulinemia</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood and urine</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To help diagnose disease, assess response to
  treatment, and look for recurrence</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Prostate-specific antigen (PSA)</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Prostate cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Blood</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To help in diagnosis, assess response to
  treatment, and &nbsp;look for recurrence</span></p>
  </td>
 </tr>
 <tr>
  <td width=96 valign=top>
  <p style="text-align:center;"><span>Thyroglobulin</span></p>
  </td>
  <td width=105 valign=top>
  <p style="text-align:center;"><span>Thyroid cancer</span></p>
  </td>
  <td width=86 valign=top>
  <p style="text-align:center;"><span>Tumor tissue</span></p>
  </td>
  <td width=110 valign=top>
  <p style="text-align:center;"><span>To evaluate response to treatment and to look
  for recurrence</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Answer E is correct. </b><span lang=EN-GB>Serous papillary cystadenocarcinomas of the ovaries are derived from the
surface epithelium of the ovaries and express CA-125. </span><b></b></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 15-year-old boy has a lifelong history of
developmental delays and unusual movements such as hand-flapping. He has a
meager vocabulary. Two maternal uncles have mental retardation. Physical
examination shows coarse facial features and large testes. DNA testing shows an
expansion of a trinucleotide repeat. The patient has four sisters. If the
parents appear healthy, on average how many of the sisters are likely to be
carriers of the gene mutation?</span></span></p>

<p><span></span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";mso-bidi-font-weight:bold'><span>A.<span>&nbsp;&nbsp; </span></span></span></span><span>0</span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";mso-bidi-font-weight:bold'><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span>1</span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";mso-bidi-font-weight:bold'><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span>2</span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";mso-bidi-font-weight:bold'><span>D.<span>&nbsp;&nbsp; </span></span></span></span><span>3</span></span></p>

<p><span style='font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";mso-bidi-font-weight:bold'><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span>4</span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span><span >&nbsp;</span></span></span></p>

<p><span>Fragile</span></span><span> <span
 syndrome</span><span> is the most common heritable form of mental
retardation. The syndrome is named after a “fragile site” on the <span
 chromosome that prevents chromatin from condensing
properly during mitosis. The syndrome is inherited as an <span
 disorder. Testing for F<span syndrome is a common indication for DNA
analysis and genetic counseling. </span></p>

<p><span></span></p>

<p><span>The
disorder is caused by massive expansion of the trinucleotide gene sequence,
CGG, in a gene called <i>FMR1</i> (<span <span
 mental retardation 1). In normal individuals, this
sequence is repeated less than 60 times. In patients with F<span
 <span syndrome, up to
several thousand repeats occur. These additional repeats interfere with DNA
replication and chromatin condensation.</span></p>

<p><span><span>&nbsp;</span></span></p>

<p>Prominent features of the
syndrome include mental retardation, long face, large ears, flat feet, and
large testes (macroorchidism). Behavioral features include stereotypic
movements (e.g., hand-flapping) and atypical social development, particularly
shyness and limited eye contact. Some individuals meet the diagnostic criteria
for autism. </p>

<p></p>

<p>Because the syndrome is
X-linked, males are predominantly affected, and their mothers are obligatory
carriers of the abnormal gene. </p>

<p></p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer C is correct</b>. The patient in the clinical vignette has
Fragile X syndrome, an X-linked disorder. As expected, only males in the family
are affected (which in this case includes the patient and two maternal uncles).
The patient’s mother must be a carrier of the mutation because males get their
X chromosome from the mother (and their Y chromosome from the father). The
mother is healthy, so only one of her X chromosomes is affected. The father is
also healthy, so his X chromosome is fine. The mother and father have four daughters.
Each has inherited an X chromosome from the mother and an X chromosome from the
father. The X chromosome from the father is normal; the X chromosome from the
mother has a 50% chance of being abnormal. (The mother has one normal and one
abnormal X chromosome). Therefore, each daughter has a 50% chance of inheriting
the “bad” X chromosome (and becoming a carrier). Because there are four
daughters, two of them will, on average, carry the mutated gene. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span>A 30-year-old woman has severe abdominal pain, nausea,
vomiting, and diarrhea, and is admitted to the hospital for 2 weeks for a
suspected intestinal infection. Evaluation, including upper and lower
endoscopies, does not establish a definite cause for her symptoms. She gradually
improves and is discharged after 2 weeks. Symptoms recur 2 years later, leading
to multiple emergency department visits. She is admitted to a psychiatric unit
with mental status changes and hallucinations, and then transferred to the
emergency department with abdominal pain, a grand mal seizure, and
hyponatremia. On admission to a medical unit her pulse is 120 bpm and BP is
174/114 mmHg. She is disoriented but has no focal neurologic signs. MRI shows
subcortical abnormalities, and the spinal fluid is normal. After
cholecystectomy for a distended gallbladder, she is discharged and stays with a
family member in another city because her symptoms are worse and muscle
weakness has developed. She is admitted to the hospital and progresses to
quadriparesis, respiratory failure, and aspiration pneumonia. Urinary
porphobilinogen (PBG) is reported as 44 mg/24 hours (reference range 0-4).
Following treatment with intravenous glucose and stopping harmful drugs
(including phenytoin), she improves gradually and is discharged for physical
therapy and rehabilitation. She recovers almost completely over a period of
several months, although residual painful hyperesthesia of the lower
extremities, mild proximal muscle weakness, and impaired short-term memory are
noted. Deficiency of which of the following enzymes is most likely in this
patient?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>Ferrochelatase</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Porphobilinogen deaminase</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Protoporphyrinogen oxidase</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Uroporphyrinogen decarboxylase</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Uroporphyrinogen III cosynthase</span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><b><span>Porphyrias</span></b></p>
  </td>
 </tr>
</table>

<p></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064019></a><i><span>Porphyria</span></i><span>&nbsp;is the name given to a group of genetic
  or acquired diseases associated with deficient synthesis of heme. Heme is an
  essential cofactor for the structure and function of hemoglobin and proteins
  such as cytochrome P-450. Bone marrow produces more than 80% of body heme.
  Liver produces about 15% of total heme, but its synthesis can be increased
  10-fold. For example, heme synthesis will be induced by ingestion of a drug
  that relies on a heme-containing enzyme for detoxification. This induction of
  hepatic heme synthesis underlies the important observation that certain drugs
  trigger porphyria attacks. </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><a name=T064003></a><span></span></p>

<p><span></span></p>

<div align=center>

<table border=0 cellspacing=0 cellpadding=0>
 <tr>
  <td>
  <p style="text-align:center;"><b><span>List of Drugs Precipitating Attacks of Acute Intermittent
  Porphyria</span></b></p>
  </td>
 </tr>
</table>

</div>

<p><a name=T064003.50></a><a name=T064003.100></a><a name=T064003.150></a><a
name=T064003.200></a><a name=T064003.250></a><a name=T064003.300></a><a
name=T064003.350></a><a name=T064003.400></a><a name=T064003.450></a><a
name=T064003.500></a><a name=T064003.550></a><a name=T064003.600></a><a
name=T064003.650></a><a name=T064003.700></a><a name=T064003.750></a><a
name=T064003.800></a><a name=T064003.850></a><a name=T064003.900></a><a
name=T064003.950></a><a name=T064003.1000></a><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td valign=top>
  <p><span>Barbiturates</span></p>
  <p><span>Carbamazepine</span></p>
  <p><span>Chlorpropamide</span></p>
  <p><span>Chlordiazepoxide</span></p>
  <p><span>Danazol</span></p>
  <p><span>Dapsone</span></p>
  <p><span>Ergot preparations</span></p>
  </td>
  <td valign=top>
  <p><span>Estrogens</span></p>
  <p><span>Ethanol</span></p>
  <p><span>Glutethimide</span></p>
  <p><span>Griseofulvin</span></p>
  <p><span>Meprobamate</span></p>
  <p><span>Oral contraceptives</span></p>
  <p><span>Phenytoin</span></p>
  </td>
  <td valign=top>
  <p><span>Progestins</span></p>
  <p><span>Pyrazinamide</span></p>
  <p><span>Sulfonamide
  antibiotics</span></p>
  <p><span>Theophylline</span></p>
  <p><span>Tolbutamide</span></p>
  <p><span>Valproic acid</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<div align=center>

<table border=0 cellspacing=0 cellpadding=0 width="90%">
 <tr>
  <td width="100%"></td>
 </tr>
</table>

</div>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064020></a><span></span></p>
  <p><span>Porphyrias result from
  partial deficiency of one of seven enzymes involved in biosynthesis of heme.
  Attacks of porphyria are associated with the accumulation of the biochemical
  intermediates in the heme synthesis pathway that precede the deficient
  enzyme. Some of these intermediates are toxic and can lead to the observable
  sign of dark, reddish urine. The two major classes of porphyria, bone marrow
  and hepatic, derive from the organ accounting for the overproduction of heme
  synthesis intermediates.</span></p>
  <p><span></span></p>
  <p><span>Most hepatic
  porphyrias (e.g., acute intermittent porphyria and porphyria cutanea tarda)
  have acute onset of pain as a result of the accumulation of early
  intermediates of heme synthesis such as &#948;-aminolevulinic acid (ALA) and
  porphobilinogen (PBG). Named&nbsp;<i>acute</i>&nbsp;for their hallmark abrupt
  presentation (and sometimes resolution), these porphyrias also have chronic
  features, including pain, neuropathy, and depression. Excess porphyrins,
  produced in bone marrow porphyrias (e.g., erythropoietic porphyria) deposit
  in skin and absorb light, which confers photosensitivity and results in
  cutaneous manifestations such as blistering of sun-exposed skin. </span></p>
  <p><span>The three most common
  porphyrias are discussed below.</span></p>
  </td>
 </tr>
</table>

<p></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=HC064013></a><span>ACUTE INTERMITTENT
  PORPHYRIA</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064021></a><i><span>Acute
  intermittent porphyria</span></i><span>&nbsp;(AIP)
  is an autosomal dominant disorder due to diminished activity of
  porphobilinogen (PBG) deaminase. PBG deaminase is the third enzyme in the
  pathway of heme biosynthesis. There is accumulation of the two intermediates
  of the pathway before this enzyme (ALA and PBG). A high urinary PBG level
  during an attack is a critical diagnostic feature, although the level is
  often normal between attacks. Finding deficient PBG deaminase enzyme activity
  in red blood cells confirms the diagnosis.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><a name=F064001></a><span></span></p>

<p><a name=P064023></a><span></span></p>

<p><a name=T064004></a><span></span></p>

<p><a name=T064004.50></a><a name=T064004.100></a><a name=T064004.150></a><a
name=T064004.200></a><a name=T064004.250></a><a name=T064004.300></a><a
name=T064004.350></a><a name=T064004.400></a><a name=T064004.450></a><span></span></p>

<p><span></span></p>

<div align=center>

<table border=0 cellspacing=0 cellpadding=0 width="90%">
 <tr>
  <td width="100%"></td>
 </tr>
</table>

</div>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064022></a><span>Acute attacks
  punctuate prolonged well periods in patients with AIP. The acute presentation
  of AIP can be dramatic and life-threatening. Abdominal pain, largely thought
  to be the result of neurotoxicity, is present in more than 90% of patients
  with acute attacks. Abdominal pain may be severe enough to prompt surgical
  evaluation for an acute abdomen and can be associated with nausea, vomiting,
  and bowel dysmotility. Neuropathy is evidenced by decreased sensation or
  muscle weakness that may involve cranial and respiratory nerves. Sympathetic
  tone is high with hypertension and tachycardia. Central nervous system
  manifestations include anxiety, paranoia, depression, and seizures, which may
  result in part from hyponatremia due to inappropriate secretion of
  antidiuretic hormone.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064024></a><span>Most patients suffer
  their initial attack after puberty. Triggers of attacks include drugs,
  particularly barbiturates, carbamazepine, and sulfonamides. Caloric
  restriction, fasting, surgery, and infections can precipitate attacks.
  Treatment of patients starts with prevention. Adequate caloric intake,
  particularly carbohydrates, and avoidance of triggers such as alcohol and
  offending drugs are important. Intravenous formulations of heme, such as
  hematin, are effective in reducing the duration and severity of attacks.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><a name=HC064014></a><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%"><a
  name=P064026></a></td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=HC064015></a><span>PORPHYRIA CUTANEA
  TARDA</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064027></a><i><span>Porphyria
  cutanea tarda</span></i><span>&nbsp;(PCT) is the
  most common porphyria and shows the cardinal feature of bullous involvement
  of sun-exposed skin. This results from accumulation of uroporphyrinogen,
  which absorbs light and confers photosensitivity. PCT is due to decreased
  activity of the hepatic enzyme uroporphyrinogen decarboxylase. More than 75%
  of patients have sporadic&nbsp;disease. Most other cases occur in people
  heterozygous for a mutation in&nbsp;<i>UROD</i>, the gene that codes the
  enzyme.</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064028></a><span>PCT typically begins
  in early adulthood with subacute appearance of fragile skin and includes
  vesicles and bullae, grayish skin discoloration, and hypertrichosis of the
  face. Liver disease is typical. Increased porphyrins in plasma, urine, and
  feces are required to attribute clinical manifestations to PCT. Avoiding and
  minimizing liver toxins such as alcohol and excess iron is a mainstay of
  therapy. Treatment includes avoiding triggers or removing any excess iron by
  phlebotomy and chloroquine (which forms a complex with porphyrin that
  improves excretion).</span></p>
  </td>
 </tr>
</table>

<p></span></p>

<p name=P064029></a><span></span></p>

<p></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%"><a
  name=P064030></a></td>
 </tr>
</table>

<p></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=HC064016></a><span>ERYTHROPOIETIC
  PORPHYRIA</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%">
  <p><a name=P064031></a><i><span>Erythropoietic
  porphyria</span></i><span>&nbsp;(EPP) results
  from deficiency of the last enzyme in heme biosynthesis, ferrochelatase.
  Large amounts of protoporphyrin accumulate and produce serious cutaneous
  damage through a photodynamic reaction as observed in patients with PCT. A
  brief exposure to sunlight can produce burning, redness, and edema suggestive
  of angioedema developing within hours and resolving over several days.
  Manifestations of EPP typically occur in childhood. A massive increase in
  erythrocyte protoporphyrin levels is the diagnostic hallmark of EPP, so much
  so that fluorescent red blood cells can sometimes be visualized on a blood
  smear. Avoidance of sun or use of potent sunscreens is the mainstay of
  prevention. </span></p>
  <p><span></span></p>
  <p><span></span></p>
  <p><span><img border=0 width=470 height=279
  src="_%20Tutorials_files/image170.png" v:shapes="Picture_x0020_347254"></span><span></span></p>
  </td>
 </tr>
</table>

<p></span></p>

<table border=0 cellspacing=0 cellpadding=0 width="100%">
 <tr>
  <td width="100%"><a
  name=P064032></a></td>
 </tr>
</table>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p></span></p>

<p><b><span>Answer A is
correct. </span></b><span>The presence of intermittent acute attacks of
severe abdominal pain associated with neuropsychiatric findings, hyponatremia,
and a hyperadrenergic response, with elevated levels of urinary
porphobilinogen, suggests a diagnosis of acute intermittent porphyria. The
deficient enzyme is porphobilinogen deaminase.</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"><span
class="Section"></span></p>

<p style="text-align:center;"><span
class="Section">Microbiology</span></p>

<p style="text-align:center;"><span
class="Section">&amp;</span></p>

<p style="text-align:center;"><span
class="Section">Infectious
Diseases</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
32-year-old man with AIDS and a CD4 count of 50/mm<sup>3</sup> develops an
infection that affects the eyes, lungs, gastrointestinal tract, and central
nervous system.<span >&nbsp; </span>A tissue biopsy is
shown below. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=212 height=147
src="_%20Tutorials_files/image172.png"
alt="Description: Histopathology_of_cytomegalovirus_infection_of_kidney_-_PHIL_09G0036_lores"
v:shapes="Picture_x0020_347241"></span><span></span></p>

<p><span></span></p>

<p><span>Which of
the following organisms is the most likely cause of infection? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Candida
albicans</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cryptococcus
neoformans</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cytomegalovirus</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Herpes
simplex</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mycobacterium
avium</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Pneumocystis<span>&nbsp; </span>jiroveci</span></p>

<p><span></span></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><i><span></span></i></p>

<p><span>Cells
infected with cytomegalovirus (CMV) typically have a large, round intranuclear
inclusion with a perinuclear halo. This resembles an “owl’s eye.”<span>&nbsp; </span>CMV infection may cause retinitis,
pneumonitis, inflammation of the GI tract, and inflammation of the nervous
system. In patients with HIV, infection usually occurs when the CD4 count is
less than 100/mm<sup>3</sup>.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><i><span>Candida albicans</span></i><span> has a range of clinical
presentations, from superficial mucocutaneous disease in immunocompetent
individuals to invasive illness in immunocompromised hosts. Histologically, the
fungus may appear as ovoid yeast cells, hyphae, or pseudohyphae. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=247 height=150
src="_%20Tutorials_files/image174.png" alt="Description: candida" v:shapes="Picture_x0020_347240"></span><span></span></p>

<p style="text-align:center;"><i><span>Candida albicans</span></i></p>

<p style="text-align:center;"><span>(potassium hydroxide preparation)</span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><i><span>Cryptococcus neoformans</span></i><span> causes meningitis in
people with AIDS. The fungus is visualized by methenamine silver or periodic
acid-Schiff stain, and appears as a round or oval yeast with a polysaccharide
capsule. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=242 height=170
src="_%20Tutorials_files/image176.png" alt="Description: 01G0018_lores" v:shapes="Picture_x0020_347239"></span><span></span></p>

<p style="text-align:center;"><i><span>Cryptococcus neoformans</span></i></p>

<p style="text-align:center;"><span>(methenamine silver stain)<br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></p>

<p><span></span></p>

<p><span>Herpes
simplex virus causes recurrent orolabial, genital, and perianal lesions in
HIV-infected individuals. Tzanck smear shows multinucleated epithelial giant
cells. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=218 height=165
src="_%20Tutorials_files/image178.png" alt="Description: f4-u1" v:shapes="Picture_x0020_347238"></span><span></span></p>

<p style="text-align:center;"><span>Multinucleated giant cell caused by herpes simplex</span></p>

<p style="text-align:center;"><span>(Tzanck smear)</span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><i><span>Mycobacterium avium</span></i><span> causes disseminated
disease in immunocompromised hosts. The bacterium travels by blood from the
lungs to the liver, spleen, and bone marrow. Bacteria can be seen in
macrophages, granulomas, and giant cells with acid-fast staining.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=244 height=161
src="_%20Tutorials_files/image180.png" alt="Description: AIDS071" v:shapes="Picture_x0020_347237"></span><span></span></p>

<p style="text-align:center;"><i><span>Mycobacterium avium</span></i><span></span></p>

<p style="text-align:center;"><span>Macrophages containing numerous acid-fast bacilli</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><i><span>Pneumocystis jiroveci</span></i><span> causes pneumonia in
people with AIDS.</span></p>

<p><span><span>&nbsp; </span></span></p>

<p style="text-align:center;"><span><img border=0 width=280 height=195
src="_%20Tutorials_files/image182.png" alt="Description: pneuomcyst" v:shapes="Picture_x0020_347236"></span><span></span></p>

<p style="text-align:center;"><i><span>Pneumocystis jiroveci</span></i></p>

<p style="text-align:center;"><span>(fungal cysts stained with methenamine silver)</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer C is correct.</span></b><span> The infection is most
likely caused by cytomegalovirus. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Match each
of the following organisms with the most appropriate clinical scenario.</span></p>

<p><span></span></p>

<p><i><span><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Streptococcus agalactiae</span></i></p>

<p><i><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Streptococcus bovis</span></i></p>

<p><i><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Hemophilus influenzae</span></i></p>

<p><i><span><span>D.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Legionella pneumophila</span></i></p>

<p><i><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Pseudomonas aeruginosa</span></i></p>

<p><i><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Salmonella enteritidis</span></i></p>

<p><i><span><span>G.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Yersinia enterocolita</span></i></p>

<p><i><span><span>H.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Bartonella henselae</span></i></p>

<p><i><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Chlamydia trachomatis</span></i></p>

<p><i><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Rickettsia rickettsii</span></i><i><span></span></i></p>

<p><i><span><span>K.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Helicobacter pylori</span></i><i><span></span></i></p>

<p><i><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Clostridium difficile</span></i><i><span></span></i></p>

<p><i><span><span>M.<span>&nbsp;&nbsp;
</span></span></span></i><span>Respiratory syncytial virus</span><i><span></span></i></p>

<p><i><span><span>N.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Proteus mirabilis</span></i><i><span></span></i></p>

<p><i><span><span>O.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Mycoplasma pneumoniae</span></i><i><span></span></i></p>

<p><i><span><span>P.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Rhizopus oryzae</span></i><i><span></span></i></p>

<p><i><span><span>Q.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Pasteurella multocida</span></i><i><span></span></i></p>

<p><span></span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>63-year-old
man with colon cancer and bacteremia</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>9-year-old
girl with a pruritic, erythematous rash that develops days after soaking in a
hot tub </span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>50-year-old
man who developed fever and cough ten days after attending a convention. Two
colleagues developed similar symptoms after the convention. Temperature is 101<sup>o</sup>F,
pulse is 76/minute, blood pressure is 130/70 mm Hg, and respirations are
18/minute. Chest X-ray shows a patchy infiltrate in the right lower lobe.
Sputum Gram stain shows neutrophils and small gram-negative rods that stain
poorly. Sputum cultures grow opal-like colonies on yeast extract. </span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>13-year-old
girl with sickle cell disease has pain in the right arm. X-ray shows bony
lesions consistent with osteomyelitis</span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>24-year-old
man has pain with urination for three days. He is sexually active with three
partners and does not use condoms. His temperature is 37°C (98.6°F). Physical
examination is normal except for a clear, watery urethral discharge. Urinalysis
shows 10&#8211;20 white blood cells per high-powered field, but no bacteria.</span></p>

<p><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>1-year-old
baby evaluated for sepsis has gram-positive cocci in pairs and chains in the
blood. The bacteria agglutinate with group B antiserum. </span></p>

<p><span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>8-year-old
boy has fever, difficulty with swallowing, drooling, hoarseness, and stridor.
He holds his head forward and insists on sitting in bed.</span></p>

<p><span><span>8.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>6-year-old
boy has fever, abdominal pain, tenderness in the right lower quadrant, and
leukocytosis. At surgery, he is found to have a normal appendix, terminal
ileitis, and mesenteric lymphadenitis.<span >&nbsp;
</span></span></p>

<p><span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>16-year-old
boy has fever, malaise, and a red nodule on his forearm one week after playing
with a kitten. He develops axillary lymphadenopathy. </span></p>

<p><span><span>10.<span>&nbsp;
</span></span></span><span>43-year-old
man develops fever, malaise, headache, and a petechial rash on his palms and
soles four days after hiking in the woods</span></p>

<p><span><span>11.<span>&nbsp;
</span></span></span><span>80-year-old
woman develops watery diarrhea and mild abdominal cramping soon after
completing a ten-day course of clindamycin.</span></p>

<p><span><span>12.<span>&nbsp;
</span></span></span><span>32-year-old
man with one-week history of epigastric burning that is worse on an empty
stomach and improved after eating. The urea breath test is positive.<span>&nbsp; </span></span></p>

<p><span><span>13.<span>&nbsp;
</span></span></span><span>An
8-month-old girl has a 1-day history of rapid breathing. Her temperature is
38.4<sup>o</sup>C (101.1<sup>o</sup>F), pulse is 160/minute, respirations are
60/minute, and blood pressure is 100/70 mm Hg. Bilateral expiratory wheezing
and crackles are heard on auscultation. Chest x-ray shows areas of atelectasis
and hyperinflation.</span></p>

<p><span><span>14.<span>&nbsp;
</span></span></span><span>A
65-year-old woman has a two-day history of fever, flank pain, and burning with
urination. She has had three urinary tract infections in the past year. Her
temperature is 39.1<sup>o</sup>C (102.3<sup>o</sup>F). Physical examination
reveals right flank tenderness. Her white blood cell count is 16,000/mm<sup>3</sup>.
The urine has an aromatic smell. Urine pH is 9, with numerous white blood cells
and &gt;100,000 bacterial colonies/mL. Urine culture grows a urease-positive
organism. </span></p>

<p><span><span>15.<span>&nbsp;
</span></span></span><span>A
40-year-old woman with poorly controlled type 1 diabetes mellitus has a
one-week history of facial pain and swelling. Examination shows ecchymoses over
the left orbital and periorbital regions with proptosis. There is a necrotic
lesion with a black eschar in the left naris. Microscopic examination of the
lesion shows broad, irregularly shaped, nonseptate hyphae with braches at right
angles.</span></p>

<p><span><span>16.<span>&nbsp;
</span></span></span><span>A
32-year-old woman has a three-day history of fever and dry cough. Laboratory
tests show cold agglutinating antibodies in the serum. Routine blood and sputum
cultures are negative. A chest x-ray is abnormal.</span></p>

<p><span><span>17.<span>&nbsp;
</span></span></span><span lang=EN-GB>A
38-year-old letter carrier is severely bitten by a pit bull guarding a
junkyard. Several days later, the wound is inflamed and purulent. The exudate
is cultured on blood agar and yields gram-negative rods.</span></span><span></span></p>

<p><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answers</span></b></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>6.<span>&nbsp; </span><span>Group
B Streptococcus (GBS)</span>, or “<i><span>Streptococcus
agalactiae</span></i><span>,”</span> is the leading cause of sepsis, pneumonia, and meningitis in
newborns in the United States and Europe.<span >&nbsp;
</span>The bacterium, which colonize the mother’s vagina, is transmitted to the
baby during delivery. In pregnant women, GBS causes urinary tract infection,
chorioamnionitis, postpartum endometritis, and peripartum bacteremia. Its
virulence is largely due to a capsular polysaccharide that resists phagocytic
ingestion. In the U.S., testing for GBS is recommended at the 36-week antenatal
appointment of every pregnancy. The vagina and rectum are swabbed and cultures
are grown in enriched media. Prophylactic antibiotics are given to all women
who test positive. This strategy has led to a marked reduction in newborn
infection.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>1.
<span >&nbsp;</span><i>Streptococcus
bovis</i> bacteremia is associated with colon cancer (for unknown reasons).</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>7.<span>&nbsp; </span><i>Hemophilus
influenzae</i>, type B, is the most common cause of epiglottitis.</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>3.<span>&nbsp; </span><i>Legionella
pneumophila</i> causes Legionnaire’s disease.</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>2.<span>&nbsp; </span><i>Pseudomonas
aeruginosa</i> causes “hot tub folliculitis.”</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>4.<span>&nbsp; </span>Children with sickle cell disease are
predisposed to osteomyelitis caused by salmonella.</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>8.<span>&nbsp; </span><i>Yersinia
enterocolita</i> can cause an appendicitis-like syndrome characterized by
terminal ileitis and mesenteric lymphadenitis.<span>&nbsp; </span></span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>9.<span>&nbsp; </span><i>Bartonella
henselae</i> causes “cat scratch disease.”</span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>5.<span>&nbsp; </span><i>Chlamydia
trachomatis</i> is the most common cause of non-gonococcal urethritis.</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>10.
<i>Rickettsia rickettsii</i><span> causes
Rocky Mountain spotted fever.</span></span></p>

<p><span><span>K.<span>&nbsp;&nbsp;
</span></span></span><span>12.
<i>Helicobacter pylori</i> is a gram-negative, curved bacterium that can
inhabit various areas of the stomach, particularly the antrum. It causes a
chronic low-level inflammation of the stomach lining and is strongly linked to
the development of duodenal and gastric ulcers and stomach cancer. Over 80% of
individuals infected with the bacterium are asymptomatic. The bacterium
produces urease, which converts urea to ammonia and carbon dioxide. Four tests
are available for detecting <i>H. pylori</i><span>: blood antibody test, urea breath test, stool antigen test, and
stomach biopsy. During the urea breath test, p</span>atients swallow urea
labelled with an uncommon isotope, either radioactive carbon-14 or
non-radioactive carbon-13. In the subsequent 10&#8211;30 minutes, the detection
of isotope-labelled carbon dioxide in exhaled breath indicates that the urea
was split; this indicates that urease is present in the stomach, and hence that
<i>H. pylori</i> bacteria are present. The <span>Rapid urease test</span>, also known as the CLO test (Campylobacter-like
organism test), is a rapid test for diagnosis of <i>Helicobacter pylori</i>.
The test is performed at the time of gastroscopy. A biopsy of mucosa is taken
from the antrum of the stomach, and is placed into a medium containing urea and
an indicator such as phenol red. The urease produced by <i>H. pylori</i>
hydrolyzes urea to ammonia, which raises the pH of the medium, and changes the
color of the specimen from yellow (negative) to red (positive).</span></p>

<p><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>11.
<i>Clostridium difficile</i><span> is the
most common infectious cause of antibiotic-associated colitis. </span></span></p>

<p><span><span>M.<span>&nbsp; </span></span></span><span>13.<span>&nbsp; </span>Respiratory syncytial virus (</span><span>RSV) is the most common
cause of bronchiolitis (and pneumonia) in children under 1 year of age.
Symptoms include coughing, wheezing, and shortness of breath. Fever,
tachycardia, and tachypnea <span>are
typical. </span></span></p>

<p><span><span>N.<span>&nbsp;&nbsp;
</span></span></span><span>14. <i>Proteus mirabilis</i> is a gram-negative rod
with urease activity. </span><span>Urease
hydrolyzes urea to ammonia (NH<sub>3</sub>), which gives the urine an aromatic
smell. Ammonia makes the urine more alkaline (pH of 9, in this example). If
left untreated, the increased alkalinity can lead to the formation of crystals
of struvite, calcium carbonate, and/or apatite. The bacteria can be found
throughout the stones, and these bacteria lurking in the stones can reinitiate
infection after antibiotic treatment.</span></p>

<p><span><span>O.<span>&nbsp;&nbsp;
</span></span></span><span>16.
<i>Mycoplasma pneumoniae</i><span> is
associated with pneumonia and cold agglutinins in the serum. </span></span></p>

<p><span><span>P.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>15.
<i>Rhizopus oryzae</i><span> is the
principal cause of mucormycosis, an aggressive fungal disease characterized by </span>invasion
of the vasculature, resulting in thrombosis and death of surrounding tissue.
Affected skin progresses from erythematous to black, due to necrosis.
Mucormycosis predominates in individuals with poorly controlled diabetes
mellitus. </span></p>

<p><span><span>Q.<span>&nbsp;&nbsp;
</span></span></span><span>17.
<i>Pasteurella multocida</i></span><span> </span></span><span lang=EN-GB>Pasteurella multocida is
a gram-negative rod that is normal flora of the oral cavity of dogs and cats.
It often causes a local abscess following introduction under the skin by an
animal bite. Most cases occur in children who are injured while playing with a
pet. </span><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A newborn
girl has fever, irritability, a deformed nasal bridge, and a rash on the palms
and soles. Which of the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Congenitally
acquired toxoplasmosis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congenitally
acquired syphilis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congenitally
acquired rubella</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Congenitally
acquired cytomegalovirus</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congenitally
acquired herpes simplex</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span><br>
<![if !supportLineBreakNewLine]><br>
<![endif]></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p>The TORCH complex is a group
of congenital infections with similar presentations. TORCH is an acronym for
toxoplasmosis, other (syphilis), rubella, cytomegalovirus, and herpes simplex.
These conditions may be associated with abnormalities of the brain, heart,
skin, eyes, and ears. Findings include fever, poor feeding, irritability, low
birth weight, microcephaly, mental retardation, visual impairment, hearing
impairment, hepatosplenomegaly, jaundice, and a “blueberry muffin” rash.
(“Blueberry muffin” rash, originally described in infants with congenital
rubella syndrome, can occur with any of the TORCH organisms.) Typically, the
infected mother is asymptomatic or mildly symptomatic.<span>&nbsp; </span></p>

<p></p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=145 height=124
src="_%20Tutorials_files/image184.png" v:shapes="Picture_x0020_347235"></span></p>

<p style="text-align:center;">“Blueberry
muffin” rash</p>

<p style="text-align:center;"><b></b></p>

<p><span>In
newborns, <b>congenital syphilis</b> is
associated with fever, irritability, deformity of the nasal bridge (saddle
nose), and a rash affecting the palms and soles. In older infants and young
children, findings include bone pain, clouding of the cornea, blindness,
deafness, peg-shaped teeth (Hutchinson teeth), joint swelling, and saber shins.
Newborns may have a rash around the mouth, genitalia, and anus that eventually
scars.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=119 height=171
src="_%20Tutorials_files/image186.png" v:shapes="Picture_x0020_347234"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>“Saddle nose” deformity</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=170 height=127
src="_%20Tutorials_files/image188.png" v:shapes="Picture_x0020_347233"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Hutchinson teeth</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=179 height=274
src="_%20Tutorials_files/image190.png"
alt="Taken from:004-01, v4htp/tp page 168Extracted on 31/10/2003" v:shapes="Picture_x0020_347232"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>“Saber shin” deformity</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=141 height=207
src="_%20Tutorials_files/image192.png" alt="Description: Secondary Syphilis"
v:shapes="Picture_x0020_347231"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Syphilitic rash affecting the palms and soles</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Congenital toxoplasmosis</span></b><span> is associated with
hepatosplenomegaly, jaundice, retinal disease, hearing loss, and rash
(petechial or ecchymotic). </span></p>

<p><span></span></p>

<p>The classic triad of <b>congenital rubella syndrome</b> is
sensorineural deafness, ocular abnormalities (especially cataracts and
microphthalmia), and congenital heart disease (especially patent ductus
arteriosus). </p>

<p><span>&nbsp;</span></p>

<p><b><span>Cytomegalovirus</span></b><span> (CMV) infection is
associated with hepatosplenomegaly, jaundice, retinal disease, seizures,
microcephaly, and rash (petechial).</span></p>

<p><span></span></p>

<p><b><span>Congenital herpes
simplex</span></b><span>
is associated with encephalitis, meningitis, and blisters.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is correct. </span></b><span>The most likely
diagnosis is congenitally acquired syphilis.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>Which
of the following organisms is the most frequently identified parasite causing
chronic diarrhea in AIDS?</p>

<p></p>

<p><i><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></i><i>Cryptosporidium
parvum</i></p>

<p><i><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></i><i>Isospora
belli</i></p>

<p><i><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></i><i>Giardia
lamblia</i></p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span><i>Entamoeba
histolytica</i></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>More
than one hundred million individuals around the world are currently infected
with the human immunodeficiency virus (HIV). A very substantial number of these
patients have developed or will ultimately develop diarrhea. Diarrhea occurs in
about 50% of the HIV-infected individuals in the United States. Specific
enteric pathogens can be isolated (if patients undergo very exhaustive and
intensive evaluation) in most individuals with severe diarrhea. </p>

<p></p>

<p>Clinical
presentations vary among patients with AIDS-related diarrhea. Small-bowel
diarrhea tends to produce postprandial stools that are very large in volume.
These patients also often have severe postprandial peri-umbilical abdominal
pain. Diarrhea can be lessened by the avoidance of food and nutrients. Weight
loss commonly occurs in these patients. By contrast, large-intestinal diarrhea,
also called “colitic diarrhea,” is associated with frequent, small-volume
stools. These patients do not commonly become dehydrated. Colonic diarrhea may
also be associated with the presence of visible blood and mucus. Patients with
large-bowel diarrhea often have lower quadrant abdominal pain and/or the
sensation of rectal urgency (tenesmus).</p>

<p></p>

<p><span>A
large number of organisms have been identified in the stools or
gastrointestinal tract mucosa of patients with refractory AIDS-related
diarrhea.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=339 height=212
src="_%20Tutorials_files/image194.png" alt="Description: cello_table_01"
v:shapes="Picture_x0020_347230"></span><span></span></p>

<p><span></span></p>

<p><span>The
major identified causes of AIDS-related diarrhea are <i>Cryptosporidium</i> and
<i>Microsporidium</i> protozoa. Enteric pathogenic bacteria such as <i>Salmonella</i>,
<i>Campylobacter</i>, <i>Shigella</i>, and <i>Clostridium difficile</i>, along
with other pathogens such as mycobacterium (principally <i>Mycobacterium avium</i>
complex or MAC), and occasionally <i>Mycobacterium tuberculosis</i>, can also
cause diarrhea. Viruses and fungi also can play a significant role in
AIDS-related diarrhea. Classifying the etiology of HIV-infected patients with
diarrhea can be a problem because many different organisms may be found in the
stools of patients with AIDS who have refractory diarrhea. It is not known if
these organisms are true pathogens, but they are clearly associated with the
stools of patients with refractory diarrhea.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>Cryptosporidium parvum</span></i><span> is the most frequently identified
parasite causing chronic diarrhea in AIDS, even in developed countries. This
organism is extracellular, lining the brush border of the enterocytes in the
small bowel and less frequently the large bowel. </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cytomegalovirus
(CMV) is a parenteral infection, which can involve the gastrointestinal tract
anywhere from the mouth to the anus. CMV typically is associated with very
large ulcers that disproportionately involve the right colon. However, very
characteristic of early CMV in the gut are submucosal hemorrhages, not
dissimilar to those seen with ischemic colitis. CMV is very well named, and it
tends to produce both large intranuclear and intracytoplasmic inclusions. The
infected cell is gigantic in size. </span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mycobacterium
avium complex includes atypical mycobacteria that involve the
reticuloendothelial system. Characteristically, MAC-infected patients have
extensive adenopathy, very large livers, and large spleens. They also have
substantial systemic illness, with fevers, anorexia, and massive infiltration
of the gut lamina propria mononuclear cells. The organism is visible with
acid-fast stains.</span></p>

<p><span></span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Microsporidia are unique
intracellular organisms. These organisms are found in the supranuclear apical
surfaces of the enterocytes. Various life cycles of the organism, all of which
are intracellular, can be seen with the use of special stains. Microsporidia
are a major cause of diarrhea in patients with AIDS.<span></span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A
is correct. </span></b><i><span>Cryptosporidium parvum</span></i><span> is the most frequently
identified parasite causing chronic diarrhea in AIDS.</span></p>

<p><span></span></p>

<p><b><span>Answer B
is incorrect</span></b><span>.<span>&nbsp; </span><i>Isospora
belli</i> is found thus far only in the human small intestine.<span>&nbsp; </span>It is transmitted by fecal-oral route
and may cause diarrhea in immunocompetent hosts.<span>&nbsp; </span>It can cause prolonged and severe
diarrhea in AIDS patients.</span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>.<span>&nbsp; </span><i>Giardia
lamblia </i>is a flagellated protozoan and is a common cause of diarrhea
world-wide.<span >&nbsp; </span>It is transmitted by
ingestion of the cyst from contaminated water.<span>&nbsp; </span>The trophozoite form lives in the upper
small intestine and causes irritation leading to gastrointestinal
symptoms.<span >&nbsp; </span>Patients with giardiasis
have a characteristic light-colored fatty stool with abdominal pain, cramps
with flatulence.</span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>.<span>&nbsp; </span><i>Entamoeba
histolytica</i> commonly causes diarrhea and dysentery in developing countries
where sanitation is poor.<span >&nbsp; </span>Humans
are the only host and it is acquired by ingesting the cyst stage.<span>&nbsp; </span>Blood and mucus are found in the stools
and if the disease progress, the bowel may become perforated.<span>&nbsp; </span>The organism may also spread to the
liver and cause abscesses.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A patient
who was treated with clindamycin for aspiration pneumonia develops diarrhea.
The stool contains a toxin that kills cultured epithelial cells. Stool culture
grows an anaerobic gram-positive rod. The same organism is cultured from the
bedpan. Which of the following is most likely to sterilize the bedpan? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Boiling
for 45 minutes</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Exposure
to benzalkonium chloride for 1 hour</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Exposure
to ethyl alcohol for 1 hour</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Exposure
to high-pressure saturated steam (121<sup>o</sup>C) for 15 minutes</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Heating
in an oven at 150<sup>o</sup>C for 30 minutes</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Disinfection</span></b><span>: the process of
eliminating most pathogenic microorganisms, but <i>not</i> bacterial spores</span></p>

<p><span></span></p>

<p><b><span>Sterilization</span></b><span>: the process of killing all living
microorganisms, <i>including</i> bacterial
spores</span></p>

<p><span></span></p>

<p style="text-align:center;"><span>***</span></p>

<p style="text-align:center;"><span></span></p>

<p><span>This
patient has <i>Clostridium difficile</i>
colitis, a common cause of diarrhea usually occurring in patients who have been
treated with broad-spectrum antibiotics. <i>C.
difficile</i> is an anaerobic, gram-positive, toxin-producing rod, which can
exist as an endospore. </span></p>

<p><span></span></p>

<p><span>An
endospore is a “stripped-down,” dormant form of a bacterium. It is not a true
spore (i.e. not an offspring). Most bacteria cannot convert themselves into
endospores, but bacteria of the genera <i>Bacillus</i> and <i>Clostridium</i>
can.<span >&nbsp; </span>When these bacteria are exposed
to an inhospitable environment (e.g., desiccation), they can convert themselves
from a vegetative form to an endospore form. The endospore enables the bacteria
to survive for years, even millennia, in an untoward environment. When the
environment becomes favorable, the endospore converts back to the bacterium’s
vegetative state. </span></p>

<p><span></span></p>

<p>An endospore consists of a
bacterium's DNA and part of its cytoplasm, surrounded by a very tough outer
coating. Endospores can survive without nutrients. They are resistant to
ultraviolet radiation, desiccation, high temperature, extreme freezing, and
chemical disinfectants. Common anti-bacterial agents that destroy vegetative
cell walls do not destroy endospores. Household cleaning products are
ineffective, as are most alcohols, quaternary ammonium compounds (e.g.
benzalkonium chloride), and detergents. Endospores are able to survive boiling
at 100°C for hours. While resistant to extreme heat and radiation, endospores <i>can</i> be destroyed by autoclaving. An <span>autoclave</span> sterilizes material by
subjecting it to high pressure saturated steam at 121&nbsp;°C or more,
typically for 15&#8211;20 minutes. </p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. <i>Clostridium difficile</i> can exist as an endospore, which is resistant
to standard techniques of disinfection. Sterilization is necessary to eliminate
endospores. The most common method of sterilization is autoclaving, by which
materials are subjected to high-pressure saturated steam at 121&nbsp;°C or
more, typically for 15&#8211;20 minutes. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
14-year-old boy presents with a 2-day history of left ear pain. He swims every
morning. The left ear canal is red and swollen. He experiences pain when the auricle
is pulled and when the tragus is pushed. What is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
bacterial otitis media</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Serous
otitis media</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Bullous
myringitis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>External
otitis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mastoiditis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Otitis externa</span></b><span>, or swimmer’s ear, is inflammation of
the external auditory canal, usually caused by bacterial infection (although
sometimes caused by fungal infection). Patients have ear pain and erythema and
swelling of the ear canal, occasionally with discharge. The pain worsens when
the auricle is pulled and when the tragus is pushed. Excessive moisture and
trauma are the most common precipitants.</span></p>

<p><b><span></span></b></p>

<p><b><span>Otitis media</span></b><span> (inflammation of the middle ear) often
occurs with viral upper respiratory tract infection. The ear gets congested,
with mild discomfort and popping. If bacterial contamination occurs, pus and
pressure may develop, causing fever and severe, continuous ear pain. Otoscopic
examination will then show a bulging, erythematous ear drum with indistinct
landmarks and displacement of the light reflex. In severe cases, the ear drum
may perforate. Rare complications include mastoiditis and meningitis.</span></p>

<p><b><span></span></b></p>

<p><b><span>Serous otitis media</span></b><span> is a collection of
fluid in the middle ear caused by negative pressure resulting from Eustachian
tube dysfunction. The fluid may accumulate after a viral upper repiratory tract
infection or before or after acute bacterial otitis media.</span></p>

<p><b><span></span></b></p>

<p><b><span>Bullous myringitis</span></b><span> is an inflammatory
condition of the ear drum, characterized by severe ear pain and painful,
fluid-filled vesicles on the ear drum. It is usually associated with acute
bacterial otitis media.<b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Mastoiditis</span></b><b><span> </span></b><span>is
an infection of the mastoid process (the portion of the temporal bone located
behind the ear). It is usually caused by untreated acute bacterial otitis
media. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct. </span></b><span>The most likely
diagnosis is external otitis. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>A 57-year-old woman with a
history of frequent urinary tract infections has fever, nausea, flank pain, and
muscle aches. Her temperature is 39.7<sup>o</sup>C (103.5<sup>o</sup>F) and her
blood pressure is 80/50 mm Hg. Blood cultures are positive for a Gram-negative
rod. Which of the following is the most likely cause of hypotension?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp;
</span></span>Endotoxin</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span>Superantigen</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span>Erythrogenic toxin</p>

<p><span>D.<span>&nbsp;&nbsp;
</span></span>Hemolysin</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>An endotoxin is a structural
part of a bacterium. The prototypical example of an endotoxin is
lipopolysaccharide (LPS), which is found in the cell wall of most Gram-negative
bacteria.<span >&nbsp; </span>LPS consists of a core
polysaccharide chain, O-specific polysaccharide side chains (O-antigen), and a
lipid component, Lipid A,<span> </span>which is
responsible for the toxic effects. Injection of a small amount of endotoxin in
human volunteers causes fever, hypotension, and activation of inflammation and
coagulation. Endotoxins are largely responsible for the dramatic clinical
manifestations of infections with pathogenic Gram-negative bacteria.</p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=231 height=233
src="_%20Tutorials_files/image196.png"
alt="Description: http://www.glycosan.com/images/endotoxin_structure.jpg"
v:shapes="Picture_x0020_347229"></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;">Endotoxin</p>

<p style="text-align:center;"></p>

<p>A comparison of endotoxin
and exotoxins appears below. </p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Endotoxin</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Exotoxin</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Disease
  (examples)</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Gram-negative
  sepsis</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Tetanus,
  Botulism, Diphtheria</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Source</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Lipopolysaccharide
  found in the cell wall of most gram-negative bacteria; released when lysed</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Polypeptide
  secreted by certain species of gram-positive and gram-negative bacteria</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Gene
  location</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Bacterial
  chromosome</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Plasmid
  or bacteriophage</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Clinical
  effects</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Fever,
  shock</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Depends
  on toxin</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Antigenicity</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Poorly
  antigenic</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Induces
  high-titer antibodies, called antitoxins</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Vaccines</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>None</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Toxoids
  used as vaccines</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Heat
  stability</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Stable
  at 100<sup>o</sup>C for 1 hour</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Destroyed
  rapidly at 60<sup>o</sup>C</span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct</span></b><span>. Endotoxin is the main
cause of fever and hypotension in patients with Gram-negative sepsis.
Inflammation and activation of the coagulation cascade occur. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>.<span> Superantigens </span>are produced by many different micro-organisms.
They stimulate T-cell activation, resulting in massive cytokine release.
Compared to a normal T-cell response in which .001-.0001% of T-cells are
activated, superantigens activate up to 20% of T-cells. Toxic Shock Syndrome
Toxin 1 (TSST-1) is a superantigen produced by <i>Staphylococcus aureus</i>. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>.<b> </b><span>Erythrogenic toxin, produced by </span><i>Streptococcus
pyogenes</i>, is the cause of scarlet fever. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. <span>Hemolysins</span> are exotoxins that cause
lysis of red blood cells <i>in vitro</i>. Visualization of hemolysis on agar
plates facilitates the categorization of some bacteria, such as <i>Streptococcus</i>
and <i>Staphylococcus</i>.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Each of
the following clinical vignettes describes a condition that is caused by an
exotoxin-producing bacterium. Match the vignette with the causative organism.</span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
72-year woman develops fever, abdominal pain, and non-bloody diarrhea after
being treated for aspiration pneumonia with clindamycin. Sigmoidoscopy shows
patches of yellow exudate in the distal colon. </span></p>

<p><span></span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
4-year old boy in Uzbekistan develops low-grade fever, sore throat, and a
thick, tough, gray-to-black coating in the back of the throat. </span></p>

<p><span></span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
26-year old man in India has vomiting and profuse, watery diarrhea, which
results in hypotension and death within hours.</span></p>

<p><span></span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
3-year old boy has bloody diarrhea. Blood tests show a low hemoglobin
concentration, a low platelet count, and an elevated serum creatinine level.
The reticulocyte count is elevated and the haptoglobin level is low.
Examination of a peripheral blood smear shows a few schistocytes. </span></p>

<p><span></span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
10-year old girl has sneezing, runny nose, and a mild cough. Two weeks later,
she develops uncontrollable fits of coughing followed by an inspiratory gasp.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
64-year old man with peripheral arterial disease sustains a deep injury to his
leg. The area becomes swollen and painful, its color changes from red to bronze
to blackish green, and a foul-smelling discharge develops. Large blisters
appear, and gas bubbles are felt beneath the skin. </span></p>

<p><span></span></p>

<p><span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
24-year old woman develops high fever, delirium, and a sunburn-like rash, which
is intensely red and affects the entire body, including eyes, lips, mouth,
palms, and soles. She is hypotensive. Her delirium progresses to coma, and she
develops multi-organ failure. The rash desquamates ten days later. </span></p>

<p><span></span></p>

<p><span><span>8.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A
13-year old girl develops high fever, sore throat, and a rash that begins on
her neck and spreads to her chest and back. The rash is red, fine, and
rough-textured. It is worse in the skin folds. (Converging erythematous lines
appear in the axilla and groin.) Examination reveals tonsillar exudate,
cervical lymphadenopathy, and a bright, red “strawberry” tongue. The rash peels
five days later. Anti-streptolysin O titers are elevated.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>After
eating home-canned asparagus, a 42-year old man develops blurred vision and
difficulty with swallowing and speaking, followed by weakness of the arms and
legs. </span></p>

<p><span></span></p>

<p><span><span>10.<span>&nbsp;
</span></span></span><span>Seven
days after injuring his leg, a 32-year old man develops tightening of his jaw,
stiffness of his neck, and trouble swallowing. This is followed by tightening
of the pectoral and calf muscles. His temperature, pulse, and blood pressure
are elevated. </span></p>

<p><span></span></p>

<p><span><span>11.<span>&nbsp;
</span></span></span><span>A
1-month old neonate develops a diffuse, erythematous rash with blistering.
Large patches of skin can be seen peeling away. Gentle stroking causes the skin
to separate. </span></p>

<p><span></span></p>

<p><span><span>12.<span>&nbsp;
</span></span></span><span>Two
hours after eating a sandwich of sliced meat, a 43-year old woman becomes
violently ill with nausea, vomiting, abdominal pain, and diarrhea. Her symptoms
resolve the following day.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>13.<span>&nbsp;
</span></span></span><span>A
43-year old man who makes drums out of animal hide develops a boil-like lesion
on his forearm, which evolves into a large, painless, necrotic ulcer. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><i><span><span>A.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Staphylococcus aureus</span></i><span> <i></i></span></p>

<p><i><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Streptococcus pyogenes</span></i></p>

<p><i><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Corynebacterium diphtheriae</span></i></p>

<p><i><span><span>D.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Vibrio cholerae</span></i></p>

<p><i><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Escherichia coli<span>&nbsp; </span></span></i><span>0157:H7<i></i></span></p>

<p><i><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Bordetella pertussis</span></i></p>

<p><i><span><span>G.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Clostridium perfringens</span></i></p>

<p><i><span><span>H.<span>&nbsp;&nbsp;
</span></span></span></i><i><span>Clostridium tetani</span></i></p>

<p><i><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Clostridium botulinum</span></i></p>

<p><i><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Clostridium difficile</span></i></p>

<p><i><span><span>K.<span>&nbsp;&nbsp;&nbsp;
</span></span></span></i><i><span>Bacillus anthracis</span></i></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><i>Clostridium difficile</i> colitis should be suspected when diarrhea
occurs in a patient who has recently taken antibiotics. The diarrhea is usually
non-bloody and may be accompanied by fever and abdominal pain. <i>Clostridium difficile</i> colitis is
classically associated with clindamycin use, but any broad-spectrum antibiotic
can cause the condition. “Pseudomembranes,” patches of yellowish exudate
comprised of inflammatory debris, can be seen using sigmoidoscopy or
colonoscopy (hence, the term “pseudomembranous colitis”).<span>&nbsp; </span>Clostridia are Gram-positive, anaerobic,
spore-forming bacilli.<span >&nbsp; </span>Eradication
of normal gut flora with antibiotic use causes overpopulation of these
bacteria, which naturally reside in the colon. The bacteria release toxins that
can cause bloating, diarrhea, and abdominal pain. There are several known
toxins. The best-characterized are enterotoxin (<span>toxin A</span>) and cytotoxin (<span>toxin
B</span>), both of which cause diarrhea and inflammation. Enzyme-linked
immunoabsorbant assays (ELISA) are available for detecting toxins A and B in
the stool. Experts recommend sending as many as three stool samples for ELISA
testing if initial tests are negative. Patients with <i>C. difficile</i><span> colitis should be treated with oral </span>metronidazole
or vancomycin. If treatment is effective, the toxin clears from the stool.<span>&nbsp; </span></p>

<p></p>

<p>D<span>iphtheria</span> is an upper respiratory tract illness caused by <i>Corynebacterium
diphtheriae</i>, a Gram-positive bacterium. The condition is characterized by
sore throat, low fever, and an adherent membrane (a “<span>pseudomembrane”</span>) on the tonsils, pharynx, or nasal cavity.
Patients may present with a “bull” neck. Diphtheria has largely been eradicated
in industrialized nations through widespread vaccination. The vaccine is
composed of the diphtheria toxoid. </p>

<p></p>

<p><span>Cholera</span> is an infection of the small intestine caused by the
bacterium <i>Vibrio cholerae</i>. The main symptoms are profuse watery diarrhea
and vomiting. The diarrhea is frequently described as &quot;rice water.&quot;
An untreated person may produce 10-20 liters of stool a day. Disease
transmission is primarily through consumption of contaminated water or food.
The severity of the diarrhea and vomiting can lead to rapid dehydration and
electrolyte imbalance. Primary treatment is rehydration. Cholera affects 3-5
million people worldwide and causes more than 100,000 deaths each year.</p>

<p></p>

<p><i><span>Escherichia coli</span></i><span>
O157:H7</span> is an enterohemorrhagic strain of the bacterium <i>Escherichia
coli</i><span>.</span> Infection often leads
to hemorrhagic diarrhea and, occasionally, to renal failure, especially in
young children and the elderly. Transmission is via the fecal-oral route. <i>E.
coli</i> is a Gram-negative bacillus, of which there are hundreds of serotypes.
Most are harmless. Serotype O157:H7, however, can produce Shiga-like toxins,
which cause severe illness. In some individuals (particularly children under
five years of age and the elderly), infection can lead to hemolytic uremic
syndrome (HUS), a condition characterized by hemolytic anemia,
thrombocytopenia, and acute renal failure. In HUS, bacterial toxins stimulate
platelet activation and the formation of microthrombi in arterioles and
capillaries. Platelets are consumed and red blood cells are damaged as they
squeeze through the narrowed blood vessels. This process is called
&quot;microangiopathic hemolysis.&quot; Schistocytes, or fragments of sheared
red blood cells, appear in the blood and are a key finding in the diagnosis of
HUS. </p>

<p></p>

<p><span>Pertussis</span>, also known as <span>whooping
cough, </span>is a highly contagious disease caused by the bacterium <i>Bordetella
pertussis</i>. The condition lasts about six weeks and is named after the
&quot;whoop&quot; sound made from the inspiration of air after a cough. (The
high-pitched “whoop” occurs mainly in infants and children.) The classic
symptoms are paroxysmal cough, inspiratory whoop, and post-tussive vomiting
(after-cough vomiting). The cough is violent and has been associated with
subconjunctival hemorrhage, rib fracture, and syncope. Patients present with
mild respiratory symptoms, such as sneezing, runny nose, and cough (catarrhal
stage). After one to two weeks, the cough develops into uncontrollable fits,
each followed by a high-pitched &quot;whoop&quot; (in younger children) or a
gasp (in older children). This is the paroxysmal stage. The “whoop” or gasp
occurs as the patient struggles to inhale. Between coughing fits, the patient
often appears well. The pertussis vaccine, an acellular vaccine, saves many
lives each year. </p>

<p></p>

<p><span>Gas gangrene</span> (also known as &quot;Clostridial myonecrosis&quot; or
&quot;myonecrosis&quot;) is a deadly form of gangrene usually caused by <i>Clostridium
perfringens.</i> The condition usually occurs at the site of trauma or a recent
surgical wound. The onset of illness is sudden and dramatic. Predisposing
conditions include peripheral arterial disease and diabetes. Clostridia produce
many different toxins that can cause potentially deadly syndromes. The site of
infection becomes inflamed, swollen, and very tender. Palpation of the region
elicits crackling because of subcutaneous gas. Vesicles appear which merge into
large blisters. A serosanguinous discharge is common. The edge of the infected
area may expand over minutes. High fever, tachycardia, sweating, and exquisite
pain are typical.<span >&nbsp; </span>If the condition
is not treated, shock ensues and death soon follows. </p>

<p><span></span></p>

<p>Toxic shock syndrome usually
results from infection with <i>Staphylococcus aureus</i><span>. Patients present with</span> high fever, low blood pressure, and
confusion, which may progress rapidly to stupor, coma, and multi-organ failure.
The characteristic rash, often seen early in the course of illness, resembles
sunburn, and can involve any region of the body, including the lips, mouth,
eyes, palms and soles. D<span>esquamation
occurs </span>after 10&#8211;14 days. Toxic shock syndrome is caused by a
superantigen toxin, which is produced by <i>Staphylococcus aureus</i><span>. The superantigen is called toxic shock
syndrome toxin 1 (TSST-1). </span></p>

<p></p>

<p><span>Scarlet fever</span> is caused by an exotoxin (“erythrogenic toxin”)
produced by <i>Streptococcus pyogenes</i>. The disease is characterized by high
fever, sore throat, tonsillar exudate, cervical lymphadenopathy, bright red
tongue (“strawberry tongue”), and characteristic rash. The rash is fine, red,
and rough-textured. It usually appears on the neck and face, often leaving a
clear unaffected area around the mouth. It then spreads to the chest, back, and
extremities. Classic red streaks that run together (Pastia lines) appear in body
creases, especially the axillae, elbows, and groin. The rash blanches with
pressure and fades by the sixth day. The affected skin desquamates. Blood tests
show marked leukocytosis and an elevated antistreptolysin O titer. Streptococci
may be cultured from the throat. Two types of complications are possible:
“septic” and “immune.” Septic complications result from bacteremia, and include
sinusitis, pneumonia, and meningitis. Immune complications include acute
glomerulonephritis, rheumatic fever and erythema nodosum. </p>

<p></p>

<p><span>Botulism</span> is a paralytic illness caused by botulinum toxin, which
is produced by the bacterium <i>Clostridium botulinum</i><span>. The toxin prevents the release of
acetylcholine at motor nerve endings in the parasympathetic system. It</span>
enters the body in one of three ways: by colonization of the digestive tract by
the bacterium, by ingestion of toxin from foods, or by bacterial wound
contamination.<span >&nbsp; </span>All forms lead to
paralysis, which typically starts with the muscles of the face and spreads to
the limbs. Initial manifestations include blurred vision, ptosis, loss of
facial expression, swallowing problems, and difficulty speaking. Severe
botulism can lead to respiratory failure. The autonomic nervous system may be
impaired, causing dry mouth, postural hypotension, and constipation.</p>

<p></p>

<p><span>Tetanus</span> is characterized by prolonged contraction of skeletal
muscle. The condition is caused by a neurotoxin produced by the Gram-positive,
anaerobic bacterium <i>Clostridium tetani</i>. The toxin acts by binding
inhibitory neurons, blocking the release of neurotransmitters. Infection
generally occurs through wound contamination. <span>Generalized tetanus</span> occurs in 80% of cases and follows a
descending pattern. The first sign is trismus (“lockjaw”) and facial spasm,
followed by stiffness of the neck, difficulty swallowing, and rigidity of
pectoral and calf muscles. Other findings include elevated temperature,
elevated blood pressure, rapid heart rate, and sweating. The tetanus vaccine,
composed of tetanus toxoid, is very effective at preventing disease.</p>

<p></p>

<p><span>Staphylococcal scalded skin syndrome </span>is induced by epidermolytic
exotoxins A and B, which are released by <i>Staphylococcus aureus</i> and cause
detachment within the epidermal layer. The exotoxins are proteases that cleave
desmoglein-1, which holds the granulosum and spinosum layers of the epidermis
together. The disease most commonly affects neonates and usually begins with
fever, irritability, and a faint rash. Within 1-2 days, the rash progresses to
a blistering eruption. Tissue paper-like wrinkling of the epidermis occurs and
large bullae appear. As sheets of epidermis are shed, a moist erythematous base
is revealed. Although the clinical picture is dramatic, the process usually
ends with desquamation, and healing is complete in 5-7 days.</p>

<p></p>

<p>Staphylococcal food
poisoning is caused by enterotoxins produced by <em>Staphylococcus aureus</em><em><span>. The bacteria multiply in
food, where they produce heat-resistant enterotoxins (toxins that cannot be
destroyed by cooking). When ingested, the </span></em>toxins are fast-acting,
sometimes causing illness in as little as thirty minutes. On average, symptoms
occur one to six hours after eating, and include nausea, vomiting, abdominal
pain, and diarrhea. The illness is usually brief, and most patients recover in
one to three days. <span>Foods associated with staph food
poisoning include meats; poultry and egg products; salads such as egg, tuna,
chicken, potato, and macaroni; bakery products such as cream-filled pastries,
cream pies, and chocolate éclairs; sandwich fillings; and milk and dairy
products. </span></p>

<p></p>

<p><span>Anthrax</span> is a disease caused by the bacterium <i>Bacillus anthracis</i>.
The bacterium enters the body through the lungs, intestines, or skin. Symptoms
depend on site of entry. Lung infection causes flu-like symptoms, followed by
respiratory collapse. Intestinal infection causes abdominal pain, hematemesis,
and diarrhea. Cutaneous infection results in a boil-like lesion that forms a
large, painless, necrotic ulcer. Anthrax can be contracted in laboratory
accidents or by handling infected animals or their wool or hides.</p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Answers </span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>J</span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>C</span></p>

<p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>D</span></p>

<p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>E</span></p>

<p><span><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>F</span></p>

<p><span><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>G</span></p>

<p><span><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>A</span></p>

<p><span><span>8.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>B</span></p>

<p><span><span>9.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>I</span></p>

<p><span><span>10.<span>&nbsp; </span></span></span><span>H</span></p>

<p><span><span>11.<span>&nbsp; </span></span></span><span>A</span></p>

<p><span><span>12.<span>&nbsp; </span></span></span><span>A</span></p>

<p><span><span>13.<span>&nbsp; </span></span></span><span>K</span></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of
the following molecules is considered an endogenous pyrogen?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Interleukin-1</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Histamine</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Serotonin</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Nitric
oxide</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Platelet-activating
factor</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Infection
can be defined as invasion of a pathogen that triggers an immune response.
Manifestations of infection are protean and are due as much to our immune
response as to the attributes of the particular pathogen. The inflammatory
response that accompanies infection is usually marked by fever. </span></p>

<p><span></span></p>

<p><span>Fever is
an elevation in body temperature above the normal range in response to a
central nervous system change in the set point. Normal oral temperature ranges
from 36.0 to 37.7° C, with a circadian variation of 1° C or more between the
morning nadir and the evening peak. Mean oral temperature in healthy adults is
36.8 ± 0.4° C, with women exhibiting slightly higher values than men. Rectal
temperatures are 0.4° C higher than oral and 0.8° C higher than aural (tympanic
membrane) temperatures. Clinicians generally define significant fever as a
temperature higher than 38.3° C (101.0° F). </span></p>

<p><span></span></p>

<p><span>The vast
majority of acute febrile illnesses lasting less than two weeks have an
infectious cause. These infections occur predominantly where body surfaces
interact with the environment, such as the upper and lower respiratory tracts,
gastrointestinal and genitourinary systems, and skin. The majority of acute
respiratory and gastrointestinal infections are viral in nature. As the duration
of the febrile illness lengthens beyond three weeks, other inflammatory
illnesses become more prominent in the differential diagnosis. Most chronic
febrile illnesses are not caused by infection.</span></p>

<p><span></span></p>

<p><a name=4-u1.0-B978-1-4377-1604-7..00288-8--s001></a><a
name=4-u1.0-B978-1-4377-1604-7..00288-8--st00></a><span>Infection ensues when a pathogen overcomes both
nonspecific innate and specific adaptive humoral and cellular immune responses.
The normal indigenous microflora, host physical barriers (e.g., skin, mucous
membranes, cilia), and soluble factors (e.g., cytokines, complement) provide
important barricades to pathogen invasion. Disruption of these barriers, which
provide a first line of defense, permits the invasion of pathogens. </span></p>

<p><span></span></p>

<p><span>The acute
phase response triggered by such disruption provides direct antimicrobial
activity and prompts the development of adaptive immunity mediated by
lymphocytes and macrophages. This inflammatory response plays an important role
in containing infection. Unfortunately, an exaggerated response may worsen the
clinical condition. </span></p>

<p><span></span></p>

<p><span>Body
temperature is regulated both physiologically and behaviorally. Basal metabolic
processes, governed especially by thyroid hormones but also by catecholamines
and growth hormone, are responsible for the normal resting body temperature.
Thermogenesis may be increased up to 80% by hyperthyroidism and decreased as
much as 50% by hypothyroidism. Moderate activity increases thermogenesis and
results in a transiently increased temperature until heat-dissipating processes
are engaged.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The
hypothalamus contains temperature-sensitive neurons that have receptors for
pro-inflammatory and anti-inflammatory cytokines, which are continuously
balanced to maintain a homeothermic set point. When body temperature becomes
elevated, cutaneous vasodilation and sweating occur, and people may reduce
activity and seek a cooler environment. In contrast, low body temperature is
increased by shivering, piloerection, cutaneous vasoconstriction, adding
clothes, and seeking a warmer environment. </span></p>

<p><span>In febrile
illness, symptoms are often due to the fever itself. Malaise is the rule, and many
febrile patients experience myalgia secondary to muscle contractions used to
raise temperature. The chill associated with rigors may be related to surface
vasoconstriction that accompanies the increase in core temperature. The body’s
thermoregulatory mechanisms rarely allow fevers to exceed 41° C (106° F).
Temperatures exceeding 41° C are often due to a drug-induced imbalance in these
mechanisms and may cause direct cellular damage. </span></p>

<p><span></span></p>

<p><span>Fever is a
complex physiologic process involving metabolic and immunologic responses.
Bacteria release cell wall products such as peptidoglycans and endotoxin, as
well as enterotoxins, which bind to Toll-like receptors (TLRs) on phagocytes
(neutrophils, macrophages) and endothelial cells. As a result, pyrogenic
cytokines such as interleukin-1, interleukin-6, and tumor necrosis factor
(TNF)-&#945; are released into the circulation and bind to cytokine receptors
in the hypothalamus. This stimulates the brain to produce prostaglandin E<sub>2</sub>
(PGE<sub>2</sub>) and cyclic adenosine monophosphate (cAMP), which trigger
neurons in the thermoregulatory center to raise the hypothalamic thermostatic
set point. In addition, neuronal signals to the cortex prompt behavioral
changes to conserve heat (e.g., shivering, adding clothing). The hypothalamus
also triggers sympathetic peripheral efferent nerves that constrict peripheral
blood vessels and conserve central heat.</span></p>

<p><a name=4-u1.0-B978-1-4377-1604-7..00288-8--f001></a><span></span></p>

<p><span>Leukocytosis
often occurs in response to infection. Neutrophilia is the norm in most acute
infections, whatever the cause. Neutropenia may be seen in rickettsial, severe
viral and overwhelming bacterial infections. Eosinophilia is typical of
invasive helminthic and some protozoal infections. Lymphocytosis may accompany
many viral and rickettsial infections and is common during convalescence from
acute bacterial infection. Monocytosis may be seen in tuberculosis. Virtually
all infections have an impact on the erythroid system, but given the long
half-life of erythrocytes, usually only chronic infections or other
inflammatory diseases result in anemia. Few acute infections produce anemia. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct. </span></b><span>A pyrogen is a substance
that causes fever. Exogenous pyrogens are usually microbes or their products.
The best studied exogenous pyrogens are the lipopolysaccharides of
gram-negative bacteria (commonly called endotoxins) and <i>Staphylococcus aureus</i> toxin, which causes toxic shock syndrome.
Exogenous pyrogens usually cause fever by inducing release of endogenous
pyrogens. The principal endogenous pyrogens are interlekin-1, interleukin-6,
and tumor necrosis factor-&#945;. They stimulate production of Prostaglandin E2,
which plays a critical role in adjusting the hypothalamic set point. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect.<span>&nbsp; </span></span></b><span>Histamine is a vasoactive amine released by mast
cells upon activation and promotes inflammation by altering permeability of the
endothelium.<span >&nbsp; </span>It is responsible for
many of the symptoms associated with allergies.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect.<span>&nbsp; </span></span></b><span>Serotonin (5-hydroxytryptamine) is a monoamine
neurotransmitter found in the gastrointestinal tract and the CNS.<span>&nbsp; </span>It affects intestinal movements, mood,
appetite, sleep, muscle contraction, hemostasis, and blood clotting.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect.<span>&nbsp; </span></span></b><span>Nitric oxide (NO) is produced from arginine by
three forms of nitric oxide synthase, depending on the cell type.<span>&nbsp; </span>Inside of a phagocyte, NO is
microbicidal but NO also mediates vasodilation.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect.<span>&nbsp; </span></span></b><span>Platelet-activating factor (PAF) is a
phospholipid mediator released by platelets, endothelial cells, neutrophils,
monocytes, and macrophages.<span >&nbsp; </span>PAF is
proinflammatory in that it attracts leukocytes, amplifies production of lipid
mediators and activates neutrophils, eosinophils, and platelets.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A healthy
42-year old man travels to California. Six weeks later, he develops fever,
cough, pleuritic chest pain, sore muscles, and left knee swelling. Red tender
nodules appear on his shins. A chest x-ray shows a left pleural effusion. Which
of the following conditions is most likely? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Coccidioidomycosis
</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Histoplasmosis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Blastomycosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Aspergillosis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cryptococcosis</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mucormycosis</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Fungal
pathogens can be classified as endemic or opportunistic. Endemic pathogens,
which occur in specific geographic areas, can cause disease in immunocompetent
individuals. Opportunistic pathogens, which are ubiquitous, cause disease in
immunocompromised hosts. In the proper setting, all can cause pneumonia and
other respiratory diseases. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=338 colspan=3 valign=top>
  <p style="text-align:center;"><span>Fungal Pathogens</span></p>
  </td>
 </tr>
 <tr>
  <td width=338 colspan=3 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=77 rowspan=3 valign=top>
  <p><span>Endemic</span></p>
  </td>
  <td width=109 valign=top>
  <p><span>Coccidioidomycosis<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Southwestern
  U.S. </span></p>
  </td>
 </tr>
 <tr>
  <td width=109 valign=top>
  <p><span>Histoplasmosis</span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Mississippi
  and Ohio Rivers</span></p>
  </td>
 </tr>
 <tr>
  <td width=109 valign=top>
  <p><span>Blastomycosis</span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Mississippi
  and Ohio Rivers</span></p>
  </td>
 </tr>
 <tr>
  <td width=338 colspan=3 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=77 rowspan=4 valign=top>
  <p><span>Opportunistic</span></p>
  </td>
  <td width=109 valign=top>
  <p><span>Candidiasis</span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Ubiquitous</span></p>
  </td>
 </tr>
 <tr>
  <td width=109 valign=top>
  <p><span>Aspergillosis</span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Ubiquitous</span></p>
  </td>
 </tr>
 <tr>
  <td width=109 valign=top>
  <p><span>Mucormycosis</span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Ubiquitous</span></p>
  </td>
 </tr>
 <tr>
  <td width=109 valign=top>
  <p><span>Cryptococcosis</span></p>
  </td>
  <td width=152 valign=top>
  <p><span>Ubiquitous</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span>Risk
factors for endemic pathogens include travel to endemic regions and exposure to
bird, bat, or rodent droppings. Risk factors for opportunistic pathogens
include immunocompromised states, such as HIV infection, immunosuppressive
therapy, and oncologic therapy. Symptoms of fungal lung infection include
fever, cough, chest pain, and shortness of breath. </span></p>

<p><span></span></p>

<p><span>Endemic
mycoses are prone to causing rheumatologic symptoms, such as pericarditis,
pleuritis, arthritis, and rash (e.g., erythema multiforme and erythema
nodosum.)(See images below.) Lymphadenopathy is common and may result in large
airway obstruction (pressure effect). In a minority of patients, fungemia leads
to disseminated disease.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Erythema nodosum: red, tender nodules, usually on the shins </span></p>

<p style="text-align:center;"><span>.</span></p>

<p style="text-align:center;"><span><img border=0 width=377 height=248
src="_%20Tutorials_files/image198.png" alt="Description: erythem nodosum"
v:shapes="Picture_x0020_347228"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span>Erythema multiforme: “target lesions”</span></p>

<p><span></span></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/6/68/EMminor09.JPG"><span><img border=0 width=362 height=272
src="_%20Tutorials_files/image200.png" alt="Description: File:EMminor09.JPG"
v:shapes="Picture_x0020_347227"></span></a><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer A is correct</span></b><span>. This patient has both
respiratory and rheumatologic symptoms. Endemic mycoses can produce
rheumatologic symptoms, such as pleuritis, arthritis, and erythema nodosum (red
tender nodules on the shins). This patient most likely has coccidioidomycosis
(also known as California disease, desert rheumatism, San Joaquin Valley fever,
and Valley fever) given his recent travel to California. <i>Coccidioides immitis</i> appears in tissue as a spherule with
endospores.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Histoplasmosis is an
endemic mycosis of the Mississippi and Ohio River Valleys. <i>Histoplasma capsulatum</i> appears in tissue (often macrophages) as
intracellular yeasts.</span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. Blastomycosis is an
endemic mycosis of the Mississippi and Ohio River Valleys. <i>Blastomyces dermatitidis</i> appears in tissue as broad-based budding
yeasts.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Aspergillosis affects
mainly immunocompromised individuals. <i>Aspergillus
sp. </i>appears in tissue as branching, septate hyphae.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Cryptococcus is best
known for causing meningitis in patients with AIDS. <i>Cryptococcus neoformans</i> appears in tissue as encapsulated yeast.</span></p>

<p><span></span></p>

<p><b><span>Answer F is incorrect</span></b><span>. Mucormycosis occurs in
immunocompromised hosts, especially those with diabetes. The most common sites
of infection are sinus, brain, and lung. <i>Mucor
spp.</i> appears in tissue as coenocytic hyphae branching with wide angles.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 40-year
old man with AIDS is started on highly active antiretroviral therapy (HAART).
He subsequently notices increased abdominal fat, thinning of the arms and legs,
prominence of the superficial veins, and a “hallowing out” of the face. These
changes are probably caused by a medicine in which of the following classes? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Protease
inhibitor</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nucleoside
analog reverse transcriptase inhibitor (NARTI)</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nucleotide
analog reverse transcriptase inhibitor (NtARTI)</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Non-nucleoside
reverse transcriptase inhibitor (NNRTI)</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Fusion
inhibitor</span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>Antiretroviral drugs</span> are medications for the treatment of
infection by retroviruses, primarily HIV. When several such drugs, typically
three or four, are taken in combination, the approach is known as <span>Highly Active Antiretroviral Therapy</span>,
or <span>HAART</span>. The National
Institutes of Health and other organizations recommend offering antiretroviral
treatment to all patients with AIDS. Because of the complexity of selecting and
following a regimen, the severity of the side-effects, and the importance of
compliance to prevent viral resistance, such organizations emphasize the
importance of involving patients in therapy choices, and recommend analyzing
the risks and the potential benefits to patients with low viral loads.<b></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct</span></b><span>. Protease inhibitors
can cause a redistribution of fat. This may result in truncal obesity, thinning
of the arms and legs, prominence of the superficial veins, and a “hallowed out”
face. The following drugs are protease inhibitors: saquinavir, ritonavir, indinavir,
nelfinavir, and amprenavir.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect. </span></b><span>Some nucleoside analog
reverse transcriptase inhibitors (NARTIs) can cause anemia, bone marrow
suppression, pancreatitis, peripheral neuropathy, and gastrointestinal
disturbance. The following drugs are NARTIs: zidovudine,&nbsp;didanosine,
zalcitabine, stravudine, lamivudine, abacavir, emtricitabine, entecavir, and
apricitabine.&nbsp;</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect. </span></b><span>Nucleotide analog
reverse transcriptase inhibitors (NtARTIs) can cause gastrointestinal
disturbance. Tenofovir is an NtARTI.<span >&nbsp;&nbsp;
</span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect. </span></b><span>Some non-nucleoside
reverse transcriptase inhibitors (NNRTIs) can cause hepatitis and rash. The
following drugs are NNRTIs: efavirenz, nevirapine, delavirdine, etravirine,
rilpivirine&nbsp;<b></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect</span></b><span>. The fusion inhibitor,
infuvirtide, can cause a reaction at the injection site. This drug is not
recommended for HAART.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 60-year-old
woman has never been vaccinated for hepatitis B. Her serological tests show the
following:</span></p>

<p><span></span></p>

<p>HBsAg<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p>HBeAg <span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p>HBcAb IgM<span>&nbsp;&nbsp;&nbsp; </span>negative</span></p>

<p>HBcAb IgG<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>positive</span></p>

<p>HBsAb<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>positive</span></p>

<p><span></span></p>

<p><span>Which is
correct?</span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>She
was exposed to hepatitis B but was not infected.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>She
was exposed to hepatitis B and is in the acute disease phase</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>She
was exposed to hepatitis B and is in the “window” phase<span>&nbsp; </span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>She
was exposed to hepatitis B and is chronically infected</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>She
was exposed to hepatitis B and has recovered</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hepatitis
B Serology</span></p>

<p><span></span></p>

<p><span>What do
the different Hepatitis B serologic markers mean?</span></p>

<p><span></span></p>

<p><span>Hepatitis B surface antigen (HBsAg): </span><span>A protein on the surface of HBV; it can be
detected in high levels in serum during acute or chronic HBV infection. The
presence of HBsAg indicates that the person is infectious. The body normally
produces antibodies to HBsAg as part of the normal immune response to
infection. HBsAg is the antigen used to make Hepatitis B vaccine. </span></p>

<p><span></span></p>

<p><span>Hepatitis B surface antibody (anti-HBs): </span><span>The presence of anti-HBs indicates
recovery and immunity from HBV infection. Anti-HBs develop in people who have
been successfully vaccinated against Hepatitis B. </span></p>

<p><span></span></p>

<p><span>Total Hepatitis B core antibody (anti-HBc): </span><span>Appears at the onset of
symptoms in acute Hepatitis B and persists for life. The presence of anti-HBc
indicates previous or ongoing infection with HBV in an undefined time frame.</span></p>

<p><span></span></p>

<p><span>IgM antibody to Hepatitis B core antigen (IgM anti-HBc):</span><span> Indicates recent
infection with HBV (≤6 months). Its presence indicates acute infection. </span></p>

<p><span></span></p>

<p><span>Hepatitis B e antigen (HBeAg):</span><span> A secreted product of the nucleocapsid gene of
HBV that is found in serum during acute and chronic Hepatitis B. Its presence
indicates that the virus is replicating and the infected person has high levels
of HBV. </span></p>

<p><span></span></p>

<p><span>Hepatitis B e antibody (HBeAb or anti-HBe):</span><span> Produced by the immune system
temporarily during acute HBV infection or consistently during or after a burst
in viral replication. </span></p>

<p><span></span></p>

<p><span>Spontaneous
conversion from e antigen to e antibody (a change known as seroconversion) is a
predictor of long-term clearance of HBV in patients undergoing antiviral
therapy and indicates lower levels of HBV. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>How to interpret Hepatitis B serologic test results</span></p>

<p><span></span></p>

<p><span>The
following table provides interpretations for Hepatitis B serologic markers. </span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0 width="95%">
 <thead>
  <tr>
   <td colspan=3 valign=top>
   <p style="text-align:center;"><b><span>Interpretation of Hepatitis B
   Serologic Test Results</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td width=102>
  <p style="text-align:center;"><b><span>Tests</span></b></p>
  </td>
  <td width=106>
  <p style="text-align:center;"><b><span>Results</span></b></p>
  </td>
  <td width=249>
  <p style="text-align:center;"><b><span>Interpretation</span></b></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>HBsAg<br>
  anti-HBc<br>
  anti-HBs </span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>negative<br>
  negative<br>
  negative</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>Susceptible</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>HBsAg<br>
  anti-HBc<br>
  anti-HBs </span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>negative<br>
  positive<br>
  positive</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>Immune due to natural infection</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>HBsAg<br>
  anti-HBc<br>
  anti-HBs </span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>negative<br>
  negative<br>
  positive</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>Immune due to Hepatitis B vaccination</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>HBsAg<br>
  anti-HBc<br>
  IgM anti-HBc<br>
  anti-HBs </span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>positive<br>
  positive<br>
  positive<br>
  negative</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>Acutely infected </span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>HBsAg<br>
  anti-HBc<br>
  IgM anti-HBc<br>
  anti-HBs </span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>positive<br>
  positive<br>
  negative<br>
  negative</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>Chronically infected</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><span>HBsAg<br>
  anti-HBc<br>
  anti-HBs </span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>negative<br>
  positive<br>
  negative</span></p>
  </td>
  <td>
  <p><span>Interpretation
  unclear; four possibilities: </span></p>
  <p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>&nbsp;Resolved infection (most common) </span></p>
  <p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>False-positive anti-HBc, thus susceptible </span></p>
  <p><span><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>&quot;Low level&quot; chronic infection </span></p>
  <p><span><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span><span>Resolving acute infection </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=306 height=205
src="_%20Tutorials_files/image202.png"
alt="Description: http://pathmicro.med.sc.edu/virol/hepb-cd1.gif" v:shapes="Picture_x0020_347226"></span><span></span></p>

<p style="text-align:center;"><span><img border=0 width=306 height=205
src="_%20Tutorials_files/image204.png"
alt="Description: http://pathmicro.med.sc.edu/virol/hepb-cd2.gif" v:shapes="Picture_x0020_347225"></span></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span></span></b></p>

<p><span>Answer E is correct</span></b><span>. The presence of HBcAb IgG and HBsAb
indicates that she has been exposed to hepatitis B and has produced antibodies
conferring immunity. </span></p>

<p></span></p>

<p><span>Answer A is incorrect</span></b><span>. The presence of HBcAb IgG and HBsAb
indicates previous infection with hepatitis B.</span></p>

<p></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. In the acute phase of
disease, hepatitis B surface antigen (HBsAg) is positive and hepatitis B
surface antibody (HBsAb) is negative.</span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect</span></b><span>. In the serological
“window,” hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody
(HBsAb) are negative, while IgM hepatitis B core antibody (IgM HBcAb) is
positive.<span >&nbsp;&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect</span></b><span>. In chronic infection,
hepatitis B surface antigen (HBsAg) is positive and hepatitis B surface
antibody (HBsAb) is negative. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
41-year-old woman develops high spiking fevers and chills a week after
returning from central Africa. Which of the following tests on the patient’s
blood will most likely establish the diagnosis? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Gram
stain</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Giemsa
stain</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Silver
stain</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Acid-fast
stain</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>KOH
stain</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>India
ink stain</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The <b>Gram</b> stain is the most
commonly used stain in microbiology. Bacteria are categorized as gram-positive
or gram-negative based on their ability to take up the stain. Those with large
amounts of peptidoglycan in their cell walls retain methyl (or crystal) violet and
are called gram-positive. Those with walls composed mainly of lipids and
lipopolysaccharides do not retain methyl (or crystal) violet and are called
gram-negative. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=424 height=186
src="_%20Tutorials_files/image206.png"
alt="Description: Gram Positive and Gram Negative Bacteria" v:shapes="Picture_x0020_347224"></span><span></span></p>

<p><span><span>&nbsp;&nbsp;&nbsp; </span>Gram-positive
Staphylococcus<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>Gram-negative E. Coli</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The <b>Giemsa</b> stain is the principal
stain used in the diagnosis of malaria. It is an effective stain for detecting
protozoa, such as trichomonas, cryptosporidium, giardia, toxoplasma, and
leishmania. It is also effective for <i>Helicobacter pylori </i>and for bacteria
that lack peptidoglycan cell walls (e.g., rickettsia, chlamydia). </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=235 height=160
src="_%20Tutorials_files/image208.png" alt="Description: 070525090316-large"
v:shapes="Picture_x0020_347223"></span><span></span></p>

<p style="text-align:center;"><span>Malaria:
Giemsa stain</span></p>

<p><span></span></p>

<p><b><span>Silver</span></b><span> stains are primarily
used when Gram and Giemsa stains are ineffective. Because silver stains are
laborious to implement, they are usually reserved for cases in which the
suspected pathogen is a spirochete, legionella, bartonella, or <i>H. pylori.</i></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=310 height=216
src="_%20Tutorials_files/image210.png" alt="Description: T" v:shapes="Picture_x0020_347222"></span><span></span></p>

<p style="text-align:center;"><span>Syphilis:
Silver stain<span></span></span></p>

<p><i><span></span></i></p>

<p><b><span>Acid-fast</span></b><span> stains are primarily
used for mycobacteria, such as <i>Mycobacterium tuberculosis</i>. These
bacteria have thick, waxy cell walls, which contain large amounts of a lipid
called mycolic acid. Mycolic acid resists staining and decolorization by
acid-alcohol (hence, the term “acid-fast”).<span>&nbsp; </span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=304 height=196
src="_%20Tutorials_files/image212.png"
alt="Description: M tuberculosis acid fast" v:shapes="Picture_x0020_347221"></span><span></span></p>

<p style="text-align:center;"><span>Tuberculosis:
Acid-fast stain</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The <b>KOH</b> (potassium hydroxide)
stain is commonly used to diagnose fungal infections of the skin and nails. The
stain dissolves debris, allowing the fungal hyphae to be visualized.<span>&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=271 height=198
src="_%20Tutorials_files/image214.png" alt="Description: Fungus" v:shapes="Picture_x0020_347220"></span><span></span></p>

<p style="text-align:center;"><span>Dermatophyte:
KOH</span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>India Ink</span></b><span> can be used to
visualize the capsule of <i>Cryptococcus neoformans</i>. By staining the
background, the capsule becomes visible.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=273 height=184
src="_%20Tutorials_files/image216.png"
alt="Description: 180px-Cryptococcus_neoformans_using_a_light_India_ink_staining_preparation_PHIL_3771_lores"
v:shapes="Picture_x0020_347219"></span><span></span></p>

<p style="text-align:center;"><span>Cryptococcus:
India ink</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><b><span>Answer
B is correct.</span></b><span><span>&nbsp; </span>Spiking fevers and chills in a patient
who has visited central Africa is suggestive of malaria. The diagnosis can be made
by detecting the parasite (Plasmodium) on a Giemsa-stained blood smear.<span>&nbsp; </span><b></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 32-year
old man had unprotected anal intercourse with a male prostitute seven days ago.
He is asymptomatic but worried that he may have acquired HIV. He underwent HIV
testing 3 and 6 months ago. Both tests were negative. Which of the following
provides the earliest evidence of HIV infection?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>CD4
cell count</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Western
blot assay</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>RNA
polymerase chain reaction (PCR)</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Enzyme-linked
immunosorbent assay (ELISA)</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span><img border=0 width=376 height=263
src="_%20Tutorials_files/image218.png" alt="Description: HIV_Virion-en-2"
v:shapes="Picture_x0020_347218"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p>HIV is a retrovirus. A <span>retrovirus</span> is an RNA virus that is
duplicated in a host cell using the reverse transcriptase enzyme to produce DNA
from its RNA genome. The DNA is then incorporated into the host cell’s genome
by an integrase enzyme. This allows the virus to replicate as part of the host
cell’s DNA. HIV is composed of two copies of single-stranded RNA, which is
bound to reverse transcriptase, integrase, and proteins that protect the RNA
from nucleases. The RNA is enclosed by a capsid, or protein shell. The capsid
is surrounded by a matrix, which ensures the integrity of the virion. The
matrix, in turn, is surrounded by an envelope, which is comprised of plasma
membrane from the host cell and viral glycoproteins.</p>

<p></p>

<p><span>HIV
is most commonly diagnosed by testing blood or saliva for antibodies to the
virus. Antibody tests include Western blot assay and ELISA (enzyme-linked
immunosorbent assay). These tests are not accurate immediately after infection
because up to 12 weeks are needed to form antibodies to the virus. In rare
cases, six months may elapse before antibodies are detected. By contrast,
nucleic acid-based tests (NAT) allow HIV to be detected as early as four days
following infection. A commonly used NAT employs the polymerase chain reaction
to amplify viral RNA. </span></p>

<p><span><span>&nbsp;</span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is correct</span></b><span>. The polymerase chain
reaction can be used to amplify viral RNA, allowing HIV to be detected as early
as four days following infection.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. The CD4 count is
neither sensitive nor specific for early diagnosis of acute HIV infection. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. The Western blot assay
is used to detect antibodies to HIV. These antibodies usually appear 3-4 weeks
after infection.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. The enzyme-linked
immunosorbent assay (ELISA) is used to detect antibodies to HIV. These
antibodies usually appear 3-4 weeks after infection. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
22-year-old man receives the tetanus vaccine. Six hours later, he has pain and
massive swelling at the site of injection. The following day, the skin breaks
down, forming an ulcer at the site. Which of the following events plays a
critical role in this reaction?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Local
release of histamine</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Predominant
synthesis of IgM antibodies</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Local
fixation of complement by preformed circulating antibodies</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Antigen
capture by Langerhans cells in the epidermis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Accumulation
of mononuclear cells at the site of injection</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Hypersensitivity
refers to excessive and undesirable reactions produced by the normal immune
system. Hypersensitivity reactions require a pre-sensitized (immune) host
state. They are divided into four types based on mechanism and time taken for
the reaction. A particular clinical condition may involve more than one type of
reaction.</span></p>

<p><span>&nbsp;</span></p>

<p><b><span>Type I Hypersensitivity</span></b></p>

<p><b><span></span></b></p>

<p><span>Type I
hypersensitivity is known as immediate or anaphylactic hypersensitivity. The
reaction may involve skin (urticaria and eczema), eyes (conjunctivitis),
nasopharynx (rhinitis), bronchopulmonary tissues (asthma), or gastrointestinal
tract (gastroenteritis). Reactions range from minor to deadly, and typically
occur 15-30 minutes after antigen exposure. </span></p>

<p><span></span></p>

<p><span>Immediate
hypersensitivity is mediated by<b> </b>IgE. The primary cellular component is
the mast cell or basophil. The reaction is amplified by neutrophils,
eosinophils, and platelets. Biopsy of affected tissue demonstrates mainly<b> </b>mast
cells and eosinophils. IgE is produced in response to certain allergens. It has
a very high affinity for receptor on mast cells and basophils. Subsequent
exposure to the same allergen cross-links the cell-bound IgE and triggers mast
cell degranulation. </span></p>

<p><span></span></p>

<p><span>Mast cells
can be triggered by other stimuli, such as exercise, emotional stress,
chemicals, and anaphylotoxins (<i>e.g.</i>, C4a, C3a, C5a, <i>etc.</i>). These
non-IgE-mediated reactions are not hypersensitivity reactions, although they
produce similar symptoms.</span></p>

<p><span></span></p>

<p><span>Diagnostic
tests for immediate hypersensitivity include skin tests, measurement of total
IgE, and measurement of specific IgE to a suspected allergen. Total IgE and
specific IgE are measured by enzyme immunoassay (ELISA). </span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Type II Hypersensitivity</span></b></p>

<p><span></span></p>

<p><span>Type II
hypersensitivity is known as cytotoxic hypersensitivity. It is primarily
mediated by complement and antibodies of the IgM or IgG class. Triggering
antigens are usually endogenous, although some exogenous antigens can attach to
cells and cause type II hypersensitivity. Drug-induced hemolytic anemia,
Goodpasture’s syndrome, and pemphigus are examples of type II hypersensitivity.
The reaction occurs minutes to hours after antigenic exposure. </span></p>

<p><span></span></p>

<p><span>Diagnosis
involves detection of antibodies against affected tissue. These antibodies may
be circulating or may be found in biopsied tissue by immunofluorescent
staining. The staining pattern is smooth and linear. Treatment often involves
anti-inflammatory or immunosuppressive agents.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span>Type III Hypersensitivity</span></b><span></span></p>

<p><span></span></p>

<p><span>Type III
hypersensitivity is known as immune complex hypersensitivity. The reaction may
be general (<span>e.g.</span>, serum
sickness) or may involve an individual organ, such as the skin (systemic lupus
erythematosus, Arthus reaction), kidneys (lupus nephritis), lungs (aspergillosis),
blood vessels (polyarteritis), or joints (rheumatoid arthritis). Many
microorganisms elicit a type III hypersensitivity reaction.</span></p>

<p><span></span></p>

<p><span>The
reaction, which occurs 3-10 hours after exposure to an antigen, is mediated by
soluble immune complexes, usually of the IgG class, sometimes of the IgM class.
The antigen may be exogenous (chronic bacterial, viral, or parasitic infection)
or endogenous (systemic lupus erythematosus). The antigen is soluble and not
attached to the involved organ. Lesions are composed of soluble immune
complexes and complement. Damage is wrought by neutrophils and platelets. </span></p>

<p><span></span></p>

<p><span>Diagnosis
involves detection of immune complexes in the serum or biopsied tissue. The
immunofluorescent pattern is “granular” (as opposed to the “linear” pattern of
type II hypersensitivity). Serum complement levels are depleted. Treatment
includes anti-inflammatory and immunosuppressive agents.</span></p>

<p><span></span></p>

<p><b><span>Type IV Hypersensitivity</span></b></p>

<p><b><span></span></b></p>

<p><span>Type IV
hypersensitivity is known as cell-mediated or delayed-type hypersensitivity.
The classical example is the tuberculin (Montoux) reaction, which peaks 48
hours after injection of antigen and is characterized by erythema and
induration.&nbsp; </span></p>

<p><span>&nbsp;</span></p>

<p><span>Type IV
hypersensitivity occurs in many infectious diseases (e.g., tuberculosis,
leprosy, blastomycosis, histoplasmosis, toxoplasmosis, leishmaniasis).
Granulomas are a product of type IV hypersensitivity. Contact dermatitis due to
poison ivy, chemicals, and heavy metals is another example of delayed
hypersensitivity. &nbsp;</span></p>

<p><span></span></p>

<p><span>Damage is
wrought by T lymphocytes and monocytes or macrophages. Cytotoxic T cells cause
direct damage; helper T cells secrete cytokines, which activate cytotoxic T
cells and recruit monocytes and macrophages. Corticosteroids and other
immunosuppressive agents are used in treatment.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><b><span>Hypersensitivity Reactions</span></b></p>

<p style="text-align:center;"><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td valign=bottom>
   <p><b><span>Type of Reaction</span></b></p>
   </td>
   <td valign=bottom>
   <p><b><span>Prototypic
   Disorder</span></b></p>
   </td>
   <td valign=bottom>
   <p><b><span>Immune
   Mechanisms</span></b></p>
   </td>
   <td valign=bottom>
   <p><b><span>Pathologic
   Lesions</span></b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td valign=top>
  <p><b><span>Immediate
  (type I) hypersensitivity</span></b><span></span></p>
  </td>
  <td valign=top>
  <p><span>Anaphylaxis<sup>1</sup>,
  </span></p>
  <p><span>Allergic
  rhinitis, </span></p>
  <p><span>Bronchial
  asthma (atopic forms)</span></p>
  </td>
  <td valign=top>
  <p><span>Production
  of IgE antibody; immediate release of vasoactive amines and other mediators
  from mast cells; later recruitment of inflammatory cells</span></p>
  </td>
  <td valign=top>
  <p><span>Vascular
  dilation, edema, smooth muscle contraction, mucus production, tissue injury,
  inflammation</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Antibody-mediated
  (type II) hypersensitivity</span></b><span></span></p>
  </td>
  <td valign=top>
  <p><span>Autoimmune
  hemolytic anemia,</span></p>
  <p><span>Goodpasture
  syndrome</span></p>
  </td>
  <td valign=top>
  <p><span>IgG, IgM
  binding to antigen on target cell or tissue; complement activation; lysis or
  phagocytosis of target cell; recruitment of leukocytes</span></p>
  </td>
  <td valign=top>
  <p><span>Phagocytosis
  and lysis of cells; inflammation</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Immune
  complex&#8211;mediated (type III) hypersensitivity</span></b><span></span></p>
  </td>
  <td valign=top>
  <p><span>Systemic
  lupus erythematosus,</span></p>
  <p><span>Glomerulonephritis
  (some types), </span></p>
  <p><span>Serum
  sickness<sup>2</sup>, Arthus reaction<sup>3</sup></span></p>
  </td>
  <td valign=top>
  <p><span>Deposition
  of antigen-antibody complexes;<span >&nbsp;
  </span>complement activation; recruitment of leukocytes; release of enzymes
  and other toxic molecules</span></p>
  </td>
  <td valign=top>
  <p><span>Inflammation,
  necrotizing vasculitis (fibrinoid necrosis)</span></p>
  </td>
 </tr>
 <tr>
  <td valign=top>
  <p><b><span>Cell-mediated
  (type IV) hypersensitivity</span></b><span></span></p>
  </td>
  <td valign=top>
  <p><span>Contact
  dermatitis, Multiple sclerosis, </span></p>
  <p><span>Type I
  diabetes, Rheumatoid arthritis, Inflammatory bowel disease </span></p>
  <p><span>Tuberculosis</span></p>
  </td>
  <td valign=top>
  <p><span>Cytokine
  release by activated T cells; inflammation and macrophage activation; T-cell
  mediated cytotoxicity</span></p>
  </td>
  <td valign=top>
  <p><span>Perivascular
  cellular infiltrates; edema; granuloma formation; cell destruction</span></p>
  </td>
 </tr>
</table>

<p></p>

<p><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b>Anaphylaxis</b>
is an acute, multi-system, severe, type I hypersensitivity reaction caused by
IgE-mediated degranulation of mast cells and basophils. Symptoms develop over
minutes to hours and can include hypotension; swelling of the lips, tongue and
throat; cardiac ischemia; stridor; wheezing; shortness of breath; abdominal
pain; vomiting; diarrhea; flushing; hives; and loss of consciousness. Common
triggers include insect bites or stings, foods, medication, and latex.
Anaphylaxis is a medical emergency that may require resuscitation measures,
such as airway management, supplemental oxygen, and intravenous fluids.<span>&nbsp; </span>Epinephrine (adrenaline) is the primary
treatment for anaphylaxis. It improves airway patency and blood pressure, and
may be life-saving.</p>

<p></p>

<p></p>

<p><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b>Serum sickness</b> can develop as a result
of exposure to antibodies derived from animals. These sera are generally
administered in order to prevent or treat an infection or envenomation. When
antiserum is given, the immune system can mistake the proteins for harmful antigens.
Antibodies are produced, which combine with these proteins to form immune
complexes. Symptoms include fever, malaise, rash, arthralgia, and
lymphadenopathy. Hypotension, splenomegaly, glomerulonephritis, and proteinuria
may occur. </p>

<p></p>

<p><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b>Arthus reactions</b> (type III
hypersensitivity reactions) can occur after vaccination for tetanus or
diphtheria. The reactions are characterized by local vasculitis, immune complex
deposition, and complement activation. Immune complexes form in the setting of
high concentrations of vaccine antigen and circulating antibody. Severe pain,
swelling, induration, edema, hemorrhage, and even necrosis occur 4&#8211;12
hours after vaccination.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct</span></b><span>. The patient in the
vignette has had an Arthus reaction to the tetanus vaccine. This is a type III
hypersensitivity reaction, characterized by deposition of immune complexes and
activation of complement.</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. Local release of
histamine occurs in type I hypersensitivity reactions. </span></p>

<p><span><span>&nbsp;</span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. IgM binding to antigen
occurs in some type II hypersensitivity reactions. </span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Antigen capture by
Langerhans cells occurs in type IV hypersensitivity reactions.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Mononuclear cell
accumulation occurs in type IV hypersensitivity reactions. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An
11-year-old girl is brought to the emergency department because of a 4-day
history of fever and an 8-hour history of lethargy. Her parents say that she
has been sleeping most of the day and has been unresponsive when awake. Her
temperature is 102.6<sup>o</sup>F. Physical examination shows nuchal rigidity
and numerous petechial hemorrhages. A lumbar puncture yields cloudy
cerebrospinal fluid (CSF). Microscopic examination of the CSF shows numerous
segmented neutrophils and a Gram stain shows gram-negative diplococci. Which of
the following is correct? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>She
should be placed in a private room. Hospital personnel should wear a mask.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>She
should be placed in a private room. Hospital personnel should wear a gown. </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>She
should be placed in a negative-pressure room. </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>She
may be placed in a semi-private room. Hospital personnel should wear a gown.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>There are two tiers of
precautions to prevent transmission of infectious agents: standard precautions
and transmission-based precautions. Standard precautions apply to all patients,
regardless of diagnosis. Transmission-based precautions apply to patients who
may be infected or colonized with infectious agents that require additional
measures to prevent transmission. Since the infecting agent is often unknown at
the time of admission, transmission-based precautions may be applied
empirically according to the clinical syndrome or likely etiologic agent, and
then modified when the pathogen is identified or ruled out. There are three
categories of transmission-based precautions: contact, droplet, and airborne.</p>

<p><span>&nbsp;</span></p>

<p><strong>Contact Precautions.</strong>
Contact precautions reduce transmission of infectious agents spread by direct
or indirect contact with the patient. (“Indirect” contact is contact with
potentially contaminated materials.) These precautions apply to patients with
excessive wound drainage and fecal incontinence. A single-patient room is
recommended. Healthcare personnel should wear a gown and gloves. Conditions for
which contact precautions apply include certain <span>gastrointestinal
infections (e.g., C. difficile colitis), skin and wound infections (e.g.
impetigo), and colonization with multidrug-resistant organisms (e.g., MRSA).</span></p>

<p></p>

<p><strong>Droplet Precautions.
</strong><strong><span>Droplet
precautions</span></strong> <span>reduce transmission of
infectious agents released by sneezing or coughing. Large droplet sprays can
spread as far as three feet. </span>A single-patient room is recommended.
Healthcare personnel should wear a mask. <span>Conditions
for which droplet precautions apply include influenza, meningococcal
meningitis, mumps, rubella, and pertussis.</span> </p>

<p></p>

<p><strong>Airborne Precautions</strong>
<strong><span>Airborne
precautions</span></strong><span> reduce transmission of
airborne particles (i.e., particles so small that they can be suspended in the
air for long periods of time). </span>Patients should be placed in an
airborne-infection isolation room (AIIR), which is a single-patient room with
special air handling capacity (e.g., negative pressure ventilation, frequent
air exchanges, adequate exhaust system). Healthcare personnel should wear a
respirator or mask. Conditions for which airborne precautions apply include
tuberculosis, measles, and chicken pox.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer A is correct.</span></b><span> The patient has
meningitis due to <i>Neisseria meningitidis</i>
as indicated by the Gram stain (gram-negative diplococci) and the presence of
petechial hemorrhages. This condition is associated with spread by respiratory
droplets (often by sneezing or coughing). Suspected cases should be placed
under “droplet precautions.” Droplets are not generally communicable beyond
three feet; therefore, a negative-pressure room is unnecessary.
(Negative-pressure rooms are used to prevent airborne pathogens, such as <i>M. tuberculosis</i>, from escaping the room
when the door is open.) Gowns are not needed because spread occurs through the
respiratory route, not by contact.</span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect. </span></b><span>Gowns are used for
contact precautions, not droplet precautions. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect. </span></b><span>A negative-pressure room
is used for airborne precautions, not droplet precautions. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect. </span></b><span>A private room is
recommended for droplet precautions. A gown is not needed. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 37-year-old woman presents to the
emergency department with a fever. Chest x-ray film shows multiple patchy
infiltrates in both lungs. Echocardiography and blood cultures suggest a
diagnosis of acute bacterial endocarditis limited to the tricuspid valve. Which
of the following is the most probable etiology?&nbsp; </span></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB><span>A.<span>&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Congenital
heart disease</span></span></p>

<p><span lang=EN-GB><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Illicit
drug use</span></span></p>

<p><span lang=EN-GB><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Rheumatic
fever</span></span></p>

<p><span lang=EN-GB><span>D.<span>&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Rheumatoid
arthritis</span></span></p>

<p><span lang=EN-GB><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span></span><span
 lang=EN-GB>Systemic
lupus erythematosus</span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span></span></span></p>

<p><span>Infective
endocarditis (IE) can be clinically classified as follows: </span></p>

<p><span></span></p>

<p><b><span>Native
valve endocarditis (NVE)</span></b></p>

<p><span>The
following are the main underlying causes of NVE:</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Rheumatic
valvular disease - Primarily involves the mitral valve followed by the aortic
valve</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Congenital
heart disease - Underlying etiologies include a patent ductus arteriosus,
ventricular septal defect, tetralogy of Fallot, or any native or surgical
high-flow lesion. </span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Mitral
valve prolapse with an associated murmur</span></p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>Degenerative
heart disease - Including calcific aortic stenosis due to a bicuspid valve,
Marfan syndrome, or syphilitic disease</span></p>

<p><span></span></p>

<p><span>Approximately
70% of infections in NVE are caused by <i>Streptococcus</i> species, including <i>S
viridans, Streptococcus bovis</i>, and enterococci. <i>Staphylococcus</i>
species cause 25% of cases and generally demonstrate a more aggressive acute
course.</span></p>

<p><span></span></p>

<p><b><span>Prosthetic
valve endocarditis (PVE)</span></b></p>

<p><span>Early PVE,
which presents shortly after surgery, has a different bacteriology and
prognosis than late PVE, which presents in a subacute fashion similar to NVE.
Infection associated with aortic valve prostheses is particularly associated
with local abscess and fistula formation, and valvular dehiscence. This may
lead to shock, heart failure, heart block, pericardial tamponade, and
peripheral emboli to the central nervous system and elsewhere. Early PVE may be
caused by a variety of pathogens, including <i>S aureus</i> and <i>S
epidermidis</i>. Late disease is most commonly caused by streptococci.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>IVDA
infective endocarditis</span></b></p>

<p><span>Diagnosis
of endocarditis in intravenous drug users can be difficult and requires a high
index of suspicion. Two thirds of patients have no previous history of heart
disease or murmur on admission. A murmur may be absent in those with tricuspid
disease, owing to the relatively small pressure gradient across this valve.
Pulmonary manifestations may be prominent in patients with tricuspid infection:
one third have pleuritic chest pain, and three quarters demonstrate chest
radiographic abnormalities. <i>S aureus</i> is the most common etiologic
organism in patients IE die to intravenous drug use.</span></p>

<p><b><span></span></b></p>

<p><b><span>Healthcare-associated
infective endocarditis</span></b></p>

<p><span>Endocarditis
may be associated with new therapeutic modalities involving intravascular
devices such as central or peripheral intravenous catheters, rhythm control
devices such as </span><span><span>pacemakers</span></span><span> and defibrillators,
hemodialysis shunts and catheters, and chemotherapeutic and hyperalimentation
lines. Thr most coomon cause of health-care associated IE is <i>S aureus.</i><span>&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Fungal
endocarditis</span></b></p>

<p><span>Fungal
endocarditis is found in intravenous drug users and intensive care unit
patients who receive broad-spectrum antibiotics.</span><a
href="file://localhost/javascript/showrefcontent('refrenceslayer')%3B"></a><sup><span> </span></sup><span><span>&nbsp;</span></span></p>

<p><span><span><strong><span lang=EN-GB>Answer B is correct.</span></strong><span
 lang=EN-GB> The most
probable etiology of bacterial endocarditis involving the tricuspid valve is
illicit intravenous drug use, which can introduce skin organisms into the
venous system that then attack the tricuspid valve. Staphylococcus aureus
accounts for most cases of endocarditis in intravenous drug users.</span></span><span
lang=EN-GB></span></p>

<p><span lang=EN-GB>&nbsp;</span></p>

<p><strong><span lang=EN-GB>Answer A is incorrect.</span></strong><span
 lang=EN-GB> The
endocarditis associated with congenital heart disease typically involves either
damaged valves or atrial or ventricular septal defects. The tricuspid valve is
not particularly vulnerable.&nbsp; </span></span></p>

<p><span lang=EN-GB></span></p>

<p><strong><span lang=EN-GB>Answer C is incorrect.</span></strong><span
 lang=EN-GB> Rheumatic
fever most commonly damages the mitral and aortic valves, and tricuspid damage
is usually less severe and seen only when the mitral and aortic valves are
heavily involved. </span></span><span lang=EN-GB></span></p>

<p><span lang=EN-GB>&nbsp;</span></p>

<p><strong><span lang=EN-GB>Answer D is incorrect.</span></strong><span
 lang=EN-GB> Rheumatoid
arthritis is not associated with bacterial endocarditis.&nbsp; </span></span></p>

<p><span lang=EN-GB></span></p>

<p><strong><span lang=EN-GB>Answer E is incorrect.</span></strong><span
 lang=EN-GB> Systemic
lupus erythematosus can produce small, aseptic vegetations on valves, but is
not associated with bacterial endocarditis.</span></span><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span lang=EN-GB></span></p>

<p><span>Pandemics
of influenza type A occurred in 1918 (Spanish flu), 1957 (Asian flu), 1968
(Hong Kong flu). Which of the following best explains these pandemics? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Degradation
of nucleoprotein and involution of the lipid envelope</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Absence
of hemagglutinin </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Absence
of neuraminidase</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Antigenic
drift</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Antigenic
shift</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=297 height=175
src="_%20Tutorials_files/image220.png"
alt="Description: http://www.chm.bris.ac.uk/webprojects2006/Kelly/influenzafigure1.jpg"
v:shapes="Picture_x0020_347217"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span>The
influenza virus has hemagglutinin (HA) and neuraminidase (NA) molecules on its
surface. These molecules allow the virus to penetrate the host cell.<span>&nbsp; </span>Hemagglutinin, named for its ability to
agglutinate red blood cells, binds to sialic acid receptors, allowing fusion of
the virus with the host cell. Neuraminidase degrades neuraminic acid, a
component of mucin, which protects the airways. </span></p>

<p><span></span></p>

<p><span>Humans
develop immunity to a particular strain of influenza by producing antibodies to
HA and NA. A change in either of these molecules impedes recognition of the
virus by the host’s immune system. Pandemic spread can occur when two different
strains of the influenza virus infect the same cell and exchange RNA. This is
called antigenic shift. An example of this is “avian flu,” in which a human
influenza virus and an avian influenza virus infect the same porcine host and
exchange RNA, producing a new virus. </span></p>

<p><span></span></p>

<p><span>Flu
strains are named after the HA and NA molecules on their surface (e.g., H3N2).
Here’s an example of antigenic shift: An H3N2 virus and an H5N1virus infect the
same cell, exchange RNA, and produce a new virus, H3N1. H3N1 would not be
recognized by the host’s pre-existing antibodies. </span></p>

<p><span></span></p>

<p><span>Antigenic
shift differs from antigenic drift, in which minor changes in HA and NA are
caused by genetic mutations. Such mutations make the virus less antigenic to
pre-existing antibodies. The molecular changes occurring with antigenic shift
are more dramatic than those that occur with antigenic drift. Increases in
viral toxicity are usually greater with antigenic shift, though they may be
quite great with antigenic drift. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer E is correct</span></b><span>. Antigenic shift best
explains pandemics.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A scientific investigator injects an experimental animal with a newly
discovered strain of bacteria to evaluate T-lymphocyte activation. It is found
that bacterial engulfment by macrophages results in the presentation of
bacterial-derived peptide ligands to CD4+ T lymphocytes. Which of the following
cell surface molecules on the macrophage is most directly involved in the
presentation of the processed peptides?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp; </span></span></span><span>CD28</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Class II MHC </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Fc receptor</span></p>

<p><span><span>D.<span>&nbsp;&nbsp; </span></span></span><span>Interleukin-2 receptor</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span><span>Membrane immunoglobulin</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>The major histocompatibility complex</span> (<span>MHC</span>) is a large gene family that encodes MHC molecules. MHC
molecules play an important role in the immune system and autoimmunity.</p>

<p></p>

<p>Proteins are continually
synthesized and destroyed in the cell. These include normal proteins (self) and
microbial pathogens (nonself). The MHC proteins act as “signposts” that serve
to alert the immune system if foreign material is present inside a cell. They
achieve this by displaying fragmented pieces, or <i>antigens</i><span>,</span> on the host cell’s surface. These
antigens may be <i>self</i> or <i>nonself</i>. (The protein fragment is
sometimes compared to a hot dog, and the MHC protein to the bun.) The
presentation of MHC/peptide on cell surfaces allows for pathogen surveillance
by immune cells, usually T cells or natural killer (NK) cells. If T cells or NK
cells recognize an MHC/peptide combination, the cells become activated and
launch an immune response against the presented antigen. </p>

<p></p>

<p>Because MHC genes must
defend against a great variety of microbes in the environment, the MHC
molecules (coded for by the MHC genes) must be able to present a wide range of
peptides. MHC genes achieve this through several mechanisms: (1) the MHC locus
is polygenic, (2) MHC genes are highly polymorphic and numerous alleles exist,
and (3) several MHC genes are codominantly expressed.</p>

<p></p>

<p>There are two general
classes of MHC molecules: Class I and Class II. Class I MHC molecules are found
on all nucleated cells and present peptides to cytotoxic T cells. Class II MHC
molecules are found on certain immune cells, chiefly macrophages, B cells and
dendritic cells, collectively known as professional antigen-presenting cells
(APCs). These APCs specialize in the uptake of pathogens and subsequent
processing into peptide fragments within phagosomes. The Class II MHC molecules
on APCs present these fragments to helper T cells, which stimulate an immune
reaction from other cells.</p>

<p></p>

<p><span>There are
two classical pathways by which proteins can be processed and displayed.</span></p>

<p><span></span></p>

<p><span><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>Phagocytic cells such as
macrophages and immature dendritic cells engulf pathogens in a process known as
phagocytosis. Pathogen-containing endosomes then fuse with lysosomes and
mediate their destruction. Degraded particles are then loaded onto MHC Class II
molecules and trafficked to the cell surface. </span></p>

<p><span><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span>All nucleated cells can
also present cytosolic peptides on their class I MHC. This pathway is
particularly important during infection by a bacterium or virus, or if the cell
is cancerous. In a normal cell, class I MHC continually present self-peptides
derived from basal protein turnover and defective ribosomal products. However,
during a viral infection or tumor development, peptides loaded onto class I MHC
will include those of processed pathogens degraded in the proteasome.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer B is correct</span></b><span>. Class II MHC molecules
are found on certain immune cells, chiefly macrophages, B cells, and dendritic
cells, collectively known as professional antigen-presenting cells (APCs).
These APCs specialize in the uptake of pathogens and subsequent processing into
peptide fragments within phagosomes. The Class II MHC molecules on APCs present
these fragments to helper T cells (CD4+ lymphocytes).</span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect.<span>&nbsp; </span></span></b><span>CD28 is a molecule on the surface of T cells
that recognizes B7-1 (CD80) and B7-2 (CD86) on professional antigen presenting
cells.<span >&nbsp; </span>This interaction is the
“second” signal required for T cell activation.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect.</span></b><span><span>&nbsp; </span>Fc receptors are expressed on a wide
range of cells and serve to recognize the Fc portion of an immunoglobulin
molecule.<span >&nbsp; </span>Thus, Fc receptors for
IgG are designated Fc&#61543; and so on.<span >&nbsp;
</span>These receptors facilitate the effector function of the different
classes of antibodies.<span >&nbsp; </span>For example,
macrophages and neutrophils express Fc&#61543; receptors and bind to IgG-coated
pathogens to facilitate phagocytosis.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect.</span></b><span><span>&nbsp; </span>The IL-2 receptor on resting T cells is
composed of 2 subunits, alpha and beta.<span >&nbsp;
</span>Following activation of T cells, the &#945; subunit (CD25) is expressed
resulting in a high-affinity receptor for IL-2.<span>&nbsp; </span>IL-2 serves as an autocrine growth
factor to stimulate proliferation of T cells in response to activation signals.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect.</span></b><span><span>&nbsp; </span>Membrane immunoglobulins are integral
proteins on B cell surfaces that bind foreign antigens and are critically
involved in the regulation of the immune response.<span>&nbsp; </span>Naïve B cells express membrane-bound IgM
and IgD.<span >&nbsp; </span>Plasmablasts express high
levels whereas plasma cells express low levels of membrane
immunoglobulins.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Malaria
can be caused by any of four major species of Plasmodium. Which species causes
cerebral malaria? Which species have a dormant phase in the liver? And which
species produces the longest interval between febrile episodes?</span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=23 valign=top>
  <p><span></span></p>
  </td>
  <td width=90 valign=top>
  <p><span>Cerebral
  malaria</span></p>
  </td>
  <td width=153 valign=top>
  <p><span>Dormant
  phase in liver</span></p>
  </td>
  <td width=135 valign=top>
  <p><span>Longest
  interval between febrile episodes</span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span></span></p>
  </td>
  <td width=90 valign=top>
  <p><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><span></span></p>
  </td>
  <td width=135 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>A.</span></p>
  </td>
  <td width=90 valign=top>
  <p><i><span>P.
  falciparum</span></i><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><i><span>P.
  vivax, P. ovale</span></i><span></span></p>
  </td>
  <td width=135 valign=top>
  <p><i><span>P.
  malariae</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>B.</span></p>
  </td>
  <td width=90 valign=top>
  <p><i><span>P.
  malariae</span></i><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><i><span>P.
  falciparum, P. vivax</span></i><span></span></p>
  </td>
  <td width=135 valign=top>
  <p><i><span>P.
  ovale</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>C.</span></p>
  </td>
  <td width=90 valign=top>
  <p><i><span>P.
  ovale</span></i><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><i><span>P. malariae,</span></i><span> <i>P. falciparum</i></span></p>
  </td>
  <td width=135 valign=top>
  <p><i><span>P.
  vivax</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=23 valign=top>
  <p><span>D.</span></p>
  </td>
  <td width=90 valign=top>
  <p><i><span>P.
  vivax</span></i><span></span></p>
  </td>
  <td width=153 valign=top>
  <p><i><span>P.
  ovale, P. malariae</span></i><span></span></p>
  </td>
  <td width=135 valign=top>
  <p><i><span>P.
  falciparum</span></i><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><span><span>&nbsp;</span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Malaria is
caused by parasites of the genus Plasmodium. Four major species can infect
humans: <i>P. falciparum</i><span>, <i>P.
vivax</i></span>, <i>P. ovale</i><span>,</span>
and <i>P. malariae</i><span>. <i>P.
falciparum</i> is the most deadly; <i>P. vivax</i></span>, <i>P.</i> <i>ovale</i> and <i>P. malariae</i> cause milder disease. </span></p>

<p><span></span></p>

<p><span>Symptoms
of malaria include fever, chills, vomiting, anemia (due to intravascular
hemolysis), arthralgias, and seizures. Malaria is characterized by recurrent
episodes of chills and rigors followed by fevers and sweating.<span>&nbsp; </span>These recurrences typically occur every
three days with <i>P. malariae</i><span>, </span>every
two days with <i>P. vivax</i> and <i>P. ovale</i>, and every 36-48 hours with <i>P.
falciparum </i><span>(although</span> a less
pronounced, almost continuous, fever can occur with <i>P. falciparum</i><span>)</span>. </span></p>

<p><span></span></p>

<p>Severe malaria is caused
almost exclusively by <i>P. falciparum</i>. Cerebral ischemia may result in
encephalopathy, stroke, seizure, coma, and death. Young children and pregnant
women are especially vulnerable. Other findings may include splenomegaly,
hepatomegaly, hypoglycemia, hemolytic anemia with hemoglobinuria, and renal
failure. (In “blackwater fever,” hemoglobin from lysed red blood cells darkens
the urine and causes renal failure.) Falciparum malaria can progress rapidly
and cause death within hours or days. The morbidity and mortality of falciparum
malaria are due to the high levels of parasitemia and the adherence of
parasites to erythrocytes. Sticky erythrocytes bind to the endothelium,
clogging the capillaries in the central nervous system and elsewhere. </p>

<p></p>

<p>Infection with <i>P. vivax</i>
and <i>P. ovale</i> (but not <i>P. falciparum</i><span>) can cause chronic malaria. (Parasites r</span>emain dormant in the
liver for months or years, then re-emerge in the blood, causing disease.)<span>&nbsp; </span></p>

<p></p>

<p><span>Malaria
develops in two phases: exoerythrocytic and erythrocytic. During a mosquito
bite, sporozoites enter the blood and migrate to the liver, where they infect
hepatocytes and multiply into merozoites (exoerythrocytic phase). The
merozoites then escape into the blood, where they infect red blood cells and
develop into ring forms (erythrocytic phase).<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span>The
diagnosis of malaria is usually made by detecting ring forms of the parasite in
blood smears.</span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=243 height=179
src="_%20Tutorials_files/image222.png" alt="Description: Malaria1" v:shapes="Picture_x0020_347216"></span><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct. </span></b><span>Severe malaria,
including cerebral malaria, is caused almost exclusively by <i>P. falciparum</i>.
Cerebral ischemia may result in encephalopathy, stroke, seizure, coma, and
death. <i>P. vivax</i> and <i>P. ovale</i><span> are the only species that have a dormant phase in the liver. Patients
infected with these organisms may be asymptomatic for months or years, and then
become ill when the parasites leave the liver and enter the blood. <i>P. vivax</i></span>
and <i>P. ovale</i><span> are the only
species of <i>Plasmodium</i> associated with relapse, which can occur even in
people who were adequately treated for malaria initially. On average, infection
with <i>P. malariae</i></span> is associated with the longest interval between <span>febrile episodes &#8211; three days. </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>An 18-year-old man is brought to the
emergency department because of fever, a poorly localized headache, and a stiff
neck for 12 hours. The symptoms were preceded by nasal congestion, muscle
aches, and chills 3 days ago. His temperature is 38.7°C (101.6°F). Physical
examination shows nuchal rigidity and photophobia. There is no papilledema.
Neurologic examination shows no focal findings. Which of the following is the
most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Acute
meningitis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cluster
headache</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Idiopathic
intracranial hypertension</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Migraine</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Subarachnoid
hemorrhage</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Temporal
arteritis</span></p>

<p><span><span>G.<span>&nbsp;&nbsp; </span></span></span><span>Tension-type headache<span></span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Meningitis</span> is inflammation of the protective membranes covering
the brain and spinal cord, known collectively as the meninges. The inflammation
is usually caused by microbial infection and less commonly by certain drugs.
Meningitis can be life-threatening because of the inflammation’s proximity to
the brain and spinal cord; therefore the condition is classified as a medical
emergency.</p>

<p><span>&nbsp;</span></p>

<p>The most common symptoms of
meningitis are headache and neck stiffness associated with fever, confusion or
altered consciousness, vomiting, and an inability to tolerate light
(photophobia) or loud noises (phonophobia). Sometimes, especially in small
children, only nonspecific symptoms may be present, such as irritability and
drowsiness. If a rash is present, it may indicate a particular cause of
meningitis; for instance, meningitis caused by meningococcal bacteria may be
accompanied by a characteristic rash.</p>

<p><span>&nbsp;</span></p>

<p>A lumbar puncture may be
used to diagnose or exclude meningitis. This involves inserting a needle into
the spinal canal to extract a sample of cerebrospinal fluid (CSF), the fluid
that envelops the brain and spinal cord. The CSF is then examined in a medical
laboratory. The usual treatment for meningitis is the prompt application of
antibiotics (for bacterial meningitis).</p>

<p></p>

<p>Meningitis can lead to
serious long-term consequences such as deafness, epilepsy, hydrocephalus and
cognitive deficits, especially if not treated quickly. Some forms of meningitis
(such as those associated with meningococci, <i>Haemophilus influenzae</i> type
B, pneumococci or mumps virus infections) may be prevented by immunization. </p>

<p><span></span></p>

<p><span>In adults,
a severe headache is the most common symptom of meningitis &#8211; occurring in
almost 90% of cases of bacterial meningitis, followed by nuchal rigidity
(inability to flex the neck forward passively due to increased neck muscle tone
and stiffness). The classic triad of diagnostic signs consists of nuchal
rigidity, sudden high fever, and altered mental status; however, all three
features are present in less than half of all cases of bacterial meningitis.</span></p>

<p><span></span></p>

<p><span>Nuchal
rigidity occurs in 70% of adult cases of bacterial meningitis. Other signs of
meningism include the presence of positive Kernig sign or Brudzinski sign.
Kernig sign is assessed with the patient lying supine, with the hip and knee flexed
to 90 degrees. In a patient with a positive Kernig sign, pain limits passive
extension of the knee. A positive Brudzinski's sign occurs when flexion of the
neck causes involuntary flexion of the knee and hip. Although Kernig and
Brudzinski signs are both commonly used to screen for meningitis, the
sensitivity of these tests is limited. They do, however, have very good
specificity for meningitis: the signs rarely occur in other diseases.</span></p>

<p><span></span></p>

<p><span>Meningitis
caused by the bacterium <i>Neisseria meningitidis</i> (known as “meningococcal
meningitis”) can be differentiated from meningitis with other causes by a
rapidly spreading petechial rash which may precede other symptoms. The rash
consists of numerous small, irregular purple or red spots (“petechiae”) on the
trunk, lower extremities, mucous membranes, conjuctiva, and (occasionally) the
palms of the hands or soles of the feet. The rash is typically non-blanching:
the redness does not disappear when pressed with a finger or a glass tumbler.
Although this rash is not necessarily present in meningococcal meningitis, it
is relatively specific for the disease.</span></p>

<p></p>

<p>The types of bacteria that
cause bacterial meningitis vary by age group. In premature babies and newborns
up to three months old, common causes are <i>group B streptococci</i> (which
normally inhabit the vagina and are mainly a cause during the first week of
life) and those that normally inhabit the digestive tract such as <i>Escherichia
coli</i> (carrying K1 antigen). <i>Listeria monocytogenes</i> may affect the
newborn and occurs in epidemics. Older children are more commonly affected by <i>Neisseria
meningitidis</i> (meningococcus), <i>Streptococcus pneumoniae</i> (serotypes 6,
9, 14, 18 and 23) and those under five by <i>Haemophilus influenzae</i> type B
(mainly in countries that do not offer vaccination). In adults, <i>N.
meningitidis</i> and <i>S. pneumoniae</i> together cause 80% of all cases of
bacterial meningitis, with increased risk of <i>L. monocytogenes</i> in those
over 50 years old. Since the pneumococcal vaccine was introduced, however,
rates of pneumococcal meningitis have declined in children and adults. </p>

<p></p>

<p>Recent trauma to the skull
gives bacteria in the nasal cavity the potential to enter the meningeal space.
Similarly, individuals with a cerebral shunt or related device are at increased
risk of infection through those devices. In these cases, infections with
staphylococci are more likely, as well as infections by pseudomonas and other
Gram-negative bacilli. The same pathogens are also more common in those with an
impaired immune system. In some people, an infection in the head and neck area,
such as otitis media or mastoiditis, can lead to meningitis. Tuberculous
meningitis, meningitis due to infection with <i>Mycobacterium tuberculosis</i>,
is more common in those from countries where tuberculosis is common, but is
also encountered in those with immune problems, such as AIDS. </p>

<p></p>

<p>A literature review of 363
reported cases of <i>recurrent</i>
meningitis showed that 59% of cases are due to anatomical abnormalities, 36%
due to immune deficiencies (such as complement deficiency, which predisposes
especially to recurrent meningococcal meningitis), and 5% due to ongoing
infections in areas adjacent to the meninges.</p>

<p></p>

<p>The term <i>aseptic
meningitis</i> refers loosely to all cases of meningitis in which no bacterial
infection can be demonstrated. This is usually due to viruses, but it may be
due to bacterial infection that has already been partially treated, with
disappearance of the bacteria from the meninges, or by infection in a space
adjacent to the meninges (e.g. sinusitis). Endocarditis (infection of the heart
valves with spread of small clusters of bacteria through the bloodstream) may
cause aseptic meningitis. Aseptic meningitis may also result from infection
with spirochetes, a type of bacteria that includes <i>Treponema pallidum</i>
(the cause of syphilis) and <i>Borrelia burgdorferi</i> (known for causing Lyme
disease). Meningitis may be encountered in cerebral malaria (malaria infecting
the brain). Fungal meningitis, e.g. due to <i>Cryptococcus neoformans</i>, is
typically seen in people with immune deficiency such as AIDS.</p>

<p></p>

<p>Meningitis may occur as the
result of several non-infectious causes: spread of cancer to the meninges (<i>malignant
meningitis</i>) and certain drugs (mainly non-steroidal anti-inflammatory drugs
and antibiotics). It may also be caused by several inflammatory conditions such
as sarcoidosis (which is then called neurosarcoidosis), connective tissue
disorders such as systemic lupus erythematosus, and certain forms of vasculitis
such as Behçet's disease. </p>

<p>The most important test in
identifying or ruling out meningitis is analysis of the cerebrospinal fluid
through lumbar puncture (LP, spinal tap). However, lumbar puncture is
contraindicated if there is a mass in the brain or the intracranial pressure
(ICP) is elevated, as it may lead to brain herniation. If someone is at risk
for either a mass or raised ICP (recent head injury, a known immune system
problem, localizing neurological signs, or evidence on examination of a raised
ICP), a CT or MRI scan is recommended prior to the lumbar puncture. If a CT or
MRI is required before LP, or if LP proves difficult, professional guidelines
suggest that antibiotics should be administered first to prevent delay in
treatment, especially if this may be longer than 30&nbsp;minutes.</p>

<p></p>

<div align=center>

<table border=1 cellpadding=0>
 <tr>
  <td width=390 colspan=4>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><b><span>CSF Findings in
  Meningitis</span></b></p>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=390 colspan=4>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><b><span>Type of </span></b></p>
  <p style="text-align:center;"><b><span>meningitis</span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><b><span>Glucose</span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><b><span>Protein</span></b></p>
  </td>
  <td width=170>
  <p style="text-align:center;"><b><span>Cells</span></b></p>
  </td>
 </tr>
 <tr>
  <td>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
  <td width=170>
  <p style="text-align:center;"><b><span></span></b></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><b><span>Acute
  bacterial</span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><span>low</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>high</span></p>
  </td>
  <td width=170>
  <p><span>Neutrophils
  predominate; </span></p>
  <p><span>WBCs
  &gt; 500/mm&sup3;</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><b><span>Acute
  viral</span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><span>normal</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>normal or high</span></p>
  </td>
  <td width=170>
  <p><span>Lymphocytes
  predominate;</span></p>
  <p><span>WBCs
  &lt; 100/mm&sup3;</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><b><span>Tuberculous</span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><span>low</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>high</span></p>
  </td>
  <td width=170>
  <p><span>Lymphocytes
  predominate;</span></p>
  <p><span>WBC
  count variable</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><b><span>Fungal</span></b></p>
  </td>
  <td>
  <p style="text-align:center;"><span>low</span></p>
  </td>
  <td>
  <p style="text-align:center;"><span>high</span></p>
  </td>
  <td width=170>
  <p><span>Lymphocytes
  predominate;</span></p>
  <p><span>WBC
  count variable</span></p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b>Answer A is correct. </b>Fever, headache, stiff neck, and photophobia
suggest a diagnosis of acute meningitis.</p>

<p></p>

<p><b>Answer B is incorrect. </b>Cluster headaches are excruciating
unilateral headaches of extreme intensity. The duration of the common attack
ranges from as short as 15 minutes to three hours or more. The onset of an
attack is rapid, and most often without the preliminary signs that are
characteristic of a migraine. Cluster headaches occur periodically: spontaneous
remissions interrupt active periods of pain. The pain may be very sharp and may
cause pain around the eye area and may also be a pain within the back of the
eye.</p>

<p></p>

<p><b>Answer C is incorrect. </b><span>Idiopathic
intracranial hypertension</span>, also called <span>pseudotumor cerebri</span>, is a neurological disorder characterized by
increased intracranial pressure in the absence of a tumor or other diseases.
The main symptoms are headache, nausea and vomiting, as well as pulsatile
tinnitus, double vision, and other visual symptoms. If untreated, it may lead
to swelling of the optic disc in the eye (papilledema), which can progress to
vision loss. Fever and nuchal rigidity are not typical.<span>&nbsp; </span></p>

<p></p>

<p><b>Answer D is incorrect. </b>The typical migraine headache is unilateral
and pulsating and lasts from two to 72 hours. Symptoms include nausea,
vomiting, photophobia (increased sensitivity to light) and phonophobia (increased
sensitivity to sound). Approximately one-third of people who suffer from
migraine headaches perceive an aura &#8211; transient visual, sensory,
language, or motor disturbances signaling the migraine will soon occur. Fever
and nuchal rigidity are not typical of migraine. </p>

<p></p>

<p><b>Answer E is incorrect. </b>A <span>subarachnoid
hemorrhage</span><a
href="http://en.wikipedia.org/wiki/Wikipedia:IPA_for_English#Key"
title="Wikipedia:IPA for English"></a> is bleeding into the subarachnoid
space&#8212;the area between the arachnoid membrane and the pia mater
surrounding the brain. This may occur spontaneously, usually from a ruptured
cerebral aneurysm, or may result from head injury. Symptoms of SAH include a
severe headache with a rapid onset (“thunderclap headache”), vomiting,
confusion or a lowered level of consciousness, and sometimes seizures. The
diagnosis is generally confirmed with a CT scan of the head, or occasionally by
lumbar puncture.</p>

<p></p>

<p><b>Answer F is incorrect.</b> <span>Giant-cell
arteritis</span> is an inflammatory disease of blood vessels most commonly
involving large and medium arteries of the head. It is a form of vasculitis.
The name giant cell arteritis reflects the type of inflammatory cell involved
as seen on a biopsy. The terms “giant-cell arteritis” and “temporal arteritis”
are sometimes used interchangeably, because of the frequent involvement of the
temporal artery. However, it can involve other large vessels (such as the
aorta). The disease typically affects older people. Symptoms include fever,
malaise, headache, scalp tenderness, jaw claudication, tongue claudication, and
visual changes. Diagnosis is made by temporal artery biopsy. Corticosteroids
are the mainstay of treatment.<span >&nbsp; </span></p>

<p></p>

<p><b>Answer G is incorrect. </b>A <span>tension
headache</span> is the most common type of primary headache. The pain can
radiate from the neck, back, eyes, or other muscle groups in the body. It is
often described as a constant pressure, as if the head were being squeezed in a
vise, and it is frequently bilateral and typically mild to moderate in severity.
Fever and nuchal rigidity are not characteristic of trension-type headache. </p>

<p><span>An
18-year-old man presents to his physician with fever, headache, and malaise.
Physical examination shows exudative pharyngitis, cervical lymphadenopathy, and
hepatosplenomegaly.<span >&nbsp; </span>The white blood
cell (WBC) count is 13,000/mm<sup>3</sup> with 60% lymphocytes. Atypical
lymphocytes are seen on peripheral blood smear. The heterophile antibody test
is positive. Which organism is the most likely cause of this condition?<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Epstein-Barr
virus</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cytomegalovirus</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Toxoplasma
gondii</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>HIV<span>&nbsp; </span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Streptococcus,
group A</span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=231 height=176
src="_%20Tutorials_files/image224.png"
alt="Description: http://nmagz.files.wordpress.com/2009/09/190px-tonsillitis.jpg"
v:shapes="Picture_x0020_347215"></span><span></span></p>

<p style="text-align:center;"><span>Exudate on the tonsils</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=232 height=175
src="_%20Tutorials_files/image226.png"
alt="Description: http://farm1.static.flickr.com/56/145052719_6d46149085.jpg"
v:shapes="Picture_x0020_347214"></span><span></span></p>

<p style="text-align:center;"><span>Blood smear with atypical lymphocytes</span></p>

<p style="text-align:center;"><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Lymphocytosis
can be reactive or malignant. Reactive lymphocytosis is usually caused by viral
infection. The lymphocytes may be normal or “atypical.” Normal lymphocytes have
a large, dark-staining nucleus with scant cytoplasm. The nucleus is about the
size of a red blood. </span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=224 height=154
src="_%20Tutorials_files/image228.png"
alt="Description: http://upload.wikimedia.org/wikipedia/commons/1/17/Lymphocyte2.jpg"
v:shapes="Picture_x0020_347213"></span><span></span></p>

<p style="text-align:center;"><span>Normal lymphocyte</span></p>

<p style="text-align:center;"><span></span></p>

<p><span>“Atypical”
lymphocytes are larger and have abundant basophilic cytoplasm and a large
irregularly-shaped nucleus. They resemble monocytes, hence the term
“mononucleosis.”</span></p>

<p><span><span>&nbsp;</span></span></p>

<p style="text-align:center;"><span><img border=0 width=215 height=164
src="_%20Tutorials_files/image230.png" alt="Description: atypical lymphocyte"
v:shapes="Picture_x0020_347212"></span><span></span></p>

<p style="text-align:center;"><span>Atypical lymphocyte</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p><span>Several
infectious agents cause a “mononucleosis-like” pattern on peripheral blood
smear. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span>Mononucleosis-like Syndromes</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span>Epstein-Barr Virus</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span>Cytomegalovirus</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span>Toxoplasmosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=217 valign=top>
  <p style="text-align:center;"><span>HIV</span></p>
  </td>
 </tr>
</table>

</div>

<p><b><span>Answer A is correct</span></b><span>. The prototype of a
mononucleosis syndrome is infectious mononucleosis, caused by the Epstein-Barr
virus. (The Epstein-Barr virus infects B lymphocytes.) Infectious mononucleosis
is characterized by fever, malaise, and sore throat. Physical examination may
show exudative pharyngitis, cervical lymphadenopathy, and hepatosplenomegaly.
The white blood cell (WBC) count is usually elevated with a preponderance of
atypical lymphocytes. A positive heterophile antibody test is specific for the
disease. </span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Cytomegalovirus (CMV)
infection is usually asymptomatic in immunocompetent hosts. Cervical
lymphadenopathy and exudative pharyngitis are rare. In immunocompromised hosts,
CMV can cause retinitis, hepatitis, and colitis. Congenital CMV is associated
with low birth weight, microcephaly, seizures, hepatosplenomegaly, and a
petechial rash similar to the &quot;blueberry muffin&quot; rash of congenital
rubella syndrome. </span></p>

<p><span></span></p>

<p><b><span>Answer C is incorrect</span></b><span>. The protozoan, <i>Toxoplasma gondii</i>, is transmitted by
ingesting undercooked meat or food contaminated by cat feces. Toxoplasmosis is
usually asymptomatic in immunocompetent hosts. In immunocompromised
individuals, it can present as a brain lesion with focal neurological deficits.</span></p>

<p><span></span></p>

<p><b><span>Answer D is incorrect</span></b><span>. Two to four weeks after
exposure the HIV, patients often develop a flu-like illness characterized by fever,
malaise, sore throat, lymphadenopathy, and rash. The symptoms usually subside
within fourteen days. The diagnosis of acute HIV infection is based on a
positive HIV-1 RNA test and a negative HIV antibody test (by enzyme-linked
immunosorbent antibody assay (ELISA) and Western blot analysis). (The ELISA and
Western blot tests are negative because the host has not yet developed
antibodies to the virus.)</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Group A beta-hemolytic
streptococcus causes pharyngitis (“strep throat”). As in infectious
mononucleosis, patients usually have fever, cervical lymphadenopathy, and
exudative pharyngitis. Unlike the Epstein-Barr virus, however, Group A
Streptococcus does not cause hepatosplenomegaly. Also, the heterophile antibody
test would be negative in Group A streptococcal infection. Throat culture is
the gold standard for diagnosing “strep throat.” </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>After
infection with the measles virus, an 8-year old boy produces antibodies to all
eight viral proteins. The next year he is again exposed to the measles virus.
Antibodies to which of the following viral proteins are most likely to be
protective?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Nucleocapsid</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Polymerase</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Matrix</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Hemagglutinin</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Nonstructural
</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=326 height=245
src="_%20Tutorials_files/image232.png" alt="Description: 5769426" v:shapes="Picture_x0020_347211"></span><span></span></p>

<p><span></span></p>

<p>Paramyxoviruses include the <span>measles,</span> mumps, <span>parainfluenza,</span> and <span>respiratory syncytial (RSV) viruses.</span>
These viruses are transmitted in respiratory droplets and initiate infection in
the respiratory tract. The measles virus causes a generalized infection
characterized by a maculopapular rash <span>(rubeola)</span>.
Parainfluenza virus causes upper and lower respiratory tract infection,
primarily in children, including pharyngitis, croup, bronchitis, bronchiolitis,
and pneumonia. The mumps virus causes a systemic infection whose most prominent
manifestation is parotitis. RSV causes mild upper respiratory tract infections
in children and adults, but can cause life-threatening pneumonia in infants.</p>

<p></p>

<p><span>The
paramyxoviruses have similar morphologies. They consist of a negative-sense, <span>single-stranded ribonucleic acid (RNA)</span>
molecule in a helical nucleocapsid surrounded by an <span>envelope</span>. The envelope contains a viral attachment protein. For
the measles virus, the attachment protein is hemagglutinin (H). For the mumps
and parainfluenza viruses, the attachment protein is
hemagglutinin-neuraminidase (HN). For the respiratory syncytial virus, the
attachment protein is glycoprotein (G). In addition to having an attachment
protein, the envelope of each of these viruses contains a fusion protein (F). </span></p>

<p><span></span></p>

<p>Replication of the
paramyxoviruses begins with the binding of H, HN, or G proteins to sialic acid
residues on the host cell surface. This allows the virus to fuse with the
plasma membrane and penetrate the cell. The RNA then replicates in the
cytoplasm, and the virion exits the cell by budding from the plasma membrane.
The measles and mumps virus have only <span>one
serotype. The use of l</span>ive attenuated vaccines has made these conditions
rare in developed countries.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer D is correct</span></b><span>. Each of the
paramyxoviruses has a viral attachment protein in its envelope. For the measles
virus, the attachment protein is hemagglutinin. Antibodies to hemagglutinin
would protect the host from infection. </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Eight
weeks after a renal transplant, a patient develops fever and leukopenia,
followed by prostration and severe pulmonary and hepatic dysfunction. Which of
the following is the most likely viral cause? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Parvovirus
B19</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Influenza
virus</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cytomegalovirus</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Coxsackie
virus</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Adenovirus
type 12</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Lifelong
immunosuppression is generally necessary for all recipients of solid organ
transplants. As a result, infection is the primary cause of mortality after
transplantation. Two-thirds of transplant patients have at least one
significant infection. Signs of <span are
often blunted by an impaired inflammatory response. Feverishness or mild,
non-specific symptoms may herald a severe <span management usually translates into increased patient survival and
graft function.</span></p>

<p><span></span></p>

<p>The timing of post-transplant
<span can be separated into three periods.</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>&lt;1 month</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>1-6 months</p>

<p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span>&gt;6 months </p>

<p><i><span></span></i></p>

<p><i><span>First Month after Transplant </span></i></p>

<p><i><span></span></i></p>

<p><span>These
infections are likely to be related to the transplant procedure, catheters, or
intubation, although “standard” infections may also occur. Nosocomial pathogens
are especially prominent. </span></p>

<p><a name=4-u1.0-B978-0-323-05472-0..00182-1--s003></a><i><span></span></i></p>

<p><i><span>Months 1 through 6<span>&nbsp; </span></span></i></p>

<p><i><span></span></i></p>

<p><span>These
infections are divided into two general types: immunomodulating viral
infections and opportunistic infections. Immunomodulating viruses include
cytomegalovirus (CMV), hepatitis B and C, BK polyomavirus, human herpesvirus 6,
and Epstein-Barr virus (EBV). Opportunistic infections include <i>Pneumocystis</i>,
<i>Listeria</i>, and fungal species.</span></p>

<p><span></span></p>

<p><span>CMV is the
most important and prevalent viral pathogen after transplantation. It can
infect many systems and cause severe pneumonitis, hepatitis, GI inflammation,
and leukopenia. CMV infection may be primary or secondary due to reactivation
of latent virus in lymphocytes. Although survival has improved with earlier
diagnosis (bronchoscopy) and early treatment (gangcyclovir and CMV-specific
immunoglobulin), CMV infection is often fatal. </span></p>

<p><span></span></p>

<p><span>EBV can
also infect transplant recipients. It causes a mononucleosis-like syndrome,
associated with lymphadenopathy, weakness, and low-grade fever. EBV is also
associated with B-cell lymphoproliferative disease<a
name=4-u1.0-B978-0-323-05472-0..00182-1--s004></a><a
name=4-u1.0-B978-0-323-05472-0..00182-1--st00></a>.</span></p>

<p><span></span></p>

<p><i><span></span></i></p>

<p><i><span>After 6 Months</span></i></p>

<p><i><span></span></i></p>

<p><span>Six months
after transplant, patients receiving immunosuppressive therapy are divided into
three groups relative to infection susceptibility: healthy transplant, chronic
rejection, and chronic (and typically progressive) viral infection. The latter
group includes infection with CMV, EBV, varicella, herpes simplex, or viral
hepatitis.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span>Answer C is correct. </span></b><span>CMV is the most
important and prevalent viral pathogen after transplantation. It can infect
many systems and cause severe pneumonitis, hepatitis, GI inflammation, and
leukopenia.</span></p>

<p><span></span></p>

<p><span>CMV is a
member of the Human Herpesvirus family and is a double-stranded enveloped virus
with icosahedral symmetry.<span >&nbsp; </span>The
virus attaches to C3 receptors on B cells and after entering the cell, it
replicates its genome and matures in the nucleus.<span>&nbsp; </span>After the primary infection, the virus
may remain latent in WBCs for an indefinite period of time.<span>&nbsp; </span>Transplant patients can acquire CMV from
donor tissues or lymphocytes or from an endogenous reactivation.<span>&nbsp; </span>CMV prophylaxis is essential in
transplant patients.</span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 27-year-old man with AIDS is brought to
the hospital 30 minutes after having a seizure. He currently takes no
medications. A CT scan of the head shows multiple ring-enhancing lesions. Which
of the following is the most likely diagnosis?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Amoebiasis</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Cysticercosis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Echinococcosis</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Schistosomiasis</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Toxoplasmosis</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Trichinosis</span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span><img border=0 width=332 height=313
src="_%20Tutorials_files/image234.png" alt="Description: F2" v:shapes="Picture_x0020_347210"></span><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>A <span>ring-enhancing lesion</span> is an abnormal
finding on CT scan obtained using radiocontrast. On the image there is an area
of decreased radiodensity surrounded by a bright rim from concentration of the
enhancing contrast dye. </span></p>

<p><span></span></p>

<p><b><span>Multiple ring-enhancing lesions</span></b><span> of the brain can be
caused by a variety of infectious, neoplastic, inflammatory, or vascular
diseases. Although newer imaging techniques are useful in making a diagnosis,
early brain biopsy is often needed because several of these diseases are
potentially life-threatening.The differential diagnosis of multiple
ring-enhancing lesions depends on the age and the immune status of the patient.
In the immunocompetent host, malignancies (both primary and metastatic) and
pyogenic abscesses remain the most likely diagnoses in patients with
large-sized lesions. Primary and metastatic tumors, on imaging, often manifest
as rounded, well-circumscribed, ring-enhancing lesions of variable sizes
surrounded by a variable amount of edema. Metastatic tumors are the most common
intracranial neoplasm in adults. Lung cancer, breast cancer and melanoma
account for the majority of patients with metastasis in the brain. Pyogenic
brain abscesses are often caused by hematogenous spread of bacteria from a
primary source. The likely sources of primary infection include cyanotic heart
disease, endocarditis, suppurative lung diseases, skin infection, and abdominal
and pelvic infections.</span></p>

<p><span></span></p>

<p><span>Abscesses caused by
atypical microorganisms and demyelinating disease should also be considered in
the differential diagnosis of multiple enhancing lesions of the brain. In
tropical countries, cysticercus granuloma frequently needs to be differentiated
from intracranial tuberculoma. Cysticercosis is an infection by a parasite, <i>Taenia
solium</i> (a pork tapeworm) that creates cysts in different areas in the body.
The organism is acquired by eating undercooked meat that contain the larvae or
by ingesting eggs from contaminated food and water.<span><span>&nbsp; </span></span>The term “neurocysticercosis” is
used when cysts appear in the brain parenchyma. Neurocysticercosis is the most
common parasitic disease of the CNS and is a major cause of seizures worldwide.
Tuberculomas are frequently encountered brain lesions in tropical countries.
Intracranial tuberculoma can occur with or without tuberculous meningitis.</span></p>

<p><span></span></p>

<p><span>In
HIV-infected patients, the leading causes of multiple enhancing lesions are
toxoplasmosis and primary CNS lymphoma. Toxoplasmosis is a common cause of
multiple intracranial mass lesions in patients with acquired immunodeficiency
syndrome (AIDS). <i>Toxoplasma gondii </i>is
the etiologic agent and is acquire by ingestion of oocysts from cat feces or
tissue cysts from undercooked meat.<span >&nbsp;
</span>It is also one of the TORCH infections, which are transmitted
transplacentally.<span><span >&nbsp;
</span></span>It occurs in 3-10% of patients with AIDS in the United States and
in up to 50% of the patients in Europe and Africa. For an immunosuppressed
patient who presents with focal neurologic signs and multiple ring-enhancing
lesions of the brain on imaging, cerebral toxoplasmosis would be the most
likely diagnosis, and current guidelines suggest that all such patients be
treated with antitoxoplasma treatment. Combination of pyrimethamine/sulfadiazine
and folinic acid is considered the standard regime for the treatment of
cerebral toxoplasmosis. After approximately two weeks of treatment, a decrease
in the number and size of lesions with reduction in edema should be observed. A
lack of response to such therapy should alert the clinician about the
possibility of other conditions such as CNS lymphoma or progressive multifocal
leukoencephalopathy. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct</span></b><span>. Toxoplasmosis would be
the most likely cause of multiple ring-enhancing lesions in the brain of a
patient with AIDS. </span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>A 26-year-old man with multiple sexual
partners has a painful ulcer on his penis. Physical examination shows a 1-cm
ulcer with no induration on the frenulum. Tender lymphadenopathy is noted in
the right inguinal region. A culture of the ulcer grows colonies on
supplemented chocolate agar. A Gram stain of the colonies shows gram-negative
coccobacilli. Which of the following organisms is the most likely cause of
disease?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><i><span>Treponema pallidum</span></i><span></span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Herpes
simplex virus</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>Neisseria gonorrhoeae</span></i><span></span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><i><span>Trichomonas vaginalis</span></i><span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><i><span>Haemophilus ducreyi</span></i><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A useful
clinical approach to evaluating sexually transmitted diseases (STDs) is based
on the pattern of presenting symptoms. Four basic patterns exist: genital
discharge syndromes, genital ulcer syndromes, pelvic inflammatory disease, and
dermatologic syndromes. </span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=154 valign=top>
  <p style="text-align:center;"><span>STD Patterns</span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span>Genital
  discharge syndromes</span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span>Genital
  ulcer syndromes</span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span>Pelvic
  inflammatory disease</span></p>
  </td>
 </tr>
 <tr>
  <td width=154 valign=top>
  <p><span>Dermatologic
  syndromes</span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><b><span>Genital
discharge syndromes.</span></b><span>&nbsp;Discharge
syndromes can be further divided into those causing urethritis/cervicitis and
those causing vaginitis. </span></p>

<p><span></span></p>

<p><span>The
principal causes of urethritis and cervicitis are <i>Neisseria gonorrhoeae</i>
and <i>Chlamydia trachomatis</i>. Concurrent infection with these organisms
often occurs. Their clinical manifestations are similar and patients are often
treated presumptively for both organisms. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=479 colspan=3 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>STDs Causing Genital Discharge</span></p>
  <p style="text-align:center;"><i><span></span></i></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><i><span></span></i></p>
  <p style="text-align:center;"><i><span>Neisseria gonorrhoeae</span></i></p>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><i><span></span></i></p>
  <p style="text-align:center;"><i><span>Chlamydia trachomatis</span></i><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Gram
  Stain</span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>Gram-negative diplococci</span></p>
  <p style="text-align:center;"><span></span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>---</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Incubation
  period</span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>2-30 days</span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>1-3 weeks</span></p>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Manifestations</span></p>
  </td>
  <td width=319 colspan=2 valign=top>
  <p><span></span></p>
  <p><span>Urethritis,
  cervicitis, epididymitis, prostatitis, orchitis, conjunctivitis, pharyngitis,
  proctitis, pelvic inflammatory </span></p>
  <p><span>disease,
  and perihepatitis (Fitz-Hugh&#8211;Curtis syndrome)</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Symptoms</span></p>
  </td>
  <td width=319 colspan=2 valign=top>
  <p><span></span></p>
  <p><span>Men:
  Dysuria, penile discharge, scrotal pain</span></p>
  <p><span></span></p>
  <p><span>Female:
  May be asymptomatic; symptoms may include dysuria, vaginal discharge, pelvic
  pain, abnormal vaginal bleeding</span></p>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Special
  features</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Disseminated
  gonococcal infection<sup>1</sup>: </span></p>
  <p><span>1)
  arthritis-dermatitis syndrome </span></p>
  <p><span>2)
  septic arthritis</span></p>
  <p><span>3)
  endocarditis, myocarditis meningitis</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>Diagnosis</span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>1) Gram
  stain</span></p>
  <p><span>2)
  Culture</span></p>
  <p><span>3)
  Nucleic acid amplification tests</span></p>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  <p><span>1) Cell
  culture</span></p>
  <p><span>2)
  Nucleic acid amplification tests </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><a name=4-u1.0-B978-0-323-05472-0..00096-7--f005></a><sup><span>1</span></sup><span>Disseminated gonococcal
infection (DGI) results from gonococcal bacteremia. The principal manifestation
is the arthritis-dermatitis syndrome, characterized by fever, chills,
monoarticular or oligoarticular arthritis, non-itchy rash, and tenosynovitis.
The rash consists of tender, hemorrhagic pustules on an erythematous base,
usually on the distal extremities. The second most common manifestation is
septic arthritis, which presents as an acute monoarticular or oligoarticular
arthritis. The knees are most commonly involved. The affected joint is warm,
erythematous, swollen, and tender. DGI can also cause endocarditis,
myocarditis, and meningitis.</span></p>

<p><span>The principal conditions
associated with vaginitis are listed below.<span>&nbsp; </span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td colspan=5>
   <p style="text-align:center;"><span></span></p>
   <p style="text-align:center;"><span>Vaginitis</span></p>
   <p style="text-align:center;"><span></span></p>
   </td>
  </tr>
  <tr>
   <td>
   <p style="text-align:center;"><span>Condition</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Vaginal</span></p>
   <p style="text-align:center;"><span>pH</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Discharge </span></p>
   <p style="text-align:center;"><span>Appearance</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Wet mount</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Treatment</span></p>
   </td>
  </tr>
  <tr>
   <td>
   <p style="text-align:center;"><span></span></p>
   </td>
   <td>
   <p style="text-align:center;"><span></span></p>
   </td>
   <td>
   <p style="text-align:center;"><span></span></p>
   </td>
   <td>
   <p style="text-align:center;"><span></span></p>
   </td>
   <td>
   <p style="text-align:center;"><span></span></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td>
  <p><span>Bacterial*
  vaginosis</span></p>
  </td>
  <td>
  <p><span>&gt;4.5</span></p>
  </td>
  <td>
  <p><span>Gray,
  white, milky/creamy; amine odor present</span></p>
  </td>
  <td>
  <p><span>Clue
  cells** </span></p>
  </td>
  <td>
  <p><span>Metronidazole</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><i><span>Trichomonas</span></i><span> infection</span></p>
  </td>
  <td>
  <p><span>&gt;4.5</span></p>
  </td>
  <td>
  <p><span>Gray,
  yellow, greenish, or white; often frothy; homogeneous</span></p>
  </td>
  <td>
  <p><span>Trichomonads
  </span></p>
  </td>
  <td>
  <p><span>Metronidazole</span></p>
  </td>
 </tr>
 <tr>
  <td>
  <p><i><span>Candida</span></i><span>***<i> </i>infection</span></p>
  </td>
  <td>
  <p><span>&lt;4.5</span></p>
  </td>
  <td>
  <p><span>White,
  often curdy</span></p>
  </td>
  <td>
  <p><span>Mycelia </span></p>
  </td>
  <td>
  <p><span>Fluconazole,
  intravaginal imidazoles</span></p>
  </td>
 </tr>
</table>

<p><span>*The role
of sexual activity in transmitting bacterial vaginosis is unknown. </span></p>

<p><span></span></p>

<p><span>**Clue
cells are vaginal </span><a href="http://en.wikipedia.org/wiki/Epithelial"
title=Epithelial><span>epithelial</span></a><span> cells that are covered
with </span><a href="http://en.wikipedia.org/wiki/Bacteria" title=Bacteria><span>bacteria</span></a><span>, causing a stippled
appearance.</span></p>

<p><span></span></p>

<p><span>***
Candida vaginitis is not an STD.<span >&nbsp; </span></span></p>

<p><b><span>Genital
ulcer syndromes.</span></b><span>&nbsp;The
vast majority of genital ulcers are caused by herpes simplex virus and
syphilis. Other important causes include chancroid and lymphogranuloma
venereum.<span >&nbsp; </span></span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <thead>
  <tr>
   <td width=472 colspan=6>
   <p style="text-align:center;"><span></span></p>
   <p style="text-align:center;"><span>STDs Causing Genital Ulcers</span></p>
   <p style="text-align:center;"><span></span></p>
   </td>
  </tr>
  <tr>
   <td width=97>
   <p style="text-align:center;"><span>Disease</span></p>
   </td>
   <td width=88>
   <p style="text-align:center;"><span>Ulcer</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Incubation period</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Pain with ulcer</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Inguinal adenopathy</span></p>
   </td>
   <td>
   <p style="text-align:center;"><span>Diagnostic test</span></p>
   </td>
  </tr>
  <tr>
   <td width=97>
   <p><span></span></p>
   </td>
   <td width=88>
   <p><span></span></p>
   </td>
   <td>
   <p><span></span></p>
   </td>
   <td>
   <p><span></span></p>
   </td>
   <td>
   <p><span></span></p>
   </td>
   <td>
   <p><span></span></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td width=97>
  <p style="text-align:center;"><span>Syphilis </span></p>
  <p style="text-align:center;"><span>(primary)</span></p>
  <p style="text-align:center;"><span>(<i>Treponema pallidum</i>)</span></p>
  </td>
  <td width=88>
  <p><span>Chancre:
  papule that ulcerates;<span >&nbsp; </span>painless
  and indurated (firm); clean base with sharp borders; single lesion (usually);
  heals spontaneously; leaves thin, atrophic scar </span></p>
  </td>
  <td>
  <p><span>10&#8211;90
  days (average 21 days)</span></p>
  </td>
  <td>
  <p><span>No</span></p>
  </td>
  <td>
  <p><span>Firm,
  discrete, movable, nontender, nonsuppurative, may last for months</span></p>
  </td>
  <td>
  <p><span>Darkfield
  examination; </span></p>
  <p><span>VDRL
  positive (77%);</span></p>
  <p><span>FTA-ABS
  positive</span></p>
  <p><span>(86%)</span></p>
  </td>
 </tr>
 <tr>
  <td width=97>
  <p style="text-align:center;"><span>Herpes genitalis</span></p>
  <p style="text-align:center;"><span>(HSV-2, HSV-1)</span></p>
  </td>
  <td width=88>
  <p><span>Multiple
  small grouped vesicles on a red base, which form shallow ulcers; may
  coalesce; resolve spontaneously, but recurrence is common; associated fever</span></p>
  </td>
  <td>
  <p><span>2&#8211;7
  days</span></p>
  </td>
  <td>
  <p><span>Yes</span></p>
  </td>
  <td>
  <p><span>Bilateral,
  soft, tender</span></p>
  </td>
  <td>
  <p><span>Tzank
  smear positive;</span></p>
  <p><span>Tissue
  culture isolation;</span></p>
  <p><span>HSV-2
  antigen</span></p>
  </td>
 </tr>
 <tr>
  <td width=97>
  <p style="text-align:center;"><span>Chancroid</span></p>
  <p style="text-align:center;"><span>(<i>Haemophilus ducreyi</i>)</span></p>
  </td>
  <td width=88>
  <p><span>Soft,
  non-indurated, very painful ulcer</span></p>
  </td>
  <td>
  <p><span>3&#8211;6
  days</span></p>
  </td>
  <td>
  <p><span>Yes</span></p>
  </td>
  <td>
  <p><span>Unilateral
  (usually), very tender, suppurative</span></p>
  </td>
  <td>
  <p><span>Gram stain
  (Gram-negative coccobacillus);</span></p>
  <p><span>Culture</span></p>
  </td>
 </tr>
 <tr>
  <td width=97>
  <p style="text-align:center;"><span>Lymphogranuloma venereum*</span></p>
  <p style="text-align:center;"><span>(<i>Chlamydia trachomatis</i>)</span></p>
  </td>
  <td width=88>
  <p><span>Transient
  ulcer, often not noticed; usually single</span></p>
  </td>
  <td>
  <p><span>5&#8211;21
  days</span></p>
  </td>
  <td>
  <p><span>No</span></p>
  </td>
  <td>
  <p><span>Firm,
  tender, matted, caseating, suppurative; sinus tracts; fistulas; multiple
  abscesses</span></p>
  </td>
  <td>
  <p><span>Lymphogranuloma
  venereum complement fixation </span></p>
  <p><span></span></p>
  <p><span></span></p>
  </td>
 </tr>
</table>

<p><span>*Lymphogranuloma
venereum may be associated with fever, arthritis, pericarditis, proctitis,
meningoencephalitis, keratoconjunctivitis, preauricular adenopathy, edema of
eyelids, erythema nodosum</span></p>

<p><span></span></p>

<p><b>Pelvic inflammatory
disease. </b>Pelvic inflammatory disease (PID) is characterized by inflammation
of the upper female genital tract. <i>C. trachomatis </i>and <i>N</i>. <i>gonorrhoeae</i>
are the most common causes. Low abdominal pain is the dominant symptom. Fever,
malaise, and anorexia are common. Vaginal discharge is often present.
Examination usually shows low abdominal tenderness, cervical motion tenderness,
and bilateral adnexal tenderness, sometimes with a palpable mass. Most women
have signs of cervicitis. Right upper quadrant abdominal tenderness is
sometimes present due to Fitz-Hugh-Curtis syndrome, in which intra-abdominal
extension of infection results in perihepatitis, which can mimic acute
cholecystitis or viral hepatitis. Complications of PID include ectopic
pregnancy and infertility. </p>

<p><span></span></p>

<p><b><span>Dermatologic
syndromes.</span></b><span>&nbsp;The
most common STDs with primarily dermatologic presentations are listed below. </span></p>

<p><span></span></p>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=479 colspan=3 valign=top>
  <p style="text-align:center;"><span></span></p>
  <p style="text-align:center;"><span>STDs with Skin Manifestations</span></p>
  <p style="text-align:center;"><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p style="text-align:center;"><span>Organism</span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><span>Condition</span></p>
  </td>
  <td width=160 valign=top>
  <p style="text-align:center;"><span>Description</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><span>Human
  papillomavirus</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Genital
  warts (condyloma acuminata)<span >&nbsp; </span></span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Discrete,
  papillary, cauliflower-like lesions on a moist surface</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><i><span>Treponema
  pallidum</span></i></p>
  </td>
  <td width=160 valign=top>
  <p><span>Secondary
  syphilis</span></p>
  <p><span><span>1)<span>&nbsp;&nbsp;&nbsp;
  </span></span></span><span>rash</span></p>
  <p><span><span>2)<span>&nbsp;&nbsp;&nbsp;
  </span></span></span><span>condyloma lata</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Symmetrical,
  reddish-pink, non-itchy lesions on trunk and extremities, often involving
  palms and soles. In moist areas (vulva, scrotum), rash produces flat, broad,
  whitish, wart-like lesions called <i>condyloma lata</i> </span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><i><span>Neisseria
  gonorrhea</span></i></p>
  </td>
  <td width=160 valign=top>
  <p><span>Disseminated
  gonococcal infection</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Hemorrhagic
  pustules on an erythematous base, usually on distal extremities </span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><i><span>Phthirus
  pubis</span></i><span>
  (crab louse)</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>“Crabs”
  or “Pubic lice” (pediculosis pubis)</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Itching;
  lice and nits on pubic hairs</span></p>
  </td>
 </tr>
 <tr>
  <td width=160 valign=top>
  <p><i><span>Sarcoptes
  scabiei</span></i><span>
  (mite)</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Scabies</span></p>
  </td>
  <td width=160 valign=top>
  <p><span>Itching;
  trails of burrowing mites with pimple-like “bites” </span></p>
  </td>
 </tr>
</table>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=280 height=210
src="_%20Tutorials_files/image236.png" v:shapes="Picture_x0020_347209"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><i><span>Neisseria gonorrhoeae</span></i><span>:</span></p>

<p style="text-align:center;"><span>Gram-negative diplococci</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=290 height=188
src="_%20Tutorials_files/image238.png" v:shapes="Picture_x0020_347208"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Disseminated Gonococcal Infection (DGI): </span></p>

<p style="text-align:center;"><span>hemorrhagic pustule on an erythematous base</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=194 height=224
src="_%20Tutorials_files/image240.png" v:shapes="Picture_x0020_347207"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><i><span>Trichomonas vaginalis</span></i><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=337 height=226
src="_%20Tutorials_files/image242.png" v:shapes="Picture_x0020_347206"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Herpetic ulcers</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=206 height=140
src="_%20Tutorials_files/image244.png" v:shapes="Picture_x0020_347205"></span><span></span></p>

<p style="text-align:center;"><span>Primary syphilis:</span></p>

<p style="text-align:center;"><span>Chancre</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=250 height=341
src="_%20Tutorials_files/image246.png" v:shapes="Picture_x0020_347204"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Secondary syphilis:</span></p>

<p style="text-align:center;"><span>Erythematous rash on palms and soles</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=262 height=171
src="_%20Tutorials_files/image248.png" v:shapes="Picture_x0020_347203"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Secondary syphilis:</span></p>

<p style="text-align:center;"><span>Condyloma lata</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=242 height=183
src="_%20Tutorials_files/image250.png" v:shapes="Picture_x0020_347202"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Condyloma acuminatum</span></p>

<p style="text-align:center;"><span>(genital warts)</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=251 height=187
src="_%20Tutorials_files/image252.png" v:shapes="Picture_x0020_347201"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Crab louse</span></p>

<p style="text-align:center;"><span>(causes “crabs,” or pediculosis pubis)</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=261 height=241
src="_%20Tutorials_files/image254.png" v:shapes="Picture_x0020_347200"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Scabies mite</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=252 height=150
src="_%20Tutorials_files/image256.png" alt="Description: clue2" v:shapes="Picture_x0020_347199"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Clue cells:</span></p>

<p style="text-align:center;"><span>Bacterial vaginosis</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=403 height=241
src="_%20Tutorials_files/image258.png" v:shapes="Picture_x0020_347198"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Candida</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=434 height=289
src="_%20Tutorials_files/image260.png" alt="Description: tzank" v:shapes="Picture_x0020_347197"></span><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span>Tzank smear:</span></p>

<p style="text-align:center;"><span>Multinucleated giant cells associated with herpes infection</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is correct</span></b><span>.<span>&nbsp; </span><i>Haemophilus ducreyi</i><span> is the cause of chancroid, which is
characterized by painful, non-indurated ulceration and tender lymphadenopathy.
The organism is a gram-negative coccobacillus.<span>&nbsp; </span></span></span></p>

<p><span></span></p>

<p><b><span>Answer A is incorrect</span></b><span>. <i>Treponema pallidum</i><span> is the cause of syphilis. Primary syphilis
usually presents as a chancre, which is a painless, indurated ulcer, usually
associated with non-tender lymphadenopathy. The organism is a spirochete.<span>&nbsp;&nbsp;&nbsp; </span></span></span></p>

<p><span></span></p>

<p><b><span>Answer B is incorrect</span></b><span>. Herpes genitalis
usually presents with shallow, painful ulceration and tender lymphadenopathy.
It is usually caused by herpes simplex virus 2, but may be caused by herpes
simplex virus 1. The Tzank smear shows multi-nucleated giant cells. Herpes
simplex is a DNA virus.<span >&nbsp;&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer C
is incorrect</span></b><span>.
<i>Neisseria gonorrhoeae</i><span> usually
presents with genital discharge, not genital ulceration. Gram stain shows
gram-negative diplococci. </span></span></p>

<p><span></span></p>

<p><b><span>Answer D
is incorrect</span></b><span>.
<i>Trichomonas vaginalis</i><span> is a
protozoan that causes vaginitis, not genital ulceration. </span></span></p>

<p><span></span></p>

<p><span></span></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><span>Which of
the following is <i>not</i> true of <i>Staphylococcus aureus</i>? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>It
is a gram-positive, cluster-forming coccus.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is a catalase-positive, coagulase-positive bacterium. </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is most commonly identified by latex agglutination (It clumps latex beads
coated with fibrinogen and IgG.) </span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>It
colonizes the skin and nares.</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is the most common cause of suppuration (pus-formation).</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is the most common cause of boils and abscesses.</span></p>

<p><span><span>G.<span>&nbsp;&nbsp;
</span></span></span><span>It
is the most common cause of osteomyelitis and septic arthritis.</span></p>

<p><span><span>H.<span>&nbsp;&nbsp;
</span></span></span><span>It
is a major cause of surgical wound infections.</span></p>

<p><span><span>I.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is a major cause of spontaneous bacterial peritonitis.</span></p>

<p><span><span>J.<span>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
is a major cause of intravascular catheter-related infections.</span></p>

<p><span><span>K.<span>&nbsp;&nbsp;
</span></span></span><span>It
produces enterotoxins, which cause vomiting and diarrhea.<span>&nbsp; </span></span></p>

<p><span><span>L.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>It
produces toxic shock syndrome toxin (TSST-1), the main cause of toxic shock
syndrome.</span></p>

<p><span><span>M.<span>&nbsp;
</span></span></span><span>It
produces exfoliatin toxin, which causes scalded skin syndrome.</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=353 height=265
src="_%20Tutorials_files/image262.png" alt="Description: 191428_xlarge" v:shapes="Picture_x0020_347196"></span><span></span></p>

<p><span></span></p>

<p><span>Staphylococci
are gram-positive, catalase-positive cocci that occur in microscopic clusters
resembling grapes. These bacteria are identified by latex agglutination. (The
bacteria clump latex beads coated with fibrinogen and IgG). Bacteriologic
cultures of the nose and skin of normal humans invariably yields staphylococci.
Difference between <i>Staphylococcus aureus</i> and <i>Staphylococcus
epidermidis </i><span>are summarized below. </span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=176 valign=top>
  <p style="text-align:center;"><i><span>Staphylococcus aureus</span></i></p>
  </td>
  <td width=189 valign=top>
  <p style="text-align:center;"><i><span>Staphylococcus epidermidis</span></i></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><i><span></span></i></p>
  </td>
  <td width=189 valign=top>
  <p><i><span></span></i></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Large
  yellow colonies<span></span></span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Small
  white colonies<span></span></span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Hemolytic
  on blood agar <span></span></span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Non-hemolytic
  on blood agar<span></span></span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Coagulase-positive </span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Coagulase-negative</span></p>
  </td>
 </tr>
 <tr>
  <td width=176 valign=top>
  <p><span>Often pathogenic</span></p>
  </td>
  <td width=189 valign=top>
  <p><span>Usually non-pathogenic (but may cause disease in
  the hospital setting)</span></p>
  </td>
 </tr>
</table>

</div>

<p><i><span></span></i></p>

<p><i><span>Staphylococcus
aureus</span></i><span>
causes a variety of suppurative (pus-forming) infections and toxic states. It
causes superficial skin lesions such as <span>boils</span>,
<span>sties,</span> and <span>furuncules</span>; more serious infections,
such as <span>pneumonia</span>; and
deep-seated infections, such as endocarditis, <span>osteomyelitis, and septic arthritis</span>. <i>S. aureus</i> is a major
cause of <span>hospital acquired (nosocomial)
pneumonia, </span>surgical wound infections, and infections associated with
intravascular catheters and indwelling medical devices. The organism causes <span>food poisoning</span> by releasing
enterotoxins into food, <span>toxic shock
syndrome</span> by releasing superantigens (principally toxic shock syndrome
toxin-1, or TSST-1) into blood, and scalded skin syndrome by releasing
exfoliatin toxin. </span></p>

<p><span></span></p>

<p><i><span>S.
aureus</span></i><span>
expresses many potential <span>virulence
factors</span>: (1) <span>surface proteins</span>
that promote colonization of host tissues; (2) invasins that promote bacterial
spread in tissues (<span>leukocidin</span>, <span>kinases</span>, <span>hyaluronidase</span>); (3) surface factors that inhibit phagocytic
engulfment (<span>capsule</span>, <span>Protein A</span>); (4) biochemical properties
that enhance their survival in phagocytes (<span>carotenoids</span>, <span>catalase</span>
production); (5) immunological disguises (<span>Protein A</span>, <span>coagulase</span>);
(6) membrane-damaging toxins that lyse eukaryotic cell membranes (<span>hemolysins</span>, <span>leukotoxin</span>, <span>leukocidin)</span>;
(7) exotoxins that damage host tissues; and (8) inherent and acquired <span>resistance to antimicrobial agents</span>.</span></p>

<p><span></span></p>

<p><span>Hospital
strains of <i>S. aureus</i> are usually resistant to a variety of different
antibiotics. A few strains are resistant to all clinically useful antibiotics
except vancomycin, and vancomycin-resistant strains are increasingly reported.
The term “<span>MRSA”</span> refers to m<span>ethicillin-resistant <i>Staphylococcus aureus</i></span>.
Methicillin resistance is widespread and most methicillin-resistant strains are
also multi-drug-resistant.</span></p>

<p><span></span></p>

<p><span>The principal mechanism by which <i>Staphylococcus
aureus</i> resists beta-lactam antibiotics (e.g. penicillin) is production of
beta-lactamase. </span><span>Genes
encoding for beta-lactamase are widespread in the bacterial kingdom and are
found on the chromosome and on plasmids.<a
name=4-u1.0-B978-0-323-04475-2..50037-6--p487></a> The <span of gram-positive bacteria (e.g. <i>Staphylococcus aureus</i>) are released into
the extracellular environment. The <span of gram-negative bacteria remain within the
periplasm.<b> </b><span>(The<b> </b>periplasm</span>
is the space between the peptidoglycan cell wall and the external outer
membrane of gram-negative bacteria.) Hundreds of different <span
 enzymes
have been described. All have the same function but with differing amino acid
sequences that influence their affinity for different <span><span></span></p>

<p><span>Staphylococcal
disease has been a perennial problem in the hospital environment since the
beginning of the antibiotic era. <i>S aureus</i> has responded to the
introduction of antibiotics by the usual bacterial means of developing drug
resistance: (1) mutation in chromosomal genes and (2) acquisition of resistance
genes as extrachromosomal plasmids. <span>MRSA
represents an increasingly large proportion of </span>staphylococcal infections
occurring in and out of the hospital.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer I is correct</span></b><span>. <i>Staphylococcus aureus</i> is not a major cause of spontaneous bacterial
peritonitis.<span >&nbsp; </span>Spontaneous bacterial
peritonitis is usually caused by gram-negative bacteria, especially <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>. Other causes
include streptococci (often pneumococcus) and enterococci. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>Which of
the following clinical scenarios is <i>least</i>
likely to be associated with <i>Streptococcus
pyogenes</i> infection? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>8-year
old boy with sore throat is found to have high fever, tonsillar exudate, and
cervical lymphadenopathy.</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>8-year
old boy has fever, shortness of breath, and migratory arthitis two weeks after
developing a sore throat. Examination shows a new heart murmur, non-tender
subcutaneous nodules, and a serpiginous rash. </span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>8-year
old boy has hematuria, renal insufficiency, edema, and mild elevation of blood
pressure ten days after developing a sore throat</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>8-year
old boy develops fever and sore throat. Examination shows a bright red, tongue
with a “strawberry” appearance, and a fine, red “sandpaper-like” rash on the
chest.<span >&nbsp; </span></span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>8-year
old boy develops fever and a red, swollen, warm, hardened and painful rash on
the arm. The rash has the consistency of an orange peel and has a raised,
sharply demarcated border.</span></p>

<p><span><span>F.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>1-day
old newborn evaluated for sepsis has blood cultures that grow gram-positive
cocci in pairs and chains. The bacteria agglutinate with group B antiserum.</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><span>The classification of Streptococcus is shown
below:</span></p>

<p><span></span></p>

<p style="text-align:center;"><a
href="http://upload.wikimedia.org/wikipedia/commons/9/9d/Strep_Classification.svg"><span><img border=0 width=392 height=234
src="_%20Tutorials_files/image264.png"
alt="Description: File:Strep Classification.svg" v:shapes="Picture_x0020_347195"></span></a><span></span></p>

<p><i><span></span></i></p>

<p><span></span></p>

<p><i><span>Streptococcus pyogenes</span></i> (Group A, beta-hemolytic streptococcus)
can cause pharyngitis (Strep throat), rheumatic fever, post-streptococcal
glomerulonephritis, erysipelas, and scarlet fever. <i><span>Streptococcus agalactiae</span></i> (Group B, beta-hemolytic
streptococcus) can cause neonatal sepsis and meningitis (if the bacterium
colonizes the mother’s vagina and is transmitted to the newborn during
delivery). <i><span>Streptococcus pneumoniae</span></i><span> can cause a
number of different conditions, including </span>pneumonia, acute sinusitis,
otitis media, meningitis, cellulitis, and spontaneous bacterial peritonitis. <i><span>Streptococcus viridans</span></i><span> can cause dental
caries and endocarditis. </span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer F is correct. </span></b><span>Neonatal sepsis
associated with streptococcal bacteremia would be due to Group B “strep” (<i><span>Streptococcus agalactiae</span></i><span>), not Group A
“strep” (<i>Streptococcus pyogenes</i>). </span><span>&nbsp;&nbsp;&nbsp;</span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is incorrect. </span></b><span>Group A streptococcus
causes streptococcal pharyngitis (Strep throat), which is characterized by the
following triad: high fever, tonsillar exudate, and cervical
lymphadenopathy.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b>Answer B is incorrect. </b>Acute rheumatic fever (ARF) is a
complication of pharyngeal respiratory infection with Group A streptococcus.
Infection triggers the formation of antibodies, which cross-react with
auto-antigens on interstitial connective tissue particularly of the endocardium
and synovium. Findings may include pancarditis (inflammation of the
endocardium, myocardium, and pericardium); migratory polyarthritis;
subcutaneous nodules; rash; and Sydenham’s chorea (involuntary, purposeless
movement). The most common clinical finding is a migratory arthritis involving
multiple joints. The test for anti-streptolysin O (ASO) antibodies is often
used to make the diagnosis. </p>

<p></p>

<p><b><span>Answer C is incorrect. </span></b><span>Post-streptococcal
glomerulonephritis (PSGN) is an uncommon complication of either respiratory or
skin infection with Group A streptococcus. It is classified as a type III
hypersensitivity reaction. Symptoms develop within 10 days of developing “strep
throat” or within 3 weeks of acquiring a skin infection. PSGN is characterized
by hematuria, renal insufficiency, edema, and a rise in blood pressure. </span></p>

<p><b><span></span></b></p>

<p><b><span>Answer D is incorrect. </span></b><span>Group A streptococcus is
the cause of scarlet fever, which is characterized by fever; sore throat; a
bright red, “strawberry” tongue; and a fine, red “sandpaper-like” rash.</span></p>

<p><span></span></p>

<p><b><span>Answer E is incorrect</span></b><span>. Group A streptococcus
is the cause of erysipelas, which is characterized by a red, painful rash with
a sharply-demarcated raised border.<b></b></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 33-year-old woman living in Maryland has a one-week history of
low-grade fever, fatigue, and a red rash over the skin behind her left knee.
She is an avid hiker. Her temperature is 38<sup>o</sup>C (100.4<sup>o</sup>F).
Physical examination shows an 8-cm, warm, nontender, erythematous lesion with
partial central clearing over the skin of the left popliteal area. Which of the
following is the most likely causal organism? </span></p>

<p><span></span></p>

<p><i><span><span>A.<span>&nbsp;&nbsp;&nbsp; </span></span></span></i><i><span>Borrelia burgdorferi</span></i></p>

<p><i><span><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span></span></i><i><span>Ehrlichia chaffeensis</span></i></p>

<p><i><span><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span></span></i><i><span>Francisella tularensis</span></i></p>

<p><i><span><span>D.<span>&nbsp;&nbsp; </span></span></span></i><i><span>Rickettsia rickettsii<span>&nbsp;&nbsp; </span></span></i></p>

<p><i><span><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span></span></i><i><span>Babesia microti</span></i></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Rocky
Mountain spotted fever</span></b><span> is the most lethal and most frequently reported rickettsial
illness in the United States. The disease is caused by <i>Rickettsia rickettsii</i>,
an intracellular species of bacterium that is spread to humans by <i>Dermacentor</i>
ticks. The disease can be difficult to diagnose in the early stages, and can be
fatal without prompt treatment.</span></p>

<p><span></span></p>

<p><span>The name
“Rocky Mountain spotted fever” is a misnomer, as the disease is broadly
distributed throughout the continental United States, and occurs as far north
as Canada and as far south as Central America and parts of South America.
People infected with <i>R. rickettsii</i> usually notice symptoms after an
incubation period of one to two weeks. The early clinical presentation is
nonspecific. Initial symptoms include fever, severe headache, nausea, vomiting,
and muscle pain. Later signs and symptoms include maculopapular rash, petechial
rash, abdominal pain, and joint pain.</span></p>

<p><span></span></p>

<p>The classic triad of
findings is fever, rash, and history of tick bite; however, this combination is
often not identified when the patient presents initially. The rash has a
centripetal pattern of spread, meaning it begins at the extremities and courses
toward the trunk.</p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=217 height=139
src="_%20Tutorials_files/image266.png" alt="Description: RMSF" v:shapes="Picture_x0020_347194"></span></p>

<p></p>

<p>The rash first appears after
the onset of fever and is often subtle. Most often it begins as small, flat,
pink, non-itchy spots (macules) on the wrists, forearms, and ankles. These turn
pale when pressure is applied and eventually become raised. The characteristic
red, spotted, petechial rash is usually not seen until the sixth day or later,
but this type of rash occurs in less than 60% of patients. The rash involves
the palms or soles in as many as 50% to 80%; however, this distribution may not
occur until later in the course of the disease. 10-15% may never develop a
rash.</p>

<p></p>

<p>Abnormal laboratory findings
include thrombocytopenia and elevated liver enzyme levels. The disease can be
very severe, and patients often require hospitalization. <i>R. rickettsii</i>
can infect endothelial cells throughout the body, causing dysfunction of the
respiratory, gastrointestinal, renal, and neurologic systems. Diagnostic tests
include IFA on blood samples, immunostaining of biopsy of the rash, or PCR on
blood and skin biopsies.<span >&nbsp;
</span>Appropriate antibiotic treatment should be initiated <span>immediately.</span> Doxycycline is the
treatment of choice. (Failure to respond to a tetracycline antibiotic argues
against a diagnosis of Rocky Mountain spotted fever.)</p>

<p></p>

<p><b></b></p>

<p><b>Lyme disease</b> is the
most common tick-borne disease in the Northern Hemisphere.<span>&nbsp; </span>It is named after the town of Lyme,
Connecticut, where a number of cases were identified in 1975. Lyme disease is
caused by spirochetes belonging to the genus <i>Borrelia</i>. Most cases are
caused by <i>Borrelia burgdorferi.</i> <i>Borrelia</i> is transmitted to humans
by the bite of infected ticks belonging to the genus <i>Ixodes</i> (“hard
ticks”). </p>

<p></p>

<p>Lyme disease can produce a
range of symptoms. The incubation period is usually one to two weeks, but can
be shorter (days) or longer (months to years). The disease usually occurs
during tick season (May to September). Asymptomatic infection occurs in less
than 7% of infected individuals. Early symptoms include fever, malaise,
headache, and muscle soreness. A classic sign is a circular, outwardly
expanding rash, called erythema chronicum migrans. It appears at the site of
the tick bite within a month of the bite. The rash is red, may be warm, and is
generally painless. Classically, the innermost part is dark red and indurated
(firm), the outer edge remains red, and the portion in between clears. This
gives the lesion the appearance of a bullseye (see figure). Erythema chronicum
migrans is thought to occur in 80% of infected patients. </p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=161 height=190
src="_%20Tutorials_files/image268.png" alt="Description: lyme-disease-rash"
v:shapes="Picture_x0020_347193"></span></p>

<p></p>

<p>Days to weeks after
infection, the bacteria may spread through the bloodstream. Symptoms of early
dissemination include migrating pain in the muscles, joints, and tendons, and
heart palpitations due to arrhythmia. Various neurological problems may occur,
including facial palsy, meningitis, and encephalitis (resulting in memory loss,
sleep disturbance, or mood change). After several months, untreated patients
may go on to develop chronic symptoms that affect the brain, nerves, eyes,
joints, and heart. </p>

<p>The diagnosis of Lyme
disease is based on symptoms, objective physical findings (such as erythema
migrans, facial palsy, or arthritis), history of possible exposure to infected
ticks, and serological blood tests. The classic “bullseye” rash is considered
sufficient to establish a diagnosis, even when serologic blood tests are
negative. Doxycycline is the drug of choice in adults. </p>

<p><b><span></span></b></p>

<p><b><span>Ehrlichiosis </span></b><span>(sometimes called Rocky Mountain
“spotless” fever) is a tick-borne disease caused by bacteria belonging to the
genus <em>Ehrlichia</em><em><span> or </span>Anaplasma</em><em><span>. Most cases are caused by </span></em><i>Ehrlichia chaffeensis</i><span>, a </span>tiny, obligate intracellular
bacterium that resembles <em>Rickettsia</em><em><span>. The organism</span></em> infects white blood
cells, multiplies within the cytoplasm, and forms large, mulberry-shaped
aggregates, called morulae. The incubation period is 1-2 weeks. Symptoms are
usually acute and range from mild to severe. Most patients have fever, chills,
malaise, headache, and myalgias. Cough, vomiting, arthralgias, neurologic
symptoms (e.g. altered sensorium and neck stiffness) also occur, but rash is
uncommon. Laboratory abnormalities include leukopenia, thrombocytopenia, and
elevated hepatic transaminase levels. The estimated death rate is 1% to 10%;
hospitalization rates are as high as 60%. Most deaths are due to cardiac,
respiratory, or renal failure.</span></p>

<p><span></span></p>

<p><b><span>Tularemia
</span></b><span>is a
serious disease caused by the bacterium <i>Francisella tularensis</i><span>,</span> a gram-negative coccobacillus. The
disease affects a variety of wild animals, including rabbits, deer, squirrels,
muskrat, and beaver. Humans can acquire the bacteria from direct contact with
these animals, from the bite of a tick or fly that has fed on an infected
animal, or from contaminated food or water. Tularemia usually occurs in the
summer months and is most common in people who have had contact with infected
animals (e.g. hunters, furriers, butchers, laboratory workers, game wardens,
and veterinarians). In the U.S., most cases occur in the southeastern and Rocky
Mountain states. The primary vectors are ticks and deer flies.<span>&nbsp; </span>This organism is also listed on the
CDC’s list of category A biological weapons.</span></p>

<p><span></span></p>

<p>The incubation period is
1-14 days. Symptoms include fever, chills, malaise, anorexia, rash, and
enlarged lymph nodes. There are five characteristic clinical syndromes:
ulceroglandular/glandular (the most common type, representing 75% of all
forms), oropharyngeal, pneumonic, oculoglandular, and typhoidal. In
ulceroglandular fever, a tender red bump appears in the area of the tick bite.
Within a few weeks, the bump ulcerates. Nearby lymph nodes swell enormously,
become very tender, and may drain purulent fluid (see figure). Smears of
aspirates from enlarged lymph nodes usually contain the organisms.<span>&nbsp; </span>Streptomycin and gentamicin are the
drugs of choice for treating tularemia.</p>

<p></p>

<p style="text-align:center;"><span><img border=0 width=190 height=186
src="_%20Tutorials_files/image270.png" alt="Description: tularemia_2" v:shapes="Picture_x0020_347192"></span></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Babesiosis</b> is a
tick-borne disease caused by the malaria-like parasite, <i>Babesia</i><span>. </span>In North America, the disease is
primarily found in eastern Long Island, Fire Island, Nantucket Island, and
Martha's Vineyard off of the coast of Massachusetts. It is sometimes called
“the malaria of the Northeast.”<span> </span>Most
cases of <i>Babesia</i> infection are asymptomatic. Some individuals have mild
fever and diarrhea. In severe cases, symptoms resemble malaria, with fevers up
to 40.5°C (105°F), shaking chills, and severe hemolytic anemia. Organ failure
may follow. Fulminant cases occur mostly in the very young, the very old, and
in people who are asplenic or otherwise immunocompromised. Diagnosis is made by
identifying parasites (which resemble a “Maltese cross”) on a Giemsa-stained
thin blood smear (see figure). Treatment is usually a two-drug regimen (quinine
and clindamycin or atovaquone and azithromycin).</p>

<p><b><span></span></b></p>

<p style="text-align:center;"><span><img border=0 width=213 height=181
src="_%20Tutorials_files/image272.png" alt="Description: cow40_answer2" v:shapes="Picture_x0020_347191"></span><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer A is correct. </span></b><span>The skin lesion in the
popliteal area, which resembles a bullseye, is called erythema chronicum
migrans. This is a common characteristic of Lyme disease, which is caused by
the spirochete, <i><span>Borrelia burgdorferi</span></i><span>.</span><span>&nbsp;&nbsp; </span><b><span >&nbsp;</span></b></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer B is incorrect. </span></b><i><span>Ehrlichia chaffeensis</span></i><span> causes ehrlichiosis.<span >&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer C is incorrect. </span></b><i><span>Francisella tularensis</span></i><span> causes tularemia.</span><span></span></p>

<p><i><span></span></i></p>

<p><b><span>Answer D is incorrect. </span></b><i><span>Rickettsia rickettsii </span></i><span>causes </span><span>Rocky
Mountain spotted fever.<i><span><span >&nbsp; </span></span></i></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer E is incorrect. </span></b><i><span>Babesia microti</span></i><span> causes babesiosis.</span></p>

<p></p>

<p></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A&nbsp;38-year-old
man presents to the emergency department with a two-day history of cough
productive of blood-tinged sputum. He reports fevers, night sweats, and a
15-pound weight loss. He smokes two packs of cigarettes a day and occasionally
uses intravenous drugs.&nbsp;He lives in a homeless shelter and is
HIV-positive. </span></p>

<p><span></span></p>

<p><span>Blood
tests show:</span></p>

<p><span></span></p>

<p><span>Hemoglobin<span>&nbsp;&nbsp;&nbsp;&nbsp; </span>12 g/dl</span></p>

<p><span>WBC<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>11,500/mm3</span></p>

<p><span>Platelet<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>380,000/mm3
</span></p>

<p><span></span></p>

<p><span>Chest
X-ray shows a cavitary lesion in the right upper lobe. </span></p>

<p><span>&nbsp;</span></p>

<p><span>What is
the most likely diagnosis? </span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Squamous
cell carcinoma of the lung</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Tuberculosis</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Lung
abscess from chronic aspiration</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Aspergilloma</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=244 valign=top>
  <p style="text-align:center;"><span>Risk Factors for Tuberculosis</span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Immunosuppression</span></b><span> </span></p>
  <p><i><span>Diseases</span></i><span>: HIV/AIDS, diabetes,
  end-stage renal disease, cancer, silicosis, gastrectomy </span></p>
  <p><i><span>Drugs</span></i><span>: glucocorticoids,
  chemotherapeutic agents, immunosuppressive drugs</span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Close
  contact with infected person</span></b><span> </span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Migration
  from country with high rate of TB</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Advanced
  age</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Substance
  abuse</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Malnutrition</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Lack
  of medical care</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Living
  or working in residential care facility</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Living
  in refugee camp or shelter</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>Health
  care work</span></b><span></span></p>
  </td>
 </tr>
 <tr>
  <td width=244 valign=top>
  <p><b><span>International
  travel</span></b><span></span></p>
  </td>
 </tr>
</table>

</div>

<p><span></span></p>

<p><span></span></p>

<p><span>Pulmonary
tuberculosis can produce fever, night sweats, weight loss, cough, hemoptysis,
and adenopathy. The patient in this vignette has several symptoms of active
tuberculosis and several risk factors as well: homelessness, HIV infection, and
substance abuse. Cavitation in the upper lobe is highly suspicious for
tuberculosis. The patient should be placed in negative-pressure&nbsp;isolation
room. Three&nbsp;sputum samples should be obtained, stained, and cultured for
acid-fast bacilli (AFB). If the patient has active tuberculosis, treatment
should be started with a four-drug regimen: isoniazid, pyrazinamide, rifampin,
and ethambutol. “Direct observed therapy” (DOT) may be continued in the
outpatient setting. (Note: HIV-positive patients often do not generate a robust
response to the tuberculin skin test. Induration &lt;5 mm is often seen.)</span></p>

<p><span></span></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer
B is correct.<span >&nbsp; </span></span></b><span>The patient has symptoms and risk factors of active pulmonary
tuberculosis.<span >&nbsp; </span></span></p>

<p><b><span></span></b></p>

<p><b><span>Answer
A is incorrect</span></b><span>.
Bronchogenic carcinoma is uncommon in people under the age of 40, although it
can occur. Squamous cell carcinoma is particularly prone to cavitation. </span></p>

<p><span>&nbsp;</span></p>

<p><b><span>Answer
C is incorrect</span></b><span>.<span>&nbsp; </span>Alcoholism and drug abuse can produce
altered levels of consciousness predisposing to aspiration pneumonia. The right
lower lobe is usually involved and cavitation may occur. </span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect</span></b><span>.&nbsp;&nbsp;Aspergillus
infection is more common in patients undergoing chemotherapy. An aspergilloma
is a fungal mass that colonizes a pre-existing cavity formed by a necrotizing
infection. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A
43-year-old man presents with a chronic cough, night sweats, and weight loss. A
chest x-ray shows infiltrates in the right upper lobe. A lung biopsy shows
multiple necrotizing granulomas. Acid-fast staining of the granulomatous tissue
shows numerous acid-fast bacilli. Tissue culture grows <i>Mycobacterium
tuberculosis</i>. Which of the following inflammatory mediators is principally
responsible for controlling tuberculous infection?</span></p>

<p><span></span></p>

<p><span></span></p>

<p style="text-align:center;"><span><img border=0 width=154 height=205
src="_%20Tutorials_files/image274.png"
alt="Description: http://pathhsw5m54.ucsf.edu/overview/imagesover/pneumonia/cheese1.jpg"
v:shapes="Picture_x0020_347190"></span><span></span></p>

<p style="text-align:center;"><span>Caseous necrosis of tuberculosis</span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span><img border=0 width=149 height=148
src="_%20Tutorials_files/image276.png"
alt="Description: http://pathhsw5m54.ucsf.edu/overview/imagesover/pneumonia/afb.jpg"
v:shapes="Picture_x0020_347189"></span></p>

<p style="text-align:center;"><span>Acid-fast stain: <i>Mycobacterium tuberculosis</i></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A.<span>&nbsp; </span>Bradykinin</span></p>

<p><span>B.<span>&nbsp; </span>Interferon-&#947;</span></p>

<p><span>C.<span>&nbsp; </span>Leukotriene B4</span></p>

<p><span>D.<span>&nbsp; </span>Prostaglandin E2</span></p>

<p><span>E.<span>&nbsp; </span>Trimolecular complex (C567)</span></p>

<p><span></span></p>

<p><span></span></p>

<p><a
name=4-u1.0-B978-1-4377-0792-2..50013-4--p368></a>Macrophages are the primary
cells infected by <i>M. <span Early
in infection, the bacilli replicate essentially unchecked, while later in
infection, the cell response stimulates macrophages to contain the
proliferation of bacteria.<a name=4-u1.0-B978-1-4377-0792-2..50013-4--celi></a>
</p>

<p></p>

<p><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></span><span </i></span><span
 enters macrophages
by endocytosis</span></p>

<p><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></span><span inside the
macrophage, <i>M. </i></span><span replicates within the phagosome by blocking fusion of the phagosome
and lysosome. </span>Infected macrophages are eventually destroyed and bacteria
are released, causing bacteremia, seeding of multiple sites, and infection of
other macrophages. <span"mso-spacerun:yes">&nbsp;</span>Despite the bacteremia, most people at
this stage are asymptomatic or have a mild flu-like illness.</span></p>

<p><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></span><span cells
(i.e., dendritic cells) encounter mycobacterial antigens in draining lymph
nodes. These APCs produce IL-12, which allows differentiation of T<sub>H</sub>1
cells. (This process occurs about 3 weeks after infection and represents the
body’s mounting of an immune response). </span></p>

<p><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></span><span T<sub>H</sub>1
cells produce IFN-&#947;. <i>INF-</i>&#947; <i>is the critical mediator that
enables macrophages to contain the M. </i></span><span infection</i>. IFN-&#947; stimulates formation of the
phagolysosome in infected macrophages, exposing the bacteria to an inhospitable
acidic environment. IFN-&#947; also stimulates expression of inducible nitric
oxide synthase, which produces nitric oxide, capable of destroying several
mycobacterial constituents, from cell wall to DNA.</span></p>

<p><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></span><span cells also
orchestrate the formation of granulomas and caseous necrosis. They produce
IFN-&#947;, which causes macrophages to differentiate into the “epithelioid
histiocytes” that characterize the granulomatous response. Some of these
epithelioid histiocytes fuse to form giant cells. In many people this response
halts the infection before significant tissue destruction occurs. In others,
the infection progresses due to advanced age or immunosuppression, and the
ongoing immune response results in tissue destruction with caseation and
cavitation. </span></p>

<p><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></span><span macrophages
secrete tumor necrosis factor (TNF), which recruits monocytes. The importance
of TNF is underscored by the fact that patients with rheumatoid arthritis who
are treated with a TNF antagonist have an increased risk of </span><span
 reactivation.</span></p>

<p></p>

<p>In summary, immunity to <i>M.
<span is primarily mediated by T<sub>H</sub>1
cells, which stimulate macrophages to kill the bacteria via <span immune response, while largely effective, comes at the cost of
hypersensitivity and tissue destruction. Reactivation of the infection or
re-exposure to the bacilli in a previously sensitized host results in rapid
mobilization of a defensive reaction, but also increased tissue necrosis. Just
as hypersensitivity and resistance are correlated, so, too, the loss of
hypersensitivity (indicated by tuberculin negativity in a previously
tuberculin-positive individual) may be an ominous sign that resistance to the
organism has faded.</p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b>Answer B is correct</b>. <span
 T<sub>H</sub>1 cells produce IFN-&#947;, a critical mediator
that enables macrophages to contain the M. </span><span infection. IFN-&#947; stimulates formation of the phagolysosome in
infected macrophages, exposing the bacteria to an inhospitable acidic
environment. IFN-&#947; also stimulates expression of inducible nitric oxide
synthase, which produces nitric oxide, capable of destroying several
mycobacterial constituents, from cell wall to DNA.</span></p>

<p><span><b><span>Answer
A is incorrect</span></b><span>.
Bradykinin is a small vasoactive peptide produced in response to injured blood
vessels.<span >&nbsp; </span>Factor XII initiates the
kinin cascade by activating kallikrein. This cascade produces bradykinin, which
increases vascular permeability and permits the efflux of plasma proteins into
injured tissue. This contributes to the pain associated with inflammation.</span></p>

<p><span></span></p>

<p><b><span>Answer
C is incorrect</span></b><span>.
Leukotriene B4 is a lipid mediator of inflammation. It acts as a
chemoattractant for leukocytes and increases vascular permeability.<span>&nbsp; </span>Leukotrienes and prostaglandins are
derived from arachidonic acid, which is generated from membrane
phospholipids.<span >&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
D is incorrect</span></b><span>.
Prostaglandin E2 is a lipid mediator of inflammation. It is a vasodilator and
an inducer of fever. Prostaglandins and leukotrienes are derived from
arachidonic acid, which is generated from membrane phospholipids.<span>&nbsp; </span></span></p>

<p><span></span></p>

<p><b><span>Answer
E is incorrect</span></b><span>.
The trimolecular complex (C567) is part of the terminal complement pathway,
which generates the membrane attack complex (MAC).<span>&nbsp; </span>The MAC appears on the surface of
intruding bacteria and produces transmembrane channels, which disrupt the
phospholipid bilayer, leading to osmotic lysis and cell death. </span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span>A 4-year-old boy is brought to the
physician because of a 2-day history of fever and an itchy rash. The rash began
on his face and then spread to his trunk, arms, and legs. Several children at
his day-care center have had similar symptoms. His temperature is 38.9°C
(102°F), pulse is 100/min, respirations are 20/min, and blood pressure is
110/60 mm Hg. Physical examination shows multiple red papules and vesicles over
the face, trunk, and upper and lower extremities. Some vesicles contain clear
fluid, whereas others are crusted. Which of the following is the most likely
causal virus?</span></p>

<p><span></span></p>

<p><span><span>A.<span>&nbsp;&nbsp;
</span></span></span><span>Measles</span></p>

<p><span><span>B.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Rubella</span></p>

<p><span><span>C.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Herpes
simplex virus 1</span></p>

<p><span><span>D.<span>&nbsp;&nbsp;
</span></span></span><span>Erythrovirus
B19</span></p>

<p><span><span>E.<span>&nbsp;&nbsp;&nbsp;
</span></span></span><span>Varicella-zoster
virus</span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><b>Measles</b>, also known
as <span>rubeola</span> or <span>morbilli</span>, is an infection of the
respiratory system caused by a paramyxovirus of the genus <i>Morbillivirus</i>.
Morbilliviruses, like other paramyxoviruses, are enveloped, single-stranded RNA
viruses. </p>

<p>Classic symptoms of measles
include four-day fevers and the three Cs &#8211; cough, coryza (runny nose) and
conjunctivitis (red eyes). The fever may reach 40°C (104°F). Koplik's spots
inside the mouth are pathognomonic (diagnostic) for measles, but are not often
seen because they are transient, disappearing within a day. The characteristic
rash is a generalized erythematous maculopapular rash that begins several days
after fever commences. The rash, often itchy, starts on the head and spreads to
most of the body. It appears two to four days after initial symptoms, lasts for
up to eight days, and changes color from red to brown before disappearing.</p>

<p><span>&nbsp; </span></p>

<p>Measles is spread through
droplets from a person’s nose or mouth, and is highly contagious &#8211; 90% of
those sharing a living space with an infected person will catch it.
Complications are relatively common and include diarrhea, pneumonia, and acute
encephalitis.</p>

<p></p>

<p><b>Rubella</b>, commonly
known as <span>German measles</span>, is a
disease caused by the rubella virus, a member of the togaviridae family. The
name “rubella” is derived from the Latin word meaning <i>little red</i>. The
disease is transmitted via airborne droplets from the upper respiratory tract
and is usually mild, lasting 1-3 days. Children recover more quickly than
adults. Infection of the mother during pregnancy can be serious; if the mother
is infected within the first 20 weeks of pregnancy, the child may be born with
congenital rubella syndrome (CRS).<span >&nbsp; </span></p>

<p></p>

<p>The primary finding is rash
on the face that spreads to the trunk and limbs, and usually fades after three
days (hence, the term “three-day measles”). Other symptoms include fever,
lymphadenopathy, joint pains, headache, and conjunctivitis. The fever rarely
rises above 38 <sup>o</sup>C (100.4 <sup>o</sup>F), and the rash (usually
itchy) is pink or light red. It disappears with no staining or peeling of the
skin. </p>

<p></p>

<p><b>Herpes simplex virus-1 (HSV-1) </b>is a double-stranded DNA virus and
belongs to the Alpha Herpesvirus family.<span >&nbsp;
</span>Herpesviruses can establish latent infection and persist indefinitely in
the host.<span >&nbsp; </span>HSV-1is acquired via
close contact to the virus from mucosal or genital and oral secretions.<span>&nbsp; </span>Primary HSV infection results in
orolabial herpes or gingovostomatitis and recurrent infections manifest as cold
sores and fever blisters.<span >&nbsp; </span>HSV-1
infection in neonates or immunocompromised hosts can be very severe.<span>&nbsp; </span>Symptoms associated with orolabial
herpes include fever, chills, mayalgias, cervical lymphadenopathy, and
irritability.</p>

<p></p>

<p><b>Erythrovirus B19</b> causes “slapped cheek syndrome” or Fifth’s
disease.<span >&nbsp; </span>This single-stranded DNA
virus belongs to the parvoviridae family and can be spread by aerosal, fomites
or transplacental transmission.<span >&nbsp;
</span>Most cases are subclinical and occur in late winter to early spring.<span>&nbsp; </span>After a 7-10 day incubation, most
patients present with low-grade fever, headache, and mild respiratory
symptoms.<span >&nbsp; </span>A slapped-cheek rash
appears 7 days later.<span >&nbsp; </span>The rash
spreads and red blotches extend down to the trunk, arms, and legs.<span>&nbsp; </span>The rash, which has a lacy net-like
appearance, usually spares the palms and soles.<span>&nbsp; </span>Serious complications include still
births if the mother is infected during the second trimester and transient
aplastic crises in sickle-cell patients.<span >&nbsp;
</span>The virus lyses immature erythroid precursors. </p>

<p><b>Varicella zoster virus</b>
(<b>VZV</b>) is one of eight herpes viruses known to infect humans. It commonly
causes chickenpox in children and zoster (shingles) in adults. Primary
infection results in chickenpox (varicella), a highly contagious disease spread
by coughing and sneezing and by direct contact with fluid from infected
vesicles on the skin.<span >&nbsp; </span></p>

<p>Initial symptoms may include
fever, malaise, headache, sore throat, myalgia, and itching. The chicken pox
rash begins on the face and trunk and spreads to the extremities. Lesions start
as 2-4 mm erythematous papules that develop an irregular outline (rose petal).
A thin-walled, clear vesicle (dew drop) develops on top of the erythematous
area. This “dew drop on a rose petal” is characteristic of chicken pox. After
8-12 hours, the fluid gets cloudy and the vesicle breaks, leaving a crust. The
fluid is highly contagious, but once the lesions crust over, the patient is no
longer infectious. The crust usually falls off after 7 days. Each lesion goes
through this cycle in about 7 days, and new lesions crop up daily. Rare
complications include pneumonia and encephalitis. </p>

<p></p>

<p>When clinical symptoms have
resolved, VZV remains dormant in the nervous system, particularly in the
trigeminal and dorsal root ganglia. In about 10&#8211;20% of cases, the virus
reactivates later in life causing shingles. Shingles usually presents with pain
and vesicular rash in a dermatomal distribution. Complications include
postherpetic neuralgia (severe pain in the distribution of the affected nerve).<span>&nbsp; </span>The rash described in the vignette is
typical of chickenpox, which is caused by the varicella-zoster virus.</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b></b></p>

<p><b>Answer E is correct. </b>The rash described in the vignette is typical
of chickenpox, which is caused by the varicella-zoster virus.</p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p><span></span></p>

<p>HIV-1 is sensitive to
solvents such as chloroform and 20% diethyl ether, whereas hepatitis A virus is
resistant to such solvents. This resistance is best explained by the absence of
which of the following in hepatitis A virus?</p>

<p></p>

<p><span>A.<span>&nbsp;&nbsp; </span></span>Single-stranded
RNA</p>

<p><span>B.<span>&nbsp;&nbsp;&nbsp; </span></span>Reverse
transcriptase</p>

<p><span>C.<span>&nbsp;&nbsp;&nbsp; </span></span>Spherical
structure</p>

<p><span>D.<span>&nbsp;&nbsp; </span></span>Icosahedral
symmetry</p>

<p><span>E.<span>&nbsp;&nbsp;&nbsp; </span></span>Viral
envelope</p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p></p>

<p>Many viruses have an <span>envelope</span> surrounding the protein
capsid. The envelope is usually derived from portions of the host cell membrane
(which is comprised of phospholipids and proteins), but also includes virally
derived glycoproteins. Functionally, the envelope is used by viruses to enter
the host cell. Glycoproteins on the surface of the envelope bind to receptor
sites on the host’s membrane. The viral envelope then fuses with the host’s
membrane, allowing the capsid and viral genome to enter the host.</p>

<p></p>

<p>The viral envelope, which is
composed of a lipid bilayer, is relatively sensitive to desiccation, heat, and
detergents. Consequently, enveloped viruses are easier to sterilize than
non-enveloped viruses. They have limited survival outside the host and
typically must transfer directly from host to host.</p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=131 valign=top>
  <p>Naked DNA viruses</p>
  </td>
  <td width=216 valign=top>
  <p>Enveloped DNA viruses</p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p></p>
  </td>
  <td width=216 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p>Adenovirus</p>
  <p>Human papillomavirus</p>
  <p>Jacob-Creutzfeld</p>
  <p>Parvovirus (e.g., B19)</p>
  <p></p>
  <p></p>
  </td>
  <td width=216 valign=top>
  <p>Hepatitis B virus</p>
  <p>Herpesvirus</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Epstein-Barr virus</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Cytomegalovirus</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Herpes simplex virus 1 </p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Herpes simplex virus 2</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Varicella zoster virus</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Roseola virus (HHV-6)</p>
  <p><span><span>·<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span></span>Kaposi’s sarcoma virus (HHV-8)<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></p>
  <p>Smallpox</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p></p>

<div align=center>

<table border=1 cellspacing=0 cellpadding=0>
 <tr>
  <td width=131 valign=top>
  <p>Naked RNA viruses</p>
  </td>
  <td width=216 valign=top>
  <p>Enveloped RNA viruses</p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p></p>
  </td>
  <td width=216 valign=top>
  <p></p>
  </td>
 </tr>
 <tr>
  <td width=131 valign=top>
  <p>Hepatitis A virus</p>
  <p>Poliovirus</p>
  <p>Rhinovirus</p>
  <p>Coxsackievirus</p>
  <p>Norwalk virus</p>
  <p>Rotavirus</p>
  <p></p>
  </td>
  <td width=216 valign=top>
  <p>Hepatitis C</p>
  <p>HIV</p>
  <p>Influenza</p>
  <p>Parainfluenza</p>
  <p>Measles</p>
  <p>Mumps</p>
  <p>Rubella</p>
  <p>Respiratory syncitial
  virus</p>
  <p>Rabies</p>
  </td>
 </tr>
</table>

</div>

<p></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span></span></b></p>

<p><b><span>Answer E
is correct</span></b><span>.<span>&nbsp; </span>Enveloped viruses possess an outer
coating, or envelope, which is composed of a lipid layer (fat-like substance
that is water insoluble). The envelope is relatively sensitive to detergents
and is needed to aid in attachment of the virus to the host cell. Loss of the
envelope results in loss of infectivity. Enveloped viruses are easily
inactivated by routine surface cleaning and disinfection. HIV-1 has an
envelope; hepatitis A virus does not. This explains why HIV is more sensitive
to detergents than hepatitis A.<span >&nbsp; </span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"><span></span></p>

<p style="text-align:center;"></p>

<p style="text-align:center;"></p>

</div>

</body>

</html>
